<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-5840400061415282598</id><updated>2026-10-12T12:25:04.846+00:00</updated><category term="Egypt"/><category term="Archived"/><category term="Antibiotic"/><category term="EIPICO"/><category term="Pharco"/><category term="Pain Relief"/><category term="Anti-inflammatory"/><category term="GSK"/><category term="Amoun"/><category term="Antihistamine"/><category term="Injection"/><category term="Mucolytic"/><category term="Paracetamol"/><category term="CID"/><category term="NSAID"/><category term="Antibiotics"/><category term="Chlorpheniramine"/><category term="Cough"/><category term="Digital Products"/><category term="HTML Tools"/><category term="MUP"/><category term="SEDICO"/><category term="Amoxicillin"/><category term="Bronchitis"/><category term="Decongestant"/><category term="Penicillin"/><category term="Pharmacy Students"/><category term="dermatology"/><category term="Allergy"/><category term="Anti-Acne"/><category term="Cold and Flu"/><category term="Dietary Supplement"/><category term="Heartburn"/><category term="Acetylcysteine"/><category term="Acne Treatment"/><category term="Cephalosporin"/><category term="Pseudoephedrine"/><category term="Respiratory Infection"/><category term="UTI"/><category term="Amriya"/><category term="Antipyretic"/><category term="Bacterial Infection"/><category term="Bronchodilator"/><category term="Eva Pharma"/><category term="Expectorant"/><category term="Fever"/><category term="Medical Simulators"/><category term="Memphis"/><category term="Sigma"/><category term="Vitamin C"/><category term="ADCO"/><category term="Analgesic"/><category term="Arthritis"/><category term="Corticosteroid"/><category term="Cough Syrup"/><category term="Drug Safety"/><category term="EL NILE"/><category term="Egyptian Drugs"/><category term="Eye Drops"/><category term="Hypertension"/><category term="NAC"/><category term="Peptic Ulcer"/><category term="Rameda"/><category term="Skin Infection"/><category term="Acetaminophen"/><category term="Alexandria"/><category term="Allergic Rhinitis"/><category term="Ambroxol"/><category term="Betamethasone"/><category term="Cardiovascular"/><category term="Diuretic"/><category term="Drug Interactions"/><category term="Drug Monograph"/><category term="Ear Drops"/><category term="Erythromycin"/><category term="GERD"/><category term="Global Napi"/><category term="H. pylori"/><category term="Kahira"/><category term="MISR"/><category term="MISR Pharma"/><category term="Novartis"/><category term="Nursing Students"/><category term="Omeprazole"/><category term="Pariet"/><category term="Rabeprazole"/><category term="Retinoid"/><category term="Salicylic Acid"/><category term="Topical Gel"/><category term="Trimethoprim"/><category term="VZV"/><category term="Zinc"/><category term="Abbott"/><category term="Acyclovir"/><category term="Adwia"/><category term="Al Ansar"/><category term="Alpha-Lipoic Acid"/><category term="Ampicillin"/><category term="Analgesics &amp; Antipyretics"/><category term="Analgesics &amp; NSAIDs"/><category term="Antacid"/><category term="Antioxidant"/><category term="Antispasmodic"/><category term="Antiviral"/><category term="Asthma"/><category term="Bloating"/><category term="Bone Health"/><category term="Cardiology"/><category term="Cephradine"/><category term="Co-trimoxazole"/><category term="Cold"/><category term="Cyanocobalamin"/><category term="Delta Pharma"/><category term="Dexamethasone"/><category term="Diarrhea"/><category term="Diphenhydramine"/><category term="Ear Pain"/><category term="Edema"/><category term="Flucloxacillin"/><category term="Fluoroquinolone"/><category term="Furosemide"/><category term="Guaifenesin"/><category term="HSV"/><category term="Heart Failure"/><category term="Herpes"/><category term="Historical"/><category term="IBS"/><category term="Indigestion"/><category term="Kidney Stones"/><category term="Macrolide"/><category term="Minapharm"/><category term="NDMA"/><category term="Nucleoside Analogue"/><category term="ORS"/><category term="October Pharma"/><category term="Oily Skin"/><category term="Ophthalmology"/><category term="Osteoporosis"/><category term="Otitis Externa"/><category term="PDE5 Inhibitor"/><category term="PPI"/><category term="Pharmacists"/><category term="Polymyxin B"/><category term="Pregnancy"/><category term="Proton Pump Inhibitor"/><category term="Ranitidine"/><category term="Salbutamol"/><category term="Sanofi"/><category term="Sildenafil"/><category term="Simethicone"/><category term="Skincare"/><category term="Study Tools"/><category term="Theophylline"/><category term="Tinea"/><category term="Urology"/><category term="Urticaria"/><category term="Velosef"/><category term="Vitamin B Complex"/><category term="acne vulgaris"/><category term="ACE Inhibitor"/><category term="Abdominal Pain"/><category term="Acne Cream"/><category term="Agranulocytosis"/><category term="Amriya Pharma"/><category term="Anti-gas"/><category term="Antibacterial"/><category term="Anticholinergic"/><category term="Anticonvulsant"/><category term="Antidiarrheal"/><category term="Antiemetic"/><category term="Antifungal"/><category term="Antifungals"/><category term="Antihypertensive"/><category term="Antiplatelet"/><category term="Antitussive"/><category term="Apex Pharma"/><category term="Back Pain"/><category term="Bayer"/><category term="Benzodiazepine"/><category term="Beta Blocker"/><category term="Beta-Lactamase Inhibitor"/><category term="Betamethasone Dipropionate"/><category term="Betamethasone Valerate"/><category term="Bromhexine"/><category term="COPD"/><category term="Calcium"/><category term="Calcium Carbonate"/><category term="Calcium Channel Blocker"/><category term="Cancelled Drug"/><category term="Cefotaxime"/><category term="Ciprofloxacin"/><category term="Clarithromycin"/><category term="Clavulanic Acid"/><category term="Clioquinol"/><category term="Clotrimazole"/><category term="Co-amoxiclav"/><category term="Cold &amp; Flu"/><category term="Declophen"/><category term="Dermatitis"/><category term="Dextromethorphan"/><category term="Diabetic Neuropathy"/><category term="Diclofenac"/><category term="Diclofenac Potassium"/><category term="Dicloflam"/><category term="Dietary Supplements"/><category term="Digestive Enzymes"/><category term="Dipyrone"/><category term="Dysmenorrhea"/><category term="E-MOX"/><category term="Earwax"/><category term="Eczema"/><category term="Effervescent"/><category term="El Nasr"/><category term="Ephedrine"/><category term="Erectile Dysfunction"/><category term="Famotidine"/><category term="Farcosolvin"/><category term="Flu"/><category term="Fluoroquinolones"/><category term="Folic Acid"/><category term="Foxime"/><category term="Frusemide"/><category term="GNP"/><category term="GPI"/><category term="Gastroenteritis"/><category term="Gastroenterology"/><category term="Gentamicin"/><category term="Glaucoma"/><category term="GlaxoSmithKline"/><category term="Glycolic Acid"/><category term="Gout"/><category term="Haleon"/><category term="Hay Fever"/><category term="Headache"/><category term="Hi-Care"/><category term="High Blood Pressure"/><category term="Hydrochlorothiazide"/><category term="Hyoscine Butylbromide"/><category term="IV Infusion"/><category term="Ibuprofen"/><category term="Immune Support"/><category term="Isoptin"/><category term="Jedco"/><category term="Kahira Pharmaceuticals"/><category term="Klarimix"/><category term="Liver Support"/><category term="MEPACO"/><category term="Magaldrate"/><category term="Marcyrl"/><category term="Mash Premiere"/><category term="Mebeverine"/><category term="Medical Calculators"/><category term="Medical Reference"/><category term="Medical Writers"/><category term="Memory"/><category term="Menstrual Pain"/><category term="Metamizole"/><category term="Mineral Supplement"/><category term="Muscle Relaxant"/><category term="NSAIDs"/><category term="Nausea"/><category term="Nerhadou"/><category term="Neurology"/><category term="Nootropic"/><category term="OXY-POL"/><category term="Otic"/><category term="Outdated"/><category term="Oxytetracycline"/><category term="PHAROPHARMA"/><category term="Pharaopharma"/><category term="Pharmacare"/><category term="Piperazine"/><category term="Piracetam"/><category term="Propolis"/><category term="Psoriasis"/><category term="Pyridoxine"/><category term="Respiratory"/><category term="Rheumatology"/><category term="SJS/TEN"/><category term="Sandoz"/><category term="Shingles"/><category term="Stevens-Johnson Syndrome"/><category term="Sulbactam"/><category term="Sulfamethoxazole"/><category term="Supplement"/><category term="Syrup"/><category term="Tea Tree Oil"/><category term="Terbutaline"/><category term="Thiamine"/><category term="Thiazide Diuretic"/><category term="Thioctic Acid"/><category term="Thiotex"/><category term="Thyme"/><category term="Topical Corticosteroid"/><category term="Topical Solution"/><category term="Vasodilator"/><category term="Verapamil"/><category term="Vertigo"/><category term="Viatris"/><category term="Vitamin B12"/><category term="Vitamin E"/><category term="Vomiting"/><category term="Withdrawn"/><category term="Withdrawn Drug"/><category term="Zinc Acetate"/><category term="Zinc Deficiency"/><category term="adapalene"/><category term="rheumatoid arthritis"/><category term="ACETYLOVAN"/><category term="ACHTENON"/><category term="ACICONE"/><category term="ACICONE-S"/><category term="ACIDIPAN"/><category term="ACIK Cream"/><category term="ACNE ZINC"/><category term="ACNE-JED"/><category term="ACNE-STOP"/><category term="ACNEBLESS"/><category term="ACNEFENCE"/><category term="ACNELOFIX"/><category term="ACNESCAVE"/><category term="ADWIC"/><category term="ALA"/><category term="AMRI-K"/><category term="APC"/><category term="ARAB IMPORTERS TRADING"/><category term="Abdominal Cramps"/><category term="Abraxane"/><category term="Acdima"/><category term="Acdisteron"/><category term="Aceclofenac"/><category term="Acefylline Piperazine"/><category term="Acemetacin"/><category term="Acenewrax"/><category term="Acetasee"/><category term="Acetazolamide"/><category term="Aceto-v"/><category term="Acetoflu"/><category term="Acetoflu Syrup"/><category term="Acetoflul for Women"/><category term="Acetolytic"/><category term="Acetorphan"/><category term="Acetothyme"/><category term="Acetylcistein"/><category term="Acetylcystdar"/><category term="Acetylsalicylic Acid"/><category term="Aciclovir Viatris"/><category term="Acid Relief"/><category term="Acidophilus"/><category term="Aciglotir"/><category term="Acilight"/><category term="Aciloc"/><category term="Acino"/><category term="Acitretin"/><category term="Acivirax"/><category term="Aclasta"/><category term="Acless Soap"/><category term="Acne"/><category term="Acne Benz"/><category term="Acne Biotic"/><category term="Acne-Free"/><category term="Acnefence Gel"/><category term="Acyclovir Egypt"/><category term="Acyclovir IV"/><category term="Advocure"/><category term="Aescin"/><category term="Airway Obstruction"/><category term="Al Andalous"/><category term="Al Esraa Pharma Optima"/><category term="Albuterol"/><category term="Alcon"/><category term="Aldomet"/><category term="Alexandria Pharmaceuticals"/><category term="All-Vent"/><category term="Allergic Reaction"/><category term="Allergy &amp; Antihistamines"/><category term="Allergyl"/><category term="Allopurinol"/><category term="Alpha-2 Agonist"/><category term="Alpharma"/><category term="Altitude Sickness"/><category term="Aluminium Hydroxide"/><category term="Aminoglycoside"/><category term="Aminoglycosides"/><category term="Aminopenicillin"/><category term="Amoxicid"/><category term="Analgin"/><category term="Androgen"/><category term="Angina"/><category term="Angina Pectoris"/><category term="Angiofox"/><category term="Anti-Scorpion Serum"/><category term="Anti-asthmatic"/><category term="Antianginal"/><category term="Antiarrhythmics"/><category term="Antibiotic Stewardship"/><category term="Anticoagulant Reversal"/><category term="Antidepressant"/><category term="Antiepileptic"/><category term="Antigout Preparations"/><category term="Antihypertensives"/><category term="Antimicrobial Resistance"/><category term="Antioxidants &amp; Vitamins"/><category term="Antiparasitic"/><category term="Antiparasitics"/><category term="Antiparkinson"/><category term="Antiparkinsonian"/><category term="Antiplatelets"/><category term="Antipyrine"/><category term="Antiseizure"/><category term="Antiseptic Wash"/><category term="Antiseptics"/><category term="Antispasticity"/><category term="Antivenom"/><category term="Antiviral Injection"/><category term="Anxiety"/><category term="Anxiolytic"/><category term="Arab Drug Company"/><category term="Arax"/><category term="Arrhythmia"/><category term="Ascites"/><category term="Aspirin"/><category term="Aspocid"/><category term="Asthma Syrup"/><category term="Asthmatic Bronchitis"/><category term="Athlete&#39;s Foot"/><category term="Audax"/><category term="Augmentin"/><category term="Averroes Pharma"/><category term="Azithromycin"/><category term="B1"/><category term="B12"/><category term="B6"/><category term="BACTICURE"/><category term="BCPS"/><category term="BIOPHARM"/><category term="BORG"/><category term="Bacterial Infections"/><category term="Bacticlor"/><category term="Beclo"/><category term="Beclometasone Dipropionate"/><category term="Beclomethasone"/><category term="Benfotiamine"/><category term="Benzocaine"/><category term="Benzoyl Peroxide"/><category term="Beta-2 Agonist"/><category term="Beta-lactam Antibiotic"/><category term="Beta-val"/><category term="Betaxolol"/><category term="Betolvex"/><category term="Betoptic"/><category term="Bioflavonoids"/><category term="Biotin"/><category term="Biperiden"/><category term="Bipolar Disorder"/><category term="Bisoprolol"/><category term="Bisphosphonate"/><category term="Black Box Warning"/><category term="Blepharitis"/><category term="Blood Pressure Medication"/><category term="Boehringer Ingelheim"/><category term="Brain Circulation"/><category term="Breast Cancer"/><category term="Bristaflam"/><category term="Bromazepam"/><category term="Bronchalin"/><category term="Bronchodilators"/><category term="Bronchophane"/><category term="Bronchoterol"/><category term="Brufen"/><category term="Bruises"/><category term="Bumadizone"/><category term="CETAL"/><category term="COPAD Pharma"/><category term="CYP1A2"/><category term="Caffeine"/><category term="Cal-Preg"/><category term="Calamine"/><category term="Calcimate"/><category term="Calcimate Forte"/><category term="Calcium Channel Blockers"/><category term="Calcium Supplement"/><category term="Calmepam"/><category term="Capital Pharma"/><category term="Captopril"/><category term="Carbonic Anhydrase Inhibitor"/><category term="Cardivo-Care"/><category term="Cardivocare"/><category term="Cefaclor"/><category term="Cefadroxil"/><category term="Cefotax"/><category term="Ceftriaxone"/><category term="Celgene"/><category term="Central Alpha-2 Agonist"/><category term="Central Nervous System"/><category term="Cephalosporins"/><category term="Cerebral Edema"/><category term="Cervitam"/><category term="Cetrimide"/><category term="Cevamol"/><category term="Chamomile"/><category term="Chemidica"/><category term="Chemotherapy"/><category term="Chesty Cough"/><category term="Chickenpox"/><category term="Chiesi"/><category term="Children&#39;s Diarrhea"/><category term="Chlorantine-M"/><category term="Chlorhexidine"/><category term="Cholecalciferol"/><category term="Choline Salicylate"/><category term="Cilostazol"/><category term="Cinchocaine"/><category term="Ciprocin"/><category term="Clarinase"/><category term="Clenil Compositum"/><category term="Clinical Abbreviations"/><category term="Clinical Research"/><category term="Co-fluampicil"/><category term="Codilar"/><category term="Cognitive Enhancer"/><category term="Colchicine"/><category term="Coli-urinal"/><category term="Colimex"/><category term="Colistin"/><category term="Colon Spasm"/><category term="Combination Cream"/><category term="Comedonal Acne"/><category term="Congestal"/><category term="Conjunctivitis"/><category term="Constipation"/><category term="Copad"/><category term="Coprimasept"/><category term="Coronary Artery Disease"/><category term="Corticosteroids"/><category term="Cosmeceutical"/><category term="Cough Linctus"/><category term="Cream"/><category term="Curisafe"/><category term="Cyclizine"/><category term="Cynara"/><category term="Cystitis"/><category term="Darier Disease"/><category term="Decal B12-N"/><category term="Declophen Plus"/><category term="Decongestants"/><category term="Decongestants &amp; Antihistamines"/><category term="Dehydration"/><category term="Delarex"/><category term="Delta Grand Pharma"/><category term="Deltaclav"/><category term="Dependence"/><category term="Depo-Medrol"/><category term="Depreban"/><category term="Dermatin"/><category term="Dermatin Cort"/><category term="Desloratadine"/><category term="Dexaron Plus"/><category term="Diabetes"/><category term="Diarrhea Treatment"/><category term="Diclofenac Sodium"/><category term="Dicyclomine"/><category term="Diethylamine Salicylate"/><category term="Digestive Health"/><category term="Diprofos"/><category term="Discontinued"/><category term="Diuretics"/><category term="Domperidone"/><category term="Dopamine Agonists"/><category term="Dopamine Antagonist"/><category term="Dreams El Habboba"/><category term="Drug Comparison"/><category term="Dry Cough"/><category term="ED"/><category term="EGYPHAR"/><category term="EPCI"/><category term="EREC"/><category term="EZAPRIL-CO"/><category term="Ear Care"/><category term="Ear Hygiene"/><category term="Ear Infection"/><category term="Ear Preparations"/><category term="Earwax Removal"/><category term="Effox"/><category term="Egypt Medicines"/><category term="El Obour"/><category term="El-Obour"/><category term="Emergency Medicine"/><category term="Emetrex"/><category term="Enalapril"/><category term="Encephalitis"/><category term="Enterococcus"/><category term="Enteromycin"/><category term="Envenomation"/><category term="Epidron"/><category term="Epilepsy"/><category term="Epimag"/><category term="Epirant"/><category term="Erythroprim"/><category term="Extrapyramidal Symptoms"/><category term="Eye Decongestants"/><category term="Eye Infection"/><category term="Eye Inflammation"/><category term="Eye Ointment"/><category term="Ezequel"/><category term="FDA Warning"/><category term="Facial Cleanser"/><category term="Farcocin"/><category term="Farcolin"/><category term="Farcovit B12"/><category term="Fever Reducer"/><category term="First-Generation Antibiotic"/><category term="First-generation"/><category term="Floxamo"/><category term="Flucamox"/><category term="Flumox"/><category term="Fluoxetine"/><category term="Flurest"/><category term="Folate"/><category term="Four Mix syrup"/><category term="Framycetin"/><category term="Fungal Infection"/><category term="Gasec"/><category term="Gastric Motility"/><category term="Gestational Hypertension"/><category term="Global Pharma"/><category term="Globe Pharma"/><category term="Glucocorticoid"/><category term="Glycodal-M"/><category term="Gonorrhea"/><category term="Good Bacteria"/><category term="Gramicidin"/><category term="Green Tea Extract"/><category term="Gut Flora"/><category term="Gut Health"/><category term="Gut Infection"/><category term="Gynecology &amp; Women&#39;s Health"/><category term="H2 Blocker"/><category term="HI-PHARM"/><category term="Haematology"/><category term="Haemostatics"/><category term="Heart Attack Prevention"/><category term="Hemostatic"/><category term="Hepatoprotective"/><category term="Herpes Treatment"/><category term="Hexamine"/><category term="Hi-Potency Formula"/><category term="Hikma"/><category term="Hikma Pharma"/><category term="Historical Medicine"/><category term="Hochster Pharma"/><category term="Hormones &amp; Androgens"/><category term="Hub Post"/><category term="Hydrocortisone"/><category term="Hydroxocobalamin"/><category term="Hydroxyzine"/><category term="Hypertensive Crisis"/><category term="Hypocalcemia"/><category term="Hypogonadism"/><category term="Hypopigmentation"/><category term="IDA"/><category term="IDI"/><category term="IV"/><category term="IV Antivirals"/><category term="Ibugesic"/><category term="Idiopathic guttate hypomelanosis"/><category term="Imidazole"/><category term="Immunity Booster"/><category term="Indomethacin"/><category term="Infection"/><category term="Infinity Pharma"/><category term="Inhaled Corticosteroid"/><category term="Inhaler"/><category term="Inositol"/><category term="Insomnia"/><category term="Intermittent Claudication"/><category term="Interpharma"/><category term="Intramuscular Injection"/><category term="Intravenous"/><category term="Inventory Training"/><category term="Iron"/><category term="Iron Supplements"/><category term="Irritable Bowel Syndrome"/><category term="Isoptin 80"/><category term="Isoptin SR"/><category term="Isosorbide Mononitrate"/><category term="Isotretinoin"/><category term="Itching"/><category term="Ivy"/><category term="Janssen"/><category term="Jock Itch"/><category term="Julphar"/><category term="Kahira Pharma"/><category term="Kempetro"/><category term="Keratinization"/><category term="Ketofan"/><category term="Ketoprofen"/><category term="Khellin"/><category term="Laboratoires Gilbert"/><category term="Lactobacillus"/><category term="Lamotrigine"/><category term="Lappy-Spot"/><category term="Larogen"/><category term="Lasilactone"/><category term="Laxative"/><category term="Lee-flox"/><category term="Lennox-Gastaut"/><category term="Levofloxacin"/><category term="Liometacen"/><category term="Lipotropic"/><category term="Listeria"/><category term="Liver Albumin Plus"/><category term="Locasten"/><category term="Lohydran"/><category term="Loop Diuretic"/><category term="Loratadine"/><category term="Lotensine"/><category term="Lung Cancer"/><category term="MOBITIL"/><category term="MRSA topical antibiotic"/><category term="MSD"/><category term="MSM"/><category term="Madaus"/><category term="Magnesium"/><category term="Magnesium Citrate"/><category term="Magnesium Hydroxide"/><category term="Medical Sales"/><category term="Medicated Soap"/><category term="Megaloblastic Anemia"/><category term="Melano Pharma"/><category term="Meloxicam"/><category term="Meningitis"/><category term="Mepha"/><category term="Mesterolone"/><category term="Methyldopa"/><category term="Methylprednisolone"/><category term="Mifoxin"/><category term="Migraine &amp; Headache"/><category term="Milk Thistle"/><category term="Mixderm"/><category term="Mood Stabilizer"/><category term="Motion Sickness"/><category term="Moxacil"/><category term="Mucophylline"/><category term="Mucosin"/><category term="Multi-Apex"/><category term="Multivitamin"/><category term="Multivitamins"/><category term="Mundipharma"/><category term="Mupirax"/><category term="Mupirocin"/><category term="Muscarinic Antagonist"/><category term="Myolastan"/><category term="NAPLEX"/><category term="NDGA"/><category term="NILE"/><category term="NOFLU"/><category term="Naphazoline"/><category term="Nasal Spray"/><category term="Natrol"/><category term="Nebulizer"/><category term="Neo-Pulmolar"/><category term="Neomycin"/><category term="Neozoline"/><category term="Nerve Pain"/><category term="Neural Tube Defects"/><category term="Neuropathy"/><category term="Nitrate"/><category term="Nitrates"/><category term="Nodulocystic Acne"/><category term="Nose Drops"/><category term="Novalgin"/><category term="Novell Pharma"/><category term="Novogen"/><category term="Nu-Spasm"/><category term="OM Pharma"/><category term="Oblong Pharmalgin"/><category term="Obsolete"/><category term="Octomotol"/><category term="Ocular Hypertension"/><category term="Ointment"/><category term="Omepak"/><category term="Oncology"/><category term="Ophthalmic"/><category term="Oral Rehydration Salts"/><category term="Oral Suspension"/><category term="Organix"/><category term="Orotic Acid"/><category term="Osipect"/><category term="Osteoarthritis"/><category term="Otal"/><category term="Otic Analgesic"/><category term="Otic Analgesics"/><category term="Otitis Media"/><category term="Otosept"/><category term="Oxaluria"/><category term="Oxicam"/><category term="PDE3 Inhibitor"/><category term="PMS Relief"/><category term="PTCB"/><category term="PURITANS PRIDE"/><category term="Paclitaxel"/><category term="Paediatric"/><category term="Paget&#39;s Disease"/><category term="Pain &amp; Fever"/><category term="Pain &amp; Inflammation"/><category term="Pain Management"/><category term="Pamabrom"/><category term="Panadol"/><category term="Pancreatic Cancer"/><category term="Pancreatin"/><category term="Paracetamol Antidote"/><category term="Pariet Dosage"/><category term="Pariet Pharmacology"/><category term="Pariet Side Effects"/><category term="Passive Immunity"/><category term="Patient Counseling"/><category term="Pediatric Syrup"/><category term="Pediatrics"/><category term="Penicillins"/><category term="People Pharma"/><category term="Peripheral Neuropathy"/><category term="Pernicious Anemia"/><category term="Pfizer"/><category term="Pharaonia"/><category term="Pharaonia Pharma"/><category term="Pharaonia Pharmaceuticals"/><category term="Pharco B"/><category term="Pharma Cure"/><category term="Pharma Reps"/><category term="Pharmacology"/><category term="Pharmadar"/><category term="Pharmed Healthcare"/><category term="Pharo Pharma"/><category term="Phenylephrine"/><category term="Phenylpropanolamine"/><category term="Phenytin"/><category term="Phenytoin"/><category term="Philo Pharm"/><category term="Phlegm"/><category term="Pholcodine"/><category term="Pholprine"/><category term="Phytomed"/><category term="Phytomenadione"/><category term="Phytonadione"/><category term="Pirafene"/><category term="Pletaal"/><category term="Pletal"/><category term="Pneumonia"/><category term="Polyvalent Serum"/><category term="Post-operative Pain"/><category term="Prednisolone Acetate"/><category term="Priapism"/><category term="Prickly Heat"/><category term="Probiotics"/><category term="Productive Cough"/><category term="Prokinetic"/><category term="Promethazine"/><category term="Prozac"/><category term="Psychiatric"/><category term="Psychiatry"/><category term="Psychiatry &amp; Antipsychotics"/><category term="Pulmonary Edema"/><category term="Purple Glove Syndrome"/><category term="QT Prolongation"/><category term="Racecadotril"/><category term="Ranbaxy"/><category term="Red Eye"/><category term="Regulatory Affairs"/><category term="Regulatory Status"/><category term="Reig Jofre"/><category term="Renal Colic"/><category term="Reparil-Gel N"/><category term="Respiratory Drugs"/><category term="Retinol"/><category term="Retinyl Palmitate"/><category term="Reye&#39;s Syndrome"/><category term="Ringworm"/><category term="SABA"/><category term="SAJA PHARMA"/><category term="SSRI"/><category term="STADA"/><category term="Sabaa"/><category term="Sales Training"/><category term="Schwarz Pharma"/><category term="Scorpion Sting"/><category term="Secretolytic"/><category term="Sedating Antihistamine"/><category term="Sedation"/><category term="Sedative"/><category term="Seizures"/><category term="Servier"/><category term="Severe Acne"/><category term="Severe Psoriasis"/><category term="Severe Skin Reactions"/><category term="Sigma-Tec"/><category term="Silymarin"/><category term="Simulators"/><category term="Sinus Relief"/><category term="Sirdalud"/><category term="Sirdalud MR"/><category term="Skin Cream"/><category term="Skin Protectant"/><category term="Smart Drug"/><category term="Sodium Channel Blocker"/><category term="Soficopharm"/><category term="Spasmo-Amrase"/><category term="Spasmo-Digestin"/><category term="Spasmocin"/><category term="Spasmolytic"/><category term="Spasmotalin"/><category term="Spasmotalin Forte"/><category term="Spasticity"/><category term="Spimaco Misr"/><category term="Spironolactone"/><category term="Sprains"/><category term="Status Epilepticus"/><category term="Stimulan"/><category term="Streptomycin"/><category term="Sulfozinc"/><category term="Sulphamethoxazole"/><category term="Sultamicillin"/><category term="Suppository"/><category term="Surfactants"/><category term="Sutaprim"/><category term="Swelling Relief"/><category term="TMP-SMX"/><category term="Tabuk"/><category term="Tabuk Health Care"/><category term="Tabuk Pharmaceuticals"/><category term="Tendon Rupture"/><category term="Tendonitis"/><category term="Teratogen"/><category term="Teratogenic"/><category term="Teryaq"/><category term="Testosterone"/><category term="Tetrazepam"/><category term="The Nile Co"/><category term="Thiotacid"/><category term="Third-Generation Antibiotic"/><category term="Throat Preparations"/><category term="Tizanidine"/><category term="Tolnaftate"/><category term="Topical Antibiotic"/><category term="Topical Antifungal"/><category term="Topical Corticosteroids"/><category term="Topical Cream"/><category term="Topical Retinoid"/><category term="Tretinoin"/><category term="Tri-B"/><category term="Tusskan"/><category term="UP Pharma"/><category term="Ultracillin"/><category term="Unictam"/><category term="Updated Post"/><category term="Upjohn"/><category term="Urate"/><category term="Urate-Lowering Therapy"/><category term="Uric Acid"/><category term="Urinary Antiseptic"/><category term="Urosolvine"/><category term="Utopia"/><category term="Utopia Pharmaceuticals"/><category term="Uveitis"/><category term="VACSERA"/><category term="VITA-3"/><category term="Vaginal Candidiasis"/><category term="Vaginal Hygiene"/><category term="Vaginitis"/><category term="Vegaskine"/><category term="Velosef Capsules"/><category term="Velosef Injection"/><category term="Velosef Suspension"/><category term="Vigorex"/><category term="Vincamine"/><category term="Vita-Plus Zinc"/><category term="Vitamin A"/><category term="Vitamin B-Complex"/><category term="Vitamin B9"/><category term="Vitamin D3"/><category term="Vitamin K1"/><category term="Vitamins"/><category term="Vitiligo"/><category term="WHO"/><category term="Western Pharma"/><category term="Wheezing"/><category term="Xanthine Oxidase Inhibitor"/><category term="Xithrone"/><category term="Zinc Oxide"/><category term="Zinc Sulphate"/><category term="Zinc Supplement"/><category term="Zinc Syrup"/><category term="Zinctron"/><category term="Zithromax"/><category term="Zoledronic Acid"/><category term="Zyloric"/><category term="acne care"/><category term="acne facial gel"/><category term="acne foaming cleanser"/><category term="acne skincare"/><category term="anti-acne cream"/><category term="antibacterial cream"/><category term="comedolytic"/><category term="comedones"/><category term="cough relief"/><category term="erectile dysfunction tablets"/><category term="erectile dysfunction treatment"/><category term="facial wash"/><category term="fennel oil"/><category term="folliculitis"/><category term="guava extract"/><category term="herbal syrup"/><category term="impetigo treatment"/><category term="impotence therapy"/><category term="men’s health"/><category term="musculoskeletal pain"/><category term="natural supplement"/><category term="oleanolic acid"/><category term="osmotic gel"/><category term="phosphodiesterase inhibitor"/><category term="pimples solution"/><category term="respiratory support"/><category term="sebum control"/><category term="sexual health"/><category term="sildenafil 100 mg"/><category term="skin care"/><category term="skin care routine"/><category term="skin infection ointment"/><category term="skin treatment"/><category term="soft tissue injuries"/><category term="tilia flower"/><title type='text'>DrugPamphlet: Egyptian Drug Guide &amp;amp; Commentaries</title><subtitle type='html'>DrugPamphlet is your comprehensive online guide to medications available in Egypt. We provide detailed commentaries on Egyptian drug brands, covering their indications, dosage, characteristics, side effects, and interactions. Our mission is to enrich the field of pharmaceutical information by adding useful knowledge, resources, and perspectives on medicines and pharmaceutical products.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://drugpamphlet.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default?redirect=false'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default?start-index=26&amp;max-results=25&amp;redirect=false'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>390</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-3917167780262615711</id><published>2026-10-09T17:56:27.278+00:00</published><updated>2026-10-09T18:05:20.463+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Darier Disease"/><category scheme="http://www.blogger.com/atom/ns#" term="dermatology"/><category scheme="http://www.blogger.com/atom/ns#" term="Study Tools"/><title type='text'>Darier Disease: High-Yield Interactive Clinical Study &amp; Mastery Tool</title><content type='html'>&lt;!-- ======================================================== --&gt;
&lt;!-- أداة مذاكرة مرض دارييه التفاعلية - مهيأة لمنشورات بلوجر    --&gt;
&lt;!-- ======================================================== --&gt;
&lt;div id=&quot;darier-app-root&quot; class=&quot;darier-blogger-container&quot; data-theme=&quot;light&quot; dir=&quot;ltr&quot;&gt;
&lt;style&gt;
  /* عزل تام لتنسيقات الأداة داخل بلوجر */
  #darier-app-root {
    --bg-primary: #f8fafc;
    --bg-surface: #ffffff;
    --bg-card: #ffffff;
    --text-primary: #0f172a;
    --text-secondary: #334155;
    --text-muted: #64748b;
    --border-color: #cbd5e1;
    --accent: #0284c7;
    --accent-hover: #0369a1;
    --accent-light: #e0f2fe;
    --success: #15803d;
    --success-light: #dcfce7;
    --warning: #b45309;
    --warning-light: #fef3c7;
    --danger: #b91c1c;
    --danger-light: #fee2e2;
    --purple: #6d28d9;
    --purple-light: #ede9fe;
    --highlight: #fef08a;
    --highlight-text: #854d0e;
    --arabic-bg: #f1f5f9;
    --arabic-border: #64748b;
    --shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.08), 0 2px 4px -2px rgba(0, 0, 0, 0.05);
    --shadow-lg: 0 10px 15px -3px rgba(0, 0, 0, 0.1);
    --radius: 8px;
    --font-sans: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, &quot;Helvetica Neue&quot;, Arial, sans-serif;

    display: block;
    width: 100% !important;
    max-width: 100% !important;
    margin: 20px auto !important;
    padding: 16px !important;
    background-color: var(--bg-primary) !important;
    color: var(--text-primary) !important;
    border: 1px solid var(--border-color) !important;
    border-radius: 12px !important;
    box-sizing: border-box !important;
    font-family: var(--font-sans) !important;
    line-height: 1.5 !important;
    box-shadow: var(--shadow) !important;
    overflow-x: hidden !important;
    position: relative !important;
    z-index: 1 !important;
    text-align: left !important;
  }

  /* عزل الوضع الليلي داخل الأداة فقط */
  #darier-app-root[data-theme=&quot;dark&quot;] {
    --bg-primary: #090d16;
    --bg-surface: #0f172a;
    --bg-card: #1e293b;
    --text-primary: #f8fafc;
    --text-secondary: #cbd5e1;
    --text-muted: #94a3b8;
    --border-color: #334155;
    --accent: #38bdf8;
    --accent-hover: #7dd3fc;
    --accent-light: #082f49;
    --success: #4ade80;
    --success-light: #052e16;
    --warning: #fbbf24;
    --warning-light: #451a03;
    --danger: #f87171;
    --danger-light: #450a0a;
    --purple: #c084fc;
    --purple-light: #3b0764;
    --highlight: #ca8a04;
    --highlight-text: #fef08a;
    --arabic-bg: #1e293b;
    --arabic-border: #475569;
    --shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.5);
    --shadow-lg: 0 10px 15px -3px rgba(0, 0, 0, 0.6);
  }

  /* تصفير تأثيرات قالب بلوجر التلقائية على العناصر الداخلية */
  #darier-app-root *, 
  #darier-app-root *::before, 
  #darier-app-root *::after {
    box-sizing: border-box !important;
    font-family: inherit !important;
    margin: 0;
    padding: 0;
    line-height: 1.5;
  }

  #darier-app-root p {
    margin: 0 !important;
    padding: 0 !important;
  }

  /* الهيدر العلوي للأداة */
  #darier-app-root .dd-header {
    background: var(--bg-surface) !important;
    border-bottom: 1px solid var(--border-color) !important;
    border-radius: var(--radius) !important;
    padding: 10px 14px !important;
    margin-bottom: 14px !important;
    display: flex !important;
    justify-content: space-between !important;
    align-items: center !important;
    flex-wrap: wrap !important;
    gap: 10px !important;
    box-shadow: var(--shadow) !important;
  }
  #darier-app-root .dd-brand-title {
    font-size: 1.05rem !important;
    font-weight: 800 !important;
    color: var(--accent) !important;
    display: flex !important;
    align-items: center !important;
    gap: 8px !important;
  }
  #darier-app-root .dd-header-controls {
    display: flex !important;
    align-items: center !important;
    gap: 6px !important;
  }

  /* الأزرار المشتركة */
  #darier-app-root .dd-btn {
    display: inline-flex !important;
    align-items: center !important;
    justify-content: center !important;
    gap: 5px !important;
    padding: 6px 12px !important;
    font-size: 0.8rem !important;
    font-weight: 600 !important;
    border-radius: var(--radius) !important;
    border: 1px solid var(--border-color) !important;
    background: var(--bg-surface) !important;
    color: var(--text-primary) !important;
    cursor: pointer !important;
    transition: all 0.15s ease !important;
    text-decoration: none !important;
    user-select: none !important;
  }
  #darier-app-root .dd-btn:hover { background: var(--border-color) !important; }
  #darier-app-root .dd-btn-accent { background: var(--accent) !important; color: #fff !important; border-color: var(--accent) !important; }
  #darier-app-root .dd-btn-accent:hover { background: var(--accent-hover) !important; }
  #darier-app-root .dd-btn-success { background: var(--success) !important; color: #fff !important; border-color: var(--success) !important; }
  #darier-app-root .dd-btn-danger { background: var(--danger) !important; color: #fff !important; border-color: var(--danger) !important; }
  #darier-app-root .dd-btn-sm { padding: 4px 8px !important; font-size: 0.72rem !important; }

  /* شريط التبويبات */
  #darier-app-root .dd-nav-wrapper {
    overflow-x: auto !important;
    margin-bottom: 16px !important;
    padding-bottom: 4px !important;
    -webkit-overflow-scrolling: touch;
  }
  #darier-app-root .dd-nav-tabs {
    display: flex !important;
    gap: 6px !important;
    min-width: max-content !important;
    border-bottom: 1px solid var(--border-color) !important;
    padding-bottom: 6px !important;
  }
  #darier-app-root .dd-tab-btn {
    background: none !important;
    border: none !important;
    padding: 7px 11px !important;
    font-size: 0.82rem !important;
    font-weight: 700 !important;
    color: var(--text-secondary) !important;
    border-radius: var(--radius) !important;
    cursor: pointer !important;
    display: flex !important;
    align-items: center !important;
    gap: 5px !important;
    transition: all 0.15s !important;
  }
  #darier-app-root .dd-tab-btn:hover { background: var(--border-color) !important; color: var(--text-primary) !important; }
  #darier-app-root .dd-tab-btn.active { background: var(--accent) !important; color: #ffffff !important; }
  #darier-app-root .dd-badge {
    font-size: 0.68rem !important;
    padding: 2px 5px !important;
    border-radius: 10px !important;
    background: rgba(0,0,0,0.18) !important;
  }

  /* البطاقات التعليمية الأساسية */
  #darier-app-root .dd-study-card {
    background: var(--bg-card) !important;
    border: 1px solid var(--border-color) !important;
    border-radius: var(--radius) !important;
    padding: 14px 16px !important;
    margin-bottom: 16px !important;
    box-shadow: var(--shadow) !important;
  }
  #darier-app-root .dd-card-header {
    display: flex !important;
    justify-content: space-between !important;
    align-items: center !important;
    border-bottom: 2px solid var(--border-color) !important;
    padding-bottom: 8px !important;
    margin-bottom: 10px !important;
  }
  #darier-app-root .dd-card-title {
    font-size: 1rem !important;
    font-weight: 800 !important;
    color: var(--text-primary) !important;
  }
  #darier-app-root .dd-card-subtitle {
    font-size: 0.74rem !important;
    color: var(--text-muted) !important;
  }

  /* أسطر المعلومات السريعة والتظليل */
  #darier-app-root mark {
    background: var(--highlight) !important;
    color: var(--highlight-text) !important;
    padding: 1px 4px !important;
    border-radius: 3px !important;
    font-weight: 700 !important;
  }
  #darier-app-root .dd-line-row {
    display: flex !important;
    align-items: baseline !important;
    gap: 10px !important;
    padding: 6px 0 !important;
    border-bottom: 1px dashed var(--border-color) !important;
    font-size: 0.9rem !important;
  }
  #darier-app-root .dd-line-row:last-child { border-bottom: none !important; }
  #darier-app-root .dd-line-label {
    min-width: 135px !important;
    font-weight: 800 !important;
    text-transform: uppercase !important;
    font-size: 0.72rem !important;
    letter-spacing: 0.5px !important;
    color: var(--accent) !important;
    flex-shrink: 0 !important;
  }
  #darier-app-root .dd-line-val { color: var(--text-primary) !important; flex-grow: 1 !important; }

  /* الشرح العربي المساعد */
  #darier-app-root .dd-arabic-aid {
    direction: rtl !important;
    text-align: right !important;
    margin-top: 10px !important;
    padding: 10px 14px !important;
    background: var(--arabic-bg) !important;
    border-right: 4px solid var(--arabic-border) !important;
    border-radius: 4px !important;
    font-size: 0.84rem !important;
    color: var(--text-secondary) !important;
    line-height: 1.6 !important;
  }
  #darier-app-root .dd-arabic-aid-tag {
    font-weight: 800 !important;
    color: var(--accent) !important;
    font-size: 0.75rem !important;
    margin-bottom: 4px !important;
  }

  /* صناديق التنبيه ومفاتيح التذكر */
  #darier-app-root .dd-mnemonic-box {
    background: var(--purple-light) !important;
    border: 1px solid var(--purple) !important;
    border-radius: var(--radius) !important;
    padding: 10px 12px !important;
    margin: 10px 0 !important;
  }
  #darier-app-root .dd-mnemonic-badge {
    background: var(--purple) !important;
    color: #fff !important;
    font-weight: 800 !important;
    font-size: 0.7rem !important;
    padding: 2px 6px !important;
    border-radius: 4px !important;
    display: inline-block !important;
    margin-bottom: 4px !important;
  }
  #darier-app-root .dd-diff-card {
    border-left: 4px solid var(--warning) !important;
    background: var(--warning-light) !important;
    padding: 10px 14px !important;
    border-radius: 4px !important;
    margin: 10px 0 !important;
  }
  #darier-app-root .dd-diff-title {
    font-weight: 800 !important;
    font-size: 0.8rem !important;
    color: var(--warning) !important;
    text-transform: uppercase !important;
    margin-bottom: 4px !important;
  }
  #darier-app-root .dd-visual-box {
    background: var(--bg-surface) !important;
    border: 1px solid var(--border-color) !important;
    border-radius: var(--radius) !important;
    padding: 10px !important;
    margin: 10px 0 !important;
    text-align: center !important;
  }
  #darier-app-root .dd-visual-title {
    font-size: 0.76rem !important;
    font-weight: 800 !important;
    color: var(--text-muted) !important;
    text-transform: uppercase !important;
    margin-bottom: 6px !important;
  }

  /* الجداول المدمجة داخل بلوجر */
  #darier-app-root .dd-table {
    width: 100% !important;
    border-collapse: collapse !important;
    font-size: 0.84rem !important;
    margin: 10px 0 !important;
  }
  #darier-app-root .dd-table th, 
  #darier-app-root .dd-table td {
    padding: 7px 10px !important;
    border: 1px solid var(--border-color) !important;
    text-align: left !important;
  }
  #darier-app-root .dd-table th {
    background: var(--bg-surface) !important;
    font-weight: 800 !important;
    color: var(--accent) !important;
    font-size: 0.73rem !important;
    text-transform: uppercase !important;
  }

  /* الوضع 2: ملء الفراغات */
  #darier-app-root .dd-fillin-choice {
    display: inline-flex !important;
    align-items: center !important;
    margin: 2px 4px !important;
    border: 1px solid var(--border-color) !important;
    border-radius: 4px !important;
    background: var(--bg-surface) !important;
    padding: 1px 4px !important;
  }
  #darier-app-root .dd-fillin-select {
    border: none !important;
    background: transparent !important;
    color: var(--text-primary) !important;
    font-weight: 700 !important;
    font-size: 0.86rem !important;
    outline: none !important;
    cursor: pointer !important;
  }
  #darier-app-root .dd-fillin-sentence {
    padding: 10px 12px !important;
    background: var(--bg-surface) !important;
    border: 1px solid var(--border-color) !important;
    border-radius: var(--radius) !important;
    margin-bottom: 10px !important;
    font-size: 0.9rem !important;
    line-height: 1.8 !important;
  }

  /* الوضع 3: البطاقات التكرارية */
  #darier-app-root .dd-flashcard-wrapper {
    max-width: 580px !important;
    margin: 12px auto !important;
  }
  #darier-app-root .dd-flashcard {
    min-height: 250px !important;
    background: var(--bg-card) !important;
    border: 2px solid var(--border-color) !important;
    border-radius: 12px !important;
    box-shadow: var(--shadow-lg) !important;
    cursor: pointer !important;
    padding: 18px !important;
    display: flex !important;
    flex-direction: column !important;
    justify-content: space-between !important;
    transition: transform 0.15s, border-color 0.15s !important;
  }
  #darier-app-root .dd-flashcard:hover { border-color: var(--accent) !important; }
  #darier-app-root .dd-flashcard.flipped { background: var(--bg-surface) !important; border-color: var(--purple) !important; }
  #darier-app-root .dd-fc-tag {
    font-size: 0.7rem !important;
    font-weight: 800 !important;
    text-transform: uppercase !important;
    color: var(--accent) !important;
  }
  #darier-app-root .dd-fc-body {
    flex-grow: 1 !important;
    display: flex !important;
    flex-direction: column !important;
    justify-content: center !important;
    text-align: center !important;
    font-size: 1.05rem !important;
    font-weight: 700 !important;
    padding: 10px 0 !important;
  }
  #darier-app-root .dd-fc-answer { text-align: left !important; font-size: 0.9rem !important; font-weight: normal !important; display: none; }
  #darier-app-root .dd-flashcard.flipped .dd-fc-question { display: none !important; }
  #darier-app-root .dd-flashcard.flipped .dd-fc-answer { display: block !important; }
  #darier-app-root .dd-fc-footer {
    display: flex !important;
    justify-content: space-between !important;
    align-items: center !important;
    font-size: 0.74rem !important;
    color: var(--text-muted) !important;
    border-top: 1px solid var(--border-color) !important;
    padding-top: 8px !important;
  }

  /* الوضع 4: أسئلة الاختيار من متعدد */
  #darier-app-root .dd-quiz-option-btn {
    text-align: left !important;
    padding: 9px 12px !important;
    border: 1px solid var(--border-color) !important;
    background: var(--bg-surface) !important;
    border-radius: var(--radius) !important;
    color: var(--text-primary) !important;
    font-size: 0.86rem !important;
    font-weight: 600 !important;
    cursor: pointer !important;
    transition: all 0.15s !important;
    display: flex !important;
    align-items: center !important;
    gap: 8px !important;
    width: 100% !important;
    margin-bottom: 8px !important;
  }
  #darier-app-root .dd-quiz-option-btn:hover { border-color: var(--accent) !important; background: var(--accent-light) !important; }
  #darier-app-root .dd-quiz-option-btn.selected-correct {
    background: var(--success-light) !important;
    border-color: var(--success) !important;
    color: var(--success) !important;
  }
  #darier-app-root .dd-quiz-option-btn.selected-wrong {
    background: var(--danger-light) !important;
    border-color: var(--danger) !important;
    color: var(--danger) !important;
  }
  #darier-app-root .dd-quiz-explanation {
    background: var(--bg-surface) !important;
    border-left: 4px solid var(--accent) !important;
    padding: 10px 12px !important;
    border-radius: 4px !important;
    font-size: 0.86rem !important;
    display: none;
    margin-bottom: 12px !important;
  }

  /* الوضع 5: شبكة الأرقام */
  #darier-app-root .dd-drill-grid {
    display: grid !important;
    grid-template-columns: repeat(auto-fit, minmax(220px, 1fr)) !important;
    gap: 10px !important;
  }
  #darier-app-root .dd-drill-card {
    background: var(--bg-surface) !important;
    border: 1px solid var(--border-color) !important;
    border-radius: var(--radius) !important;
    padding: 12px !important;
    text-align: center !important;
  }
  #darier-app-root .dd-num-badge {
    font-size: 1.5rem !important;
    font-weight: 900 !important;
    color: var(--accent) !important;
    margin: 4px 0 !important;
  }

  /* الوضع 6: سلة التصنيف */
  #darier-app-root .dd-sorter-pool {
    display: flex !important;
    flex-wrap: wrap !important;
    gap: 6px !important;
    padding: 10px !important;
    background: var(--bg-surface) !important;
    border: 2px dashed var(--border-color) !important;
    border-radius: var(--radius) !important;
    min-height: 65px !important;
    align-items: center !important;
    margin-bottom: 12px !important;
  }
  #darier-app-root .dd-chip {
    padding: 5px 9px !important;
    background: var(--bg-card) !important;
    border: 1px solid var(--border-color) !important;
    border-radius: 14px !important;
    font-size: 0.78rem !important;
    font-weight: 700 !important;
    cursor: pointer !important;
    user-select: none !important;
    box-shadow: var(--shadow) !important;
  }
  #darier-app-root .dd-buckets-grid {
    display: grid !important;
    grid-template-columns: repeat(auto-fit, minmax(210px, 1fr)) !important;
    gap: 10px !important;
  }
  #darier-app-root .dd-bucket {
    background: var(--bg-surface) !important;
    border: 2px solid var(--border-color) !important;
    border-radius: var(--radius) !important;
    padding: 10px !important;
    min-height: 160px !important;
    display: flex !important;
    flex-direction: column !important;
    gap: 5px !important;
  }
  #darier-app-root .dd-bucket-title {
    font-size: 0.78rem !important;
    font-weight: 800 !important;
    text-transform: uppercase !important;
    text-align: center !important;
    padding-bottom: 5px !important;
    border-bottom: 1px solid var(--border-color) !important;
    color: var(--accent) !important;
  }

  /* نافذة الاختصارات المنبثقة */
  #darier-app-root .dd-modal-overlay {
    position: fixed !important;
    top: 0 !important; left: 0 !important; right: 0 !important; bottom: 0 !important;
    background: rgba(0,0,0,0.6) !important;
    display: none;
    align-items: center !important;
    justify-content: center !important;
    z-index: 999999 !important;
  }
  #darier-app-root .dd-modal-overlay.active { display: flex !important; }
  #darier-app-root .dd-modal-content {
    background: var(--bg-card) !important;
    border-radius: var(--radius) !important;
    padding: 18px !important;
    max-width: 420px !important;
    width: 90% !important;
    box-shadow: var(--shadow-lg) !important;
    border: 1px solid var(--border-color) !important;
  }
  #darier-app-root kbd {
    background: var(--border-color) !important;
    padding: 2px 4px !important;
    border-radius: 4px !important;
    font-size: 0.72rem !important;
    font-family: monospace !important;
    font-weight: bold !important;
  }

  /* استجابة الشاشات الصغيرة في بلوجر */
  @media (max-width: 600px) {
    #darier-app-root .dd-line-row { flex-direction: column !important; gap: 2px !important; }
    #darier-app-root .dd-line-label { min-width: auto !important; }
    #darier-app-root .dd-header { flex-direction: column !important; align-items: flex-start !important; }
    #darier-app-root .dd-header-controls { width: 100% !important; justify-content: space-between !important; }
  }
&lt;/style&gt;

  &lt;!-- الهيدر العلوي --&gt;
  &lt;div class=&quot;dd-header&quot;&gt;
    &lt;div class=&quot;dd-brand-title&quot;&gt;
      &lt;svg width=&quot;18&quot; height=&quot;18&quot; viewBox=&quot;0 0 24 24&quot; fill=&quot;none&quot; stroke=&quot;currentColor&quot; stroke-width=&quot;2.5&quot;&gt;&lt;path d=&quot;M12 2v20M2 12h20M4.93 4.93l14.14 14.14M19.07 4.93L4.93 19.07&quot;/&gt;&lt;/svg&gt;
      Darier Disease Study App
    &lt;/div&gt;
    &lt;div class=&quot;dd-header-controls&quot;&gt;
      &lt;button class=&quot;dd-btn dd-btn-sm&quot; id=&quot;dd-btn-theme&quot; title=&quot;Toggle Theme (D)&quot;&gt;🌓 Theme&lt;/button&gt;
      &lt;button class=&quot;dd-btn dd-btn-sm&quot; id=&quot;dd-btn-shortcuts&quot; title=&quot;Shortcuts (?)&quot;&gt;⌨️ Keys&lt;/button&gt;
      &lt;button class=&quot;dd-btn dd-btn-sm dd-btn-danger&quot; id=&quot;dd-btn-reset&quot; title=&quot;Reset Progress&quot;&gt;↺ Reset&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- شريط التبويبات --&gt;
  &lt;div class=&quot;dd-nav-wrapper&quot;&gt;
    &lt;div class=&quot;dd-nav-tabs&quot; id=&quot;dd-nav-tabs&quot;&gt;
      &lt;button class=&quot;dd-tab-btn active&quot; data-mode=&quot;study&quot;&gt;📖 1. Core Guide&lt;/button&gt;
      &lt;button class=&quot;dd-tab-btn&quot; data-mode=&quot;fillin&quot;&gt;🔤 2. Fill-in Drill&lt;/button&gt;
      &lt;button class=&quot;dd-tab-btn&quot; data-mode=&quot;flashcards&quot;&gt;🗂️ 3. Flashcards &lt;span class=&quot;dd-badge&quot; id=&quot;dd-fc-badge&quot;&gt;0/14&lt;/span&gt;&lt;/button&gt;
      &lt;button class=&quot;dd-tab-btn&quot; data-mode=&quot;quiz&quot;&gt;❓ 4. MCQ Exam &lt;span class=&quot;dd-badge&quot; id=&quot;dd-quiz-badge&quot;&gt;0/8&lt;/span&gt;&lt;/button&gt;
      &lt;button class=&quot;dd-tab-btn&quot; data-mode=&quot;numbers&quot;&gt;🎯 5. Metrics &amp; Numbers&lt;/button&gt;
      &lt;button class=&quot;dd-tab-btn&quot; data-mode=&quot;sorter&quot;&gt;🗃️ 6. Bucket Sorter&lt;/button&gt;
      &lt;button class=&quot;dd-tab-btn&quot; data-mode=&quot;cram&quot;&gt;⚡ 7. Cram Sheet&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 1: الدليل السريري المبوّب (CORE GUIDE) --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-study&quot; class=&quot;dd-mode-section&quot;&gt;

    &lt;!-- الرسم التوضيحي للفيزيولوجيا المرضية --&gt;
    &lt;div class=&quot;dd-visual-box&quot;&gt;
      &lt;div class=&quot;dd-visual-title&quot;&gt;Molecular Mechanism: SERCA2 Pump Defect &amp; Cellular Disruption&lt;/div&gt;
      &lt;svg viewBox=&quot;0 0 800 100&quot; width=&quot;100%&quot; height=&quot;auto&quot; style=&quot;max-width:760px; font-family:sans-serif;&quot;&gt;
        &lt;rect x=&quot;10&quot; y=&quot;15&quot; width=&quot;170&quot; height=&quot;70&quot; rx=&quot;6&quot; fill=&quot;#eff6ff&quot; stroke=&quot;#3b82f6&quot; stroke-width=&quot;2&quot;/&gt;
        &lt;text x=&quot;95&quot; y=&quot;38&quot; font-size=&quot;11&quot; font-weight=&quot;bold&quot; fill=&quot;#1e3a8a&quot; text-anchor=&quot;middle&quot;&gt;ATP2A2 GENE VARIANT&lt;/text&gt;
        &lt;text x=&quot;95&quot; y=&quot;55&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;Autosomal Dominant&lt;/text&gt;
        &lt;text x=&quot;95&quot; y=&quot;70&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;50% transmission risk&lt;/text&gt;

        &lt;path d=&quot;M 185 50 L 210 50&quot; stroke=&quot;#94a3b8&quot; stroke-width=&quot;2&quot;/&gt;

        &lt;rect x=&quot;215&quot; y=&quot;15&quot; width=&quot;180&quot; height=&quot;70&quot; rx=&quot;6&quot; fill=&quot;#fef2f2&quot; stroke=&quot;#ef4444&quot; stroke-width=&quot;2&quot;/&gt;
        &lt;text x=&quot;305&quot; y=&quot;38&quot; font-size=&quot;11&quot; font-weight=&quot;bold&quot; fill=&quot;#991b1b&quot; text-anchor=&quot;middle&quot;&gt;SERCA2 PUMP DEFECT&lt;/text&gt;
        &lt;text x=&quot;305&quot; y=&quot;55&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;Sarco/ER Ca2+ ATPase&lt;/text&gt;
        &lt;text x=&quot;305&quot; y=&quot;70&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;Disrupted Ca2+ regulation&lt;/text&gt;

        &lt;path d=&quot;M 400 50 L 425 50&quot; stroke=&quot;#94a3b8&quot; stroke-width=&quot;2&quot;/&gt;

        &lt;rect x=&quot;430&quot; y=&quot;15&quot; width=&quot;175&quot; height=&quot;70&quot; rx=&quot;6&quot; fill=&quot;#fefce8&quot; stroke=&quot;#eab308&quot; stroke-width=&quot;2&quot;/&gt;
        &lt;text x=&quot;517&quot; y=&quot;38&quot; font-size=&quot;11&quot; font-weight=&quot;bold&quot; fill=&quot;#713f12&quot; text-anchor=&quot;middle&quot;&gt;EPIDERMAL CLEAVAGE&lt;/text&gt;
        &lt;text x=&quot;517&quot; y=&quot;55&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;Loss of cell adhesion&lt;/text&gt;
        &lt;text x=&quot;517&quot; y=&quot;70&quot; font-size=&quot;9&quot; font-weight=&quot;bold&quot; fill=&quot;#713f12&quot; text-anchor=&quot;middle&quot;&gt;Suprabasal Acantholysis&lt;/text&gt;

        &lt;path d=&quot;M 610 50 L 635 50&quot; stroke=&quot;#94a3b8&quot; stroke-width=&quot;2&quot;/&gt;

        &lt;rect x=&quot;640&quot; y=&quot;15&quot; width=&quot;150&quot; height=&quot;70&quot; rx=&quot;6&quot; fill=&quot;#ede9fe&quot; stroke=&quot;#8b5cf6&quot; stroke-width=&quot;2&quot;/&gt;
        &lt;text x=&quot;715&quot; y=&quot;38&quot; font-size=&quot;11&quot; font-weight=&quot;bold&quot; fill=&quot;#581c87&quot; text-anchor=&quot;middle&quot;&gt;DYSKERATOSIS&lt;/text&gt;
        &lt;text x=&quot;715&quot; y=&quot;55&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;Corps ronds (spinous)&lt;/text&gt;
        &lt;text x=&quot;715&quot; y=&quot;70&quot; font-size=&quot;9&quot; fill=&quot;#334155&quot; text-anchor=&quot;middle&quot;&gt;Grains (corneum)&lt;/text&gt;
      &lt;/svg&gt;
    &lt;/div&gt;

    &lt;!-- السؤال 1 --&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Q1: What is Darier disease, its synonyms, and its underlying defect?&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Eponyms, gene mutation, and inheritance pattern&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Synonyms&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Darier–White disease&lt;/mark&gt; &amp;bull; &lt;mark&gt;Dyskeratosis follicularis&lt;/mark&gt;.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Core Mutation&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Pathogenic variants in &lt;mark&gt;ATP2A2&lt;/mark&gt; encoding the &lt;mark&gt;SERCA2 pump&lt;/mark&gt;.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Pathophysiology&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Disrupted calcium transport impairs intracellular Ca2+ regulation, &lt;mark&gt;cell-cell adhesion&lt;/mark&gt;, and differentiation.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Inheritance&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Autosomal dominant&lt;/mark&gt;; variable expression; &lt;mark&gt;50% transmission risk&lt;/mark&gt; per pregnancy.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Mosaic Variant&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Segmental lesions follow &lt;mark&gt;Blaschko&#39;s lines&lt;/mark&gt; via postzygotic mosaicism (often no family history).&lt;/span&gt;&lt;/div&gt;

      &lt;div class=&quot;dd-arabic-aid&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):&lt;/div&gt;
        مرض دارييه (دارييه-وايت) ناتج عن طفرة سائدة في جين (ATP2A2) الذي يشفر مضخة الكالسيوم (SERCA2). تعطل نقل الكالسيوم يؤدي لخلل التصاق خلايا البشرة ببعضها وتفككها وظهور تقرن شاذ، وينتقل بنسبة 50% للأبناء.
      &lt;/div&gt;
    &lt;/div&gt;

    &lt;!-- السؤال 2 --&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Q2: What are the pathognomonic clinical hallmarks (Nails, Skin, Mucosa)?&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Diagnostic features in seborrheic and acral zones&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;!-- رسم تشريحي للأظافر --&gt;
      &lt;div class=&quot;dd-visual-box&quot;&gt;
        &lt;div class=&quot;dd-visual-title&quot;&gt;Nail Pathognomonic Architecture&lt;/div&gt;
        &lt;svg viewBox=&quot;0 0 650 90&quot; width=&quot;100%&quot; height=&quot;auto&quot; style=&quot;max-width:580px; font-family:sans-serif;&quot;&gt;
          &lt;path d=&quot;M 50 15 C 50 15 150 10 250 15 C 260 35 260 55 250 75 C 150 80 50 75 50 75 C 40 55 40 35 50 15 Z&quot; fill=&quot;#f8fafc&quot; stroke=&quot;#64748b&quot; stroke-width=&quot;2&quot;/&gt;
          &lt;path d=&quot;M 245 35 L 230 45 L 245 55&quot; fill=&quot;none&quot; stroke=&quot;#dc2626&quot; stroke-width=&quot;3&quot;/&gt;
          &lt;text x=&quot;290&quot; y=&quot;48&quot; font-size=&quot;10&quot; font-weight=&quot;bold&quot; fill=&quot;#dc2626&quot;&gt;V-shaped Distal Notch&lt;/text&gt;
          &lt;line x1=&quot;60&quot; y1=&quot;28&quot; x2=&quot;245&quot; y2=&quot;28&quot; stroke=&quot;#dc2626&quot; stroke-width=&quot;2.5&quot;/&gt;
          &lt;line x1=&quot;60&quot; y1=&quot;38&quot; x2=&quot;230&quot; y2=&quot;38&quot; stroke=&quot;#94a3b8&quot; stroke-width=&quot;2.5&quot; stroke-dasharray=&quot;3,3&quot;/&gt;
          &lt;line x1=&quot;60&quot; y1=&quot;48&quot; x2=&quot;230&quot; y2=&quot;48&quot; stroke=&quot;#dc2626&quot; stroke-width=&quot;2.5&quot;/&gt;
          &lt;line x1=&quot;60&quot; y1=&quot;58&quot; x2=&quot;245&quot; y2=&quot;58&quot; stroke=&quot;#94a3b8&quot; stroke-width=&quot;2.5&quot; stroke-dasharray=&quot;3,3&quot;/&gt;
          &lt;text x=&quot;440&quot; y=&quot;32&quot; font-size=&quot;10&quot; fill=&quot;#334155&quot;&gt;&amp;bull; Red/White streaks (Erythronychia/Leukonychia)&lt;/text&gt;
          &lt;text x=&quot;440&quot; y=&quot;52&quot; font-size=&quot;10&quot; fill=&quot;#334155&quot;&gt;&amp;bull; Subungual hyperkeratosis &amp; longitudinal splits&lt;/text&gt;
        &lt;/svg&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Skin Papules&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Firm, greasy, hyperkeratotic papules&lt;/mark&gt;; skin-colored to yellowish/reddish-brown; rough/crusted.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Distribution&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Seborrheic &amp; flexural areas&lt;/mark&gt;: scalp, forehead, temples, ears, neck, central chest, back, axillae, groin.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Nail Hallmarks&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Longitudinal red &amp; white streaks&lt;/mark&gt; with &lt;mark&gt;V-shaped distal notching&lt;/mark&gt; and subungual hyperkeratosis.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Palms &amp; Soles&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Multiple small palmar pits&lt;/mark&gt;, punctate keratoses, flat wart-like papules on dorsal hands.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Oral Mucosa&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Small whitish papules producing a &lt;mark&gt;cobblestone appearance&lt;/mark&gt; (hard palate, buccal mucosa).&lt;/span&gt;&lt;/div&gt;

      &lt;div class=&quot;dd-arabic-aid&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):&lt;/div&gt;
        حطاطات دهنية متقرنة في المناطق الصدرية والوجه وثنايا الجسم برائحة كريهة. الدليل التشخيصي الأوضح في الفحص هو الأظافر: خطوط حمراء وبيضاء طولية وثلم على شكل حرف V عند الحافة الحرة، مع وجود حفر نقطية في باطن اليد ومظهر الحصى في الفم.
      &lt;/div&gt;
    &lt;/div&gt;

    &lt;!-- السؤال 3 --&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Q3: What are the pathognomonic findings on skin biopsy?&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Suprabasal acantholysis, dyskeratosis, corps ronds, and grains&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Microscopic Pattern&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Suprabasal acantholytic dyskeratosis&lt;/mark&gt;.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Corps Ronds&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Enlarged, rounded&lt;/mark&gt; dyskeratotic cells with eosinophilic cytoplasm in the &lt;mark&gt;spinous/granular layers&lt;/mark&gt;.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Grains&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Small, flattened&lt;/mark&gt; dyskeratotic cells with dense nuclei in the &lt;mark&gt;upper epidermis/stratum corneum&lt;/mark&gt;.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Lacunae &amp; Villi&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Suprabasal clefts immediately above basal cells; dermal &lt;mark&gt;villi&lt;/mark&gt; project into spaces.&lt;/span&gt;&lt;/div&gt;

      &lt;div class=&quot;dd-mnemonic-box&quot;&gt;
        &lt;span class=&quot;dd-mnemonic-badge&quot;&gt;MNEMONIC: HISTOLOGY LAYERS&lt;/span&gt;
        &lt;div style=&quot;font-size:0.84rem; color:var(--text-secondary);&quot;&gt;
          &amp;bull; &lt;b&gt;C&lt;/b&gt;orps &lt;b&gt;R&lt;/b&gt;onds = &lt;b&gt;C&lt;/b&gt;entral (Spinous/Granular), &lt;b&gt;R&lt;/b&gt;ound with halo.&lt;br&gt;
          &amp;bull; &lt;b&gt;G&lt;/b&gt;rains = &lt;b&gt;G&lt;/b&gt;round on top (Stratum corneum), Flat and small.
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-arabic-aid&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):&lt;/div&gt;
        الخزعة تظهر تفككًا وانحلالًا شوكيًا فوق الطبقة القاعدية (Acantholysis) وخلايا متقرنة شاذة: الأجسام المستديرة (Corps ronds) في الطبقة الشائكة، والحبيبات الصغيرة (Grains) في الطبقة القرنية السطحية.
      &lt;/div&gt;
    &lt;/div&gt;

    &lt;!-- السؤال 4 --&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Q4: How to differentiate Darier disease from clinical mimics?&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Hailey–Hailey vs Grover vs Darier&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;table class=&quot;dd-table&quot;&gt;
        &lt;thead&gt;
          &lt;tr&gt;
            &lt;th&gt;Condition&lt;/th&gt;
            &lt;th&gt;Clinical Distinction&lt;/th&gt;
            &lt;th&gt;Histopathological Key&lt;/th&gt;
          &lt;/tr&gt;
        &lt;/thead&gt;
        &lt;tbody&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Darier Disease&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;Seborrheic greasy papules; &lt;mark&gt;V-notched nails&lt;/mark&gt;; palmar pits&lt;/td&gt;
            &lt;td&gt;&lt;mark&gt;Suprabasal acantholytic dyskeratosis&lt;/mark&gt; with corps ronds &amp; grains&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Hailey–Hailey&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;Painful flexural erosions/maceration; &lt;mark&gt;no nail streaks&lt;/mark&gt;&lt;/td&gt;
            &lt;td&gt;Widespread acantholysis: &lt;mark&gt;&#39;dilapidated brick-wall&#39;&lt;/mark&gt; appearance&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Grover Disease&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;Pruritic trunk papules in older adults; acquired &amp; transient&lt;/td&gt;
            &lt;td&gt;Focal acantholysis; lacks inherited nail signs and family history&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Acrokeratosis (Hopf)&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;Flat wart-like papules on &lt;mark&gt;dorsal hands and feet&lt;/mark&gt;&lt;/td&gt;
            &lt;td&gt;Allelic ATP2A2 phenotype; lacks widespread seborrheic plaques&lt;/td&gt;
          &lt;/tr&gt;
        &lt;/tbody&gt;
      &lt;/table&gt;

      &lt;div class=&quot;dd-arabic-aid&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):&lt;/div&gt;
        أهم فارق: مرض هيلي-هيلي يصيب الثنايا لكنه يظهر بالمجهر كـ &quot;جدار طوب متهدم&quot; (dilapidated brick-wall) ولا تصحبه تغيرات أظافر دارييه. أما مرض غروفر فهو عارض ومكتسب لدى كبار السن.
      &lt;/div&gt;
    &lt;/div&gt;

    &lt;!-- السؤال 5 --&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Q5: What are the systemic retinoid rules and safety washouts?&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Acitretin vs Isotretinoin: Washout times, alcohol restrictions, and study data&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Acitretin Washout&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Avoid pregnancy &amp; blood donation for &lt;mark&gt;at least 3 years&lt;/mark&gt; post-stopping (US labeling).&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Acitretin &amp; Alcohol&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Strictly avoid alcohol during therapy and for &lt;mark&gt;2 months&lt;/mark&gt; afterward (prevents conversion to etretinate).&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Isotretinoin Washout&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Avoid pregnancy &amp; blood donation for &lt;mark&gt;at least 1 month&lt;/mark&gt; post-stopping; avoid tetracyclines.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Isotretinoin Data&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;In 104 patients: &lt;mark&gt;~70% improved at 1–4 wks&lt;/mark&gt;; &lt;mark&gt;98 of 104 improved at 16 wks&lt;/mark&gt;; 11 discontinued due to toxicity.&lt;/span&gt;&lt;/div&gt;

      &lt;!-- اختلاف دراسة الكالسيبوتريول --&gt;
      &lt;div class=&quot;dd-diff-card&quot;&gt;
        &lt;div class=&quot;dd-diff-title&quot;&gt;⚠️ Source Nuance / Study Flaw: Topical Calcipotriol Aggravation&lt;/div&gt;
        &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Clinical Warning&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Topical calcipotriol can &lt;mark&gt;aggravate Darier disease&lt;/mark&gt; and trigger severe irritation.&lt;/span&gt;&lt;/div&gt;
        &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;1995 Study Discrepancy&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;8 patients were withdrawn due to irritation/worsening: abstract reported this as &lt;b&gt;8 of 12 patients&lt;/b&gt;, but the enrolled population description listed &lt;b&gt;11 patients&lt;/b&gt;.&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-arabic-aid&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):&lt;/div&gt;
        الأسيتريتين يتطلب منع الحمل والتبرع بالدم لمدة 3 سنوات بعد إيقافه ومنع الكحول لمدة شهرين. الآيزوتريتينوين يتطلب شهرًا واحدًا فقط ويمنع جمعه مع التتراسيكلين. احذر: دهان الكالسيبوتريول قد يزيد المرض سوءًا.
      &lt;/div&gt;
    &lt;/div&gt;

    &lt;!-- السؤال 6 --&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Q6: What complications, infections, and oncologic risks occur?&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Eczema herpeticum emergency and keratinocyte carcinoma&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Viral Emergency&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Eczema herpeticum (Kaposi varicelliform)&lt;/mark&gt;: HSV causes punched-out erosions &amp; fevers.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Antiviral Action&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Requires &lt;mark&gt;urgent systemic acyclovir&lt;/mark&gt;; do not delay treatment awaiting lab confirmation.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Bacterial / Fungal&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;&lt;mark&gt;Staphylococcus aureus&lt;/mark&gt; (honey crusts/malodor); &lt;mark&gt;Candida&lt;/mark&gt; in macerated flexural folds.&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;Malignancy Risk&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;2024 Swedish nationwide study revealed an &lt;mark&gt;increased risk of keratinocyte carcinoma&lt;/mark&gt;.&lt;/span&gt;&lt;/div&gt;

      &lt;div class=&quot;dd-arabic-aid&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 إضافة مساعدة (شرح عربي مبسّط - ليس جزءًا من المصدر الأساسي):&lt;/div&gt;
        عدوى فيروس الهربس البسيط تسبب طفح إكزيما هربسية وهي حالة طارئة تعالج بالأسيكلوفير فورًا دون انتظار التحاليل. أظهرت دراسة سويدية عام 2024 زيادة خطر الإصابة بسرطان الخلايا الكيراتينية في الجلد.
      &lt;/div&gt;
    &lt;/div&gt;

  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 2: ملء الفراغات (FILL-IN DRILL)      --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-fillin&quot; class=&quot;dd-mode-section&quot; style=&quot;display:none;&quot;&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Concept Verification Fill-in Drill&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Select the accurate scientific option from each bracketed dropdown&lt;/div&gt;
        &lt;/div&gt;
        &lt;button class=&quot;dd-btn dd-btn-accent dd-btn-sm&quot; id=&quot;dd-btn-check-fillin&quot;&gt;Verify Answers&lt;/button&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-fillin-sentence&quot;&gt;
        1. Darier disease is caused by pathogenic variants in 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;ATP2A2&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Gene]&lt;/option&gt;
            &lt;option value=&quot;ATP2A2&quot;&gt;ATP2A2&lt;/option&gt;
            &lt;option value=&quot;ATP2C1&quot;&gt;ATP2C1&lt;/option&gt;
            &lt;option value=&quot;CARD14&quot;&gt;CARD14&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;
        which encodes the 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;SERCA2 pump&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Pump]&lt;/option&gt;
            &lt;option value=&quot;SERCA2 pump&quot;&gt;SERCA2 pump&lt;/option&gt;
            &lt;option value=&quot;SPCA1 pump&quot;&gt;SPCA1 pump&lt;/option&gt;
            &lt;option value=&quot;Na/K pump&quot;&gt;Na/K pump&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;.
      &lt;/div&gt;

      &lt;div class=&quot;dd-fillin-sentence&quot;&gt;
        2. A pathognomonic nail finding is longitudinal erythronychia or leukonychia combined with 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;V-shaped distal notching&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Nail Sign]&lt;/option&gt;
            &lt;option value=&quot;V-shaped distal notching&quot;&gt;V-shaped distal notching&lt;/option&gt;
            &lt;option value=&quot;pincer nail deformity&quot;&gt;pincer nail deformity&lt;/option&gt;
            &lt;option value=&quot;oil drop discoloration&quot;&gt;oil drop discoloration&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;.
      &lt;/div&gt;

      &lt;div class=&quot;dd-fillin-sentence&quot;&gt;
        3. Under the microscope, enlarged rounded dyskeratotic cells in spinous/granular layers are termed 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;corps ronds&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Cell]&lt;/option&gt;
            &lt;option value=&quot;corps ronds&quot;&gt;corps ronds&lt;/option&gt;
            &lt;option value=&quot;grains&quot;&gt;grains&lt;/option&gt;
            &lt;option value=&quot;Civatte bodies&quot;&gt;Civatte bodies&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;, while small flattened cells in the stratum corneum are called 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;grains&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Cell]&lt;/option&gt;
            &lt;option value=&quot;grains&quot;&gt;grains&lt;/option&gt;
            &lt;option value=&quot;corps ronds&quot;&gt;corps ronds&lt;/option&gt;
            &lt;option value=&quot;Munro abscesses&quot;&gt;Munro abscesses&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;.
      &lt;/div&gt;

      &lt;div class=&quot;dd-fillin-sentence&quot;&gt;
        4. Patients taking oral acitretin must avoid pregnancy and blood donation for at least 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;3 years&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Period]&lt;/option&gt;
            &lt;option value=&quot;1 month&quot;&gt;1 month&lt;/option&gt;
            &lt;option value=&quot;6 months&quot;&gt;6 months&lt;/option&gt;
            &lt;option value=&quot;3 years&quot;&gt;3 years&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;
        post-treatment, and avoid alcohol for 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;2 months&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Alcohol Time]&lt;/option&gt;
            &lt;option value=&quot;2 months&quot;&gt;2 months&lt;/option&gt;
            &lt;option value=&quot;1 year&quot;&gt;1 year&lt;/option&gt;
            &lt;option value=&quot;3 years&quot;&gt;3 years&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;.
      &lt;/div&gt;

      &lt;div class=&quot;dd-fillin-sentence&quot;&gt;
        5. For oral isotretinoin, the required post-treatment contraception washout period is 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;1 month&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Duration]&lt;/option&gt;
            &lt;option value=&quot;1 month&quot;&gt;1 month&lt;/option&gt;
            &lt;option value=&quot;6 months&quot;&gt;6 months&lt;/option&gt;
            &lt;option value=&quot;3 years&quot;&gt;3 years&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;
        and it should never be combined with 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;tetracyclines&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Drug]&lt;/option&gt;
            &lt;option value=&quot;tetracyclines&quot;&gt;tetracyclines&lt;/option&gt;
            &lt;option value=&quot;paracetamol&quot;&gt;paracetamol&lt;/option&gt;
            &lt;option value=&quot;topical urea&quot;&gt;topical urea&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;.
      &lt;/div&gt;

      &lt;div class=&quot;dd-fillin-sentence&quot;&gt;
        6. A flare with widespread punched-out erosions signifies eczema herpeticum, requiring urgent 
        &lt;span class=&quot;dd-fillin-choice&quot;&gt;
          &lt;select class=&quot;dd-fillin-select&quot; data-correct=&quot;systemic acyclovir&quot;&gt;
            &lt;option value=&quot;&quot;&gt;[Select Treatment]&lt;/option&gt;
            &lt;option value=&quot;systemic acyclovir&quot;&gt;systemic acyclovir&lt;/option&gt;
            &lt;option value=&quot;topical calcipotriol&quot;&gt;topical calcipotriol&lt;/option&gt;
            &lt;option value=&quot;oral isotretinoin&quot;&gt;oral isotretinoin&lt;/option&gt;
          &lt;/select&gt;
        &lt;/span&gt;.
      &lt;/div&gt;

      &lt;div id=&quot;dd-fillin-feedback&quot; style=&quot;display:none; padding:8px 12px; border-radius:6px; font-weight:700; font-size:0.86rem;&quot;&gt;&lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 3: البطاقات التكرارية (FLASHCARDS)  --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-flashcards&quot; class=&quot;dd-mode-section&quot; style=&quot;display:none;&quot;&gt;
    &lt;div style=&quot;text-align:center; margin-bottom:10px;&quot;&gt;
      &lt;span style=&quot;font-size:0.84rem; font-weight:700; color:var(--text-muted);&quot;&gt;
        Card &lt;span id=&quot;dd-fc-current-index&quot;&gt;1&lt;/span&gt; of &lt;span id=&quot;dd-fc-total-count&quot;&gt;14&lt;/span&gt; &amp;bull; 
        Mastered: &lt;span id=&quot;dd-fc-mastered-count&quot; style=&quot;color:var(--success);&quot;&gt;0&lt;/span&gt;
      &lt;/span&gt;
      &lt;div style=&quot;margin-top:6px;&quot;&gt;
        &lt;button class=&quot;dd-btn dd-btn-sm&quot; id=&quot;dd-btn-fc-filter-all&quot;&gt;All Cards&lt;/button&gt;
        &lt;button class=&quot;dd-btn dd-btn-sm dd-btn-accent&quot; id=&quot;dd-btn-fc-filter-unlearned&quot;&gt;Unlearned Only&lt;/button&gt;
      &lt;/div&gt;
    &lt;/div&gt;

    &lt;div class=&quot;dd-flashcard-wrapper&quot;&gt;
      &lt;div class=&quot;dd-flashcard&quot; id=&quot;dd-flashcard-element&quot; title=&quot;Click or Press Space to Flip&quot;&gt;
        &lt;div class=&quot;dd-fc-tag&quot; id=&quot;dd-fc-category&quot;&gt;GENETICS&lt;/div&gt;
        &lt;div class=&quot;dd-fc-body&quot;&gt;
          &lt;div class=&quot;dd-fc-question&quot; id=&quot;dd-fc-front-text&quot;&gt;Question loading...&lt;/div&gt;
          &lt;div class=&quot;dd-fc-answer&quot; id=&quot;dd-fc-back-text&quot;&gt;Answer loading...&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-fc-footer&quot;&gt;
          &lt;span&gt;Click card to flip (or Space)&lt;/span&gt;
          &lt;span id=&quot;dd-fc-status-badge&quot;&gt;Unreviewed&lt;/span&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-fc-actions&quot; style=&quot;display:flex; justify-content:center; gap:8px; margin-top:12px;&quot;&gt;
        &lt;button class=&quot;dd-btn&quot; id=&quot;dd-btn-fc-prev&quot;&gt;&amp;larr; Prev&lt;/button&gt;
        &lt;button class=&quot;dd-btn dd-btn-danger&quot; id=&quot;dd-btn-fc-fail&quot;&gt;Review 🔄&lt;/button&gt;
        &lt;button class=&quot;dd-btn dd-btn-success&quot; id=&quot;dd-btn-fc-pass&quot;&gt;Mastered ✅&lt;/button&gt;
        &lt;button class=&quot;dd-btn&quot; id=&quot;dd-btn-fc-next&quot;&gt;Next &amp;rarr;&lt;/button&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 4: بنك الأسئلة (MCQ EXAM)             --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-quiz&quot; class=&quot;dd-mode-section&quot; style=&quot;display:none;&quot;&gt;
    &lt;div class=&quot;dd-study-card&quot; style=&quot;max-width:700px; margin:0 auto;&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Board-Style Clinical Examination&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Question &lt;span id=&quot;dd-quiz-q-num&quot;&gt;1&lt;/span&gt; of &lt;span id=&quot;dd-quiz-q-total&quot;&gt;8&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div id=&quot;dd-quiz-score-badge&quot; style=&quot;font-weight:800; font-size:0.86rem; color:var(--accent);&quot;&gt;Score: 0&lt;/div&gt;
      &lt;/div&gt;

      &lt;div style=&quot;font-size:0.95rem; font-weight:700; margin-bottom:12px;&quot; id=&quot;dd-quiz-question-text&quot;&gt;Question...&lt;/div&gt;
      &lt;div id=&quot;dd-quiz-options-container&quot;&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-quiz-explanation&quot; id=&quot;dd-quiz-explanation-box&quot;&gt;&lt;/div&gt;

      &lt;div style=&quot;display:flex; justify-content:space-between; align-items:center;&quot;&gt;
        &lt;button class=&quot;dd-btn&quot; id=&quot;dd-btn-quiz-prev&quot; style=&quot;visibility:hidden;&quot;&gt;&amp;larr; Previous&lt;/button&gt;
        &lt;button class=&quot;dd-btn dd-btn-accent&quot; id=&quot;dd-btn-quiz-next&quot; style=&quot;display:none;&quot;&gt;Next Question &amp;rarr;&lt;/button&gt;
        &lt;button class=&quot;dd-btn dd-btn-danger&quot; id=&quot;dd-btn-quiz-retake-wrong&quot; style=&quot;display:none;&quot;&gt;Retake Incorrect Only ↺&lt;/button&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 5: الأرقام الصعبة (HIGH-YIELD METRICS) --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-numbers&quot; class=&quot;dd-mode-section&quot; style=&quot;display:none;&quot;&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;High-Yield Metrics, Washouts, &amp; Trial Numbers&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Essential cutoffs and study discrepancies from the clinical report&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-drill-grid&quot;&gt;
        &lt;div class=&quot;dd-drill-card&quot;&gt;
          &lt;div class=&quot;dd-line-label&quot;&gt;Acitretin Washout&lt;/div&gt;
          &lt;div class=&quot;dd-num-badge&quot;&gt;3 Years&lt;/div&gt;
          &lt;div style=&quot;font-size:0.82rem; color:var(--text-secondary);&quot;&gt;Pregnancy &amp; blood donation prohibited during treatment and for &lt;b&gt;&amp;ge;3 years&lt;/b&gt; post-stopping.&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-drill-card&quot;&gt;
          &lt;div class=&quot;dd-line-label&quot;&gt;Acitretin Alcohol&lt;/div&gt;
          &lt;div class=&quot;dd-num-badge&quot;&gt;2 Months&lt;/div&gt;
          &lt;div style=&quot;font-size:0.82rem; color:var(--text-secondary);&quot;&gt;Alcohol prohibited during treatment and for &lt;b&gt;2 months after&lt;/b&gt; to prevent etretinate formation.&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-drill-card&quot;&gt;
          &lt;div class=&quot;dd-line-label&quot;&gt;Isotretinoin Washout&lt;/div&gt;
          &lt;div class=&quot;dd-num-badge&quot;&gt;1 Month&lt;/div&gt;
          &lt;div style=&quot;font-size:0.82rem; color:var(--text-secondary);&quot;&gt;Pregnancy &amp; blood donation avoided during therapy and for &lt;b&gt;&amp;ge;1 month&lt;/b&gt; post-treatment.&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-drill-card&quot;&gt;
          &lt;div class=&quot;dd-line-label&quot;&gt;Transmission Risk&lt;/div&gt;
          &lt;div class=&quot;dd-num-badge&quot;&gt;50% Probability&lt;/div&gt;
          &lt;div style=&quot;font-size:0.82rem; color:var(--text-secondary);&quot;&gt;Autosomal dominant risk per child of an affected individual with a constitutional variant.&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-drill-card&quot;&gt;
          &lt;div class=&quot;dd-line-label&quot;&gt;Calcipotriol Discrepancy&lt;/div&gt;
          &lt;div class=&quot;dd-num-badge&quot;&gt;8 / 12 vs 11&lt;/div&gt;
          &lt;div style=&quot;font-size:0.82rem; color:var(--text-secondary);&quot;&gt;1995 trial: 8 withdrawn; abstract states &lt;b&gt;8 of 12&lt;/b&gt;, but text lists &lt;b&gt;11 enrolled patients&lt;/b&gt;.&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-drill-card&quot;&gt;
          &lt;div class=&quot;dd-line-label&quot;&gt;Isotretinoin Response&lt;/div&gt;
          &lt;div class=&quot;dd-num-badge&quot;&gt;70% &amp;rarr; 98 / 104&lt;/div&gt;
          &lt;div style=&quot;font-size:0.82rem; color:var(--text-secondary);&quot;&gt;~70% improved at 1–4 wks; 98 of 104 improved at 16 wks; 11 discontinued due to toxicity.&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 6: سلة التصنيف (BUCKET SORTER)       --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-sorter&quot; class=&quot;dd-mode-section&quot; style=&quot;display:none;&quot;&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Clinical Entity Classifier&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Click on an item, then click its matching bucket (or drag &amp; drop)&lt;/div&gt;
        &lt;/div&gt;
        &lt;button class=&quot;dd-btn dd-btn-sm dd-btn-accent&quot; id=&quot;dd-btn-reset-sorter&quot;&gt;Reset Sorter&lt;/button&gt;
      &lt;/div&gt;

      &lt;div class=&quot;dd-sorter-pool&quot; id=&quot;dd-sorter-pool&quot;&gt;&lt;/div&gt;

      &lt;div class=&quot;dd-buckets-grid&quot;&gt;
        &lt;div class=&quot;dd-bucket&quot; data-bucket=&quot;pathology&quot;&gt;
          &lt;div class=&quot;dd-bucket-title&quot;&gt;1. Histology &amp; Cells&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-bucket&quot; data-bucket=&quot;clinical&quot;&gt;
          &lt;div class=&quot;dd-bucket-title&quot;&gt;2. Clinical Hallmarks&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-bucket&quot; data-bucket=&quot;retinoids&quot;&gt;
          &lt;div class=&quot;dd-bucket-title&quot;&gt;3. Retinoid Washouts&lt;/div&gt;
        &lt;/div&gt;
        &lt;div class=&quot;dd-bucket&quot; data-bucket=&quot;investigational&quot;&gt;
          &lt;div class=&quot;dd-bucket-title&quot;&gt;4. Investigational Drugs&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div id=&quot;dd-sorter-feedback&quot; style=&quot;margin-top:10px; display:none; padding:8px; border-radius:6px; font-weight:bold; font-size:0.84rem;&quot;&gt;&lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- ========================================== --&gt;
  &lt;!-- الوضع 7: مراجعة ليلة الامتحان (CRAM SHEET)   --&gt;
  &lt;!-- ========================================== --&gt;
  &lt;div id=&quot;dd-mode-cram&quot; class=&quot;dd-mode-section&quot; style=&quot;display:none;&quot;&gt;
    &lt;div class=&quot;dd-study-card&quot;&gt;
      &lt;div class=&quot;dd-card-header&quot;&gt;
        &lt;div&gt;
          &lt;div class=&quot;dd-card-title&quot;&gt;Exam-Night Ultra-Dense Keyword Matrix&lt;/div&gt;
          &lt;div class=&quot;dd-card-subtitle&quot;&gt;Bare exam anchors for rapid 5-minute pre-test scan&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;table class=&quot;dd-table&quot;&gt;
        &lt;thead&gt;
          &lt;tr&gt;
            &lt;th&gt;Clinical Question&lt;/th&gt;
            &lt;th&gt;Bare High-Yield Answer&lt;/th&gt;
          &lt;/tr&gt;
        &lt;/thead&gt;
        &lt;tbody&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Gene &amp; Defective Pump?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;ATP2A2&lt;/strong&gt; &amp;rarr; &lt;strong&gt;SERCA2&lt;/strong&gt; (Sarco/ER Ca2+ pump).&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Inheritance &amp; Risk?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;Autosomal dominant&lt;/strong&gt;; &lt;strong&gt;50% probability&lt;/strong&gt; per pregnancy.&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Pathognomonic Nails?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;Red/white streaks&lt;/strong&gt; + &lt;strong&gt;V-shaped distal notching&lt;/strong&gt;.&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Corps Ronds vs Grains?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;Corps ronds&lt;/strong&gt; = spinous/granular, round, halo. &lt;strong&gt;Grains&lt;/strong&gt; = corneum, flat, dense.&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Acitretin Washouts?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;&amp;ge;3 years&lt;/strong&gt; for pregnancy/blood donation; &lt;strong&gt;2 months&lt;/strong&gt; for alcohol.&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Isotretinoin Washout?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;&amp;ge;1 month&lt;/strong&gt; for pregnancy/blood donation; avoid tetracyclines.&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Viral Emergency?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;Eczema herpeticum (HSV)&lt;/strong&gt; &amp;rarr; prompt &lt;strong&gt;systemic acyclovir&lt;/strong&gt;.&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Secondary Malignancy?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;Increased risk of &lt;strong&gt;keratinocyte carcinoma&lt;/strong&gt; (2024 Swedish study).&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td&gt;&lt;strong&gt;Preclinical Ca2+ Drug?&lt;/strong&gt;&lt;/td&gt;
            &lt;td&gt;&lt;strong&gt;Dantrolene&lt;/strong&gt; (corrects cell adhesion in preclinical SERCA2 models).&lt;/td&gt;
          &lt;/tr&gt;
        &lt;/tbody&gt;
      &lt;/table&gt;

      &lt;div class=&quot;dd-arabic-aid&quot; style=&quot;margin-top:10px;&quot;&gt;
        &lt;div class=&quot;dd-arabic-aid-tag&quot;&gt;💡 ملخص سريع باللغة العربية:&lt;/div&gt;
        الجين: ATP2A2 ومضخة SERCA2 • الوراثة: سائدة 50% • الأظافر: خطوط حمراء وبيضاء مع ثلم حرف V • الهستولوجيا: انحلال شوكي؛ كورب روند في الطبقة الشائكة وحبيبات في القرنية • الأسيتريتين: منع حمل 3 سنوات وكحول شهرين • الآيزوتريتينوين: منع حمل شهر وممنوع مع التتراسيكلين • الهربس يسبب إكزيما هربسية وطوارئ أسيكلوفير • زيادة خطر سرطان الخلايا الكيراتينية.
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- نافذة اختصارات لوحة المفاتيح --&gt;
  &lt;div class=&quot;dd-modal-overlay&quot; id=&quot;dd-shortcuts-modal&quot;&gt;
    &lt;div class=&quot;dd-modal-content&quot;&gt;
      &lt;div style=&quot;display:flex; justify-content:space-between; align-items:center; margin-bottom:10px;&quot;&gt;
        &lt;h3 style=&quot;font-weight:800; font-size:0.95rem; color:var(--text-primary);&quot;&gt;Keyboard Shortcuts&lt;/h3&gt;
        &lt;button class=&quot;dd-btn dd-btn-sm&quot; id=&quot;dd-btn-close-modal&quot;&gt;&amp;times;&lt;/button&gt;
      &lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;&lt;kbd&gt;1&lt;/kbd&gt; to &lt;kbd&gt;7&lt;/kbd&gt;&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Switch Study Modes&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;&lt;kbd&gt;Space&lt;/kbd&gt;&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Flip Flashcard&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;&lt;kbd&gt;&amp;larr;&lt;/kbd&gt; / &lt;kbd&gt;&amp;rarr;&lt;/kbd&gt;&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Prev / Next Flashcard &amp; Quiz&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;&lt;kbd&gt;D&lt;/kbd&gt; or &lt;kbd&gt;T&lt;/kbd&gt;&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Toggle Dark / Light Theme&lt;/span&gt;&lt;/div&gt;
      &lt;div class=&quot;dd-line-row&quot;&gt;&lt;span class=&quot;dd-line-label&quot;&gt;&lt;kbd&gt;?&lt;/kbd&gt;&lt;/span&gt;&lt;span class=&quot;dd-line-val&quot;&gt;Show this Help Modal&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;

  &lt;!-- توثيق المصادر --&gt;
  &lt;div style=&quot;margin-top:20px; padding-top:10px; border-top:1px solid var(--border-color); font-size:0.75rem; color:var(--text-muted);&quot;&gt;
    &lt;strong&gt;Source References:&lt;/strong&gt; Diagnosis and Treatment of Darier Disease: A Comprehensive Medical Report (Prepared October 09, 2026). Incorporating consensus guidelines (Has et al., 2026; Ettinger et al., 2025; Hanna et al., 2022; DermNet NZ; Burge &amp; Wilkinson, 1992; Inci et al., 2024; Hunt et al., 2024; DailyMed Acitretin &amp; Isotretinoin).
  &lt;/div&gt;

&lt;script&gt;
(function() {
  &#39;use strict&#39;;

  var root = document.getElementById(&#39;darier-app-root&#39;);
  if (!root) return;

  var STORAGE_KEY = &#39;darier_blogger_study_2026&#39;;
  var state = {
    theme: &#39;light&#39;,
    activeMode: &#39;study&#39;,
    flashcards: { mastered: [], filter: &#39;all&#39;, currentIndex: 0 },
    quiz: { currentIndex: 0, score: 0, answers: {}, retakeOnlyWrong: false },
    sorterPlaced: {}
  };

  try {
    var saved = localStorage.getItem(STORAGE_KEY);
    if (saved) state = Object.assign(state, JSON.parse(saved));
  } catch(e) {}

  function saveState() {
    try { localStorage.setItem(STORAGE_KEY, JSON.stringify(state)); } catch(e) {}
  }

  // الثيم
  function applyTheme(theme) {
    state.theme = theme;
    root.setAttribute(&#39;data-theme&#39;, theme);
    saveState();
  }
  applyTheme(state.theme || &#39;light&#39;);

  root.querySelector(&#39;#dd-btn-theme&#39;).addEventListener(&#39;click&#39;, function() {
    applyTheme(state.theme === &#39;light&#39; ? &#39;dark&#39; : &#39;light&#39;);
  });

  // التبديل بين الأوضاع
  var tabBtns = root.querySelectorAll(&#39;.dd-tab-btn&#39;);
  var modeSections = root.querySelectorAll(&#39;.dd-mode-section&#39;);

  function switchMode(modeId) {
    state.activeMode = modeId;
    tabBtns.forEach(function(b) {
      b.classList.toggle(&#39;active&#39;, b.getAttribute(&#39;data-mode&#39;) === modeId);
    });
    modeSections.forEach(function(s) {
      s.style.display = (s.id === &#39;dd-mode-&#39; + modeId) ? &#39;block&#39; : &#39;none&#39;;
    });
    saveState();

    if (modeId === &#39;flashcards&#39;) renderFlashcard();
    if (modeId === &#39;quiz&#39;) renderQuiz();
    if (modeId === &#39;sorter&#39;) initSorter();
  }

  tabBtns.forEach(function(btn) {
    btn.addEventListener(&#39;click&#39;, function() {
      switchMode(btn.getAttribute(&#39;data-mode&#39;));
    });
  });

  // نافذة الاختصارات
  var modal = root.querySelector(&#39;#dd-shortcuts-modal&#39;);
  root.querySelector(&#39;#dd-btn-shortcuts&#39;).addEventListener(&#39;click&#39;, function() { modal.classList.add(&#39;active&#39;); });
  root.querySelector(&#39;#dd-btn-close-modal&#39;).addEventListener(&#39;click&#39;, function() { modal.classList.remove(&#39;active&#39;); });
  modal.addEventListener(&#39;click&#39;, function(e) { if (e.target === modal) modal.classList.remove(&#39;active&#39;); });

  // زر إعادة الضبط
  root.querySelector(&#39;#dd-btn-reset&#39;).addEventListener(&#39;click&#39;, function() {
    if (confirm(&#39;Reset your study progress and flashcards?&#39;)) {
      try { localStorage.removeItem(STORAGE_KEY); } catch(e) {}
      state.flashcards.mastered = [];
      state.quiz.answers = {};
      state.sorterPlaced = {};
      saveState();
      switchMode(&#39;study&#39;);
      renderFlashcard();
    }
  });

  // ==========================================
  // بيانات ومحرك البطاقات التكرارية
  // ==========================================
  var flashcardsData = [
    { id: 1, category: &quot;GENETICS&quot;, front: &quot;What is the genetic cause and molecular defect in Darier disease?&quot;, back: &quot;Pathogenic variants in ATP2A2 encoding the SERCA2 pump (sarco/endoplasmic reticulum Ca2+ ATPase). Defective calcium transport disrupts intracellular Ca2+ regulation, epidermal cell adhesion, and keratinocyte differentiation.&quot; },
    { id: 2, category: &quot;INHERITANCE&quot;, front: &quot;What is the inheritance pattern and the presentation of mosaic disease?&quot;, back: &quot;Autosomal dominant with 50% transmission risk per child. Segmental disease follows Blaschko&#39;s lines via postzygotic mosaicism (often without a family history).&quot; },
    { id: 3, category: &quot;NAILS&quot;, front: &quot;What nail abnormalities are strongly suggestive of Darier disease?&quot;, back: &quot;Longitudinal red and white streaks (erythronychia/leukonychia) combined with V-shaped distal notching of the free nail edge, along with longitudinal splitting and subungual hyperkeratosis.&quot; },
    { id: 4, category: &quot;HISTOLOGY&quot;, front: &quot;What are corps ronds, and where are they located?&quot;, back: &quot;Enlarged, rounded dyskeratotic keratinocytes with eosinophilic cytoplasm and distinctive nuclei, characteristically located in the spinous and granular layers.&quot; },
    { id: 5, category: &quot;HISTOLOGY&quot;, front: &quot;What are grains, and where are they located?&quot;, back: &quot;Small, flattened dyskeratotic keratinocytes with dense nuclei, located in the upper epidermis or stratum corneum.&quot; },
    { id: 6, category: &quot;HISTOLOGY&quot;, front: &quot;What creates the suprabasal clefts (lacunae) and villi?&quot;, back: &quot;Acantholysis (loss of cell adhesion) creates spaces directly above the basal layer. Villi are projections of the papillary dermis covered by basal keratinocytes extending into these clefts.&quot; },
    { id: 7, category: &quot;DIFFERENTIAL&quot;, front: &quot;How is Hailey–Hailey disease distinguished clinically and histologically?&quot;, back: &quot;Hailey–Hailey features painful maceration/erosions in flexures without characteristic nail streaks/notching. Histology shows widespread acantholysis with a &#39;dilapidated brick-wall&#39; appearance.&quot; },
    { id: 8, category: &quot;ACITRETIN&quot;, front: &quot;What are the pregnancy and alcohol rules for oral acitretin?&quot;, back: &quot;Avoid pregnancy &amp; blood donation during and for AT LEAST 3 YEARS post-stopping (US labeling). Avoid alcohol during and for 2 MONTHS post-stopping to prevent etretinate formation.&quot; },
    { id: 9, category: &quot;ISOTRETINOIN&quot;, front: &quot;What are the washout period and major drug interaction for oral isotretinoin?&quot;, back: &quot;Avoid pregnancy &amp; blood donation for AT LEAST 1 MONTH after stopping. Avoid concomitant tetracyclines due to pseudotumor cerebri (intracranial hypertension) risk.&quot; },
    { id: 10, category: &quot;EMERGENCY&quot;, front: &quot;What is Kaposi varicelliform eruption (eczema herpeticum), and how is it managed?&quot;, back: &quot;Widespread, rapidly spreading punched-out erosions from HSV. Requires URGENT systemic acyclovir; do not delay treatment for lab confirmation.&quot; },
    { id: 11, category: &quot;MALIGNANCY&quot;, front: &quot;What increased cancer risk was identified in the 2024 Swedish study?&quot;, back: &quot;An increased risk of keratinocyte carcinoma among individuals with Darier disease.&quot; },
    { id: 12, category: &quot;CALCIPOTRIOL&quot;, front: &quot;Why must topical calcipotriol be used with caution?&quot;, back: &quot;It can cause severe irritation and disease exacerbation. In a 1995 controlled trial, 8 patients were withdrawn due to clinical worsening.&quot; },
    { id: 13, category: &quot;INVESTIGATIONAL&quot;, front: &quot;What is the proposed role of dantrolene in Darier disease?&quot;, back: &quot;Targets calcium handling; corrects cellular calcium regulation and keratinocyte adhesion in preclinical SERCA2 models (preclinical only).&quot; },
    { id: 14, category: &quot;INVESTIGATIONAL&quot;, front: &quot;What did the 2019 case series report regarding low-dose naltrexone (LDN)?&quot;, back: &quot;Administered with magnesium: 2 mild/moderate patients improved substantially at 12 weeks, but 4 severe patients worsened after 4 weeks (inconsistent &amp; uncontrolled).&quot; }
  ];

  var currentCardIndex = 0;
  var isCardFlipped = false;
  var activeDeck = flashcardsData.slice();

  var cardElem = root.querySelector(&#39;#dd-flashcard-element&#39;);
  var fcFront = root.querySelector(&#39;#dd-fc-front-text&#39;);
  var fcBack = root.querySelector(&#39;#dd-fc-back-text&#39;);
  var fcCategory = root.querySelector(&#39;#dd-fc-category&#39;);
  var fcStatus = root.querySelector(&#39;#dd-fc-status-badge&#39;);
  var fcBadge = root.querySelector(&#39;#dd-fc-badge&#39;);
  var fcCurrentIdxSpan = root.querySelector(&#39;#dd-fc-current-index&#39;);
  var fcTotalCountSpan = root.querySelector(&#39;#dd-fc-total-count&#39;);
  var fcMasteredCountSpan = root.querySelector(&#39;#dd-fc-mastered-count&#39;);

  function updateDeckFilter(filter) {
    state.flashcards.filter = filter;
    if (filter === &#39;unlearned&#39;) {
      activeDeck = flashcardsData.filter(function(c) { return !state.flashcards.mastered.includes(c.id); });
      if (activeDeck.length === 0) {
        alert(&#39;All cards mastered! Switching back to all cards.&#39;);
        activeDeck = flashcardsData.slice();
        state.flashcards.filter = &#39;all&#39;;
      }
    } else {
      activeDeck = flashcardsData.slice();
    }
    currentCardIndex = 0;
    renderFlashcard();
    saveState();
  }

  root.querySelector(&#39;#dd-btn-fc-filter-all&#39;).addEventListener(&#39;click&#39;, function() { updateDeckFilter(&#39;all&#39;); });
  root.querySelector(&#39;#dd-btn-fc-filter-unlearned&#39;).addEventListener(&#39;click&#39;, function() { updateDeckFilter(&#39;unlearned&#39;); });

  function renderFlashcard() {
    if (activeDeck.length === 0) return;
    var card = activeDeck[currentCardIndex];
    isCardFlipped = false;
    cardElem.classList.remove(&#39;flipped&#39;);
    fcCategory.textContent = card.category;
    fcFront.textContent = card.front;
    fcBack.textContent = card.back;
    fcCurrentIdxSpan.textContent = (currentCardIndex + 1);
    fcTotalCountSpan.textContent = activeDeck.length;

    var isMastered = state.flashcards.mastered.includes(card.id);
    fcStatus.textContent = isMastered ? &#39;Mastered ✅&#39; : &#39;Needs Review 🔄&#39;;
    fcStatus.style.color = isMastered ? &#39;var(--success)&#39; : &#39;var(--warning)&#39;;

    fcMasteredCountSpan.textContent = state.flashcards.mastered.length;
    fcBadge.textContent = state.flashcards.mastered.length + &#39;/&#39; + flashcardsData.length;
  }

  function flipCard() {
    isCardFlipped = !isCardFlipped;
    cardElem.classList.toggle(&#39;flipped&#39;, isCardFlipped);
  }

  cardElem.addEventListener(&#39;click&#39;, flipCard);

  root.querySelector(&#39;#dd-btn-fc-prev&#39;).addEventListener(&#39;click&#39;, function() {
    if (currentCardIndex &gt; 0) { currentCardIndex--; renderFlashcard(); }
  });
  root.querySelector(&#39;#dd-btn-fc-next&#39;).addEventListener(&#39;click&#39;, function() {
    if (currentCardIndex &lt; activeDeck.length - 1) { currentCardIndex++; renderFlashcard(); }
  });
  root.querySelector(&#39;#dd-btn-fc-pass&#39;).addEventListener(&#39;click&#39;, function() {
    var card = activeDeck[currentCardIndex];
    if (!state.flashcards.mastered.includes(card.id)) {
      state.flashcards.mastered.push(card.id);
      saveState();
    }
    if (state.flashcards.filter === &#39;unlearned&#39;) {
      updateDeckFilter(&#39;unlearned&#39;);
    } else {
      if (currentCardIndex &lt; activeDeck.length - 1) currentCardIndex++;
      renderFlashcard();
    }
  });
  root.querySelector(&#39;#dd-btn-fc-fail&#39;).addEventListener(&#39;click&#39;, function() {
    var card = activeDeck[currentCardIndex];
    state.flashcards.mastered = state.flashcards.mastered.filter(function(id) { return id !== card.id; });
    saveState();
    if (currentCardIndex &lt; activeDeck.length - 1) currentCardIndex++;
    renderFlashcard();
  });

  // ==========================================
  // الوضع 2: ملء الفراغات
  // ==========================================
  var btnCheckFillin = root.querySelector(&#39;#dd-btn-check-fillin&#39;);
  var fillinFeedback = root.querySelector(&#39;#dd-fillin-feedback&#39;);

  btnCheckFillin.addEventListener(&#39;click&#39;, function() {
    var selects = root.querySelectorAll(&#39;.dd-fillin-select&#39;);
    var correct = 0;
    var total = selects.length;

    selects.forEach(function(sel) {
      var parent = sel.closest(&#39;.dd-fillin-choice&#39;);
      var expected = sel.getAttribute(&#39;data-correct&#39;);
      if (sel.value === expected) {
        correct++;
        parent.style.borderColor = &#39;var(--success)&#39;;
        parent.style.backgroundColor = &#39;var(--success-light)&#39;;
      } else {
        parent.style.borderColor = &#39;var(--danger)&#39;;
        parent.style.backgroundColor = &#39;var(--danger-light)&#39;;
      }
    });

    fillinFeedback.style.display = &#39;block&#39;;
    if (correct === total) {
      fillinFeedback.style.backgroundColor = &#39;var(--success-light)&#39;;
      fillinFeedback.style.color = &#39;var(--success)&#39;;
      fillinFeedback.textContent = &#39;🎉 All &#39; + correct + &#39;/&#39; + total + &#39; keywords chosen correctly!&#39;;
    } else {
      fillinFeedback.style.backgroundColor = &#39;var(--warning-light)&#39;;
      fillinFeedback.style.color = &#39;var(--warning)&#39;;
      fillinFeedback.textContent = &#39;Score: &#39; + correct + &#39;/&#39; + total + &#39;. Items in red require re-evaluation!&#39;;
    }
  });

  // ==========================================
  // الوضع 4: أسئلة الاختيار من متعدد
  // ==========================================
  var quizQuestions = [
    {
      id: 1,
      q: &quot;A 22-year-old male presents with crusted greasy papules on his central chest and forehead. Which finding most strongly supports Darier disease?&quot;,
      options: [
        &quot;Oil-drop discoloration and subungual splinter hemorrhages&quot;,
        &quot;Longitudinal erythronychia/leukonychia with V-shaped distal free-edge notching&quot;,
        &quot;Pterygium formation with complete dorsal nail plate destruction&quot;,
        &quot;Pitted enamel hypoplasia and geographic tongue only&quot;
      ],
      correct: 1,
      reason: &quot;Longitudinal red and white streaks with V-shaped distal notching of the nail plate are pathognomonic of Darier disease.&quot;
    },
    {
      id: 2,
      q: &quot;On skin biopsy of a hyperkeratotic chest papule, what are the specific morphological features of &#39;corps ronds&#39;?&quot;,
      options: [
        &quot;Small, flattened dyskeratotic cells with dense nuclei in the stratum corneum&quot;,
        &quot;Enlarged, rounded dyskeratotic cells with eosinophilic cytoplasm and distinctive nuclei in the spinous or granular layers&quot;,
        &quot;Intraepidermal collections of neutrophils located in the subcorneal space&quot;,
        &quot;Vacuolated basal keratinocytes showing interface liquefactive degeneration&quot;
      ],
      correct: 1,
      reason: &quot;Corps ronds are enlarged, rounded dyskeratotic cells with eosinophilic cytoplasm in the spinous/granular layers. Grains are small flattened cells in the upper epidermis.&quot;
    },
    {
      id: 3,
      q: &quot;Which statement reflects accurate safety guidance for systemic retinoid therapy in Darier disease under US labeling?&quot;,
      options: [
        &quot;Oral isotretinoin requires pregnancy avoidance for at least 3 years following discontinuation&quot;,
        &quot;Oral acitretin requires pregnancy and blood donation avoidance for at least 3 years, and alcohol avoidance for 2 months&quot;,
        &quot;Oral acitretin is completely safe during pregnancy if serum lipids are monitored&quot;,
        &quot;Oral isotretinoin should be routinely combined with doxycycline to enhance calcium uptake&quot;
      ],
      correct: 1,
      reason: &quot;Acitretin requires at least 3 years of pregnancy and blood donation avoidance, and 2 months of alcohol avoidance to prevent conversion to etretinate.&quot;
    },
    {
      id: 4,
      q: &quot;A Darier patient develops rapid clinical deterioration, high fevers, and widespread monomorphic punched-out erosions. What is the immediate step?&quot;,
      options: [
        &quot;Initiate topical 5-fluorouracil under occlusion&quot;,
        &quot;Prescribe topical calcipotriol twice daily&quot;,
        &quot;Immediately administer systemic acyclovir for suspected eczema herpeticum&quot;,
        &quot;Perform surgical excision of the involved flexural folds&quot;
      ],
      correct: 2,
      reason: &quot;Punched-out erosions and vesicles with systemic symptoms represent eczema herpeticum (HSV), requiring urgent systemic acyclovir without waiting for lab confirmation.&quot;
    },
    {
      id: 5,
      q: &quot;How does the histopathology of Hailey–Hailey disease fundamentally differ from Darier disease?&quot;,
      options: [
        &quot;Hailey–Hailey demonstrates widespread acantholysis with a &#39;dilapidated brick-wall&#39; appearance, lacking prominent dyskeratotic corps ronds and grains&quot;,
        &quot;Hailey–Hailey shows subepidermal bullae with dense eosinophil-rich infiltrates&quot;,
        &quot;Hailey–Hailey exhibits marked hyperkeratosis without any epidermal acantholysis&quot;,
        &quot;Hailey–Hailey is characterized by follicular infundibular plugging and Civatte bodies&quot;
      ],
      correct: 0,
      reason: &quot;Hailey–Hailey shows extensive suprabasal acantholysis with a &#39;dilapidated brick-wall&#39; pattern and lacks the characteristic dyskeratotic cells of Darier disease.&quot;
    },
    {
      id: 6,
      q: &quot;A randomized controlled trial from 1995 evaluated topical calcipotriol in Darier disease. What notable clinical finding was documented?&quot;,
      options: [
        &quot;100% of patients achieved permanent genetic cure&quot;,
        &quot;8 patients were withdrawn due to severe irritation/disease worsening (abstract says 8 of 12; text lists 11 patients)&quot;,
        &quot;Calcipotriol completely prevented secondary Staphylococcus aureus infections in all enrolled subjects&quot;,
        &quot;Calcipotriol was proven to be universally superior to oral retinoids&quot;
      ],
      correct: 1,
      reason: &quot;Topical calcipotriol aggravated Darier disease, causing withdrawal of 8 patients due to irritation/worsening.&quot;
    },
    {
      id: 7,
      q: &quot;According to a 2024 nationwide Swedish registry study, what long-term oncologic risk is elevated in Darier disease?&quot;,
      options: [
        &quot;Cutaneous T-cell lymphoma (Mycosis fungoides)&quot;,
        &quot;Keratinocyte carcinoma&quot;,
        &quot;Gastrointestinal stromal tumors&quot;,
        &quot;Medullary thyroid carcinoma&quot;
      ],
      correct: 1,
      reason: &quot;The 2024 nationwide Swedish study identified an increased risk of keratinocyte carcinoma in patients with Darier disease.&quot;
    },
    {
      id: 8,
      q: &quot;Which experimental drug corrects calcium regulation and keratinocyte adhesion in preclinical models of SERCA2 dysfunction?&quot;,
      options: [
        &quot;Dantrolene&quot;,
        &quot;Trametinib&quot;,
        &quot;Baricitinib&quot;,
        &quot;Lithium carbonate&quot;
      ],
      correct: 0,
      reason: &quot;Dantrolene corrected cellular calcium regulation and keratinocyte adhesion in preclinical SERCA2 models.&quot;
    }
  ];

  var currentQuizIndex = 0;
  var activeQuiz = quizQuestions.slice();

  var quizQNum = root.querySelector(&#39;#dd-quiz-q-num&#39;);
  var quizQTotal = root.querySelector(&#39;#dd-quiz-q-total&#39;);
  var quizQText = root.querySelector(&#39;#dd-quiz-question-text&#39;);
  var quizOptionsContainer = root.querySelector(&#39;#dd-quiz-options-container&#39;);
  var quizExplanationBox = root.querySelector(&#39;#dd-quiz-explanation-box&#39;);
  var quizScoreBadge = root.querySelector(&#39;#dd-quiz-score-badge&#39;);
  var btnQuizNext = root.querySelector(&#39;#dd-btn-quiz-next&#39;);
  var btnQuizRetakeWrong = root.querySelector(&#39;#dd-btn-quiz-retake-wrong&#39;);
  var quizBadge = root.querySelector(&#39;#dd-quiz-badge&#39;);

  function renderQuiz() {
    if (activeQuiz.length === 0) return;
    var q = activeQuiz[currentQuizIndex];
    quizQNum.textContent = (currentQuizIndex + 1);
    quizQTotal.textContent = activeQuiz.length;
    quizQText.textContent = q.q;
    quizOptionsContainer.innerHTML = &#39;&#39;;
    quizExplanationBox.style.display = &#39;none&#39;;
    btnQuizNext.style.display = &#39;none&#39;;

    var savedAnswer = state.quiz.answers[q.id];

    q.options.forEach(function(optText, optIdx) {
      var btn = document.createElement(&#39;button&#39;);
      btn.className = &#39;dd-quiz-option-btn&#39;;
      btn.innerHTML = &#39;&lt;span style=&quot;display:inline-block; width:18px; height:18px; border-radius:50%; border:1px solid currentColor; text-align:center; font-size:0.72rem; line-height:16px; font-weight:800;&quot;&gt;&#39; + String.fromCharCode(65 + optIdx) + &#39;&lt;/span&gt; &#39; + optText;

      if (savedAnswer !== undefined) {
        btn.disabled = true;
        if (optIdx === q.correct) btn.classList.add(&#39;selected-correct&#39;);
        if (savedAnswer === optIdx &amp;&amp; savedAnswer !== q.correct) btn.classList.add(&#39;selected-wrong&#39;);
      } else {
        btn.addEventListener(&#39;click&#39;, function() {
          state.quiz.answers[q.id] = optIdx;
          saveState();
          renderQuiz();
        });
      }
      quizOptionsContainer.appendChild(btn);
    });

    if (savedAnswer !== undefined) {
      quizExplanationBox.style.display = &#39;block&#39;;
      quizExplanationBox.innerHTML = &#39;&lt;strong&gt;&#39; + (savedAnswer === q.correct ? &#39;✅ Correct Answer!&#39; : &#39;❌ Incorrect.&#39;) + &#39;&lt;/strong&gt; &#39; + q.reason;
      if (currentQuizIndex &lt; activeQuiz.length - 1) {
        btnQuizNext.style.display = &#39;inline-flex&#39;;
      } else {
        var wrongQs = quizQuestions.filter(function(item) {
          return state.quiz.answers[item.id] !== undefined &amp;&amp; state.quiz.answers[item.id] !== item.correct;
        });
        if (wrongQs.length &gt; 0) btnQuizRetakeWrong.style.display = &#39;inline-flex&#39;;
      }
    }
    updateQuizScore();
  }

  function updateQuizScore() {
    var score = 0;
    quizQuestions.forEach(function(q) {
      if (state.quiz.answers[q.id] === q.correct) score++;
    });
    quizScoreBadge.textContent = &#39;Score: &#39; + score + &#39; / &#39; + quizQuestions.length;
    quizBadge.textContent = score + &#39;/&#39; + quizQuestions.length;
  }

  btnQuizNext.addEventListener(&#39;click&#39;, function() {
    if (currentQuizIndex &lt; activeQuiz.length - 1) { currentQuizIndex++; renderQuiz(); }
  });

  btnQuizRetakeWrong.addEventListener(&#39;click&#39;, function() {
    var wrongQs = quizQuestions.filter(function(q) {
      return state.quiz.answers[q.id] !== undefined &amp;&amp; state.quiz.answers[q.id] !== q.correct;
    });
    if (wrongQs.length &gt; 0) {
      wrongQs.forEach(function(q) { delete state.quiz.answers[q.id]; });
      activeQuiz = wrongQs;
      currentQuizIndex = 0;
      btnQuizRetakeWrong.style.display = &#39;none&#39;;
      saveState();
      renderQuiz();
    }
  });

  // ==========================================
  // الوضع 6: سلة التصنيف
  // ==========================================
  var sorterItems = [
    { id: &#39;sb1&#39;, text: &#39;Corps Ronds (Spinous/Granular)&#39;, bucket: &#39;pathology&#39; },
    { id: &#39;sb2&#39;, text: &#39;Grains (Stratum Corneum)&#39;, bucket: &#39;pathology&#39; },
    { id: &#39;sb3&#39;, text: &#39;Suprabasal Lacunae &amp; Villi&#39;, bucket: &#39;pathology&#39; },
    { id: &#39;sb4&#39;, text: &#39;V-shaped Distal Nail Notch&#39;, bucket: &#39;clinical&#39; },
    { id: &#39;sb5&#39;, text: &#39;Longitudinal Red/White Streaks&#39;, bucket: &#39;clinical&#39; },
    { id: &#39;sb6&#39;, text: &#39;Palmar Pits &amp; Cobblestone Mouth&#39;, bucket: &#39;clinical&#39; },
    { id: &#39;sb7&#39;, text: &#39;Acitretin 3-Year Washout&#39;, bucket: &#39;retinoids&#39; },
    { id: &#39;sb8&#39;, text: &#39;Acitretin 2-Month Alcohol Rule&#39;, bucket: &#39;retinoids&#39; },
    { id: &#39;sb9&#39;, text: &#39;Isotretinoin 1-Month Washout&#39;, bucket: &#39;retinoids&#39; },
    { id: &#39;sb10&#39;, text: &#39;Dantrolene (SERCA2 Ca2+ model)&#39;, bucket: &#39;investigational&#39; },
    { id: &#39;sb11&#39;, text: &#39;Baricitinib (JAK Inhibitor)&#39;, bucket: &#39;investigational&#39; },
    { id: &#39;sb12&#39;, text: &#39;Trametinib (MEK / MAPK Inhibitor)&#39;, bucket: &#39;investigational&#39; }
  ];

  var selectedChipId = null;

  function initSorter() {
    var pool = root.querySelector(&#39;#dd-sorter-pool&#39;);
    pool.innerHTML = &#39;&#39;;
    var dropzones = root.querySelectorAll(&#39;.dd-bucket&#39;);
    dropzones.forEach(function(dz) {
      var title = dz.querySelector(&#39;.dd-bucket-title&#39;);
      dz.innerHTML = &#39;&#39;;
      dz.appendChild(title);
    });

    sorterItems.forEach(function(item) {
      var placedBucket = state.sorterPlaced[item.id];
      var chip = document.createElement(&#39;div&#39;);
      chip.className = &#39;dd-chip&#39;;
      chip.textContent = item.text;

      chip.addEventListener(&#39;click&#39;, function(e) {
        e.stopPropagation();
        root.querySelectorAll(&#39;.dd-chip&#39;).forEach(function(c) { c.style.outline = &#39;none&#39;; });
        selectedChipId = item.id;
        chip.style.outline = &#39;2px solid var(--accent)&#39;;
      });

      if (placedBucket) {
        var targetDz = root.querySelector(&#39;.dd-bucket[data-bucket=&quot;&#39; + placedBucket + &#39;&quot;]&#39;);
        if (targetDz) targetDz.appendChild(chip);
      } else {
        pool.appendChild(chip);
      }
    });

    checkSorterDone();
  }

  root.querySelectorAll(&#39;.dd-bucket&#39;).forEach(function(dz) {
    dz.addEventListener(&#39;click&#39;, function() {
      if (!selectedChipId) return;
      var item = sorterItems.find(function(i) { return i.id === selectedChipId; });
      if (!item) return;

      var targetBucket = dz.getAttribute(&#39;data-bucket&#39;);
      if (item.bucket !== targetBucket) {
        alert(&#39;⚠️ Misclassification! &quot;&#39; + item.text + &#39;&quot; does not belong here.&#39;);
        return;
      }

      state.sorterPlaced[selectedChipId] = targetBucket;
      saveState();
      selectedChipId = null;
      initSorter();
    });
  });

  function checkSorterDone() {
    var placedCount = Object.keys(state.sorterPlaced).length;
    var feedback = root.querySelector(&#39;#dd-sorter-feedback&#39;);
    if (placedCount === sorterItems.length) {
      feedback.style.display = &#39;block&#39;;
      feedback.style.backgroundColor = &#39;var(--success-light)&#39;;
      feedback.style.color = &#39;var(--success)&#39;;
      feedback.textContent = &#39;🎉 All 12 clinical items accurately categorized!&#39;;
    } else {
      feedback.style.display = &#39;none&#39;;
    }
  }

  root.querySelector(&#39;#dd-btn-reset-sorter&#39;).addEventListener(&#39;click&#39;, function() {
    state.sorterPlaced = {};
    saveState();
    initSorter();
  });

  // اختصارات لوحة المفاتيح
  window.addEventListener(&#39;keydown&#39;, function(e) {
    if ([&#39;INPUT&#39;,&#39;SELECT&#39;,&#39;TEXTAREA&#39;].includes(e.target.tagName)) return;

    if ([&#39;1&#39;,&#39;2&#39;,&#39;3&#39;,&#39;4&#39;,&#39;5&#39;,&#39;6&#39;,&#39;7&#39;].includes(e.key)) {
      var modes = [&#39;study&#39;,&#39;fillin&#39;,&#39;flashcards&#39;,&#39;quiz&#39;,&#39;numbers&#39;,&#39;sorter&#39;,&#39;cram&#39;];
      switchMode(modes[parseInt(e.key) - 1]);
      return;
    }
    if (e.key === &#39;d&#39; || e.key === &#39;D&#39; || e.key === &#39;t&#39; || e.key === &#39;T&#39;) {
      applyTheme(state.theme === &#39;light&#39; ? &#39;dark&#39; : &#39;light&#39;);
      return;
    }
    if (e.key === &#39;?&#39;) {
      modal.classList.toggle(&#39;active&#39;);
      return;
    }
    if (state.activeMode === &#39;flashcards&#39;) {
      if (e.code === &#39;Space&#39;) { e.preventDefault(); flipCard(); }
      else if (e.key === &#39;ArrowRight&#39; &amp;&amp; currentCardIndex &lt; activeDeck.length - 1) { currentCardIndex++; renderFlashcard(); }
      else if (e.key === &#39;ArrowLeft&#39; &amp;&amp; currentCardIndex &gt; 0) { currentCardIndex--; renderFlashcard(); }
    }
    if (state.activeMode === &#39;quiz&#39;) {
      if (e.key === &#39;ArrowRight&#39; &amp;&amp; btnQuizNext.style.display !== &#39;none&#39;) btnQuizNext.click();
    }
  });

  switchMode(state.activeMode || &#39;study&#39;);

})();
&lt;/script&gt;
&lt;/div&gt;
&lt;!-- نهاية كود أداة مرض دارييه لمدونة بلوجر --&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3917167780262615711'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3917167780262615711'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/10/darier-app-root-bg-primary-f8fafc-bg.html' title='Darier Disease: High-Yield Interactive Clinical Study &amp; Mastery Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-4530919071351841571</id><published>2026-10-09T06:15:23.451+00:00</published><updated>2026-10-09T06:20:24.744+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="dermatology"/><category scheme="http://www.blogger.com/atom/ns#" term="Study Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Vitiligo"/><title type='text'>Vitiligo Treatment Options: Interactive Study Guide </title><content type='html'>&lt;style&gt;#vts{--bg:#f0f4f8;--card:#fff;--ink:#12263a;--mut:#546576;--ac:#0f6f7c;--acs:#d9eef0;--mk:#ffe08a;--ok:#1f7a4a;--oks:#dcf2e5;--no:#b3321f;--nos:#fbe3df;--ln:#d3dce5;--ar:#eef1fb}#vts[data-theme=dark]{--bg:#0e1822;--card:#16232f;--ink:#e6edf3;--mut:#9fb0bf;--ac:#59c3d1;--acs:#173a41;--mk:#6b5a14;--ok:#6fd49b;--oks:#143a28;--no:#ff8f7e;--nos:#43201b;--ln:#2a3a49;--ar:#1c2540}#vts{all:initial;display:block;box-sizing:border-box;width:100%;max-width:780px;margin:0 auto;padding:12px;background:var(--bg);color:var(--ink);font:17px/1.5 Georgia,&#39;Times New Roman&#39;,serif;border-radius:14px;text-align:left;direction:ltr;overflow:hidden;-webkit-text-size-adjust:100%}#vts *,#vts *:before,#vts *:after{box-sizing:border-box;margin:0;padding:0;border:0;background:none;box-shadow:none;text-shadow:none;text-transform:none;letter-spacing:normal;text-decoration:none;float:none;font:inherit;color:inherit;text-align:inherit;list-style:none;vertical-align:baseline;opacity:1;position:static}#vts .top0{display:flex;justify-content:space-between;align-items:flex-start;gap:8px}#vts .t1{font:700 21px/1.25 system-ui,-apple-system,&#39;Segoe UI&#39;,Roboto,sans-serif}#vts .sub{color:var(--mut);font:14px system-ui,sans-serif}#vts #nav{display:flex;gap:6px;flex-wrap:wrap;margin:12px 0}#vts button{-webkit-appearance:none;appearance:none;display:inline-block;font:600 15px/1.2 system-ui,sans-serif;border:1.5px solid var(--ln);background:var(--card);color:var(--ink);border-radius:9px;padding:9px 12px;cursor:pointer;min-height:44px;text-align:center}#vts button:focus-visible,#vts .fc:focus-visible{outline:3px solid var(--ac);outline-offset:2px}#vts #nav button[aria-selected=true],#vts .pri{background:var(--ac);color:#fff;border-color:var(--ac)}#vts[data-theme=dark] #nav button[aria-selected=true],#vts[data-theme=dark] .pri{color:#06232a}#vts .kk{opacity:.65;font-size:12px;margin-left:4px}#vts .prog{display:grid;grid-template-columns:repeat(4,1fr);gap:8px;margin-bottom:8px}#vts .prog&gt;div{font:12px system-ui,sans-serif;color:var(--mut)}#vts .bar{display:block;height:7px;background:var(--ln);border-radius:5px;overflow:hidden;margin-top:3px}#vts .bar i{display:block;height:100%;background:var(--ac)}#vts .card{display:block;background:var(--card);border:1px solid var(--ln);border-radius:12px;padding:14px 16px;margin:12px 0}#vts .hd{font:700 18px/1.3 system-ui,sans-serif;margin-bottom:8px;color:var(--ac)}#vts .ln{padding:5px 0;border-top:1px solid var(--ln)}#vts .ln:first-of-type{border-top:0}#vts .ln b{display:block;font:600 13px system-ui,sans-serif;color:var(--mut)}#vts mark{background:var(--mk);color:inherit;padding:0 3px;border-radius:3px}#vts .diff{background:var(--nos);border-left:4px solid var(--no);padding:6px 10px;border-radius:6px;margin:6px 0;font-size:15px}#vts .ar{direction:rtl;text-align:right;background:var(--ar);border-radius:8px;padding:8px 12px;margin-top:10px;font:15px/1.7 system-ui,Tahoma,sans-serif}#vts .ar .sm{display:block;color:var(--mut);font-size:11px}#vts .opt{display:block;width:100%;text-align:left;margin:7px 0;font-weight:500;font-size:16px}#vts .opt.sel{border-color:var(--ac);background:var(--acs)}#vts .opt.ok{border-color:var(--ok);background:var(--oks)}#vts .opt.no{border-color:var(--no);background:var(--nos)}#vts .why{display:block;margin-top:10px;padding:8px 12px;border-radius:8px;background:var(--acs);font:15px/1.5 system-ui,sans-serif}#vts .blank{display:inline-block;min-width:90px;border-bottom:3px solid var(--ac);text-align:center;font-weight:700;color:var(--ac)}#vts .fc{min-height:170px;display:flex;align-items:center;justify-content:center;text-align:center;font-size:21px;cursor:pointer;user-select:none}#vts .row{display:flex;gap:8px;flex-wrap:wrap;margin-top:10px}#vts .row&gt;*{flex:1}#vts .chip{display:inline-block;background:var(--acs);border-radius:20px;padding:4px 12px;margin:4px 4px 0 0;font:600 15px system-ui,sans-serif}#vts .top{display:flex;justify-content:space-between;font:13px system-ui,sans-serif;color:var(--mut)}#vts table{display:table;border-collapse:collapse;width:100%;font:14px system-ui,sans-serif}#vts tr{display:table-row}#vts td,#vts th{display:table-cell;border:1px solid var(--ln);padding:6px 8px;text-align:left;vertical-align:top}#vts th{background:var(--acs);font-weight:700}#vts svg{display:block;width:100%;height:auto;max-width:100%}#vts svg text{fill:var(--ink);font:600 12px system-ui,sans-serif}#vts .shake{animation:vtsk .3s}@keyframes vtsk{25%{transform:translateX(-5px)}75%{transform:translateX(5px)}}@media(prefers-reduced-motion:reduce){#vts .shake{animation:none}}#vts .kb{font:12px system-ui,sans-serif;color:var(--mut);margin-top:8px}#vts .ft{font:12px/1.5 system-ui,sans-serif;color:var(--mut);margin-top:18px;border-top:1px solid var(--ln);padding-top:10px}@media(max-width:480px){#vts{padding:8px;border-radius:10px}#vts .prog{grid-template-columns:repeat(2,1fr)}#vts button{padding:9px 10px}}&lt;/style&gt;&lt;div id=&quot;vts&quot; dir=&quot;ltr&quot;&gt;&lt;div class=&quot;top0&quot;&gt;&lt;div&gt;&lt;div class=&quot;t1&quot;&gt;Vitiligo — Treatment Options&lt;/div&gt;&lt;div class=&quot;sub&quot;&gt;Study tool · source: Oct 2026 review · works offline&lt;/div&gt;&lt;/div&gt;&lt;button id=&quot;tb&quot; type=&quot;button&quot; aria-label=&quot;Toggle dark mode (T)&quot;&gt;◐ T&lt;/button&gt;&lt;/div&gt;&lt;div id=&quot;nav&quot; role=&quot;tablist&quot; aria-label=&quot;Study modes&quot;&gt;&lt;/div&gt;&lt;div class=&quot;prog&quot; id=&quot;prog&quot; aria-label=&quot;Progress&quot;&gt;&lt;/div&gt;&lt;div id=&quot;v&quot; aria-live=&quot;polite&quot;&gt;&lt;/div&gt;&lt;div class=&quot;kb&quot;&gt;Click the tool once to enable keys: R L C Q D S F switch mode · T theme · 1–4 choose · Enter check/next · Space flip · ← not yet · → got it&lt;/div&gt;&lt;div class=&quot;ft&quot;&gt;Sources (compiled Oct 2026): International Vitiligo Task Force incl. 2026 Consensus on Severity and Relapse; Canadian Consensus Guidelines 2025; Japanese Vitiligo Guideline 2026; FDA and EMA ruxolitinib cream product information; NEJM TRuE-V1/TRuE-V2; JEADV 2026 long-term data; IADVL surgical consensus 2024–2025. The supplied source text ends mid-way through depigmentation therapy (monobenzone), so that section is incomplete. Educational use only — not clinical advice. Arabic notes are study aids, not part of the source.&lt;/div&gt;&lt;/div&gt;&lt;script&gt;/*&lt;![CDATA[*/(function(){var R=document.getElementById(&#39;vts&#39;);var act=false;var $=function(s){return R.querySelector(s)}; var S={known:{},learn:0,quiz:0,drill:0,sort:0,theme:&#39;&#39;}; try{S=Object.assign(S,JSON.parse(localStorage.getItem(&#39;vit-study&#39;)||&#39;{}&#39;))}catch(e){} function save(){try{localStorage.setItem(&#39;vit-study&#39;,JSON.stringify(S))}catch(e){}} function h(t){return t.replace(/\*\*(.+?)\*\*/g,&#39;&lt;mark&gt;$1&lt;/mark&gt;&#39;)} function sh(a){a=a.slice();for(var i=a.length-1;i&gt;0;i--){var j=Math.floor(Math.random()*(i+1));var t=a[i];a[i]=a[j];a[j]=t}return a} /* ---------- DATA ---------- */ var REV=[ {t:&#39;Severity &amp; activity (what decides treatment)&#39;, l:[[&#39;Mild&#39;,&#39;BSA **&lt;3%**&#39;],[&#39;Moderate&#39;,&#39;BSA **3% to &lt;10%**&#39;],[&#39;Severe&#39;,&#39;BSA **≥10%** — or upgrade: active/rapid spread, visible sites, distress&#39;],[&#39;Rapidly progressive&#39;,&#39;numerous new / enlarging lesions in the last ~**3 months**&#39;],[&#39;Ready for surgery&#39;,&#39;~**12 months** documented stability&#39;]], ar:&#39;قبل اختيار العلاج: حدّد هل المرض نشط أم مستقر. النشط = علاج للسيطرة. المستقر = علاج لإعادة التصبّغ. المساحة وحدها لا تكفي لتحديد الشدة.&#39;, svg:1}, {t:&#39;Topical corticosteroids (TCS)&#39;, l:[[&#39;Role&#39;,&#39;first-line for **localized** disease&#39;],[&#39;Best sites&#39;,&#39;**trunk** and **extremities**&#39;],[&#39;Potency&#39;,&#39;**potent / very potent**, site and age dependent&#39;],[&#39;Avoid&#39;,&#39;**continuous prolonged** use&#39;],[&#39;Risks&#39;,&#39;atrophy, telangiectasia, striae, acne, folliculitis, hypertrichosis, hypopigmentation&#39;],[&#39;Strategy&#39;,&#39;**intermittent** regimens (on / off periods)&#39;]], ar:&#39;الكورتيزون الموضعي: خط أول للبقع المحدودة، يناسب الجذع والأطراف أكثر من الوجه. يُستعمل بالتناوب لتقليل الضمور.&#39;}, {t:&#39;Topical calcineurin inhibitors (TCI)&#39;, l:[[&#39;Agents&#39;,&#39;**tacrolimus**, **pimecrolimus**&#39;],[&#39;Best sites&#39;,&#39;**face, neck, eyelids, intertriginous**&#39;],[&#39;Advantage&#39;,&#39;**no steroid atrophy**&#39;],[&#39;Side effect&#39;,&#39;burning / irritation early on&#39;],[&#39;Maintenance&#39;,&#39;tacrolimus **twice-weekly**: **9.7%** relapse vs ~**40%** placebo&#39;],[&#39;With UV&#39;,&#39;individualize — **not** automatically risk-free&#39;]], ar:&#39;مثبطات الكالسينيورين (تاكروليمس/بيمكروليمس): مناسبة للوجه والعنق والجفون والثنيات لأنها لا تسبب ضمور الجلد. تاكروليمس مرتين أسبوعيًا يقلل الانتكاس بعد عودة اللون.&#39;}, {t:&#39;Ruxolitinib 1.5% cream&#39;, l:[[&#39;Class&#39;,&#39;topical **JAK1/JAK2** inhibitor&#39;],[&#39;Status&#39;,&#39;first drug **approved** for non-segmental repigmentation&#39;],[&#39;Dosing&#39;,&#39;**twice daily**, max **10% BSA**&#39;],[&#39;Week 24&#39;,&#39;F-VASI75 ≈ **30%** vs **7–11%** vehicle&#39;],[&#39;Week 52&#39;,&#39;≈ **half** reach F-VASI75&#39;],[&#39;Duration&#39;,&#39;may need **&gt;6 months**; EMA: stop if no satisfactory improvement at **1 year**&#39;],[&#39;Common AEs&#39;,&#39;application-site **acne, pruritus, erythema**; headache; nasopharyngitis&#39;],[&#39;Warnings&#39;,&#39;class: serious infection, malignancy, MACE, thrombosis&#39;],[&#39;Avoid with&#39;,&#39;other JAK inhibitors, azathioprine, cyclosporine&#39;]], cmp:1, ar:&#39;روكسوليتينيب كريم: أول علاج معتمد لإعادة التصبّغ في البهاق غير القطعي. F-VASI75 يعني تحسّن 75٪ في الوجه وليس عودة كاملة للون. التحسن بطيء وقد يحتاج أكثر من 6 أشهر.&#39;}, {t:&#39;Phototherapy&#39;, l:[[&#39;NB-UVB&#39;,&#39;**311–313 nm**; extensive, generalized, progressive, topical failure&#39;],[&#39;Frequency&#39;,&#39;**2–3×/week** common&#39;],[&#39;Duration&#39;,&#39;**6–12 months or longer**&#39;],[&#39;Excimer&#39;,&#39;**308 nm** laser/lamp; **localized** disease&#39;],[&#39;Better sites&#39;,&#39;face, neck, trunk, proximal limbs&#39;],[&#39;Harder sites&#39;,&#39;fingers, toes, hands, feet, bony prominences, **leukotrichia**&#39;],[&#39;Good sign&#39;,&#39;**perifollicular** repigmentation&#39;]], diff:&#39;Sources differ on frequency: 2–3 sessions/week is the common schedule, but once- or twice-weekly protocols are also used. 2–3/week is not a universal requirement.&#39;, ar:&#39;NB-UVB للمرض المنتشر، والإكسايمر (308 نانومتر) للبقع الموضعية. الاستجابة تحتاج شهورًا. الأصابع والقدمان والبقع ذات الشعر الأبيض أصعب استجابة.&#39;}, {t:&#39;Active / rapidly progressive disease&#39;, l:[[&#39;Goal&#39;,&#39;**stabilize first**, then repigment&#39;],[&#39;Systemic option&#39;,&#39;oral corticosteroid **mini-pulse** (dexamethasone, betamethasone)&#39;],[&#39;Add-on&#39;,&#39;NB-UVB together with or after&#39;],[&#39;Not for&#39;,&#39;routine **localized** vitiligo&#39;],[&#39;Limited evidence&#39;,&#39;methotrexate, cyclosporine, azathioprine, minocycline&#39;]], ar:&#39;المرض سريع الانتشار: الهدف أولًا إيقاف الانتشار. الكورتيزون الفموي بنظام النبضات الصغيرة هو الخيار الجهازي الأشهر. الأدوية الأخرى أدلتها محدودة.&#39;}, {t:&#39;Oral JAK inhibitors&#39;, l:[[&#39;Studied&#39;,&#39;tofacitinib, baricitinib, upadacitinib, ritlecitinib&#39;],[&#39;Rationale&#39;,&#39;**IFN-γ / JAK-STAT** pathway&#39;],[&#39;Oct 2026&#39;,&#39;only **topical ruxolitinib** is approved JAK-based (US + EU)&#39;],[&#39;Others&#39;,&#39;**investigational / off-label**&#39;]], ar:&#39;وجود دراسات تُظهر عودة اللون ليس معناه اعتماد الدواء. الوحيد المعتمد حاليًا من فئة JAK هو كريم روكسوليتينيب.&#39;}, {t:&#39;Surgery &amp; depigmentation&#39;, l:[[&#39;Candidates&#39;,&#39;**stable**, localized, resistant; esp. **segmental**&#39;],[&#39;Stability&#39;,&#39;at least **12 months**&#39;],[&#39;Tissue grafts&#39;,&#39;punch, suction blister, thin split-thickness&#39;],[&#39;Cellular&#39;,&#39;non-cultured epidermal suspension, melanocyte-keratinocyte suspension, cultured melanocytes&#39;],[&#39;Leukotrichia&#39;,&#39;white hair = **poor reservoir**, poorer response&#39;],[&#39;Depigmentation&#39;,&#39;**monobenzone**; exceptional, very extensive cases only&#39;]], ar:&#39;الجراحة للبهاق المستقر 12 شهرًا على الأقل، وتناسب القطعي. الشعر الأبيض داخل البقعة يعني مخزون خلايا صباغية أقل. إزالة التصبّغ حالة استثنائية فقط.&#39;} ]; var LOOK=[[&#39;FDA vs EMA (ruxolitinib)&#39;,&#39;FDA: non-segmental, ≥12 y · EMA: non-segmental **with facial involvement**, ≥12 y&#39;],[&#39;NB-UVB vs excimer&#39;,&#39;**311–313 nm** widespread · **308 nm** localized&#39;],[&#39;3 vs 12 months&#39;,&#39;**3** = progression window · **12** = stability for surgery&#39;],[&#39;TCS vs TCI sites&#39;,&#39;TCS: trunk/limbs · TCI: face/neck/eyelids/folds&#39;],[&#39;F-VASI75&#39;,&#39;~75% facial improvement ≠ complete repigmentation&#39;],[&#39;Trial vs approval&#39;,&#39;oral JAKi studies ≠ approved for vitiligo&#39;]]; var CLOZE=[ [&#39;Rapidly progressive vitiligo: new or enlarging lesions over the preceding about ___.&#39;,&#39;3 months&#39;,[&#39;6 months&#39;,&#39;12 months&#39;],&#39;Activity window is ~3 months.&#39;], [&#39;Surgery generally needs about ___ of documented stability.&#39;,&#39;12 months&#39;,[&#39;3 months&#39;,&#39;6 months&#39;],&#39;12 months is the usual stability criterion.&#39;], [&#39;TCIs are preferred on the face, neck, eyelids and ___ areas.&#39;,&#39;intertriginous&#39;,[&#39;trunk&#39;,&#39;acral&#39;],&#39;Steroid-sensitive sites favour TCIs.&#39;], [&#39;Ruxolitinib cream is a topical ___ inhibitor.&#39;,&#39;JAK1/JAK2&#39;,[&#39;calcineurin&#39;,&#39;glucocorticoid receptor&#39;],&#39;It targets IFN-γ signalling.&#39;], [&#39;Ruxolitinib cream: twice daily, up to ___ BSA.&#39;,&#39;10%&#39;,[&#39;3%&#39;,&#39;30%&#39;],&#39;Both FDA and EMA cap at 10% BSA.&#39;], [&#39;F-VASI75 means ~75% improvement, not ___ repigmentation.&#39;,&#39;complete&#39;,[&#39;gradual&#39;,&#39;75%&#39;],&#39;Don’t tell patients one third fully repigment.&#39;], [&#39;NB-UVB wavelength is about ___.&#39;,&#39;311–313 nm&#39;,[&#39;308 nm&#39;,&#39;340 nm&#39;],&#39;308 nm is the excimer.&#39;], [&#39;The ___ (308 nm) suits localized vitiligo.&#39;,&#39;excimer laser/lamp&#39;,[&#39;NB-UVB booth&#39;,&#39;monobenzone&#39;],&#39;Targeted delivery spares normal skin.&#39;], [&#39;Rapid progression: oral corticosteroid ___ therapy.&#39;,&#39;mini-pulse&#39;,[&#39;continuous daily&#39;,&#39;maintenance&#39;],&#39;Intermittent, not prolonged daily.&#39;], [&#39;Leukotrichia is depigmented ___ within a lesion.&#39;,&#39;hair&#39;,[&#39;nails&#39;,&#39;mucosa&#39;],&#39;Hair follicles are a melanocyte reservoir.&#39;], [&#39;Surgery is especially suited to stable ___ vitiligo.&#39;,&#39;segmental&#39;,[&#39;universal&#39;,&#39;rapidly progressive&#39;],&#39;Segmental often stabilizes, then responds to surgery.&#39;], [&#39;Tacrolimus maintenance used ___ application.&#39;,&#39;twice-weekly&#39;,[&#39;daily&#39;,&#39;monthly&#39;],&#39;9.7% vs ~40% lost pigment.&#39;], [&#39;Trial evidence for oral JAKi is not regulatory ___ for vitiligo.&#39;,&#39;approval&#39;,[&#39;efficacy&#39;,&#39;safety&#39;],&#39;Only topical ruxolitinib is approved JAK-based.&#39;]]; var QUIZ=[ [&#39;Which BSA defines MODERATE vitiligo (2026 consensus)?&#39;,&#39;3% to &lt;10%&#39;,[&#39;&lt;3%&#39;,&#39;≥10%&#39;,&#39;10% to 30%&#39;],&#39;&lt;3% mild, 3–&lt;10% moderate, ≥10% severe. Rapid spread can upgrade severity regardless of BSA.&#39;], [&#39;At week 24 of TRuE-V, F-VASI75 with ruxolitinib was about…&#39;,&#39;30% (vehicle 7–11%)&#39;,[&#39;75% (vehicle 30%)&#39;,&#39;10% (vehicle 30%)&#39;,&#39;50% (vehicle 40%)&#39;],&#39;About half reach F-VASI75 only by week 52.&#39;], [&#39;First aim in rapidly progressive vitiligo?&#39;,&#39;Stabilize the disease&#39;,[&#39;Surgical grafting&#39;,&#39;Depigmentation&#39;,&#39;Maximal repigmentation&#39;],&#39;Repigmenting while melanocytes are being destroyed is less effective.&#39;], [&#39;Which site responds WORST to phototherapy?&#39;,&#39;Fingers and toes&#39;,[&#39;Face&#39;,&#39;Neck&#39;,&#39;Trunk&#39;],&#39;Fewer melanocyte reservoirs; leukotrichia also predicts poor response.&#39;], [&#39;How does the EMA indication differ from the FDA’s?&#39;,&#39;EMA specifies facial involvement&#39;,[&#39;EMA allows ≥2 years&#39;,&#39;EMA allows &gt;10% BSA&#39;,&#39;EMA covers segmental&#39;],&#39;Both: ≥12 years, 10% BSA cap. The sources differ here, so know both.&#39;], [&#39;The FDA’s JAK class warnings mean…&#39;,&#39;Class-related risks; not proof of the same frequency in vitiligo trials&#39;,[&#39;Serious events occurred often in trials&#39;,&#39;Topical use is risk-free&#39;,&#39;Only oral JAKi carry warnings&#39;],&#39;Infection, malignancy, MACE, thrombosis are class warnings.&#39;], [&#39;NB-UVB schedule?&#39;,&#39;2–3×/week is common; once/twice weekly also used&#39;,[&#39;Always 3×/week&#39;,&#39;Daily&#39;,&#39;Always once weekly&#39;],&#39;Sources differ: common, not universal.&#39;], [&#39;TCI + UV phototherapy?&#39;,&#39;Individualize; not automatically risk-free&#39;,[&#39;Always contraindicated&#39;,&#39;Always safe&#39;,&#39;Required together&#39;],&#39;Safety and uncertainty with concomitant UV must be considered.&#39;], [&#39;Evidence for methotrexate, cyclosporine, azathioprine, minocycline?&#39;,&#39;Limited&#39;,[&#39;Strong, first-line&#39;,&#39;Equal to ruxolitinib&#39;,&#39;Approved for vitiligo&#39;],&#39;Reserve for selected difficult cases.&#39;], [&#39;Tacrolimus twice-weekly after repigmentation showed…&#39;,&#39;9.7% vs ~40% pigment loss&#39;,[&#39;No benefit&#39;,&#39;40% vs 9.7% worse&#39;,&#39;Same as placebo&#39;],&#39;It reduces relapse.&#39;], [&#39;When may depigmentation (monobenzone) be considered?&#39;,&#39;Very extensive, resistant, patient prefers uniform depigmentation&#39;,[&#39;First-line for any patch&#39;,&#39;Segmental vitiligo&#39;,&#39;Rapid progression&#39;],&#39;Fundamentally different from repigmentation.&#39;]]; var DRILL=[ [&#39;Mild vitiligo: BSA&#39;,&#39;&lt;3%&#39;,[&#39;&lt;10%&#39;,&#39;≥10%&#39;,&#39;&lt;1%&#39;],&#39;3% is the first cut-off.&#39;], [&#39;Severe vitiligo: BSA&#39;,&#39;≥10%&#39;,[&#39;≥3%&#39;,&#39;≥30%&#39;,&#39;≥50%&#39;],&#39;&#39;], [&#39;Rapid-progression window&#39;,&#39;~3 months&#39;,[&#39;~12 months&#39;,&#39;~6 weeks&#39;,&#39;~24 months&#39;],&#39;&#39;], [&#39;Stability before surgery&#39;,&#39;~12 months&#39;,[&#39;~3 months&#39;,&#39;~6 months&#39;,&#39;~2 years&#39;],&#39;&#39;], [&#39;NB-UVB&#39;,&#39;311–313 nm&#39;,[&#39;308 nm&#39;,&#39;290 nm&#39;,&#39;365 nm&#39;],&#39;&#39;], [&#39;Excimer&#39;,&#39;308 nm&#39;,[&#39;311–313 nm&#39;,&#39;254 nm&#39;,&#39;340 nm&#39;],&#39;&#39;], [&#39;Ruxolitinib max treated area&#39;,&#39;10% BSA&#39;,[&#39;3% BSA&#39;,&#39;20% BSA&#39;,&#39;30% BSA&#39;],&#39;&#39;], [&#39;Ruxolitinib minimum age&#39;,&#39;12 years&#39;,[&#39;6 years&#39;,&#39;2 years&#39;,&#39;18 years&#39;],&#39;FDA and EMA both ≥12.&#39;], [&#39;F-VASI75 at week 24 (rux / vehicle)&#39;,&#39;~30% / 7–11%&#39;,[&#39;~50% / 20%&#39;,&#39;~10% / 30%&#39;,&#39;~75% / 40%&#39;],&#39;&#39;], [&#39;Tacrolimus maintenance relapse (drug / placebo)&#39;,&#39;9.7% / ~40%&#39;,[&#39;40% / 9.7%&#39;,&#39;20% / 20%&#39;,&#39;2% / 9.7%&#39;],&#39;&#39;], [&#39;Phototherapy course&#39;,&#39;6–12 months or longer&#39;,[&#39;4–6 weeks&#39;,&#39;2 months&#39;,&#39;Exactly 3 months&#39;],&#39;&#39;], [&#39;EMA: stop ruxolitinib if no improvement after&#39;,&#39;1 year&#39;,[&#39;6 weeks&#39;,&#39;3 months&#39;,&#39;2 years&#39;],&#39;&#39;]]; var CARDS=[ [&#39;Rapidly progressive = ?&#39;,&#39;Many new / enlarging lesions in ~**3 months**&#39;],[&#39;Stable for surgery?&#39;,&#39;~**12 months** photo-documented&#39;],[&#39;Best TCS sites?&#39;,&#39;**Trunk**, extremities&#39;],[&#39;Best TCI sites?&#39;,&#39;**Face, neck, eyelids, intertriginous**&#39;],[&#39;Why tacrolimus?&#39;,&#39;No steroid **atrophy**&#39;],[&#39;Ruxolitinib mechanism?&#39;,&#39;Topical **JAK1/JAK2** inhibitor&#39;],[&#39;F-VASI75 ≠ ?&#39;,&#39;**Complete** repigmentation&#39;],[&#39;Ruxolitinib cap?&#39;,&#39;**10% BSA**, twice daily, ≥12 y&#39;],[&#39;Ruxolitinib class warnings?&#39;,&#39;Infection, malignancy, **MACE**, thrombosis&#39;],[&#39;NB-UVB vs excimer?&#39;,&#39;**311–313** widespread · **308** localized&#39;],[&#39;Phototherapy frequency?&#39;,&#39;**2–3×/week** common (1–2× also used)&#39;],[&#39;Poorest-responding sites?&#39;,&#39;Fingers, toes, hands, feet, bony areas, **leukotrichia**&#39;],[&#39;Systemic for rapid progression?&#39;,&#39;Oral corticosteroid **mini-pulse**&#39;],[&#39;Only approved JAK drug, Oct 2026?&#39;,&#39;Topical **ruxolitinib**&#39;],[&#39;Surgery best for?&#39;,&#39;Stable **segmental** vitiligo&#39;],[&#39;Leukotrichia means?&#39;,&#39;White hair = **poorer** response&#39;]]; var SORTS=[ {n:&#39;Treatment classes&#39;,b:[&#39;Topical anti-inflammatory&#39;,&#39;Topical JAK&#39;,&#39;Systemic, limited evidence&#39;,&#39;Oral JAKi (investigational)&#39;],i:[[&#39;Tacrolimus&#39;,0],[&#39;Pimecrolimus&#39;,0],[&#39;Ruxolitinib cream&#39;,1],[&#39;Methotrexate&#39;,2],[&#39;Cyclosporine&#39;,2],[&#39;Azathioprine&#39;,2],[&#39;Minocycline&#39;,2],[&#39;Tofacitinib&#39;,3],[&#39;Baricitinib&#39;,3],[&#39;Upadacitinib&#39;,3],[&#39;Ritlecitinib&#39;,3]]}, {n:&#39;Site response to phototherapy&#39;,b:[&#39;Better&#39;,&#39;Harder&#39;],i:[[&#39;Face&#39;,0],[&#39;Neck&#39;,0],[&#39;Trunk&#39;,0],[&#39;Proximal extremities&#39;,0],[&#39;Fingers&#39;,1],[&#39;Toes&#39;,1],[&#39;Hands&#39;,1],[&#39;Feet&#39;,1],[&#39;Bony prominences&#39;,1],[&#39;Lesion with leukotrichia&#39;,1]]}]; /* ---------- STATE / UI ---------- */ var MODES=[[&#39;R&#39;,&#39;Review&#39;,&#39;rev&#39;],[&#39;L&#39;,&#39;Learn&#39;,&#39;learn&#39;],[&#39;C&#39;,&#39;Cards&#39;,&#39;cards&#39;],[&#39;Q&#39;,&#39;Quiz&#39;,&#39;quiz&#39;],[&#39;D&#39;,&#39;Numbers&#39;,&#39;drill&#39;],[&#39;S&#39;,&#39;Sort&#39;,&#39;sort&#39;],[&#39;F&#39;,&#39;Fast&#39;,&#39;fast&#39;]]; var K=function(){},cur=&#39;R&#39;; function setTheme(t){R.setAttribute(&#39;data-theme&#39;,t);S.theme=t;save()} setTheme(S.theme||&#39;light&#39;); $(&#39;#tb&#39;).onclick=function(){setTheme(S.theme===&#39;dark&#39;?&#39;light&#39;:&#39;dark&#39;)}; function nav(){var n=$(&#39;#nav&#39;);n.textContent=&#39;&#39;;MODES.forEach(function(m){var b=document.createElement(&#39;button&#39;);b.setAttribute(&#39;role&#39;,&#39;tab&#39;);b.setAttribute(&#39;aria-selected&#39;,m[0]===cur);b.innerHTML=m[1]+&#39;&lt;span class=&quot;kk&quot;&gt;&#39;+m[0]+&#39;&lt;/span&gt;&#39;;b.onclick=function(){go(m[0])};n.appendChild(b)})} function prog(){var kn=Object.keys(S.known).length;var d=[[&#39;Cards&#39;,kn/CARDS.length],[&#39;Learn&#39;,S.learn],[&#39;Quiz&#39;,S.quiz],[&#39;Numbers&#39;,S.drill]];$(&#39;#prog&#39;).innerHTML=d.map(function(x){var p=Math.round(x[1]*100);return &#39;&lt;div&gt;&#39;+x[0]+&#39; &#39;+p+&#39;%&lt;div class=&quot;bar&quot;&gt;&lt;i style=&quot;width:&#39;+p+&#39;%&quot;&gt;&lt;/i&gt;&lt;/div&gt;&lt;/div&gt;&#39;}).join(&#39;&#39;)} function go(k){cur=k;nav();prog();var v=$(&#39;#v&#39;);v.textContent=&#39;&#39;;K=function(){}; ({R:rev,L:function(){mcq(CLOZE,&#39;learn&#39;)},C:cards,Q:function(){mcq(QUIZ,&#39;quiz&#39;)},D:function(){mcq(DRILL,&#39;drill&#39;)},S:function(){sort(0)},F:fast})[k]()} function el(html){var d=document.createElement(&#39;div&#39;);d.innerHTML=html;return d} /* Review */ function bsaSvg(){return &#39;&lt;svg viewBox=&quot;0 0 320 90&quot; width=&quot;100%&quot; role=&quot;img&quot; aria-label=&quot;BSA scale: under 3 mild, 3 to under 10 moderate, 10 and over severe; 3 months and 12 months&quot;&gt;&lt;rect x=&quot;5&quot; y=&quot;8&quot; width=&quot;60&quot; height=&quot;24&quot; fill=&quot;#7cc79a&quot;/&gt;&lt;rect x=&quot;65&quot; y=&quot;8&quot; width=&quot;130&quot; height=&quot;24&quot; fill=&quot;#f2c14e&quot;/&gt;&lt;rect x=&quot;195&quot; y=&quot;8&quot; width=&quot;120&quot; height=&quot;24&quot; fill=&quot;#e0705c&quot;/&gt;&lt;text x=&quot;12&quot; y=&quot;25&quot;&gt;&amp;lt;3%&lt;/text&gt;&lt;text x=&quot;95&quot; y=&quot;25&quot;&gt;3–&amp;lt;10%&lt;/text&gt;&lt;text x=&quot;232&quot; y=&quot;25&quot;&gt;≥10%&lt;/text&gt;&lt;line x1=&quot;5&quot; y1=&quot;62&quot; x2=&quot;315&quot; y2=&quot;62&quot; stroke=&quot;currentColor&quot; stroke-width=&quot;2&quot;/&gt;&lt;circle cx=&quot;5&quot; cy=&quot;62&quot; r=&quot;4&quot;/&gt;&lt;circle cx=&quot;85&quot; cy=&quot;62&quot; r=&quot;5&quot; fill=&quot;#e0705c&quot;/&gt;&lt;circle cx=&quot;315&quot; cy=&quot;62&quot; r=&quot;5&quot; fill=&quot;#1f7a4a&quot;/&gt;&lt;text x=&quot;30&quot; y=&quot;52&quot;&gt;active: ~3 mo&lt;/text&gt;&lt;text x=&quot;150&quot; y=&quot;82&quot;&gt;stable for surgery: ~12 mo&lt;/text&gt;&lt;/svg&gt;&#39;} function rev(){var v=$(&#39;#v&#39;); REV.forEach(function(s){var c=el(&#39;&lt;section class=&quot;card pv&quot;&gt;&lt;div class=&quot;hd&quot;&gt;&#39;+s.t+&#39;&lt;/div&gt;&#39;+(s.svg?bsaSvg():&#39;&#39;)+s.l.map(function(x){return &#39;&lt;div class=&quot;ln&quot;&gt;&lt;b&gt;&#39;+x[0]+&#39;&lt;/b&gt;&#39;+h(x[1])+&#39;&lt;/div&gt;&#39;}).join(&#39;&#39;)+(s.diff?&#39;&lt;div class=&quot;diff&quot;&gt;⚖ &#39;+s.diff+&#39;&lt;/div&gt;&#39;:&#39;&#39;)+(s.cmp?&#39;&lt;div class=&quot;diff&quot;&gt;⚖ FDA: non-segmental, ≥12 y. EMA: non-segmental &lt;mark&gt;with facial involvement&lt;/mark&gt;, ≥12 y. Check local labelling.&lt;/div&gt;&#39;:&#39;&#39;)+&#39;&lt;div class=&quot;ar&quot;&gt;&lt;span class=&quot;sm&quot;&gt;إضافة مساعدة — ليست من المصدر&lt;/span&gt;&#39;+s.ar+&#39;&lt;/div&gt;&lt;/section&gt;&#39;);v.appendChild(c.firstChild)}); v.appendChild(el(&#39;&lt;section class=&quot;card&quot;&gt;&lt;div class=&quot;hd&quot;&gt;Look-alikes&lt;/div&gt;&lt;table&gt;&#39;+LOOK.map(function(x){return &#39;&lt;tr&gt;&lt;th&gt;&#39;+x[0]+&#39;&lt;/th&gt;&lt;td&gt;&#39;+h(x[1])+&#39;&lt;/td&gt;&lt;/tr&gt;&#39;}).join(&#39;&#39;)+&#39;&lt;/table&gt;&lt;div class=&quot;ar&quot;&gt;&lt;span class=&quot;sm&quot;&gt;إضافة مساعدة — ليست من المصدر&lt;/span&gt;أكثر ما يلتبس: 3 أشهر (النشاط) مقابل 12 شهرًا (الاستقرار)، و308 نانومتر (إكسايمر) مقابل 311–313 (NB-UVB).&lt;/div&gt;&lt;/section&gt;&#39;).firstChild); } /* Generic multiple choice: learn (cloze + check), quiz, drill */ function mcq(list,kind){var v=$(&#39;#v&#39;),ord=sh(list.map(function(_,i){return i})),i=0,ok=0,miss=[],pick=null,done=false,opts=[]; function draw(){v.textContent=&#39;&#39;; if(i&gt;=ord.length){var pct=ok/ord.length;if(pct&gt;S[kind]){S[kind]=pct;save()}prog(); v.appendChild(el(&#39;&lt;div class=&quot;card&quot;&gt;&lt;div class=&quot;hd&quot;&gt;Score &#39;+ok+&#39; / &#39;+ord.length+&#39;&lt;/div&gt;&lt;div class=&quot;why&quot;&gt;&#39;+(miss.length?miss.length+&#39; to revisit.&#39;:&#39;All correct.&#39;)+&#39; Best: &#39;+Math.round(S[kind]*100)+&#39;%&lt;/div&gt;&lt;div class=&quot;row&quot;&gt;&#39;+(miss.length?&#39;&lt;button class=&quot;pri&quot; id=&quot;rt&quot;&gt;Retry missed (Enter)&lt;/button&gt;&#39;:&#39;&#39;)+&#39;&lt;button id=&quot;ag&quot;&gt;Restart&lt;/button&gt;&lt;/div&gt;&lt;/div&gt;&#39;)); var rt=$(&#39;#rt&#39;);if(rt)rt.onclick=function(){mcq(miss.map(function(x){return list[x]}),kind)};$(&#39;#ag&#39;).onclick=function(){mcq(list,kind)}; K=function(e){if(e.key===&#39;Enter&#39;){(rt||$(&#39;#ag&#39;)).click()}};return} var it=list[ord[i]];opts=sh([it[1]].concat(it[2]));pick=null;done=false; var q=it[0];if(kind===&#39;learn&#39;)q=q.replace(&#39;___&#39;,&#39;&lt;span class=&quot;blank&quot; id=&quot;bl&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&#39;); var c=el(&#39;&lt;div class=&quot;card&quot;&gt;&lt;div class=&quot;top&quot;&gt;&lt;span&gt;&#39;+(i+1)+&#39; / &#39;+ord.length+&#39;&lt;/span&gt;&lt;span&gt;✓ &#39;+ok+&#39;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-size:19px&quot;&gt;&#39;+q+&#39;&lt;/div&gt;&lt;div id=&quot;os&quot;&gt;&lt;/div&gt;&lt;div id=&quot;fb&quot;&gt;&lt;/div&gt;&lt;div class=&quot;row&quot;&gt;&lt;button class=&quot;pri&quot; id=&quot;go&quot;&gt;&#39;+(kind===&#39;learn&#39;?&#39;Check&#39;:&#39;Next&#39;)+&#39;&lt;/button&gt;&lt;/div&gt;&lt;/div&gt;&#39;); v.appendChild(c.firstChild);var os=$(&#39;#os&#39;); opts.forEach(function(o,k){var b=document.createElement(&#39;button&#39;);b.className=&#39;opt&#39;;b.textContent=(k+1)+&#39;. &#39;+o;b.onclick=function(){choose(k)};os.appendChild(b)}); var go=$(&#39;#go&#39;);if(kind!==&#39;learn&#39;)go.style.display=&#39;none&#39;;go.onclick=act} function choose(k){if(done)return;pick=k;var bs=R.querySelectorAll(&#39;.opt&#39;);bs.forEach(function(b,j){b.classList.toggle(&#39;sel&#39;,j===k)}); if(kind===&#39;learn&#39;){$(&#39;#bl&#39;).textContent=opts[k]}else act()} function act(){var it=list[ord[i]]; if(done){i++;draw();return} if(pick===null)return;done=true;var good=opts[pick]===it[1]; R.querySelectorAll(&#39;.opt&#39;).forEach(function(b,j){b.classList.remove(&#39;sel&#39;);if(opts[j]===it[1])b.classList.add(&#39;ok&#39;);else if(j===pick)b.classList.add(&#39;no&#39;,&#39;shake&#39;)}); if(good)ok++;else miss.push(ord[i]); if(kind===&#39;learn&#39;)$(&#39;#bl&#39;).textContent=it[1]; $(&#39;#fb&#39;).appendChild(el(&#39;&lt;div class=&quot;why&quot;&gt;&#39;+(good?&#39;✓ &#39;:&#39;✗ &#39;)+(it[3]||(&#39;Answer: &#39;+it[1]))+(good?&#39;&#39;:&#39; &lt;b&gt;→ &#39;+it[1]+&#39;&lt;/b&gt;&#39;)+&#39;&lt;/div&gt;&#39;).firstChild); var g=$(&#39;#go&#39;);g.style.display=&#39;&#39;;g.textContent=&#39;Next (Enter)&#39;} K=function(e){if(e.key&gt;=&#39;1&#39;&amp;&amp;e.key&lt;=&#39;4&#39;){var k=+e.key-1;if(k&lt;opts.length)choose(k)}else if(e.key===&#39;Enter&#39;){act()}}; draw()} /* Flashcards */ function cards(){var v=$(&#39;#v&#39;);var q=sh(CARDS.map(function(_,i){return i})).sort(function(a,b){return (S.known[a]?1:0)-(S.known[b]?1:0)}),flip=false; q=q.filter(function(x){return !S.known[x]}); function draw(){v.textContent=&#39;&#39;;var kn=Object.keys(S.known).length; if(!q.length){v.appendChild(el(&#39;&lt;div class=&quot;card&quot;&gt;&lt;div class=&quot;hd&quot;&gt;All &#39;+CARDS.length+&#39; cards marked known&lt;/div&gt;&lt;div class=&quot;row&quot;&gt;&lt;button id=&quot;rs&quot;&gt;Reset known&lt;/button&gt;&lt;/div&gt;&lt;/div&gt;&#39;));$(&#39;#rs&#39;).onclick=function(){S.known={};save();go(&#39;C&#39;)};K=function(){};prog();return} var c=CARDS[q[0]];v.appendChild(el(&#39;&lt;div&gt;&lt;div class=&quot;top&quot;&gt;&lt;span&gt;Left: &#39;+q.length+&#39;&lt;/span&gt;&lt;span&gt;Known: &#39;+kn+&#39;&lt;/span&gt;&lt;/div&gt;&lt;div class=&quot;card fc&quot; id=&quot;fc&quot; tabindex=&quot;0&quot; role=&quot;button&quot; aria-label=&quot;Flip card&quot;&gt;&#39;+(flip?h(c[1]):c[0])+&#39;&lt;/div&gt;&lt;div class=&quot;row&quot;&gt;&lt;button id=&quot;no&quot;&gt;← Not yet&lt;/button&gt;&lt;button id=&quot;fl&quot;&gt;Flip (Space)&lt;/button&gt;&lt;button class=&quot;pri&quot; id=&quot;yes&quot;&gt;Got it →&lt;/button&gt;&lt;/div&gt;&lt;/div&gt;&#39;).firstChild); $(&#39;#fc&#39;).onclick=$(&#39;#fl&#39;).onclick=function(){flip=!flip;draw()};$(&#39;#yes&#39;).onclick=yes;$(&#39;#no&#39;).onclick=no} function yes(){S.known[q.shift()]=1;save();prog();flip=false;draw()} function no(){q.push(q.shift());flip=false;draw()} K=function(e){if(e.key===&#39; &#39;){e.preventDefault();flip=!flip;draw()}else if(e.key===&#39;ArrowRight&#39;)yes();else if(e.key===&#39;ArrowLeft&#39;)no()}; draw()} /* Sort */ function sort(si){var v=$(&#39;#v&#39;),set=SORTS[si],q=sh(set.i),n=0,err=0; function draw(){v.textContent=&#39;&#39;; var sel=&#39;&lt;div class=&quot;row&quot;&gt;&#39;+SORTS.map(function(s,j){return &#39;&lt;button &#39;+(j===si?&#39;class=&quot;pri&quot;&#39;:&#39;&#39;)+&#39; data-s=&quot;&#39;+j+&#39;&quot;&gt;&#39;+s.n+&#39;&lt;/button&gt;&#39;}).join(&#39;&#39;)+&#39;&lt;/div&gt;&#39;; if(!q.length){S.sort=1;save();v.appendChild(el(&#39;&lt;div class=&quot;card&quot;&gt;&lt;div class=&quot;hd&quot;&gt;Sorted! &#39;+err+&#39; slips&lt;/div&gt;&#39;+sel+&#39;&lt;div class=&quot;row&quot;&gt;&lt;button id=&quot;ag&quot;&gt;Again&lt;/button&gt;&lt;/div&gt;&lt;/div&gt;&#39;));$(&#39;#ag&#39;).onclick=function(){sort(si)};K=function(){};return} v.appendChild(el(&#39;&lt;div class=&quot;card&quot;&gt;&lt;div class=&quot;top&quot;&gt;&lt;span&gt;&#39;+(set.i.length-q.length+1)+&#39; / &#39;+set.i.length+&#39;&lt;/span&gt;&lt;span&gt;Slips: &#39;+err+&#39;&lt;/span&gt;&lt;/div&gt;&#39;+sel+&#39;&lt;div style=&quot;font-size:24px;text-align:center;margin:18px 0&quot; id=&quot;it&quot;&gt;&#39;+q[0][0]+&#39;&lt;/div&gt;&lt;div id=&quot;bk&quot;&gt;&lt;/div&gt;&lt;div id=&quot;fb&quot;&gt;&lt;/div&gt;&lt;/div&gt;&#39;).firstChild); set.b.forEach(function(b,k){var x=document.createElement(&#39;button&#39;);x.className=&#39;opt&#39;;x.textContent=(k+1)+&#39;. &#39;+b;x.onclick=function(){put(k)};$(&#39;#bk&#39;).appendChild(x)})} function put(k){if(!q.length)return;if(q[0][1]===k){q.shift();draw()}else{err++;var f=$(&#39;#fb&#39;);f.textContent=&#39;&#39;;f.appendChild(el(&#39;&lt;div class=&quot;why shake&quot; style=&quot;background:var(--nos)&quot;&gt;✗ Not “&#39;+set.b[k]+&#39;” — try again&lt;/div&gt;&#39;).firstChild);R.querySelectorAll(&#39;.opt&#39;)[k].classList.add(&#39;no&#39;)}} K=function(e){if(e.key&gt;=&#39;1&#39;&amp;&amp;e.key&lt;=&#39;4&#39;){var k=+e.key-1;if(k&lt;set.b.length)put(k)}}; draw()} /* Fast review */ function fast(){var v=$(&#39;#v&#39;);var W=[[&#39;Severity&#39;,&#39;&lt;3%&#39;,&#39;3–&lt;10%&#39;,&#39;≥10%&#39;,&#39;3 mo active&#39;,&#39;12 mo stable&#39;],[&#39;Topicals&#39;,&#39;TCS: trunk/limbs&#39;,&#39;TCI: face/folds&#39;,&#39;tacrolimus 0.1%&#39;,&#39;twice-weekly maintenance&#39;],[&#39;Ruxolitinib&#39;,&#39;JAK1/JAK2&#39;,&#39;10% BSA&#39;,&#39;≥12 y&#39;,&#39;F-VASI75 ≠ complete&#39;,&#39;&gt;6 mo&#39;,&#39;class warnings&#39;],[&#39;Light&#39;,&#39;NB-UVB 311–313&#39;,&#39;excimer 308&#39;,&#39;2–3×/wk&#39;,&#39;6–12 mo+&#39;,&#39;leukotrichia = poor&#39;],[&#39;Systemic&#39;,&#39;mini-pulse&#39;,&#39;limited: MTX · CsA · AZA · minocycline&#39;,&#39;oral JAKi = investigational&#39;],[&#39;Surgery&#39;,&#39;stable ≥12 mo&#39;,&#39;segmental&#39;,&#39;grafts · cell suspensions&#39;,&#39;monobenzone = exceptional&#39;]]; W.forEach(function(r){v.appendChild(el(&#39;&lt;div class=&quot;card pv&quot;&gt;&lt;div class=&quot;hd&quot;&gt;&#39;+r[0]+&#39;&lt;/div&gt;&#39;+r.slice(1).map(function(x){return &#39;&lt;span class=&quot;chip&quot;&gt;&#39;+x+&#39;&lt;/span&gt;&#39;}).join(&#39;&#39;)+&#39;&lt;/div&gt;&#39;).firstChild)})} document.addEventListener(&#39;pointerdown&#39;,function(e){act=R.contains(e.target)});document.addEventListener(&#39;focusin&#39;,function(e){act=R.contains(e.target)});R.addEventListener(&#39;click&#39;,function(e){var a=e.target.getAttribute&amp;&amp;e.target.getAttribute(&#39;data-s&#39;);if(a!=null)sort(+a)});document.addEventListener(&#39;keydown&#39;,function(e){if(!act||e.ctrlKey||e.metaKey||e.altKey)return;var tg=e.target.tagName;if(tg===&#39;INPUT&#39;||tg===&#39;TEXTAREA&#39;||tg===&#39;SELECT&#39;||e.target.isContentEditable)return;if(tg===&#39;BUTTON&#39;&amp;&amp;(e.key===&#39;Enter&#39;||e.key===&#39; &#39;))return;var k=e.key.toUpperCase(); if(k===&#39;T&#39;){setTheme(S.theme===&#39;dark&#39;?&#39;light&#39;:&#39;dark&#39;);return} if(k.length===1&amp;&amp;&#39;RLCQDSF&#39;.indexOf(k)&gt;-1){go(k);return}K(e)}); go(&#39;R&#39;);})();/*]]&gt;*/&lt;/script&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/4530919071351841571'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/4530919071351841571'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/10/flex1vts.html' title='Vitiligo Treatment Options: Interactive Study Guide '/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-8212191401466773563</id><published>2026-09-20T23:27:11.928+00:00</published><updated>2026-10-09T05:51:54.382+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="dermatology"/><category scheme="http://www.blogger.com/atom/ns#" term="Hypopigmentation"/><category scheme="http://www.blogger.com/atom/ns#" term="Idiopathic guttate hypomelanosis"/><title type='text'>Idiopathic Guttate Hypomelanosis: Interactive Study Guide</title><content type='html'>&lt;div id=&quot;igh-host&quot; style=&quot;display:block;max-width:100%&quot;&gt;&lt;/div&gt;&lt;noscript&gt;Please enable JavaScript to use this study tool.&lt;/noscript&gt;&lt;script&gt;(function(){&#39;use strict&#39;; let ROOT,APP,HOST,ACTIVE=false,booted=false; const TEMPLATE=&quot;\x3Cstyle&gt;:host{display:block} #app{--bg:#f4f6f9;--card:#fff;--ink:#1d2430;--muted:#5b6575;--line:#d9dfe7;--accent:#1f6f8b;--accent-ink:#fff;--good:#1b7f4b;--goodbg:#e2f5ea;--bad:#b83227;--badbg:#fde8e5;--hl:#fff0a8;--soft:#eef3f8;--ar:#f3efe6;--arline:#cfc4a6} #app[data-theme=dark]{--bg:#10151c;--card:#1a222c;--ink:#e8edf3;--muted:#9aa7b6;--line:#2b3644;--accent:#5ab4d6;--accent-ink:#06222c;--good:#4cc38a;--goodbg:#14301f;--bad:#ff8a7a;--badbg:#3a1a17;--hl:#5c4b00;--soft:#212b37;--ar:#2a2618;--arline:#5a5030} *{box-sizing:border-box} #app{margin:0;border:1px solid var(--line);border-radius:14px;overflow:hidden;display:block;max-width:100%;background:var(--bg);color:var(--ink);font-family:-apple-system,BlinkMacSystemFont,\&quot;Segoe UI\&quot;,Roboto,Arial,\&quot;Noto Naskh Arabic\&quot;,Tahoma,sans-serif;line-height:1.55;font-size:16px} header{position:relative;background:var(--card);border-bottom:1px solid var(--line);padding:8px 12px} .top{display:flex;align-items:center;gap:10px;max-width:900px;margin:0 auto} .top h1{font-size:1rem;margin:0;flex:1} .top h1 small{display:block;font-weight:400;color:var(--muted);font-size:.75rem} .bar{height:8px;background:var(--soft);border-radius:6px;overflow:hidden;flex:1;min-width:70px;max-width:180px} .bar&gt;i{display:block;height:100%;background:var(--good);width:0;transition:width .3s} button{font:inherit;cursor:pointer;color:var(--ink);background:var(--soft);border:1px solid var(--line);border-radius:8px;padding:8px 12px;min-height:44px} button:hover{border-color:var(--accent)} button:focus-visible,[tabindex]:focus-visible,input:focus-visible{outline:3px solid var(--accent);outline-offset:2px} button.primary{background:var(--accent);color:var(--accent-ink);border-color:var(--accent);font-weight:600} button:disabled{opacity:.45;cursor:not-allowed} nav{display:flex;gap:6px;overflow-x:auto;max-width:900px;margin:8px auto 0;padding-bottom:4px} nav button{white-space:nowrap;min-height:40px;padding:6px 12px} nav button[aria-selected=true]{background:var(--accent);color:var(--accent-ink);border-color:var(--accent);font-weight:700} main{max-width:900px;margin:0 auto;padding:12px} .panel{display:none}.panel.on{display:block} .card{background:var(--card);border:1px solid var(--line);border-radius:12px;padding:14px 16px;margin-bottom:14px;direction:ltr;text-align:left} .card h2{margin:0 0 8px;font-size:1.1rem;color:var(--accent)} .card h3{margin:0 0 6px;font-size:1rem} .lines{list-style:none;margin:0;padding:0} .lines li{padding:5px 0;border-bottom:1px dashed var(--line)} .lines li:last-child{border:0} strong{background:var(--hl);padding:0 3px;border-radius:3px;font-weight:700} .mn{margin-top:8px;padding:8px 10px;border-left:4px solid var(--accent);background:var(--soft);border-radius:6px} .ar{direction:rtl;text-align:right;margin-top:10px;background:var(--ar);border:1px dashed var(--arline);border-radius:8px;padding:8px 12px} .arlab{font-size:.75rem;color:var(--muted);font-weight:700;margin-bottom:2px} .ar ul{margin:0;padding:0 18px 0 0} table{width:100%;border-collapse:collapse;margin:8px 0;font-size:.95rem} th,td{border:1px solid var(--line);padding:6px 8px;vertical-align:top;text-align:left} th{background:var(--soft)} svg{max-width:100%;height:auto;display:block;margin:10px auto} svg text{fill:var(--ink);font-family:inherit} .s-dim{fill:var(--line);stroke:var(--muted)}.s-hot{fill:var(--accent);stroke:var(--accent)} .prog{display:grid;grid-template-columns:repeat(auto-fit,minmax(160px,1fr));gap:8px;direction:rtl} .prog div{background:var(--soft);border-radius:8px;padding:8px} .prog span{font-size:.8rem;color:var(--muted)} .prog .bar{max-width:none;margin-top:4px} .opts{display:grid;gap:8px;margin:12px 0} .opt{text-align:left;direction:ltr;display:flex;gap:8px;align-items:flex-start} .opt kbd{background:var(--card);border:1px solid var(--line);border-radius:4px;padding:0 6px;font-size:.8rem} .opt.sel{border-color:var(--accent);box-shadow:0 0 0 2px var(--accent) inset} .opt.ok{background:var(--goodbg);border-color:var(--good)} .opt.no{background:var(--badbg);border-color:var(--bad)} .q{font-size:1.1rem;direction:ltr;text-align:left} .blank{display:inline-block;min-width:90px;border-bottom:3px solid var(--accent);text-align:center;padding:0 6px} .blank.ok{border-color:var(--good);color:var(--good);font-weight:700}.blank.no{border-color:var(--bad)} .msg{padding:8px 10px;border-radius:8px;margin:8px 0;direction:ltr;text-align:left} .msg.ok{background:var(--goodbg)}.msg.no{background:var(--badbg)} .row{display:flex;gap:8px;flex-wrap:wrap;align-items:center;direction:rtl} .meta{color:var(--muted);font-size:.85rem;direction:rtl} .flash{min-height:180px;display:flex;align-items:center;justify-content:center;text-align:center;font-size:1.15rem;cursor:pointer;direction:ltr;border:2px solid var(--accent);border-radius:14px;padding:16px;background:var(--card);user-select:none} .flash.back{background:var(--soft);font-size:1rem} .flash ul{list-style:none;padding:0;margin:0;text-align:left} input.num{width:100%;font-size:1.1rem;padding:10px;border:2px solid var(--line);border-radius:8px;background:var(--card);color:var(--ink);direction:ltr} .chips{display:flex;flex-wrap:wrap;gap:8px} .chip{background:var(--soft);border:1px solid var(--line);border-radius:999px;padding:6px 12px;direction:ltr;text-align:left;min-height:40px;font-size:.95rem} .chip.sel{border-color:var(--accent);box-shadow:0 0 0 2px var(--accent) inset} .chip.done{background:var(--goodbg);border-color:var(--good)} .buckets{display:grid;grid-template-columns:repeat(auto-fit,minmax(200px,1fr));gap:10px;margin-top:12px} .bucket{border:2px dashed var(--line);border-radius:12px;padding:8px;min-height:90px;direction:ltr;cursor:pointer;background:var(--card)} .bucket.over,.bucket:hover{border-color:var(--accent)} .bucket h4{margin:0 0 6px;font-size:.95rem} .shake{animation:sh .35s;border-color:var(--bad)!important} @keyframes sh{0%,100%{transform:translateX(0)}25%{transform:translateX(-6px)}75%{transform:translateX(6px)}} .kw{display:flex;flex-wrap:wrap;gap:6px;margin:6px 0 10px;direction:ltr} .kw span{background:var(--hl);border-radius:6px;padding:3px 9px;font-weight:600} footer{max-width:900px;margin:0 auto;padding:12px;color:var(--muted);font-size:.8rem} footer ol{padding-left:18px;direction:ltr;text-align:left;word-break:break-word} @media print{header,nav,footer .keys,.noprint,#p-learn,#p-cards,#p-quiz,#p-lab,#p-sort,#prog{display:none!important} #p-study,#p-review{display:block!important}#app{background:#fff;color:#000;border:0}.card{break-inside:avoid;border-color:#999}} \x3C/style&gt;\x3Cdiv id=\&quot;app\&quot; dir=\&quot;rtl\&quot; lang=\&quot;ar\&quot;&gt; \x3Cheader&gt; \x3Cdiv class=\&quot;top\&quot;&gt; \x3Ch1&gt;IGH \u00b7 Idiopathic Guttate Hypomelanosis\x3Csmall&gt;\u0623\u062f\u0627\u0629 \u0645\u0630\u0627\u0643\u0631\u0629 \u062a\u0641\u0627\u0639\u0644\u064a\u0629\x3C/small&gt;\x3C/h1&gt; \x3Cdiv class=\&quot;bar\&quot; title=\&quot;\u0627\u0644\u062a\u0642\u062f\u0645 \u0627\u0644\u0643\u0644\u064a\&quot; aria-label=\&quot;Overall progress\&quot;&gt;\x3Ci id=\&quot;topbar\&quot;&gt;\x3C/i&gt;\x3C/div&gt; \x3Cspan id=\&quot;toppct\&quot; class=\&quot;meta\&quot;&gt;0%\x3C/span&gt; \x3Cbutton id=\&quot;themeBtn\&quot; aria-label=\&quot;\u0627\u0644\u0648\u0636\u0639 \u0627\u0644\u0644\u064a\u0644\u064a (D)\&quot; title=\&quot;D\&quot;&gt;\ud83c\udf19\x3C/button&gt; \x3C/div&gt; \x3Cnav role=\&quot;tablist\&quot; id=\&quot;nav\&quot;&gt;\x3C/nav&gt; \x3C/header&gt; \x3Cmain&gt; \x3Cdiv id=\&quot;prog\&quot; class=\&quot;card\&quot; style=\&quot;direction:rtl;text-align:right\&quot;&gt;\x3C/div&gt; \x3Csection id=\&quot;p-study\&quot; class=\&quot;panel on\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3Csection id=\&quot;p-learn\&quot; class=\&quot;panel\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3Csection id=\&quot;p-cards\&quot; class=\&quot;panel\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3Csection id=\&quot;p-quiz\&quot; class=\&quot;panel\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3Csection id=\&quot;p-lab\&quot; class=\&quot;panel\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3Csection id=\&quot;p-sort\&quot; class=\&quot;panel\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3Csection id=\&quot;p-review\&quot; class=\&quot;panel\&quot; role=\&quot;tabpanel\&quot;&gt;\x3C/section&gt; \x3C/main&gt; \x3Cfooter&gt; \x3Cdiv class=\&quot;keys\&quot;&gt;\u0627\u062e\u062a\u0635\u0627\u0631\u0627\u062a: Alt+1\u20267 \u0623\u0648 [ ] \u0644\u0644\u062a\u0646\u0642\u0644 \u0628\u064a\u0646 \u0627\u0644\u0623\u0648\u0636\u0627\u0639 \u00b7 D \u0648\u0636\u0639 \u0644\u064a\u0644\u064a \u00b7 \u0627\u0644\u0628\u0637\u0627\u0642\u0627\u062a: Space \u0642\u0644\u0628\u060c K \u062d\u0641\u0638\u062a\u0647\u0627\u060c J \u0644\u0627 \u00b7 \u0627\u0644\u0627\u062e\u062a\u0628\u0627\u0631: 1\u20134 \u062b\u0645 Enter \u00b7 \u0627\u0644\u062a\u0639\u0644\u0651\u0645: 1\u20133 \u062b\u0645 Enter \u00b7 \u0627\u0644\u062a\u0635\u0646\u064a\u0641: Tab/Enter \u0644\u0627\u062e\u062a\u064a\u0627\u0631 \u0627\u0644\u0639\u0646\u0635\u0631 \u062b\u0645 \u0631\u0642\u0645 \u0627\u0644\u0645\u062c\u0645\u0648\u0639\u0629\x3C/div&gt; \x3Ch3 style=\&quot;margin:12px 0 4px\&quot;&gt;Sources (listed once) \u2014 Medical information report prepared October 2026\x3C/h3&gt; \x3Col&gt; \x3Cli&gt;DermNet New Zealand. Idiopathic guttate hypomelanosis. Updated June 2021.\x3C/li&gt; \x3Cli&gt;Brown F, Syed HA, Crane JS. Idiopathic Guttate Hypomelanosis. StatPearls. Updated February 17, 2025.\x3C/li&gt; \x3Cli&gt;Juntongjin P, Laosakul K. Am J Clin Dermatol. 2016;17(4):403\u2013411. doi:10.1007/s40257-016-0195-3\x3C/li&gt; \x3Cli&gt;Aravindakshan R, et al. A Systematic Review of Interventions for IGH. Clin Exp Dermatol. 2025;50(9):1741\u20131747. doi:10.1093/ced/llaf134\x3C/li&gt; \x3Cli&gt;Kim SK, et al. Int J Dermatol. 2010;49(2):162\u2013166. doi:10.1111/j.1365-4632.2009.04209.x\x3C/li&gt; \x3Cli&gt;DermNet New Zealand. IGH Dermoscopy. December 2019.\x3C/li&gt; \x3Cli&gt;Laosakul K, Juntongjin P. Tip cryotherapy in IGH. J Dermatol Treat. 2017;28(3):271\u2013275. doi:10.1080/09546634.2016.1221498\x3C/li&gt; \x3Cli&gt;Rerknimitr P, et al. Topical tacrolimus in IGH. J Eur Acad Dermatol Venereol. 2013;27(4):460\u2013464. doi:10.1111/j.1468-3083.2012.04462.x\x3C/li&gt; \x3Cli&gt;Arbache S, Hirata SH. 5-Fluorouracil tattooing for IGH. Dermatol Surg. 2023;49(6):603\u2013608. doi:10.1097/DSS.0000000000003793\x3C/li&gt; \x3Cli&gt;Shin MK, et al. IGH in 646 subjects. Int J Dermatol. 2011;50(7):798\u2013805. doi:10.1111/j.1365-4632.2010.04743.x\x3C/li&gt; \x3C/ol&gt; \x3Cp&gt;\u0623\u062f\u0627\u0629 \u062a\u0639\u0644\u064a\u0645\u064a\u0629 \u0644\u0644\u0645\u0630\u0627\u0643\u0631\u0629\u060c \u0644\u0627 \u062a\u063a\u0646\u064a \u0639\u0646 \u062a\u0642\u064a\u064a\u0645 \u0637\u0628\u064a\u0628 \u0627\u0644\u062c\u0644\u062f\u064a\u0629. \u062a\u0639\u0645\u0644 \u062f\u0648\u0646 \u0627\u062a\u0635\u0627\u0644 \u0628\u0627\u0644\u0625\u0646\u062a\u0631\u0646\u062a. Works offline.\x3C/p&gt; \x3C/footer&gt; \x3C/div&gt;&quot;; const $=(s,r)=&gt;(r||ROOT).querySelector(s); function el(tag,cls,txt){const e=document.createElement(tag);if(cls)e.className=cls;if(txt!=null)e.textContent=txt;return e;} function clearNode(n){while(n.firstChild)n.removeChild(n.firstChild);} function rich(parent,str){str.split(&#39;**&#39;).forEach((p,i)=&gt;{if(!p)return;if(i%2)parent.appendChild(el(&#39;strong&#39;,null,p));else parent.appendChild(document.createTextNode(p));});return parent;} function shuffle(a){a=a.slice();for(let i=a.length-1;i&gt;0;i--){const j=Math.floor(Math.random()*(i+1));[a[i],a[j]]=[a[j],a[i]];}return a;} function svgFrom(str){const d=new DOMParser().parseFromString(str,&#39;image/svg+xml&#39;);return document.importNode(d.documentElement,true);} function table(t){const tb=el(&#39;table&#39;);const h=el(&#39;tr&#39;);t.head.forEach(x=&gt;h.appendChild(el(&#39;th&#39;,null,x)));tb.appendChild(h);t.rows.forEach(r=&gt;{const tr=el(&#39;tr&#39;);r.forEach(c=&gt;{const td=el(&#39;td&#39;);rich(td,c);tr.appendChild(td);});tb.appendChild(tr);});return tb;} let S={theme:null,fc:{},cl:{},qz:{best:0},nl:{},so:{}}; const KEY=&#39;igh_study_blogger_v1&#39;; function load(){try{const r=localStorage.getItem(KEY);if(r){const o=JSON.parse(r);S=Object.assign(S,o);}}catch(e){}} function save(){try{localStorage.setItem(KEY,JSON.stringify(S));}catch(e){}renderProgress();} const cnt=o=&gt;Object.keys(o).length; const SECTIONS=[ {id:&#39;def&#39;,t:&#39;1 \u00b7 Definition&#39;,lines:[ &quot;**IGH** = common, **benign**, **acquired** pigmentary disorder&quot;, &quot;**Idiopathic** = cause unknown&quot;, &quot;**Guttate** = small, drop-like&quot;, &quot;**Hypomelanosis** = \u2193 epidermal melanin&quot;, &quot;Multiple small **hypopigmented / depigmented macules**&quot;, &quot;Mainly **sun-exposed** skin&quot;, &quot;More common with **age** (middle-aged and older adults)&quot;, &quot;**Not premalignant** \u00b7 **not contagious** \u00b7 medically harmless&quot;, &quot;Cosmetic concern, esp. in **darker skin tones**&quot;, &quot;Synonyms: **guttate hypomelanosis** \u00b7 **disseminate lenticular leukoderma**&quot;], ar:[&quot;IGH = \u0628\u0642\u0639 \u0628\u064a\u0636\u0627\u0621 \u0635\u063a\u064a\u0631\u0629 \u062d\u0645\u064a\u062f\u0629 \u062a\u0638\u0647\u0631 \u063a\u0627\u0644\u0628\u064b\u0627 \u0645\u0639 \u0627\u0644\u062a\u0642\u062f\u0645 \u0641\u064a \u0627\u0644\u0639\u0645\u0631&quot;,&quot;Idiopathic = \u0627\u0644\u0633\u0628\u0628 \u063a\u064a\u0631 \u0645\u0639\u0631\u0648\u0641 \u00b7 Guttate = \u0628\u062d\u062c\u0645 \u0642\u0637\u0631\u0629 \u0635\u063a\u064a\u0631\u0629&quot;,&quot;\u063a\u064a\u0631 \u0645\u0639\u062f\u064a\u0629\u060c \u0648\u0644\u064a\u0633\u062a \u0645\u0631\u062d\u0644\u0629 \u0633\u0631\u0637\u0627\u0646\u064a\u0629&quot;]}, {id:&#39;epi&#39;,t:&#39;2 \u00b7 Epidemiology&#39;,lines:[ &quot;**All** ethnic groups, phototypes, both sexes&quot;, &quot;**Age:** \u2191 with age; mostly after the **4th decade**; rarely in children&quot;, &quot;**Sex:** both; earlier reports of **female predominance** may reflect cosmetic awareness / care-seeking&quot;, &quot;**Phototype:** all; more **conspicuous** in darker skin&quot;, &quot;**Sun:** chronically exposed skin \u2192 cumulative **UV**&quot;, &quot;**Family** clustering reported \u2192 possible genetic role&quot;, &quot;Prevalence **varies** with population, age, criteria, exam method&quot;, &quot;Study A: **1,174** participants \u2192 **87%** of those **\u226540 y** (study-specific, do not generalize)&quot;, &quot;Study B: **47** patients \u2192 **~30%** first lesions **before age 20**&quot;], ar:[&quot;\u062a\u0632\u064a\u062f \u0645\u0639 \u0627\u0644\u0639\u0645\u0631 \u0648\u062e\u0627\u0635\u0629 \u0628\u0639\u062f \u0627\u0644\u0623\u0631\u0628\u0639\u064a\u0646&quot;,&quot;\u062a\u0635\u064a\u0628 \u0627\u0644\u062c\u0646\u0633\u064a\u0646 \u0648\u0643\u0644 \u0623\u0644\u0648\u0627\u0646 \u0627\u0644\u0628\u0634\u0631\u0629\u060c \u0648\u062a\u0638\u0647\u0631 \u0623\u0648\u0636\u062d \u0641\u064a \u0627\u0644\u0628\u0634\u0631\u0629 \u0627\u0644\u062f\u0627\u0643\u0646\u0629&quot;,&quot;\u0631\u0642\u0645 87% \u062e\u0627\u0635 \u0628\u062f\u0631\u0627\u0633\u0629 \u0648\u0627\u062d\u062f\u0629 \u0648\u0644\u0627 \u064a\u064f\u0639\u0645\u064e\u0651\u0645&quot;]}, {id:&#39;etio&#39;,t:&#39;3 \u00b7 Etiology and Pathogenesis&#39;,lines:[ &quot;Cause **incompletely understood** \u2014 multifactorial&quot;, &quot;**UV:** important contributor, causal link **not proven**&quot;, &quot;Lesions on sun-protected skin + uncommon on some heavily exposed areas \u2192 **UV alone \u2260 explanation**&quot;, &quot;**Aging:** melanocyte\u2013keratinocyte\u2013dermal changes&quot;, &quot;**Melanocytes:** \u2193 epidermal melanin \u00b7 \u2193 functional melanocytes (some lesions) \u00b7 \u2193 dendrites \u00b7 \u2193 melanosomes \u00b7 degenerative changes \u00b7 impaired melanin transfer&quot;, &quot;**Genetics:** familial clustering; **no single defect** established&quot;, &quot;**Other proposals:** minor trauma \u00b7 keratinocyte function \u00b7 senescence \u00b7 local regulatory factors&quot;, &quot;**Autoimmune:** proposed, role **uncertain** \u2014 **not** an established autoimmune disease&quot;, &quot;**Not contagious** \u00b7 no established link to vitamin deficiency or systemic disease (ordinary cases)&quot;], ar:[&quot;\u0627\u0644\u0633\u0628\u0628 \u063a\u064a\u0631 \u0645\u062d\u0633\u0648\u0645: \u0639\u0648\u0627\u0645\u0644 \u0645\u062a\u0639\u062f\u062f\u0629&quot;,&quot;\u0627\u0644\u0634\u0645\u0633 \u0639\u0627\u0645\u0644 \u0645\u0647\u0645 \u0644\u0643\u0646 \u0644\u0645 \u064a\u062b\u0628\u062a \u0623\u0646\u0647\u0627 \u0627\u0644\u0633\u0628\u0628 \u0627\u0644\u0648\u062d\u064a\u062f&quot;,&quot;\u0644\u0627 \u062f\u0644\u064a\u0644 \u0639\u0644\u0649 \u0646\u0642\u0635 \u0641\u064a\u062a\u0627\u0645\u064a\u0646\u060c \u0648\u0644\u0627 \u0647\u064a \u0645\u0631\u0636 \u0645\u0646\u0627\u0639\u064a \u0630\u0627\u062a\u064a \u0645\u062b\u0628\u062a&quot;]}, {id:&#39;clin&#39;,t:&#39;4 \u00b7 Clinical Manifestations&#39;,svg:&#39;body&#39;,lines:[ &quot;**Morphology:** small round / oval / occasionally irregular **macules**&quot;, &quot;**White / porcelain-white**, lighter than surrounding skin&quot;, &quot;Usually **2\u20135 mm** (larger occasionally)&quot;, &quot;**Flat**, discrete, fairly well-defined margins; smooth, **no inflammation or scaling**&quot;, &quot;Some: irregular / stellate / **scalloped** borders; rare mild **hyperkeratosis**&quot;, &quot;**Sites:** extensor/dorsal **forearms** \u00b7 anterior lower legs (**shins**) \u00b7 dorsal **hands** \u00b7 other sun-exposed limbs \u00b7 occasionally upper chest/trunk&quot;, &quot;**Face:** less common&quot;, &quot;**Symptoms:** none \u2014 no itch, pain, burning, tenderness&quot;, &quot;Patients come for **cosmetics** or worry about the white spots&quot;, &quot;**Course:** slow, over **years**; lesions **persist**; new ones appear with age&quot;, &quot;Slow enlargement possible; **rapid** expansion not typical; spontaneous repigmentation **uncommon**&quot;], ar:[&quot;\u0628\u0642\u0639 \u0628\u064a\u0636\u0627\u0621 \u0645\u0633\u0637\u062d\u0629 \u0635\u063a\u064a\u0631\u0629 2\u20135 \u0645\u0644\u0645 \u0639\u0644\u0649 \u0627\u0644\u0633\u0627\u0639\u062f\u064a\u0646 \u0648\u0627\u0644\u0633\u0627\u0642\u064a\u0646&quot;,&quot;\u0644\u0627 \u062d\u0643\u0629 \u0648\u0644\u0627 \u0623\u0644\u0645 \u0648\u0644\u0627 \u0642\u0634\u0648\u0631&quot;,&quot;\u062a\u0628\u0642\u0649 \u0648\u062a\u0632\u064a\u062f \u0628\u0628\u0637\u0621 \u0645\u0639 \u0627\u0644\u0639\u0645\u0631&quot;]}, {id:&#39;histo&#39;,t:&#39;5 \u00b7 Histopathology&#39;,lines:[ &quot;Biopsy **not routine** \u2014 usually clinical diagnosis&quot;, &quot;1 \u00b7 \u2193 **epidermal melanin** (basal layer, focal absence)&quot;, &quot;2 \u00b7 **Melanocytes:** \u2193 in some lesions, preserved in others&quot;, &quot;3 \u00b7 **Flattened rete ridges** (variable)&quot;, &quot;4 \u00b7 **Epidermal thinning** (not in every case)&quot;, &quot;5 \u00b7 **Orthokeratotic hyperkeratosis** (basket-weave or compact)&quot;, &quot;6 \u00b7 **Skip areas:** small foci of retained basal melanin&quot;, &quot;Stains: **Fontana\u2013Masson** (melanin) \u00b7 melanocyte markers&quot;, &quot;No single feature is universal or independently diagnostic&quot;, &quot;47 patients: **hyperkeratosis 38.3%** \u00b7 **atrophy 10.6%** \u00b7 **flat rete ridges 14.9%**&quot;], ar:[&quot;\u0627\u0644\u062e\u0632\u0639\u0629 \u0644\u064a\u0633\u062a \u0631\u0648\u062a\u064a\u0646\u064a\u0629&quot;,&quot;\u0627\u0644\u0645\u0647\u0645: \u0646\u0642\u0635 \u0627\u0644\u0645\u064a\u0644\u0627\u0646\u064a\u0646 \u0648\u062a\u063a\u064a\u0631\u0627\u062a \u0641\u064a \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u0635\u0628\u063a\u064a\u0629&quot;,&quot;\u0644\u0627 \u062a\u0648\u062c\u062f \u0639\u0644\u0627\u0645\u0629 \u0645\u062c\u0647\u0631\u064a\u0629 \u0648\u0627\u062d\u062f\u0629 \u062a\u062d\u0633\u0645 \u0627\u0644\u062a\u0634\u062e\u064a\u0635&quot;]}, {id:&#39;diag&#39;,t:&#39;6 \u00b7 Diagnosis&#39;,lines:[ &quot;**Clinical** diagnosis: morphology + distribution + history&quot;, &quot;Typical: multiple persistent, asymptomatic small white macules, sun-exposed limbs, middle-aged/older&quot;, &quot;**Wood&#39;s lamp:** accentuates contrast; **not specific**&quot;, &quot;**Dermoscopy:** white **structureless** areas \u00b7 \u2193/absent pigment network \u00b7 irregular peripheral extensions \u00b7 retained perifollicular/peripheral pigment&quot;, &quot;**Biopsy:** atypical features, or another diagnosis can&#39;t be excluded&quot;, &quot;**Labs:** not routine; guided by the suspected alternative&quot;], tbl:{head:[&#39;Dermoscopic pattern&#39;,&#39;Description&#39;],rows:[[&quot;**Amoeboid**&quot;,&quot;White areas with pseudopod-like peripheral extensions&quot;],[&quot;**Feathery**&quot;,&quot;Irregular feather-like linear extensions at margins&quot;],[&quot;**Petaloid**&quot;,&quot;Peripheral projections resembling flower petals&quot;],[&quot;**Nebuloid**&quot;,&quot;Cloud-like white areas, poorly defined borders&quot;]]}, mn:&quot;Memory key \u2014 pond \u2192 sky: **A**moeba \u2192 **F**eather \u2192 **P**etal \u2192 **N**ebula (A-F-P-N). Supportive, not specific to IGH.&quot;, ar:[&quot;\u0627\u0644\u062a\u0634\u062e\u064a\u0635 \u0625\u0643\u0644\u064a\u0646\u064a\u0643\u064a \u0628\u0627\u0644\u0623\u0633\u0627\u0633&quot;,&quot;\u0645\u0635\u0628\u0627\u062d \u0648\u0648\u062f \u0644\u0627 \u064a\u062d\u0633\u0645\u060c \u0648\u0627\u0644\u062f\u064a\u0631\u0645\u0648\u0633\u0643\u0648\u0628\u064a \u064a\u062f\u0639\u0645&quot;,&quot;\u0627\u0644\u062e\u0632\u0639\u0629 \u0639\u0646\u062f \u0627\u0644\u0634\u0643 \u0641\u0642\u0637&quot;]}, {id:&#39;ddx&#39;,t:&#39;7 \u00b7 Differential Diagnosis&#39;,lines:[ &quot;Most important to separate from **vitiligo** \u2014 different natural history and treatment&quot;, &quot;**IGH** = flat, smooth, asymptomatic, 2\u20135 mm, forearms/shins&quot;, &quot;**Lichen sclerosus** = sclerosis / atrophy / may be symptomatic&quot;, &quot;**Pityriasis versicolor** = scale + KOH (Malassezia) \u00b7 **Pityriasis alba** = children&#39;s face&quot;, &quot;Atypical distribution / appearance / progression \u2192 consider rarer causes&quot;], tbl:{head:[&#39;Condition&#39;,&#39;Distinguishing features&#39;],rows:[ [&quot;**Vitiligo**&quot;,&quot;Often sharply demarcated depigmented patches that may enlarge or coalesce; typical distribution and Wood&#39;s lamp findings&quot;], [&quot;**Pityriasis versicolor**&quot;,&quot;Hypopigmented / variably pigmented patches, often upper trunk, sometimes fine scale; KOH may show Malassezia&quot;], [&quot;**Pityriasis alba**&quot;,&quot;Ill-defined hypopigmented patches, commonly face of children/adolescents, dryness or mild eczema&quot;], [&quot;**Post-inflammatory hypopigmentation**&quot;,&quot;Follows dermatitis, injury, infection, or a procedure&quot;], [&quot;**Lichen sclerosus**&quot;,&quot;Porcelain-white lesions; sclerosis, atrophy, surface alteration, or symptomatic inflammation&quot;], [&quot;**Guttate morphea**&quot;,&quot;Small localized sclerotic lesions, textural change, possible surrounding pigment abnormality&quot;], [&quot;**Contact leukoderma**&quot;,&quot;Depigmentation after certain chemical exposure; characteristic distribution&quot;]]}, ar:[&quot;\u0623\u0647\u0645 \u062a\u0641\u0631\u064a\u0642: \u0627\u0644\u0628\u0647\u0627\u0642 (Vitiligo)&quot;,&quot;\u0644\u0643\u0644 \u0645\u0631\u0636 \u0639\u0644\u0627\u0645\u0629 \u062a\u0645\u064a\u0632\u0647: \u0642\u0634\u0648\u0631 \u0645\u0639 KOH\u060c \u0648\u062c\u0647 \u0627\u0644\u0623\u0637\u0641\u0627\u0644\u060c \u062a\u0635\u0644\u0628\u060c \u062a\u0639\u0631\u0636 \u0643\u064a\u0645\u064a\u0627\u0626\u064a\u2026&quot;]}, {id:&#39;txg&#39;,t:&#39;8A \u00b7 Treatment \u2014 General management&#39;,lines:[ &quot;IGH benign \u2192 **no medical treatment required**&quot;, &quot;Mainstay: **reassurance + education + photoprotection**&quot;, &quot;Consider treatment only if **cosmetic concern** is substantial&quot;, &quot;**No** universally accepted, reliably curative treatment&quot;, &quot;**Reassure:** benign \u00b7 not contagious \u00b7 not a skin-cancer precursor \u00b7 usually no complications \u00b7 not usually a sign of systemic disease \u00b7 may persist indefinitely&quot;, &quot;**Photoprotection:** broad-spectrum **SPF 30+** \u00b7 protective clothing \u00b7 limit sun \u00b7 avoid tanning devices&quot;, &quot;Ability to **prevent IGH or reverse lesions** NOT conclusively shown&quot;, &quot;**Camouflage:** skin camouflage products, carefully selected self-tanners&quot;], mn:&quot;Ladder: **Reassure \u2192 Protect \u2192 Camouflage \u2192 (only then) topicals / procedures**&quot;, ar:[&quot;\u0644\u0627 \u064a\u062d\u062a\u0627\u062c \u0639\u0644\u0627\u062c\u064b\u0627 \u0637\u0628\u064a\u064b\u0627&quot;,&quot;\u0627\u0644\u0623\u0633\u0627\u0633: \u0637\u0645\u0623\u0646\u0629 + \u062d\u0645\u0627\u064a\u0629 \u0645\u0646 \u0627\u0644\u0634\u0645\u0633&quot;,&quot;\u0644\u0627 \u064a\u062b\u0628\u062a \u0623\u0646 \u0627\u0644\u0648\u0627\u0642\u064a \u064a\u0645\u0646\u0639 \u0627\u0644\u0645\u0631\u0636 \u0623\u0648 \u064a\u0639\u0643\u0633\u0647&quot;]}, {id:&#39;txt&#39;,t:&#39;8B \u00b7 Treatment \u2014 Topicals&#39;,svg:&#39;scale2&#39;,lines:[ &quot;**Retinoids (tretinoin):** limited evidence \u00b7 irritation, erythema, dryness, post-inflammatory pigment change&quot;, &quot;**Tacrolimus 0.1% ointment:** double-blind RCT, **26** patients, **6 months**&quot;, &quot;\u2192 **Colorimetric** improvement: statistically **significant** vs placebo&quot;, &quot;\u2192 **Physician-assessed:** only **11%**, difference **not significant**&quot;, &quot;\u2192 Not an established standard treatment&quot;, &quot;**Corticosteroids (topical / intralesional):** **not routinely recommended** \u2014 limited benefit; atrophy, pigment change&quot;], ar:[&quot;\u0627\u0644\u0623\u062f\u0644\u0629 \u0645\u062d\u062f\u0648\u062f\u0629 \u0644\u0643\u0644 \u0627\u0644\u0645\u0648\u0636\u0639\u064a\u0627\u062a&quot;,&quot;\u0627\u0644\u062a\u0627\u0643\u0631\u0648\u0644\u064a\u0645\u0648\u0633: \u062a\u062d\u0633\u0646 \u0628\u0627\u0644\u0642\u064a\u0627\u0633 \u0627\u0644\u062c\u0647\u0627\u0632\u064a\u060c \u0648\u062a\u062d\u0633\u0646 \u0625\u0643\u0644\u064a\u0646\u064a\u0643\u064a \u0642\u0644\u064a\u0644 \u063a\u064a\u0631 \u0645\u0639\u0646\u0648\u064a&quot;]}, {id:&#39;txc&#39;,t:&#39;8C \u00b7 Treatment \u2014 Cryotherapy&#39;,lines:[ &quot;**Liquid nitrogen** \u2014 controlled superficial injury \u2192 healing \u2192 repigmentation&quot;, &quot;Randomized, evaluator-blinded: **101** lesions = **43** treated + **58** control&quot;, &quot;**&gt;75% improvement:** **82.3%** treated vs **2%** control, at **4 months**&quot;, &quot;Percentages = **lesions**, not patients&quot;, &quot;One small study; 4 months \u2192 **durability not shown**&quot;, &quot;**Adverse:** pain/burning \u00b7 blistering \u00b7 post-inflammatory hyperpigmentation \u00b7 worse hypopigmentation \u00b7 scarring&quot;, &quot;**Darker phototypes:** pigment complications more noticeable/persistent&quot;, &quot;Only by **trained clinicians**&quot;], ar:[&quot;\u0627\u0644\u0646\u064a\u062a\u0631\u0648\u062c\u064a\u0646 \u0627\u0644\u0633\u0627\u0626\u0644: \u0646\u062a\u064a\u062c\u0629 \u0648\u0627\u0639\u062f\u0629 \u0645\u0646 \u062f\u0631\u0627\u0633\u0629 \u0648\u0627\u062d\u062f\u0629 \u0635\u063a\u064a\u0631\u0629&quot;,&quot;\u0627\u0644\u0646\u0633\u0628 \u062a\u062e\u0635 \u0627\u0644\u0628\u0642\u0639 \u0648\u0644\u064a\u0633 \u0627\u0644\u0645\u0631\u0636\u0649&quot;,&quot;\u062d\u0630\u0631 \u062e\u0627\u0635 \u0641\u064a \u0627\u0644\u0628\u0634\u0631\u0629 \u0627\u0644\u062f\u0627\u0643\u0646\u0629&quot;]}, {id:&#39;txl&#39;,t:&#39;8D \u00b7 Treatment \u2014 Laser and light&#39;,lines:[ &quot;**Fractional CO\u2082** laser&quot;, &quot;**Nonablative fractional 1,550-nm**&quot;, &quot;**Targeted 308-nm excimer** light&quot;, &quot;Aim: controlled injury \u00b7 epidermal remodeling \u00b7 melanocyte activation/migration&quot;, &quot;Some encouraging results; **small studies, inconsistent protocols, uncertain durability**&quot;, &quot;**Complications:** prolonged erythema \u00b7 PIH \u00b7 hypopigmentation \u00b7 scarring&quot;], ar:[&quot;\u0644\u064a\u0632\u0631 \u0648\u0636\u0648\u0621: \u0646\u062a\u0627\u0626\u062c \u0645\u0634\u062c\u0639\u0629 \u0644\u0643\u0646 \u0627\u0644\u062f\u0631\u0627\u0633\u0627\u062a \u0635\u063a\u064a\u0631\u0629&quot;,&quot;\u0645\u0636\u0627\u0639\u0641\u0627\u062a \u0645\u062d\u062a\u0645\u0644\u0629&quot;]}, {id:&#39;txp&#39;,t:&#39;8E \u00b7 Treatment \u2014 Other procedures and 5-FU&#39;,lines:[ &quot;Studied: **superficial dermabrasion \u00b7 microneedling \u00b7 chemical peeling \u00b7 phenol \u00b7 TCA \u00b7 grafting**&quot;, &quot;Variable repigmentation; evidence **insufficient** for routine use (IGH is harmless)&quot;, &quot;High-concentration peels: burns, permanent pigment change, scarring \u2192 **never unsupervised at home**&quot;, &quot;**5-FU tattooing (2023):** randomized, single-blinded, **split-body**, **29** patients&quot;, &quot;\u2192 5-FU (one limb) vs **saline** (other limb)&quot;, &quot;\u2192 Both sides \u2193 achromic lesions; **greater on 5-FU side**&quot;, &quot;\u2192 Saline improvement \u21d2 **injury itself** may contribute&quot;, &quot;\u2192 Small, short follow-up \u2192 **not standard**&quot;, &quot;5-FU = **cytotoxic**; intradermal use for IGH = **off-label, investigational** \u2192 specialist supervision&quot;], ar:[&quot;\u0623\u062f\u0644\u0629 \u063a\u064a\u0631 \u0643\u0627\u0641\u064a\u0629 \u0644\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0631\u0648\u062a\u064a\u0646\u064a&quot;,&quot;\u0627\u0644\u062a\u0642\u0634\u064a\u0631 \u0627\u0644\u0642\u0648\u064a \u0645\u0645\u0646\u0648\u0639 \u0645\u0646\u0632\u0644\u064a\u064b\u0627&quot;,&quot;5-FU \u062f\u0648\u0627\u0621 \u0633\u0627\u0645 \u0644\u0644\u062e\u0644\u0627\u064a\u0627\u060c \u0648\u0627\u0633\u062a\u062e\u062f\u0627\u0645\u0647 \u0647\u0646\u0627 \u062e\u0627\u0631\u062c \u0627\u0644\u062a\u0631\u062e\u064a\u0635 \u0648\u062a\u062d\u062a \u0625\u0634\u0631\u0627\u0641 \u0645\u062a\u062e\u0635\u0635 \u0641\u0642\u0637&quot;]}, {id:&#39;evid&#39;,t:&#39;9 \u00b7 Evidence on Treatment&#39;,lines:[ &quot;**Systematic review** \u2014 Clin Exp Dermatol, **2025**&quot;, &quot;Search: database inception \u2192 **November 2023** (so not all studies up to 2025)&quot;, &quot;**20** eligible studies = **9 randomized** + **11 quasi-experimental**&quot;, &quot;Many modalities can repigment \u2014 esp. **controlled therapeutic injury**&quot;, &quot;Limits: ~half of RCTs **high risk of bias** \u00b7 small samples \u00b7 different outcome measures \u00b7 unstandardized protocols \u00b7 little long-term data \u00b7 durability uncertain&quot;, &quot;\u2192 **No treatment** shown consistently superior&quot;, &quot;Balance **cosmetic benefit** vs risks, costs, expectations&quot;], ar:[&quot;\u0645\u0631\u0627\u062c\u0639\u0629 \u0645\u0646\u0647\u062c\u064a\u0629 2025: 20 \u062f\u0631\u0627\u0633\u0629 (9 \u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u064811 \u0634\u0628\u0647 \u062a\u062c\u0631\u064a\u0628\u064a\u0629)&quot;,&quot;\u0627\u0644\u0628\u062d\u062b \u062d\u062a\u0649 \u0646\u0648\u0641\u0645\u0628\u0631 2023&quot;,&quot;\u0644\u0627 \u0639\u0644\u0627\u062c \u0648\u0627\u062d\u062f \u062b\u0628\u062a \u062a\u0641\u0648\u0642\u0647&quot;]}, {id:&#39;prog&#39;,t:&#39;10\u201312 \u00b7 Prognosis, referral and take-home&#39;,lines:[ &quot;**Prognosis excellent** \u00b7 chronic, benign \u00b7 **no malignant transformation**&quot;, &quot;Usually **no physical complications**; spots may increase with age&quot;, &quot;Main consequence: **psychological / cosmetic**&quot;, &quot;Aggressive cosmetic treatment can be **worse than the condition**&quot;, &quot;**Dermatology assessment** if: uncertain diagnosis \u00b7 unusually **rapid** appearance/spread \u00b7 patches **enlarge/merge** \u00b7 inflammation, scaling, sclerosis, ulceration \u00b7 unusual distribution \u00b7 considering **procedural** treatment&quot;, &quot;**Take-home:** clinical diagnosis \u2192 reassurance + photoprotection \u2192 individualized, realistic expectations&quot;], ar:[&quot;\u0627\u0644\u0625\u0646\u0630\u0627\u0631 \u0645\u0645\u062a\u0627\u0632 \u0648\u0644\u0627 \u064a\u062a\u062d\u0648\u0644 \u0644\u0648\u0631\u0645&quot;,&quot;\u0627\u0644\u0645\u0634\u0643\u0644\u0629 \u0627\u0644\u0623\u0643\u0628\u0631 \u0646\u0641\u0633\u064a\u0629 \u0623\u0648 \u062a\u062c\u0645\u064a\u0644\u064a\u0629&quot;,&quot;\u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0637\u0628\u064a\u0628 \u0639\u0646\u062f \u0627\u0644\u0634\u0643\u060c \u0627\u0644\u0627\u0646\u062a\u0634\u0627\u0631 \u0627\u0644\u0633\u0631\u064a\u0639\u060c \u0627\u0644\u0627\u0644\u062a\u0647\u0627\u0628 \u0623\u0648 \u0627\u0644\u0642\u0634\u0648\u0631\u060c \u0623\u0648 \u0627\u0644\u062a\u0641\u0643\u064a\u0631 \u0641\u064a \u0639\u0644\u0627\u062c \u0625\u062c\u0631\u0627\u0626\u064a&quot;]} ]; const SVGS={ body:&#39;\x3Csvg xmlns=&quot;http://www.w3.org/2000/svg&quot; viewBox=&quot;0 0 320 270&quot; width=&quot;300&quot; role=&quot;img&quot; aria-label=&quot;Body map of typical IGH sites&quot;&gt;\x3Ccircle cx=&quot;160&quot; cy=&quot;26&quot; r=&quot;18&quot; class=&quot;s-dim&quot;/&gt;\x3Ctext x=&quot;190&quot; y=&quot;30&quot; font-size=&quot;11&quot;&gt;face: less common\x3C/text&gt;\x3Crect x=&quot;128&quot; y=&quot;48&quot; width=&quot;64&quot; height=&quot;88&quot; rx=&quot;14&quot; class=&quot;s-dim&quot;/&gt;\x3Ctext x=&quot;160&quot; y=&quot;95&quot; font-size=&quot;10&quot; text-anchor=&quot;middle&quot;&gt;trunk: occasional\x3C/text&gt;\x3Cline x1=&quot;128&quot; y1=&quot;58&quot; x2=&quot;100&quot; y2=&quot;104&quot; stroke=&quot;#8a95a5&quot; stroke-width=&quot;12&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Cline x1=&quot;100&quot; y1=&quot;104&quot; x2=&quot;86&quot; y2=&quot;150&quot; stroke=&quot;#1f6f8b&quot; stroke-width=&quot;12&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Ccircle cx=&quot;82&quot; cy=&quot;164&quot; r=&quot;9&quot; class=&quot;s-hot&quot;/&gt;\x3Cline x1=&quot;192&quot; y1=&quot;58&quot; x2=&quot;220&quot; y2=&quot;104&quot; stroke=&quot;#8a95a5&quot; stroke-width=&quot;12&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Cline x1=&quot;220&quot; y1=&quot;104&quot; x2=&quot;234&quot; y2=&quot;150&quot; stroke=&quot;#1f6f8b&quot; stroke-width=&quot;12&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Ccircle cx=&quot;238&quot; cy=&quot;164&quot; r=&quot;9&quot; class=&quot;s-hot&quot;/&gt;\x3Cline x1=&quot;146&quot; y1=&quot;140&quot; x2=&quot;144&quot; y2=&quot;200&quot; stroke=&quot;#8a95a5&quot; stroke-width=&quot;14&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Cline x1=&quot;144&quot; y1=&quot;200&quot; x2=&quot;142&quot; y2=&quot;252&quot; stroke=&quot;#1f6f8b&quot; stroke-width=&quot;12&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Cline x1=&quot;174&quot; y1=&quot;140&quot; x2=&quot;176&quot; y2=&quot;200&quot; stroke=&quot;#8a95a5&quot; stroke-width=&quot;14&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Cline x1=&quot;176&quot; y1=&quot;200&quot; x2=&quot;178&quot; y2=&quot;252&quot; stroke=&quot;#1f6f8b&quot; stroke-width=&quot;12&quot; stroke-linecap=&quot;round&quot;/&gt;\x3Ctext x=&quot;8&quot; y=&quot;120&quot; font-size=&quot;11&quot;&gt;forearms\x3C/text&gt;\x3Ctext x=&quot;8&quot; y=&quot;168&quot; font-size=&quot;11&quot;&gt;hands (dorsal)\x3C/text&gt;\x3Ctext x=&quot;196&quot; y=&quot;232&quot; font-size=&quot;11&quot;&gt;shins\x3C/text&gt;\x3C/svg&gt;&#39;, scale2:&#39;\x3Csvg xmlns=&quot;http://www.w3.org/2000/svg&quot; viewBox=&quot;0 0 320 110&quot; width=&quot;300&quot; role=&quot;img&quot; aria-label=&quot;Follow-up durations&quot;&gt;\x3Ctext x=&quot;4&quot; y=&quot;16&quot; font-size=&quot;12&quot;&gt;Tacrolimus RCT \u2014 6 months\x3C/text&gt;\x3Crect x=&quot;4&quot; y=&quot;22&quot; width=&quot;240&quot; height=&quot;16&quot; rx=&quot;4&quot; class=&quot;s-hot&quot;/&gt;\x3Ctext x=&quot;4&quot; y=&quot;64&quot; font-size=&quot;12&quot;&gt;Cryotherapy RCT \u2014 4 months\x3C/text&gt;\x3Crect x=&quot;4&quot; y=&quot;70&quot; width=&quot;160&quot; height=&quot;16&quot; rx=&quot;4&quot; class=&quot;s-hot&quot;/&gt;\x3Ctext x=&quot;4&quot; y=&quot;104&quot; font-size=&quot;10&quot;&gt;1 month = 40 px\x3C/text&gt;\x3C/svg&gt;&#39; }; SECTIONS.find(s=&gt;s.id===&#39;clin&#39;).svgs=[&#39;body&#39;]; SECTIONS.find(s=&gt;s.id===&#39;clin&#39;).extra=&#39;size&#39;; const SIZE_SVG=&#39;\x3Csvg xmlns=&quot;http://www.w3.org/2000/svg&quot; viewBox=&quot;0 0 320 70&quot; width=&quot;300&quot; role=&quot;img&quot; aria-label=&quot;Lesion size scale 2 to 5 mm&quot;&gt;\x3Crect x=&quot;60&quot; y=&quot;14&quot; width=&quot;180&quot; height=&quot;18&quot; class=&quot;s-hot&quot; opacity=&quot;.85&quot;/&gt;\x3Cline x1=&quot;0&quot; y1=&quot;40&quot; x2=&quot;320&quot; y2=&quot;40&quot; stroke=&quot;#8a95a5&quot;/&gt;\x3Cg font-size=&quot;11&quot; text-anchor=&quot;middle&quot;&gt;\x3Ctext x=&quot;20&quot; y=&quot;58&quot;&gt;0\x3C/text&gt;\x3Ctext x=&quot;60&quot; y=&quot;58&quot;&gt;2 mm\x3C/text&gt;\x3Ctext x=&quot;140&quot; y=&quot;58&quot;&gt;3\u20134\x3C/text&gt;\x3Ctext x=&quot;240&quot; y=&quot;58&quot;&gt;5 mm\x3C/text&gt;\x3Ctext x=&quot;300&quot; y=&quot;58&quot;&gt;6\x3C/text&gt;\x3C/g&gt;\x3Ctext x=&quot;150&quot; y=&quot;27&quot; font-size=&quot;11&quot; text-anchor=&quot;middle&quot; fill=&quot;#fff&quot; style=&quot;fill:#fff&quot;&gt;typical 2\u20135 mm\x3C/text&gt;\x3C/svg&gt;&#39;; const CARDS=[ [&quot;What is IGH?&quot;,&quot;Common, benign, acquired pigmentary disorder \u00b7 multiple small hypopigmented/depigmented macules \u00b7 mainly sun-exposed skin&quot;], [&quot;Idiopathic / Guttate / Hypomelanosis&quot;,&quot;Cause unknown / small, drop-like / \u2193 epidermal melanin&quot;], [&quot;Synonyms of IGH&quot;,&quot;Guttate hypomelanosis \u00b7 Disseminate lenticular leukoderma&quot;], [&quot;Is IGH premalignant or contagious?&quot;,&quot;Neither. Medically harmless, not premalignant, not contagious&quot;], [&quot;Age pattern&quot;,&quot;\u2191 with age \u00b7 mostly after 4th decade \u00b7 rarely younger adults/children&quot;], [&quot;Sex note&quot;,&quot;Both sexes. Earlier female predominance may reflect cosmetic awareness / care-seeking&quot;], [&quot;1,174 participants study&quot;,&quot;Prevalence 87% in those \u226540 y \u2014 study-specific, do not generalize&quot;], [&quot;47-patient clinical study: onset&quot;,&quot;~30% reported first lesions before age 20&quot;], [&quot;Role of UV&quot;,&quot;Important contributor, causation not proven; UV alone cannot explain (lesions on protected skin; uncommon on some heavily exposed areas)&quot;], [&quot;Melanocyte abnormalities (6)&quot;,&quot;\u2193 epidermal melanin \u00b7 \u2193 functional melanocytes (some) \u00b7 \u2193 dendrites \u00b7 \u2193 melanosomes \u00b7 degenerative changes \u00b7 impaired melanin transfer&quot;], [&quot;Genetics and autoimmunity&quot;,&quot;Familial clustering, no single defect \u00b7 autoimmune role uncertain, NOT an established autoimmune disease&quot;], [&quot;Typical morphology&quot;,&quot;Round/oval macules \u00b7 white/porcelain-white \u00b7 usually 2\u20135 mm \u00b7 flat, discrete, smooth, no scale/inflammation&quot;], [&quot;Typical sites&quot;,&quot;Extensor forearms \u00b7 shins \u00b7 dorsal hands \u00b7 other sun-exposed limbs \u00b7 occasionally upper chest/trunk. Face less common&quot;], [&quot;Symptoms and course&quot;,&quot;Asymptomatic \u00b7 slow over years \u00b7 persists \u00b7 new lesions with age \u00b7 spontaneous repigmentation uncommon&quot;], [&quot;Histology: 6 findings&quot;,&quot;\u2193 basal melanin \u00b7 melanocytes \u2193 or preserved \u00b7 flat rete ridges \u00b7 epidermal thinning \u00b7 orthokeratotic hyperkeratosis \u00b7 skip areas&quot;], [&quot;Histology variability (n=47)&quot;,&quot;Hyperkeratosis 38.3% \u00b7 atrophy 10.6% \u00b7 flattened rete ridges 14.9% \u2192 none universal&quot;], [&quot;Special stains&quot;,&quot;Fontana\u2013Masson (melanin) \u00b7 melanocyte markers&quot;], [&quot;Wood&#39;s lamp in IGH&quot;,&quot;Accentuates contrast, but not specific; can&#39;t separate IGH from every other hypopigmentation&quot;], [&quot;4 dermoscopic patterns&quot;,&quot;Amoeboid (pseudopods) \u00b7 Feathery \u00b7 Petaloid (petals) \u00b7 Nebuloid (clouds). Supportive, not specific&quot;], [&quot;When biopsy?&quot;,&quot;Atypical features, or another diagnosis can&#39;t be excluded&quot;], [&quot;Differential diagnosis (7)&quot;,&quot;Vitiligo \u00b7 Pityriasis versicolor \u00b7 Pityriasis alba \u00b7 Post-inflammatory hypopigmentation \u00b7 Lichen sclerosus \u00b7 Guttate morphea \u00b7 Contact leukoderma&quot;], [&quot;Why separate IGH from vitiligo?&quot;,&quot;Natural histories and treatment approaches differ&quot;], [&quot;Management mainstay&quot;,&quot;Reassurance + education + photoprotection. No treatment required&quot;], [&quot;Photoprotection&quot;,&quot;Broad-spectrum SPF 30+, protective clothing, limit sun, avoid tanning devices. Effect on IGH itself not conclusively shown&quot;], [&quot;Tretinoin / retinoids&quot;,&quot;Limited evidence of benefit; irritation, erythema, dryness, PIH&quot;], [&quot;Tacrolimus 0.1% RCT&quot;,&quot;26 pts, 6 months \u00b7 colorimetric \u2191 significant \u00b7 physician-assessed 11%, not significant&quot;], [&quot;Corticosteroids&quot;,&quot;Not routinely recommended: limited benefit; atrophy and pigment change&quot;], [&quot;Cryotherapy RCT&quot;,&quot;101 lesions (43 tx / 58 ctrl) \u00b7 &gt;75% improvement 82.3% vs 2% at 4 months \u00b7 per lesion, single small study&quot;], [&quot;Cryotherapy cautions&quot;,&quot;Pain, blistering, PIH, worse hypopigmentation, scarring \u00b7 darker phototypes \u00b7 trained clinicians only&quot;], [&quot;Laser / light options&quot;,&quot;Fractional CO\u2082 \u00b7 nonablative fractional 1,550-nm \u00b7 targeted 308-nm excimer&quot;], [&quot;5-FU tattooing trial (2023)&quot;,&quot;29 pts, split-body, 5-FU vs saline \u00b7 both improved, 5-FU more \u00b7 injury may contribute \u00b7 off-label, cytotoxic, specialist only&quot;], [&quot;2025 systematic review&quot;,&quot;20 studies (9 randomized + 11 quasi-experimental) \u00b7 search to Nov 2023 \u00b7 ~half of RCTs high bias \u00b7 no clear best treatment&quot;], [&quot;Prognosis and referral triggers&quot;,&quot;Excellent, no malignant change \u00b7 refer if uncertain, rapid spread, merging patches, inflammation/scale/sclerosis, unusual distribution, procedural treatment planned&quot;] ]; const CL=[ {t:&quot;IGH is a common, benign, acquired {{pigmentary}} disorder.&quot;,w:[&quot;vascular&quot;,&quot;blistering&quot;]}, {t:&quot;Lesions are hypopigmented or depigmented {{macules}}.&quot;,w:[&quot;papules&quot;,&quot;plaques&quot;]}, {t:&quot;The term {{guttate}} describes the small, drop-like appearance.&quot;,w:[&quot;idiopathic&quot;,&quot;hypomelanosis&quot;]}, {t:&quot;A synonym is disseminate lenticular {{leukoderma}}.&quot;,w:[&quot;vitiligo&quot;,&quot;melanosis&quot;]}, {t:&quot;In the 1,174-participant study, prevalence in people \u226540 y was {{87%}}.&quot;,w:[&quot;30%&quot;,&quot;11%&quot;]}, {t:&quot;Typical lesion diameter is {{2\u20135 mm}}.&quot;,w:[&quot;1\u20132 cm&quot;,&quot;\x3C1 mm&quot;]}, {t:&quot;Typical sites are the extensor forearms and {{shins}}.&quot;,w:[&quot;palms&quot;,&quot;scalp&quot;]}, {t:&quot;The {{face}} is less commonly involved.&quot;,w:[&quot;forearms&quot;,&quot;shins&quot;]}, {t:&quot;IGH is usually {{asymptomatic}}.&quot;,w:[&quot;pruritic&quot;,&quot;painful&quot;]}, {t:&quot;Histology shows decreased epidermal {{melanin}}.&quot;,w:[&quot;glycogen&quot;,&quot;keratin&quot;]}, {t:&quot;Small areas of retained basal melanin are called {{skip areas}}.&quot;,w:[&quot;satellite lesions&quot;,&quot;melanin pools&quot;]}, {t:&quot;Fontana\u2013Masson stains {{melanin}}.&quot;,w:[&quot;collagen&quot;,&quot;mucin&quot;]}, {t:&quot;Diagnosis of IGH is primarily {{clinical}}.&quot;,w:[&quot;serological&quot;,&quot;genetic&quot;]}, {t:&quot;Wood&#39;s lamp findings are {{not specific}} for IGH.&quot;,w:[&quot;pathognomonic&quot;,&quot;always negative&quot;]}, {t:&quot;Dermoscopy may show white {{structureless}} areas.&quot;,w:[&quot;reticular&quot;,&quot;globular&quot;]}, {t:&quot;Amoeboid, feathery, petaloid and {{nebuloid}} are dermoscopic patterns.&quot;,w:[&quot;starburst&quot;,&quot;globular&quot;]}, {t:&quot;The petaloid pattern resembles flower {{petals}}.&quot;,w:[&quot;feathers&quot;,&quot;clouds&quot;]}, {t:&quot;Distinguishing IGH from {{vitiligo}} is particularly important.&quot;,w:[&quot;pityriasis alba&quot;,&quot;lichen sclerosus&quot;]}, {t:&quot;IGH is benign and {{does not require}} medical treatment.&quot;,w:[&quot;always requires&quot;,&quot;urgently requires&quot;]}, {t:&quot;Photoprotection: broad-spectrum sunscreen with SPF {{30}} or higher.&quot;,w:[&quot;10&quot;,&quot;5&quot;]}, {t:&quot;The tacrolimus trial used {{0.1%}} ointment.&quot;,w:[&quot;0.01%&quot;,&quot;1%&quot;]}, {t:&quot;Cryotherapy uses liquid {{nitrogen}}.&quot;,w:[&quot;oxygen&quot;,&quot;helium&quot;]}, {t:&quot;5-Fluorouracil is a {{cytotoxic}} medication.&quot;,w:[&quot;antifungal&quot;,&quot;antihistamine&quot;]}, {t:&quot;The 2025 systematic review included 9 randomized and 11 {{quasi-experimental}} studies.&quot;,w:[&quot;cohort&quot;,&quot;case-control&quot;]} ]; const QZ=[ {q:&quot;Which best describes IGH?&quot;,c:&quot;Benign, acquired pigmentary disorder with small hypopigmented macules&quot;,w:[&quot;Premalignant autoimmune depigmenting disease&quot;,&quot;Infectious fungal hypopigmentation&quot;,&quot;Congenital absence of melanocytes&quot;],e:&quot;IGH is benign, acquired, not premalignant and not contagious; autoimmune role is uncertain and it is not an established autoimmune disease.&quot;}, {q:&quot;Is IGH considered premalignant?&quot;,c:&quot;No \u2014 medically harmless, not premalignant&quot;,w:[&quot;Yes \u2014 raised melanoma risk&quot;,&quot;Only in darker skin&quot;,&quot;Only when lesions exceed 5 mm&quot;],e:&quot;The source states it is not considered premalignant.&quot;}, {q:&quot;In the 1,174-participant study, prevalence in people \u226540 years was:&quot;,c:&quot;87%&quot;,w:[&quot;47%&quot;,&quot;30%&quot;,&quot;11%&quot;],e:&quot;87% \u2014 specific to that study population; should not be generalized.&quot;}, {q:&quot;In the 47-patient study, what proportion reported first lesions before age 20?&quot;,c:&quot;About 30%&quot;,w:[&quot;About 87%&quot;,&quot;About 11%&quot;,&quot;About 2%&quot;],e:&quot;\u224830%: the condition may start earlier than commonly recognized.&quot;}, {q:&quot;Typical lesion diameter:&quot;,c:&quot;2\u20135 mm&quot;,w:[&quot;\x3C1 mm&quot;,&quot;1\u20132 cm&quot;,&quot;5\u201310 cm&quot;],e:&quot;Usually 2\u20135 mm, although larger lesions occasionally occur.&quot;}, {q:&quot;Which site is LEAST commonly involved?&quot;,c:&quot;Face&quot;,w:[&quot;Extensor forearms&quot;,&quot;Shins&quot;,&quot;Dorsal hands&quot;],e:&quot;The face is less commonly involved.&quot;}, {q:&quot;In the 47-patient histology data, which finding was most frequent?&quot;,c:&quot;Hyperkeratosis (38.3%)&quot;,w:[&quot;Epidermal atrophy (10.6%)&quot;,&quot;Flattened rete ridges (14.9%)&quot;,&quot;All three in over 50% of cases&quot;],e:&quot;Hyperkeratosis 38.3%, rete ridge flattening 14.9%, atrophy 10.6% \u2014 none universal.&quot;}, {q:&quot;&#39;Skip areas&#39; on histology are:&quot;,c:&quot;Small areas of preserved basal melanin&quot;,w:[&quot;Zones of complete epidermal loss&quot;,&quot;Dermal scarring zones&quot;,&quot;Melanocyte hyperplasia zones&quot;],e:&quot;Focal retained basal melanin may support the diagnosis.&quot;}, {q:&quot;Wood&#39;s lamp in IGH:&quot;,c:&quot;Accentuates contrast but is not specific&quot;,w:[&quot;Is pathognomonic&quot;,&quot;Excludes vitiligo&quot;,&quot;Shows Malassezia fluorescence in IGH&quot;],e:&quot;Findings cannot independently distinguish IGH from every other hypopigmentation.&quot;}, {q:&quot;Which dermoscopic pattern shows pseudopod-like peripheral extensions?&quot;,c:&quot;Amoeboid&quot;,w:[&quot;Feathery&quot;,&quot;Petaloid&quot;,&quot;Nebuloid&quot;],e:&quot;Amoeboid = pseudopods; Feathery = linear feather-like; Petaloid = petals; Nebuloid = clouds.&quot;}, {q:&quot;Cloud-like white areas with poorly defined borders:&quot;,c:&quot;Nebuloid&quot;,w:[&quot;Amoeboid&quot;,&quot;Feathery&quot;,&quot;Petaloid&quot;],e:&quot;Nebuloid = cloud-like (nebula).&quot;}, {q:&quot;When may a biopsy be considered?&quot;,c:&quot;Atypical features or another diagnosis cannot be excluded&quot;,w:[&quot;Always at the first visit&quot;,&quot;Whenever lesions are larger than 2 mm&quot;,&quot;Before starting sunscreen&quot;],e:&quot;Diagnosis is clinical; biopsy is not routine.&quot;}, {q:&quot;Patches on the upper trunk with fine scale, KOH shows Malassezia:&quot;,c:&quot;Pityriasis versicolor&quot;,w:[&quot;Vitiligo&quot;,&quot;Pityriasis alba&quot;,&quot;Lichen sclerosus&quot;],e:&quot;Pityriasis versicolor (tinea versicolor).&quot;}, {q:&quot;Ill-defined hypopigmented patches on the face of children, with dryness or mild eczema:&quot;,c:&quot;Pityriasis alba&quot;,w:[&quot;Pityriasis versicolor&quot;,&quot;Contact leukoderma&quot;,&quot;Lichen sclerosus&quot;],e:&quot;Pityriasis alba.&quot;}, {q:&quot;Porcelain-white lesions with sclerosis, atrophy or symptomatic inflammation:&quot;,c:&quot;Lichen sclerosus&quot;,w:[&quot;IGH&quot;,&quot;Pityriasis alba&quot;,&quot;Contact leukoderma&quot;],e:&quot;IGH lesions are smooth and non-inflamed; lichen sclerosus may show sclerosis/atrophy/symptoms.&quot;}, {q:&quot;Cornerstone of IGH management:&quot;,c:&quot;Reassurance and photoprotection&quot;,w:[&quot;Topical corticosteroids&quot;,&quot;Liquid nitrogen&quot;,&quot;Fractional laser&quot;],e:&quot;Treatment is not required; other options only if cosmetic concern is substantial.&quot;}, {q:&quot;Regarding sunscreen (SPF 30+) and IGH:&quot;,c:&quot;Appropriate for skin health; prevention/reversal of IGH not conclusively shown&quot;,w:[&quot;Proven to reverse lesions&quot;,&quot;Proven to prevent IGH&quot;,&quot;Contraindicated&quot;],e:&quot;Recommended for overall skin health because of suspected UV role, but specific benefit isn&#39;t proven.&quot;}, {q:&quot;Tacrolimus 0.1% RCT (26 patients, 6 months):&quot;,c:&quot;Significant colorimetric gain; physician-assessed improvement only 11%, not significant&quot;,w:[&quot;Clinical improvement in most patients&quot;,&quot;No change on any measure&quot;,&quot;Significant physician-assessed improvement&quot;],e:&quot;Measurable repigmentation in some patients but limited clinical improvement; not a standard treatment.&quot;}, {q:&quot;Cryotherapy RCT result:&quot;,c:&quot;&gt;75% improvement in 82.3% of treated lesions vs 2% of controls at 4 months&quot;,w:[&quot;82.3% of patients permanently cured&quot;,&quot;2% treated vs 82.3% controls&quot;,&quot;75% of patients at 12 months&quot;],e:&quot;Percentages refer to lesions, not patients; 4 months does not show durability.&quot;}, {q:&quot;Key caution with cryotherapy:&quot;,c:&quot;Pigmentary complications more noticeable in darker phototypes&quot;,w:[&quot;Contraindicated in fair skin&quot;,&quot;Only effective in darker skin&quot;,&quot;No adverse effects reported&quot;],e:&quot;Also pain, blistering, PIH, worse hypopigmentation, scarring; trained clinicians only.&quot;}, {q:&quot;5-FU tattooing trial (2023, 29 patients):&quot;,c:&quot;Both sides improved; more on the 5-FU side&quot;,w:[&quot;Only the 5-FU side improved&quot;,&quot;Saline side worsened&quot;,&quot;Established as standard treatment&quot;],e:&quot;Saline improvement suggests injury contributes. 5-FU is cytotoxic; use is off-label.&quot;}, {q:&quot;2025 systematic review:&quot;,c:&quot;20 studies (9 randomized, 11 quasi-experimental); search to Nov 2023&quot;,w:[&quot;50 RCTs through 2025&quot;,&quot;20 studies, all low bias&quot;,&quot;9 studies through 2025&quot;],e:&quot;About half of RCTs had high risk of bias; no treatment consistently superior.&quot;}, {q:&quot;High-concentration chemical peels at home:&quot;,c:&quot;Never \u2014 risk of burns, permanent pigment change, scarring&quot;,w:[&quot;Safe if diluted at home&quot;,&quot;Recommended first line&quot;,&quot;Only risky in fair skin&quot;],e:&quot;Deliberately injurious procedures should not be unsupervised home treatments.&quot;}, {q:&quot;Which warrants dermatology assessment?&quot;,c:&quot;Rapid spread, merging into extensive patches, inflammation or scaling&quot;,w:[&quot;Any typical lesion&quot;,&quot;Only itching&quot;,&quot;Never necessary&quot;],e:&quot;Also uncertain diagnosis, unusual distribution, or considering procedural treatment.&quot;} ]; const NL=[ [&quot;Participants in the prevalence study&quot;,[&quot;1174&quot;],&quot;1,174&quot;], [&quot;Prevalence (%) in \u226540 y in that study&quot;,[&quot;87&quot;],&quot;87%&quot;], [&quot;Patients in the clinical study (onset + histology)&quot;,[&quot;47&quot;],&quot;47&quot;], [&quot;% with first lesions before age 20&quot;,[&quot;30&quot;],&quot;\u224830%&quot;], [&quot;Typical lesion diameter (mm)&quot;,[&quot;2-5&quot;],&quot;2\u20135 mm&quot;], [&quot;Hyperkeratosis in 47 patients (%)&quot;,[&quot;38.3&quot;],&quot;38.3%&quot;], [&quot;Epidermal atrophy (%)&quot;,[&quot;10.6&quot;],&quot;10.6%&quot;], [&quot;Flattened rete ridges (%)&quot;,[&quot;14.9&quot;],&quot;14.9%&quot;], [&quot;Number of named dermoscopic patterns&quot;,[&quot;4&quot;,&quot;four&quot;],&quot;4&quot;], [&quot;Sunscreen: minimum SPF&quot;,[&quot;30&quot;],&quot;SPF 30&quot;], [&quot;Tacrolimus ointment concentration (%)&quot;,[&quot;0.1&quot;],&quot;0.1%&quot;], [&quot;Patients in tacrolimus RCT&quot;,[&quot;26&quot;],&quot;26&quot;], [&quot;Tacrolimus treatment duration (months)&quot;,[&quot;6&quot;,&quot;six&quot;],&quot;6 months&quot;], [&quot;Physician-assessed improvement with tacrolimus (%)&quot;,[&quot;11&quot;],&quot;11%&quot;], [&quot;Total lesions in cryotherapy study&quot;,[&quot;101&quot;],&quot;101&quot;], [&quot;Cryotherapy-treated lesions&quot;,[&quot;43&quot;],&quot;43&quot;], [&quot;Control lesions&quot;,[&quot;58&quot;],&quot;58&quot;], [&quot;% treated lesions with &gt;75% improvement&quot;,[&quot;82.3&quot;],&quot;82.3%&quot;], [&quot;% control lesions with &gt;75% improvement&quot;,[&quot;2&quot;],&quot;2%&quot;], [&quot;Cryotherapy follow-up (months)&quot;,[&quot;4&quot;,&quot;four&quot;],&quot;4 months&quot;], [&quot;Patients in 5-FU split-body trial&quot;,[&quot;29&quot;],&quot;29&quot;], [&quot;Year of the 5-FU tattooing trial&quot;,[&quot;2023&quot;],&quot;2023&quot;], [&quot;Eligible studies in the 2025 systematic review&quot;,[&quot;20&quot;],&quot;20&quot;], [&quot;\u2026of which randomized&quot;,[&quot;9&quot;,&quot;nine&quot;],&quot;9&quot;], [&quot;\u2026of which quasi-experimental&quot;,[&quot;11&quot;,&quot;eleven&quot;],&quot;11&quot;], [&quot;Review search covered up to (month year)&quot;,[&quot;nov2023&quot;,&quot;november2023&quot;,&quot;11/2023&quot;,&quot;2023-11&quot;],&quot;November 2023&quot;] ]; const SORTS=[ {id:&#39;tx&#39;,name:&#39;Treatments \u00b7 \u0627\u0644\u0639\u0644\u0627\u062c\u0627\u062a&#39;,buckets:[&#39;General&#39;,&#39;Topical&#39;,&#39;Procedural&#39;,&#39;Light / laser&#39;],items:[ [&quot;Reassurance&quot;,0],[&quot;Broad-spectrum SPF 30+&quot;,0],[&quot;Protective clothing&quot;,0],[&quot;Camouflage / self-tanner&quot;,0], [&quot;Tretinoin&quot;,1],[&quot;Tacrolimus 0.1% ointment&quot;,1],[&quot;Corticosteroids&quot;,1], [&quot;Liquid nitrogen cryotherapy&quot;,2],[&quot;Superficial dermabrasion&quot;,2],[&quot;Microneedling&quot;,2],[&quot;Trichloroacetic acid&quot;,2],[&quot;5-FU tattooing&quot;,2],[&quot;Chemical peeling&quot;,2], [&quot;Fractional CO\u2082 laser&quot;,3],[&quot;Nonablative 1,550-nm laser&quot;,3],[&quot;308-nm excimer light&quot;,3]]}, {id:&#39;dd&#39;,name:&#39;Differential \u00b7 \u0627\u0644\u062a\u0641\u0631\u064a\u0642&#39;,buckets:[&#39;Vitiligo&#39;,&#39;P. versicolor&#39;,&#39;P. alba&#39;,&#39;Post-inflam.&#39;,&#39;Lichen sclerosus&#39;,&#39;Guttate morphea&#39;,&#39;Contact leukoderma&#39;],items:[ [&quot;Sharply demarcated depigmented patches that may coalesce&quot;,0],[&quot;Upper trunk with fine scale&quot;,1],[&quot;KOH may show Malassezia&quot;,1], [&quot;Face of children, dryness / mild eczema&quot;,2],[&quot;Follows dermatitis, injury, infection or a procedure&quot;,3], [&quot;Porcelain-white, sclerosis/atrophy, may be symptomatic&quot;,4],[&quot;Small sclerotic lesions with textural change&quot;,5], [&quot;Chemical exposure, characteristic distribution&quot;,6]]} ]; const REVIEW=[ [&quot;Definition&quot;,&quot;idiopathic \u00b7 guttate \u00b7 hypomelanosis \u00b7 benign \u00b7 acquired \u00b7 macules \u00b7 sun-exposed \u00b7 not premalignant \u00b7 not contagious \u00b7 disseminate lenticular leukoderma&quot;], [&quot;Epidemiology&quot;,&quot;\u2191 age \u00b7 4th decade \u00b7 both sexes \u00b7 all phototypes \u00b7 UV \u00b7 familial \u00b7 1,174 \u2192 87% (\u226540 y) \u00b7 47 \u2192 ~30% before 20&quot;], [&quot;Etiology&quot;,&quot;multifactorial \u00b7 UV not proven alone \u00b7 aging \u00b7 \u2193 melanin \u00b7 \u2193 melanocytes \u00b7 \u2193 dendrites \u00b7 \u2193 melanosomes \u00b7 impaired transfer \u00b7 no single gene \u00b7 autoimmune uncertain&quot;], [&quot;Clinical&quot;,&quot;2\u20135 mm \u00b7 porcelain-white \u00b7 flat \u00b7 smooth \u00b7 forearms \u00b7 shins \u00b7 dorsal hands \u00b7 face rare \u00b7 asymptomatic \u00b7 slow \u00b7 persistent&quot;], [&quot;Histology&quot;,&quot;\u2193 basal melanin \u00b7 skip areas \u00b7 flat rete \u00b7 thin epidermis \u00b7 orthokeratosis \u00b7 Fontana\u2013Masson \u00b7 38.3 / 10.6 / 14.9%&quot;], [&quot;Diagnosis&quot;,&quot;clinical \u00b7 Wood&#39;s lamp non-specific \u00b7 dermoscopy: amoeboid \u00b7 feathery \u00b7 petaloid \u00b7 nebuloid \u00b7 biopsy if atypical \u00b7 no routine labs&quot;], [&quot;Differential&quot;,&quot;vitiligo \u00b7 P. versicolor (KOH) \u00b7 P. alba (kids&#39; face) \u00b7 post-inflammatory \u00b7 lichen sclerosus \u00b7 guttate morphea \u00b7 contact leukoderma&quot;], [&quot;Treatment&quot;,&quot;reassure \u00b7 SPF 30+ \u00b7 camouflage \u00b7 tretinoin (limited) \u00b7 tacrolimus 0.1% (26 pts, 6 mo, 11%) \u00b7 steroids no \u00b7 cryo 101 lesions 82.3% vs 2% \u00b7 lasers \u00b7 5-FU (29 pts, 2023, off-label)&quot;], [&quot;Evidence&quot;,&quot;SR 2025 \u00b7 to Nov 2023 \u00b7 20 = 9 + 11 \u00b7 bias \u00b7 no clear best&quot;], [&quot;Prognosis&quot;,&quot;excellent \u00b7 no malignant change \u00b7 psychological burden \u00b7 refer: rapid \u00b7 merging \u00b7 inflammation \u00b7 procedure planned&quot;] ]; function renderProgress(){ const so=SORTS.reduce((a,s)=&gt;a+s.items.length,0); const pr=[[&#39;\u0628\u0637\u0627\u0642\u0627\u062a (Cards)&#39;,cnt(S.fc)/CARDS.length],[&#39;\u062a\u0639\u0644\u0651\u0645 (Learn)&#39;,cnt(S.cl)/CL.length],[&#39;\u0627\u062e\u062a\u0628\u0627\u0631 (Quiz) \u0623\u0641\u0636\u0644 \u0646\u062a\u064a\u062c\u0629&#39;,S.qz.best/100],[&#39;\u0623\u0631\u0642\u0627\u0645 (Numbers)&#39;,cnt(S.nl)/NL.length],[&#39;\u062a\u0635\u0646\u064a\u0641 (Sort)&#39;,cnt(S.so)/so]]; const box=$(&#39;#prog&#39;);clearNode(box); const g=el(&#39;div&#39;,&#39;prog&#39;); pr.forEach(p=&gt;{const d=el(&#39;div&#39;);d.appendChild(el(&#39;span&#39;,null,p[0]+&#39; \u00b7 &#39;+Math.round(p[1]*100)+&#39;%&#39;));const b=el(&#39;div&#39;,&#39;bar&#39;);const i=el(&#39;i&#39;);i.style.width=Math.round(p[1]*100)+&#39;%&#39;;b.appendChild(i);d.appendChild(b);g.appendChild(d);}); box.appendChild(g); const all=Math.round(pr.reduce((a,p)=&gt;a+p[1],0)/pr.length*100); $(&#39;#topbar&#39;).style.width=all+&#39;%&#39;;$(&#39;#toppct&#39;).textContent=all+&#39;%&#39;; } function renderStudy(){ const root=$(&#39;#p-study&#39;); SECTIONS.forEach(sec=&gt;{ const c=el(&#39;section&#39;,&#39;card&#39;);c.id=&#39;s-&#39;+sec.id; c.appendChild(el(&#39;h2&#39;,null,sec.t)); const ul=el(&#39;ul&#39;,&#39;lines&#39;);sec.lines.forEach(l=&gt;{const li=el(&#39;li&#39;);rich(li,l);ul.appendChild(li);});c.appendChild(ul); if(sec.tbl)c.appendChild(table(sec.tbl)); if(sec.svg&amp;&amp;SVGS[sec.svg])c.appendChild(svgFrom(SVGS[sec.svg])); if(sec.extra===&#39;size&#39;)c.appendChild(svgFrom(SIZE_SVG)); if(sec.mn){const m=el(&#39;div&#39;,&#39;mn&#39;);rich(m,sec.mn);c.appendChild(m);} const ar=el(&#39;div&#39;,&#39;ar&#39;);ar.appendChild(el(&#39;div&#39;,&#39;arlab&#39;,&#39;\u0634\u0631\u062d \u0645\u0633\u0627\u0639\u062f \u2014 \u0625\u0636\u0627\u0641\u0629 \u062a\u0639\u0644\u064a\u0645\u064a\u0629 \u0648\u0644\u064a\u0633\u062a \u062c\u0632\u0621\u064b\u0627 \u0645\u0646 \u0627\u0644\u0645\u0635\u062f\u0631&#39;)); const au=el(&#39;ul&#39;);sec.ar.forEach(x=&gt;au.appendChild(el(&#39;li&#39;,null,x)));ar.appendChild(au);c.appendChild(ar); root.appendChild(c); }); } function renderReview(){ const root=$(&#39;#p-review&#39;); const c=el(&#39;section&#39;,&#39;card&#39;);c.appendChild(el(&#39;h2&#39;,null,&#39;Quick Review \u00b7 \u0645\u0631\u0627\u062c\u0639\u0629 \u0644\u064a\u0644\u0629 \u0627\u0644\u0627\u0645\u062a\u062d\u0627\u0646&#39;)); REVIEW.forEach(r=&gt;{c.appendChild(el(&#39;h3&#39;,null,r[0]));const k=el(&#39;div&#39;,&#39;kw&#39;);r[1].split(&#39; \u00b7 &#39;).forEach(w=&gt;k.appendChild(el(&#39;span&#39;,null,w)));c.appendChild(k);}); const b=el(&#39;button&#39;,&#39;noprint&#39;,&#39;\ud83d\udda8 Print / \u0637\u0628\u0627\u0639\u0629&#39;);b.addEventListener(&#39;click&#39;,()=&gt;window.print());c.appendChild(b); root.appendChild(c); } let L={order:[],i:0,opts:[],sel:null,checked:false}; function learnStart(){L.order=shuffle(CL.map((_,i)=&gt;i));L.i=0;learnShow();} function learnShow(){ const box=$(&#39;#p-learn&#39;);clearNode(box); const card=el(&#39;div&#39;,&#39;card&#39;); if(L.i&gt;=L.order.length){card.appendChild(el(&#39;h2&#39;,null,&#39;Done \u2714 \u00b7 \u0627\u0646\u062a\u0647\u064a\u062a&#39;));card.appendChild(el(&#39;p&#39;,null,&#39;Mastered: &#39;+cnt(S.cl)+&#39; / &#39;+CL.length));const b=el(&#39;button&#39;,&#39;primary&#39;,&#39;Again \u00b7 \u0645\u0646 \u062c\u062f\u064a\u062f&#39;);b.addEventListener(&#39;click&#39;,learnStart);card.appendChild(b);box.appendChild(card);return;} const it=CL[L.order[L.i]]; L.opts=shuffle([it.a||&#39;&#39;,...[]]); const m=/^(.*)\{\{(.*)\}\}(.*)$/.exec(it.t);const ans=m[2]; L.opts=shuffle([ans,...it.w]);L.sel=null;L.checked=false;L.ans=ans; card.appendChild(el(&#39;div&#39;,&#39;meta&#39;,&#39;Learn \u00b7 &#39;+(L.i+1)+&#39; / &#39;+L.order.length+&#39; \u2014 \u0627\u062e\u062a\u0631 \u0627\u0644\u0645\u0635\u0637\u0644\u062d \u0627\u0644\u0635\u062d\u064a\u062d \u0644\u0644\u0641\u0631\u0627\u063a&#39;)); const q=el(&#39;p&#39;,&#39;q&#39;);q.appendChild(document.createTextNode(m[1]));const bl=el(&#39;span&#39;,&#39;blank&#39;,&#39;_____&#39;);bl.id=&#39;blank&#39;;q.appendChild(bl);q.appendChild(document.createTextNode(m[3]));card.appendChild(q); const og=el(&#39;div&#39;,&#39;opts&#39;); L.opts.forEach((o,idx)=&gt;{const b=el(&#39;button&#39;,&#39;opt&#39;);b.appendChild(el(&#39;kbd&#39;,null,String(idx+1)));b.appendChild(document.createTextNode(o));b.addEventListener(&#39;click&#39;,()=&gt;learnPick(idx));og.appendChild(b);}); card.appendChild(og); const row=el(&#39;div&#39;,&#39;row&#39;); const chk=el(&#39;button&#39;,&#39;primary&#39;,&#39;Check \u00b7 \u062a\u062d\u0642\u0651\u0642&#39;);chk.id=&#39;lchk&#39;;chk.disabled=true;chk.addEventListener(&#39;click&#39;,learnCheck); const nx=el(&#39;button&#39;,null,&#39;Next \u00b7 \u0627\u0644\u062a\u0627\u0644\u064a&#39;);nx.id=&#39;lnext&#39;;nx.disabled=true;nx.addEventListener(&#39;click&#39;,()=&gt;{L.i++;learnShow();}); row.appendChild(chk);row.appendChild(nx);card.appendChild(row); const fb=el(&#39;div&#39;);fb.id=&#39;lfb&#39;;card.appendChild(fb); box.appendChild(card); } function learnPick(idx){ if(L.checked)return;L.sel=idx; ROOT.querySelectorAll(&#39;#p-learn .opt&#39;).forEach((b,i)=&gt;b.classList.toggle(&#39;sel&#39;,i===idx)); $(&#39;#blank&#39;).textContent=L.opts[idx];$(&#39;#lchk&#39;).disabled=false;$(&#39;#lchk&#39;).focus(); } function learnCheck(){ if(L.sel==null||L.checked)return;L.checked=true; const ok=L.opts[L.sel]===L.ans;const bl=$(&#39;#blank&#39;);bl.textContent=L.ans;bl.className=&#39;blank &#39;+(ok?&#39;ok&#39;:&#39;no&#39;); ROOT.querySelectorAll(&#39;#p-learn .opt&#39;).forEach((b,i)=&gt;{if(L.opts[i]===L.ans)b.classList.add(&#39;ok&#39;);else if(i===L.sel)b.classList.add(&#39;no&#39;);}); const fb=$(&#39;#lfb&#39;);clearNode(fb);const m=el(&#39;div&#39;,&#39;msg &#39;+(ok?&#39;ok&#39;:&#39;no&#39;),ok?&#39;Correct \u2714&#39;:&#39;Not quite \u2014 correct answer: &#39;+L.ans);fb.appendChild(m); if(ok){S.cl[L.order[L.i]]=1;save();} $(&#39;#lchk&#39;).disabled=true;const nx=$(&#39;#lnext&#39;);nx.disabled=false;nx.focus(); } let C={q:[],flipped:false}; function cardsStart(){C.q=CARDS.map((_,i)=&gt;i).filter(i=&gt;!S.fc[i]);C.flipped=false;cardsShow();} function cardsShow(){ const box=$(&#39;#p-cards&#39;);clearNode(box);const card=el(&#39;div&#39;,&#39;card&#39;); card.appendChild(el(&#39;div&#39;,&#39;meta&#39;,&#39;Flashcards \u00b7 \u062a\u0628\u0642\u0651\u0649 &#39;+C.q.length+&#39; \u00b7 \u0645\u062d\u0641\u0648\u0638 &#39;+cnt(S.fc)+&#39; / &#39;+CARDS.length)); if(!C.q.length){card.appendChild(el(&#39;h2&#39;,null,&#39;All cards known \u2714 \u00b7 \u062d\u0641\u0638\u062a \u0643\u0644 \u0627\u0644\u0628\u0637\u0627\u0642\u0627\u062a&#39;));const b=el(&#39;button&#39;,&#39;primary&#39;,&#39;Reset deck \u00b7 \u0625\u0639\u0627\u062f\u0629&#39;);b.addEventListener(&#39;click&#39;,()=&gt;{S.fc={};save();cardsStart();});card.appendChild(b);box.appendChild(card);return;} const d=CARDS[C.q[0]]; const f=el(&#39;div&#39;,&#39;flash&#39;+(C.flipped?&#39; back&#39;:&#39;&#39;));f.id=&#39;flash&#39;;f.tabIndex=0;f.setAttribute(&#39;role&#39;,&#39;button&#39;);f.setAttribute(&#39;aria-label&#39;,&#39;Flip card&#39;); if(!C.flipped)f.textContent=d[0];else{const ul=el(&#39;ul&#39;);d[1].split(&#39; \u00b7 &#39;).forEach(x=&gt;ul.appendChild(el(&#39;li&#39;,null,&#39;\u2022 &#39;+x)));f.appendChild(ul);} f.addEventListener(&#39;click&#39;,cardFlip);card.appendChild(f); card.appendChild(el(&#39;div&#39;,&#39;meta&#39;,&#39;\u0627\u0636\u063a\u0637 \u0639\u0644\u0649 \u0627\u0644\u0628\u0637\u0627\u0642\u0629 (Space) \u0644\u0644\u0642\u0644\u0628&#39;)); const row=el(&#39;div&#39;,&#39;row&#39;); const k=el(&#39;button&#39;,&#39;primary&#39;,&#39;\u062d\u0641\u0638\u062a\u0647\u0627 \u00b7 Known (K)&#39;);k.addEventListener(&#39;click&#39;,()=&gt;cardMark(true)); const j=el(&#39;button&#39;,null,&#39;\u0644\u0645 \u0623\u062d\u0641\u0638\u0647\u0627 \u0628\u0639\u062f \u00b7 Not yet (J)&#39;);j.addEventListener(&#39;click&#39;,()=&gt;cardMark(false)); row.appendChild(k);row.appendChild(j);card.appendChild(row);box.appendChild(card); } function cardFlip(){if(!C.q.length)return;C.flipped=!C.flipped;cardsShow();} function cardMark(known){ if(!C.q.length)return;const id=C.q.shift(); if(known){S.fc[id]=1;save();}else{C.q.splice(Math.min(3,C.q.length),0,id);} C.flipped=false;cardsShow(); } let Z={list:[],i:0,score:0,wrong:[],answered:false,opts:[],total:0}; function quizStart(ids){Z.list=shuffle(ids||QZ.map((_,i)=&gt;i));Z.i=0;Z.score=0;Z.wrong=[];Z.total=Z.list.length;quizShow();} function quizShow(){ const box=$(&#39;#p-quiz&#39;);clearNode(box);const card=el(&#39;div&#39;,&#39;card&#39;); if(Z.i&gt;=Z.list.length){ const pct=Math.round(Z.score/Z.total*100); if(Z.total===QZ.length&amp;&amp;pct&gt;S.qz.best){S.qz.best=pct;save();} card.appendChild(el(&#39;h2&#39;,null,&#39;Result: &#39;+Z.score+&#39; / &#39;+Z.total+&#39; (&#39;+pct+&#39;%)&#39;)); const row=el(&#39;div&#39;,&#39;row&#39;); if(Z.wrong.length){const r=el(&#39;button&#39;,&#39;primary&#39;,&#39;Retry wrong \u00b7 \u0623\u0639\u062f \u0627\u0644\u0623\u062e\u0637\u0627\u0621 (&#39;+Z.wrong.length+&#39;)&#39;);r.addEventListener(&#39;click&#39;,()=&gt;quizStart(Z.wrong.slice()));row.appendChild(r);} const a=el(&#39;button&#39;,null,&#39;Restart all \u00b7 \u0645\u0646 \u0627\u0644\u0628\u062f\u0627\u064a\u0629&#39;);a.addEventListener(&#39;click&#39;,()=&gt;quizStart());row.appendChild(a); card.appendChild(row);box.appendChild(card);return;} const it=QZ[Z.list[Z.i]];Z.answered=false;Z.opts=shuffle([it.c,...it.w]); card.appendChild(el(&#39;div&#39;,&#39;meta&#39;,&#39;Quiz \u00b7 &#39;+(Z.i+1)+&#39; / &#39;+Z.list.length)); card.appendChild(el(&#39;p&#39;,&#39;q&#39;,it.q)); const og=el(&#39;div&#39;,&#39;opts&#39;); Z.opts.forEach((o,idx)=&gt;{const b=el(&#39;button&#39;,&#39;opt&#39;);b.appendChild(el(&#39;kbd&#39;,null,String(idx+1)));b.appendChild(document.createTextNode(o));b.addEventListener(&#39;click&#39;,()=&gt;quizPick(idx));og.appendChild(b);}); card.appendChild(og); const fb=el(&#39;div&#39;);fb.id=&#39;qfb&#39;;card.appendChild(fb); const nx=el(&#39;button&#39;,&#39;primary&#39;,&#39;Next \u00b7 \u0627\u0644\u062a\u0627\u0644\u064a&#39;);nx.id=&#39;qnext&#39;;nx.disabled=true;nx.addEventListener(&#39;click&#39;,()=&gt;{Z.i++;quizShow();});card.appendChild(nx); box.appendChild(card); } function quizPick(idx){ if(Z.answered)return;Z.answered=true;const it=QZ[Z.list[Z.i]];const ok=Z.opts[idx]===it.c; ROOT.querySelectorAll(&#39;#p-quiz .opt&#39;).forEach((b,i)=&gt;{if(Z.opts[i]===it.c)b.classList.add(&#39;ok&#39;);else if(i===idx)b.classList.add(&#39;no&#39;);}); if(ok)Z.score++;else Z.wrong.push(Z.list[Z.i]); const fb=$(&#39;#qfb&#39;);clearNode(fb);fb.appendChild(el(&#39;div&#39;,&#39;msg &#39;+(ok?&#39;ok&#39;:&#39;no&#39;),(ok?&#39;Correct \u2714 \u2014 &#39;:&#39;Incorrect \u2718 \u2014 &#39;)+it.e)); const nx=$(&#39;#qnext&#39;);nx.disabled=false;nx.focus(); } let N={order:[],i:0,done:false}; function norm(s){return String(s).toLowerCase().replace(/[,%\s]/g,&#39;&#39;).replace(/[\u2013\u2014]/g,&#39;-&#39;).replace(/(mm|months?|patients?|lesions?|studies|spf|\u2248|~)/g,&#39;&#39;);} function labStart(){N.order=shuffle(NL.map((_,i)=&gt;i));N.i=0;labShow();} function labShow(){ const box=$(&#39;#p-lab&#39;);clearNode(box);const card=el(&#39;div&#39;,&#39;card&#39;); if(N.i&gt;=N.order.length){card.appendChild(el(&#39;h2&#39;,null,&#39;Number Lab done \u2714&#39;));card.appendChild(el(&#39;p&#39;,null,&#39;Mastered: &#39;+cnt(S.nl)+&#39; / &#39;+NL.length));const b=el(&#39;button&#39;,&#39;primary&#39;,&#39;Again \u00b7 \u0645\u0646 \u062c\u062f\u064a\u062f&#39;);b.addEventListener(&#39;click&#39;,labStart);card.appendChild(b);box.appendChild(card);return;} const it=NL[N.order[N.i]];N.done=false; card.appendChild(el(&#39;div&#39;,&#39;meta&#39;,&#39;Number Lab \u00b7 &#39;+(N.i+1)+&#39; / &#39;+N.order.length+&#39; \u2014 \u0627\u0643\u062a\u0628 \u0627\u0644\u0631\u0642\u0645&#39;)); card.appendChild(el(&#39;p&#39;,&#39;q&#39;,it[0])); const inp=el(&#39;input&#39;,&#39;num&#39;);inp.id=&#39;labin&#39;;inp.type=&#39;text&#39;;inp.autocomplete=&#39;off&#39;;inp.setAttribute(&#39;aria-label&#39;,&#39;Your answer&#39;);card.appendChild(inp); const row=el(&#39;div&#39;,&#39;row&#39;);row.style.marginTop=&#39;10px&#39;; const chk=el(&#39;button&#39;,&#39;primary&#39;,&#39;Check \u00b7 \u062a\u062d\u0642\u0651\u0642&#39;);chk.id=&#39;labchk&#39;;chk.addEventListener(&#39;click&#39;,labEnter); const sk=el(&#39;button&#39;,null,&#39;Show \u00b7 \u0623\u0638\u0647\u0631&#39;);sk.addEventListener(&#39;click&#39;,()=&gt;{if(N.done)return;labReveal(false,true);}); row.appendChild(chk);row.appendChild(sk);card.appendChild(row); const fb=el(&#39;div&#39;);fb.id=&#39;labfb&#39;;card.appendChild(fb);box.appendChild(card);inp.focus(); } function labEnter(){ if(N.done){N.i++;labShow();return;} const it=NL[N.order[N.i]];const v=norm($(&#39;#labin&#39;).value);if(!v)return; const ok=it[1].some(a=&gt;norm(a)===v);labReveal(ok,false); } function labReveal(ok,skipped){ const it=NL[N.order[N.i]];N.done=true;const fb=$(&#39;#labfb&#39;);clearNode(fb); fb.appendChild(el(&#39;div&#39;,&#39;msg &#39;+(ok?&#39;ok&#39;:&#39;no&#39;),(ok?&#39;Correct \u2714 &#39;:(skipped?&#39;Answer: &#39;:&#39;Not quite \u2014 answer: &#39;))+it[2])); if(ok){S.nl[N.order[N.i]]=1;save();} const chk=$(&#39;#labchk&#39;);chk.textContent=&#39;Next \u00b7 \u0627\u0644\u062a\u0627\u0644\u064a&#39;;chk.focus(); } let SO={set:0,sel:null}; function sortShow(){ const box=$(&#39;#p-sort&#39;);clearNode(box);const set=SORTS[SO.set]; const card=el(&#39;div&#39;,&#39;card&#39;); const tabs=el(&#39;div&#39;,&#39;row&#39;);SORTS.forEach((s,i)=&gt;{const b=el(&#39;button&#39;,i===SO.set?&#39;primary&#39;:null,s.name);b.addEventListener(&#39;click&#39;,()=&gt;{SO.set=i;SO.sel=null;sortShow();});tabs.appendChild(b);}); card.appendChild(tabs); const solved=set.items.filter((_,i)=&gt;S.so[set.id+&#39;:&#39;+i]).length; card.appendChild(el(&#39;div&#39;,&#39;meta&#39;,&#39;\u0627\u062e\u062a\u0631 \u0639\u0646\u0635\u0631\u064b\u0627 \u062b\u0645 \u0627\u0636\u063a\u0637 \u0639\u0644\u0649 \u0627\u0644\u0645\u062c\u0645\u0648\u0639\u0629 (\u0623\u0648 \u0627\u0633\u062d\u0628\u0647\u060c \u0623\u0648 \u0627\u0636\u063a\u0637 \u0631\u0642\u0645 \u0627\u0644\u0645\u062c\u0645\u0648\u0639\u0629) \u00b7 &#39;+solved+&#39; / &#39;+set.items.length)); const chips=el(&#39;div&#39;,&#39;chips&#39;);chips.id=&#39;chips&#39;;chips.style.margin=&#39;10px 0&#39;; set.items.forEach((it,i)=&gt;{ if(S.so[set.id+&#39;:&#39;+i])return; const b=el(&#39;button&#39;,&#39;chip&#39;+(SO.sel===i?&#39; sel&#39;:&#39;&#39;),it[0]);b.draggable=true; b.addEventListener(&#39;click&#39;,()=&gt;{SO.sel=(SO.sel===i?null:i);sortShow();}); b.addEventListener(&#39;dragstart&#39;,e=&gt;{try{e.dataTransfer.setData(&#39;text/plain&#39;,String(i));}catch(x){}SO.sel=i;}); chips.appendChild(b);}); card.appendChild(chips); const fb=el(&#39;div&#39;);fb.id=&#39;sofb&#39;;card.appendChild(fb); const bg=el(&#39;div&#39;,&#39;buckets&#39;); set.buckets.forEach((name,bi)=&gt;{ const bk=el(&#39;div&#39;,&#39;bucket&#39;);bk.tabIndex=0;bk.setAttribute(&#39;role&#39;,&#39;button&#39;);bk.setAttribute(&#39;aria-label&#39;,&#39;Group &#39;+(bi+1)+&#39;: &#39;+name);bk.dataset.b=bi; bk.appendChild(el(&#39;h4&#39;,null,(bi+1)+&#39; \u00b7 &#39;+name)); set.items.forEach((it,i)=&gt;{if(S.so[set.id+&#39;:&#39;+i]&amp;&amp;it[1]===bi)bk.appendChild(el(&#39;span&#39;,&#39;chip done&#39;,it[0]));}); bk.addEventListener(&#39;click&#39;,()=&gt;sortAssign(bi)); bk.addEventListener(&#39;keydown&#39;,e=&gt;{if(e.key===&#39;Enter&#39;||e.key===&#39; &#39;){e.preventDefault();sortAssign(bi);}}); bk.addEventListener(&#39;dragover&#39;,e=&gt;{e.preventDefault();bk.classList.add(&#39;over&#39;);}); bk.addEventListener(&#39;dragleave&#39;,()=&gt;bk.classList.remove(&#39;over&#39;)); bk.addEventListener(&#39;drop&#39;,e=&gt;{e.preventDefault();bk.classList.remove(&#39;over&#39;);let i=SO.sel;try{const v=e.dataTransfer.getData(&#39;text/plain&#39;);if(v!==&#39;&#39;)i=parseInt(v,10);}catch(x){}SO.sel=i;sortAssign(bi);}); bg.appendChild(bk);}); card.appendChild(bg); const rs=el(&#39;button&#39;,&#39;noprint&#39;,&#39;Reset set \u00b7 \u0625\u0639\u0627\u062f\u0629&#39;);rs.style.marginTop=&#39;10px&#39;;rs.addEventListener(&#39;click&#39;,()=&gt;{set.items.forEach((_,i)=&gt;delete S.so[set.id+&#39;:&#39;+i]);SO.sel=null;save();sortShow();});card.appendChild(rs); box.appendChild(card); } function sortAssign(bi){ const set=SORTS[SO.set];if(SO.sel==null||SO.sel===undefined||isNaN(SO.sel)){const f=$(&#39;#sofb&#39;);if(f){clearNode(f);f.appendChild(el(&#39;div&#39;,&#39;msg no&#39;,&#39;\u0627\u062e\u062a\u0631 \u0639\u0646\u0635\u0631\u064b\u0627 \u0623\u0648\u0644\u064b\u0627 \u00b7 Select an item first&#39;));}return;} const it=set.items[SO.sel]; if(it[1]===bi){S.so[set.id+&#39;:&#39;+SO.sel]=1;SO.sel=null;save();sortShow();} else{const bks=ROOT.querySelectorAll(&#39;#p-sort .bucket&#39;);const b=bks[bi];if(b){b.classList.remove(&#39;shake&#39;);void b.offsetWidth;b.classList.add(&#39;shake&#39;);} const f=$(&#39;#sofb&#39;);clearNode(f);f.appendChild(el(&#39;div&#39;,&#39;msg no&#39;,&#39;\u2718 Wrong group \u2014 try again. (&#39;+it[0]+&#39;)&#39;));} } const MODES=[[&#39;study&#39;,&#39;1 \u00b7 Study&#39;,&#39;\u0645\u0630\u0627\u0643\u0631\u0629&#39;],[&#39;learn&#39;,&#39;2 \u00b7 Learn&#39;,&#39;\u062a\u0639\u0644\u0651\u0645&#39;],[&#39;cards&#39;,&#39;3 \u00b7 Cards&#39;,&#39;\u0628\u0637\u0627\u0642\u0627\u062a&#39;],[&#39;quiz&#39;,&#39;4 \u00b7 Quiz&#39;,&#39;\u0627\u062e\u062a\u0628\u0627\u0631&#39;],[&#39;lab&#39;,&#39;5 \u00b7 Numbers&#39;,&#39;\u0623\u0631\u0642\u0627\u0645&#39;],[&#39;sort&#39;,&#39;6 \u00b7 Sort&#39;,&#39;\u062a\u0635\u0646\u064a\u0641&#39;],[&#39;review&#39;,&#39;7 \u00b7 Review&#39;,&#39;\u0645\u0631\u0627\u062c\u0639\u0629&#39;]]; let mode=&#39;study&#39;; function setMode(m){ mode=m; ROOT.querySelectorAll(&#39;.panel&#39;).forEach(p=&gt;p.classList.toggle(&#39;on&#39;,p.id===&#39;p-&#39;+m)); ROOT.querySelectorAll(&#39;#nav button&#39;).forEach(b=&gt;b.setAttribute(&#39;aria-selected&#39;,String(b.dataset.m===m))); $(&#39;#prog&#39;).style.display=(m===&#39;study&#39;)?&#39;block&#39;:&#39;none&#39;; if(m===&#39;learn&#39;&amp;&amp;!$(&#39;#p-learn&#39;).firstChild)learnStart(); if(m===&#39;cards&#39;)cardsStart(); if(m===&#39;quiz&#39;&amp;&amp;!$(&#39;#p-quiz&#39;).firstChild)quizStart(); if(m===&#39;lab&#39;&amp;&amp;!$(&#39;#p-lab&#39;).firstChild)labStart(); if(m===&#39;sort&#39;)sortShow(); if(booted&amp;&amp;HOST.scrollIntoView&amp;&amp;0&gt;HOST.getBoundingClientRect().top)HOST.scrollIntoView({block:&#39;start&#39;}); } function buildNav(){ const nav=$(&#39;#nav&#39;);MODES.forEach(m=&gt;{const b=el(&#39;button&#39;,null,m[1]+&#39; \u00b7 &#39;+m[2]);b.dataset.m=m[0];b.setAttribute(&#39;role&#39;,&#39;tab&#39;);b.addEventListener(&#39;click&#39;,()=&gt;setMode(m[0]));nav.appendChild(b);}); } function applyTheme(){ if(S.theme)APP.setAttribute(&#39;data-theme&#39;,S.theme);else APP.removeAttribute(&#39;data-theme&#39;); $(&#39;#themeBtn&#39;).textContent=S.theme===&#39;dark&#39;?&#39;\u2600\ufe0f&#39;:&#39;\ud83c\udf19&#39;; } function toggleTheme(){ S.theme=(S.theme===&#39;dark&#39;)?&#39;light&#39;:&#39;dark&#39;;save();applyTheme(); } document.addEventListener(&#39;keydown&#39;,e=&gt;{ if(!ACTIVE)return;const tgt=(e.composedPath&amp;&amp;e.composedPath()[0])||e.target;const tag=(tgt.tagName||&#39;&#39;).toLowerCase(); if(e.altKey&amp;&amp;/^Digit[1-7]$/.test(e.code)){e.preventDefault();setMode(MODES[parseInt(e.code.slice(5),10)-1][0]);return;} if(e.ctrlKey||e.metaKey||e.altKey)return; if(tag===&#39;input&#39;){if(e.key===&#39;Enter&#39;&amp;&amp;mode===&#39;lab&#39;){e.preventDefault();labEnter();}return;} const k=e.key; if(k===&#39;[&#39;||k===&#39;]&#39;){const i=MODES.findIndex(m=&gt;m[0]===mode);setMode(MODES[(i+(k===&#39;]&#39;?1:MODES.length-1))%MODES.length][0]);return;} if(k===&#39;d&#39;||k===&#39;D&#39;){toggleTheme();return;} if(tag===&#39;button&#39;&amp;&amp;(k===&#39;Enter&#39;||k===&#39; &#39;))return; if(mode===&#39;cards&#39;){ if(k===&#39; &#39;||k===&#39;Enter&#39;){e.preventDefault();cardFlip();} else if(k===&#39;k&#39;||k===&#39;K&#39;)cardMark(true); else if(k===&#39;j&#39;||k===&#39;J&#39;)cardMark(false); }else if(mode===&#39;quiz&#39;){ if(/^[1-4]$/.test(k))quizPick(parseInt(k,10)-1); else if((k===&#39;Enter&#39;||k===&#39;ArrowRight&#39;)&amp;&amp;Z.answered){Z.i++;quizShow();} }else if(mode===&#39;learn&#39;){ if(/^[1-3]$/.test(k))learnPick(parseInt(k,10)-1); else if(k===&#39;Enter&#39;){if(!L.checked)learnCheck();else if(L.order.length&gt;L.i){L.i++;learnShow();}} }else if(mode===&#39;sort&#39;){ if(/^[1-9]$/.test(k)){const n=parseInt(k,10)-1;if(SORTS[SO.set].buckets.length&gt;n)sortAssign(n);} else if(k===&#39;Escape&#39;){SO.sel=null;sortShow();} } }); HOST=document.getElementById(&#39;igh-host&#39;); if(!HOST)return; ROOT=HOST.attachShadow?HOST.attachShadow({mode:&#39;open&#39;}):HOST; ROOT.innerHTML=TEMPLATE; APP=ROOT.querySelector(&#39;#app&#39;); try{if(!document.getElementById(&#39;igh-print&#39;)){const ps=document.createElement(&#39;style&#39;);ps.id=&#39;igh-print&#39;;ps.textContent=&#39;@media print{body *{visibility:hidden!important}#igh-host,#igh-host *{visibility:visible!important}#igh-host{position:absolute;left:0;top:0;width:100%}}&#39;;document.head.appendChild(ps);}}catch(x){} HOST.addEventListener(&#39;pointerdown&#39;,()=&gt;{ACTIVE=true;}); HOST.addEventListener(&#39;focusin&#39;,()=&gt;{ACTIVE=true;}); document.addEventListener(&#39;pointerdown&#39;,e=&gt;{const p=e.composedPath?e.composedPath():[];if(-1===p.indexOf(HOST))ACTIVE=false;},true); document.addEventListener(&#39;focusin&#39;,e=&gt;{const p=e.composedPath?e.composedPath():[];if(-1===p.indexOf(HOST))ACTIVE=false;},true); load();buildNav();renderStudy();renderReview();applyTheme(); $(&#39;#themeBtn&#39;).addEventListener(&#39;click&#39;,toggleTheme); renderProgress();setMode(&#39;study&#39;);booted=true;})();&lt;/script&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8212191401466773563'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8212191401466773563'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/09/idiopathic-guttate-hypomelanosis-root.html' title='Idiopathic Guttate Hypomelanosis: Interactive Study Guide'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-7660074429951464710</id><published>2026-07-28T18:06:30.385+00:00</published><updated>2026-07-28T18:06:30.385+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Reference"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Writers"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><category scheme="http://www.blogger.com/atom/ns#" term="Regulatory Affairs"/><title type='text'>LabelCraft: Pharmaceutical Labeling Text Drafting Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;LabelCraft&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;An offline reference tool for drafting pharmaceutical labeling text from a curated phrase library.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/PqkWjPbH/labelcraft.jpg&quot; alt=&quot;LabelCraft Pharmaceutical Labeling Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            LabelCraft is an offline reference tool for drafting pharmaceutical labeling text. It provides a curated library of 211 phrase templates spanning 20 label-content categories — including dosage and administration, storage and handling, pregnancy and lactation, pediatric and geriatric use, renal/hepatic impairment, drug interactions, contraindications, warnings, boxed warnings, adverse reactions, overdose management, OTC Drug Facts panels, Schedule II controlled-substance labeling, and biologics/biosimilars. It is intended for regulatory affairs professionals, pharmaceutical labeling specialists, and students learning labeling conventions who need a starting point for assembling draft label text before formal review.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            Users browse or search the phrase library, add relevant phrases to a draft document, and reorder them into sections using drag-and-drop or one-click auto-sort. Five quick-load templates (Package Insert, Carton Label, Container Label, CII Label, OTC Drug Facts ) pre-populate a starting phrase set for common label types. Each phrase is written as a fill-in-the-blank template with bracketed placeholders (e.g., [Product name], [X mg]) and includes its regulatory source citation (FDA, USP, or CFR reference). The finished draft can be copied as plain text, a numbered list, or Word-formatted rich text, or printed directly from the browser.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Library of 211 pre-written pharmaceutical labeling phrases across 20 categories&lt;/li&gt;
                    &lt;li&gt;Search matches phrase text, category/subcategory label, and the citation note all at once — not just one field&lt;/li&gt;
                    &lt;li&gt;Five one-click quick-load templates that pre-populate a starting phrase set: Package Insert, Carton Label, Container Label, CII (Schedule II) Label, and OTC Drug Facts&lt;/li&gt;
                    &lt;li&gt;Click any phrase to add it to a draft document assembled on the same screen&lt;/li&gt;
                    &lt;li&gt;Drag-and-drop reordering of phrases in the draft document, with touch support for mobile&lt;/li&gt;
                    &lt;li&gt;One-click &quot;auto-sort&quot; restores draft phrases to their original library order&lt;/li&gt;
                    &lt;li&gt;Insert custom section headers/separators anywhere in the draft document&lt;/li&gt;
                    &lt;li&gt;Remove any individual phrase or separator from the draft with one click&lt;/li&gt;
                    &lt;li&gt;Live phrase count of the current draft&lt;/li&gt;
                    &lt;li&gt;Warns before copying if the draft still contains unfilled bracket placeholders (e.g. [X] or [Product name])&lt;/li&gt;
                    &lt;li&gt;Three copy-out formats: Plain text, Numbered list, and Word-formatted (rich text)&lt;/li&gt;
                    &lt;li&gt;Direct browser printing of the assembled document&lt;/li&gt;
                    &lt;li&gt;Mobile-friendly tabbed layout (Categories / Phrases / Document) in addition to the desktop 3-panel view&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/fTrC6zgf/labelcraft1.jpg&quot; alt=&quot;LabelCraft Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Browse phrase categories in the left panel, or use the search box to find phrases by keyword, category, or citation&lt;/li&gt;
            &lt;li&gt;Click a category to filter the phrase library, or select &quot;All&quot; to see everything&lt;/li&gt;
            &lt;li&gt;Click the &quot;+&quot; button on any phrase to add it to your draft document&lt;/li&gt;
            &lt;li&gt;Optionally, use a quick-load template (Package Insert, Carton Label, Container, CII Label, or OTC Drug Facts ) to start with a pre-selected set of phrases&lt;/li&gt;
            &lt;li&gt;In the document panel, drag phrases to reorder them, or click &quot;Auto-Sort&quot; to restore library order&lt;/li&gt;
            &lt;li&gt;Add section separators to organize the document into labeled parts&lt;/li&gt;
            &lt;li&gt;Remove any phrase you don&#39;t need&lt;/li&gt;
            &lt;li&gt;Copy the document as Plain text, a Numbered list, or Word-formatted text — or print it directly&lt;/li&gt;
            &lt;li&gt;Review and complete every bracketed placeholder, and verify all content against current official sources before real-world use&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~89.5 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Current versions of Chrome, Edge, Safari, Firefox&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.1&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;July 20, 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Regulatory affairs professionals and pharmaceutical labeling specialists drafting label text&lt;/li&gt;
                    &lt;li&gt;Students or trainees learning pharmaceutical labeling conventions and terminology&lt;/li&gt;
                    &lt;li&gt;Reference during the labeling drafting/review process, prior to formal regulatory submission&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Final, submission-ready regulatory labeling without professional review&lt;/li&gt;
                    &lt;li&gt;Patient-facing medical or dosing advice&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Sole source for a specific product&#39;s approved labeling — always verify against the current official source&lt;/li&gt;
                    &lt;li&gt;Controlled-substance or high-alert medication labeling without dedicated pharmacist/regulatory sign-off&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 12 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all data stays on your device (browser local storage only)&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Compatible with current evergreen browsers (Chrome, Edge, Safari, Firefox)&lt;/li&gt;
            &lt;li&gt;Lightweight file (~89.5 KB) — opens instantly&lt;/li&gt;
            &lt;li&gt;Clipboard copy includes an automatic fallback if the browser blocks the primary copy method&lt;/li&gt;
            &lt;li&gt;Keyboard-accessible navigation with visible focus indicators throughout&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Every phrase includes its regulatory source citation (FDA/USP/CFR) directly in the tool&lt;/li&gt;
            &lt;li&gt;Version number and last-updated date shown in the tool&lt;/li&gt;
            &lt;li&gt;States clearly that content is static and must be verified against current official sources&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States the jurisdiction the content is written for, with a warning that other countries&#39; requirements differ&lt;/li&gt;
            &lt;li&gt;Shows specific examples of what NOT to use this tool for&lt;/li&gt;
            &lt;li&gt;Warns before copying if a phrase still has an unfilled placeholder&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal or internal organizational use&lt;/li&gt;
                    &lt;li&gt;Reference during professional labeling drafting&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for reference purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using LabelCraft, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20LabelCraft%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20LabelCraft%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get LabelCraft Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start drafting pharmaceutical labels offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk7aAnZLOHju75asNljw?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/7660074429951464710'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/7660074429951464710'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/07/labelcraft-pharmaceutical-labeling-text-tool.html' title='LabelCraft: Pharmaceutical Labeling Text Drafting Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-8643018291547616132</id><published>2026-07-28T17:46:10.235+00:00</published><updated>2026-07-28T17:46:10.236+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Calculators"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Simulators"/><category scheme="http://www.blogger.com/atom/ns#" term="Nursing Students"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>CrCl Trainer: Cockcroft-Gault Creatinine Clearance Calculator</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;CrCl Trainer&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;An offline educational calculator for practicing the Cockcroft-Gault creatinine clearance calculation.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/Ls7xLHLw/crcl.jpg&quot; alt=&quot;CrCl Trainer Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            CrCl Trainer is an educational tool for learning and practicing the Cockcroft-Gault (1976 ) creatinine clearance calculation, including correct weight selection (Actual, Ideal, or Adjusted Body Weight). It is designed for pharmacy, nursing, and medical students, as well as healthcare educators teaching renal dosing methodology. It addresses the need for repeated, low-stakes practice with this specific calculation before applying it in supervised clinical settings.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The user enters patient parameters (age, sex, height, weight, serum creatinine) either through 25 built-in practice cases or free-form Manual Entry, in either metric or imperial units. The tool calculates estimated creatinine clearance (mL/min) using the Cockcroft-Gault 1976 equation, applies Devine (1974) Ideal Body Weight and Adjusted Body Weight (0.4 correction factor) selection logic based on the %IBW ratio, and displays the result alongside its educational KDIGO 2012/2024 GFR category label, the calculation assumptions made, and the reasoning behind which weight was used.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Two modes: Practice Cases (guided scenarios) and Manual Entry (free-form calculation)&lt;/li&gt;
                    &lt;li&gt;25 built-in practice cases with varied patient scenarios&lt;/li&gt;
                    &lt;li&gt;Check Answer, Show Answer, Next Case, and Random Case navigation in Practice mode&lt;/li&gt;
                    &lt;li&gt;Running accuracy tracker for your last 10 attempted cases, with a progress bar&lt;/li&gt;
                    &lt;li&gt;Automatic weight-selection logic (Actual vs. Ideal vs. Adjusted Body Weight) based on the %IBW ratio, with the reason shown alongside the result&lt;/li&gt;
                    &lt;li&gt;Educational KDIGO GFR category label shown with each result&lt;/li&gt;
                    &lt;li&gt;Calculation assumptions displayed alongside every result&lt;/li&gt;
                    &lt;li&gt;Unit toggle for height (cm/in), weight (kg/lbs), and serum creatinine (mg/dL/µmol/L), with automatic conversion&lt;/li&gt;
                    &lt;li&gt;Contextual info-icon tooltips explaining inputs and methodology throughout&lt;/li&gt;
                    &lt;li&gt;Bio-range input validation (flags physiologically implausible values before calculating)&lt;/li&gt;
                    &lt;li&gt;Automatic detection and blocking of accidental entry of sensitive personal information (SSN, phone, email, credit card, medical record number, and long ID-number patterns)&lt;/li&gt;
                    &lt;li&gt;Source citations (with PMID/DOI where applicable) shown directly in the tool&lt;/li&gt;
                    &lt;li&gt;Version number and last-updated date displayed in the tool&#39;s footer&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/wvCb86BX/crcl1.jpg&quot; alt=&quot;CrCl Trainer Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Read the notice screen and confirm you understand the tool&#39;s educational scope&lt;/li&gt;
            &lt;li&gt;Choose a mode: &lt;strong&gt;Practice Cases&lt;/strong&gt; or &lt;strong&gt;Manual Entry&lt;/strong&gt;&lt;/li&gt;
            &lt;li&gt;&lt;strong&gt;In Practice Cases:&lt;/strong&gt; review the scenario shown, enter your calculated CrCl, then select Check Answer (to see if you&#39;re correct ) or Show Answer (to reveal it directly); use Next Case or Random Case to continue&lt;/li&gt;
            &lt;li&gt;&lt;strong&gt;In Manual Entry:&lt;/strong&gt; enter age, sex, height, weight, and serum creatinine (switching units if needed), then select Calculate&lt;/li&gt;
            &lt;li&gt;Review the result, the KDIGO educational category, the weight-selection reasoning, and the listed assumptions&lt;/li&gt;
            &lt;li&gt;Select Reset to clear Manual Entry fields and start over&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~101 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Modern versions of Chrome, Firefox, Safari, and Edge (specific minimum versions not separately tested)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.2.1&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;2026-07-17&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmacy, nursing, and medical students learning the Cockcroft-Gault CrCl calculation&lt;/li&gt;
                    &lt;li&gt;Healthcare educators teaching renal dosing methodology&lt;/li&gt;
                    &lt;li&gt;Self-directed practice and review of weight-selection logic for drug dosing calculations&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams (as a sole resource)&lt;/li&gt;
                    &lt;li&gt;Production use without expert validation&lt;/li&gt;
                    &lt;li&gt;Pediatric patients, pregnant individuals, acute kidney injury, dialysis patients, or extreme body composition (BMI &amp;lt;15 or &amp;gt;40) — outside the validated population for this formula&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 15 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all inputs stay on your device&lt;/li&gt;
            &lt;li&gt;Blocks accidental entry of sensitive information (SSN, phone numbers, emails, credit card numbers, medical record numbers, and long ID numbers)&lt;/li&gt;
            &lt;li&gt;Validates that entered values are within realistic physiological ranges&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Compatible with modern versions of Chrome, Firefox, Safari, and Edge&lt;/li&gt;
            &lt;li&gt;Lightweight file (~101 KB) — opens instantly&lt;/li&gt;
            &lt;li&gt;Clear input labels throughout, with keyboard navigation support&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Based on Cockcroft-Gault (1976), Devine IBW (1974), and KDIGO 2012/2024 GFR categories (versions stated in tool)&lt;/li&gt;
            &lt;li&gt;Sources cited within the tool, including PMID/DOI references&lt;/li&gt;
            &lt;li&gt;Assumptions displayed alongside every result&lt;/li&gt;
            &lt;li&gt;Clear unit labels throughout (mg/dL, µmol/L, kg, lbs, cm, in), with a warning about international unit differences&lt;/li&gt;
            &lt;li&gt;Version number and last-updated date shown in the tool&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States which populations this tool covers (adults 18–92 with stable renal function) and which it excludes&lt;/li&gt;
            &lt;li&gt;Includes a warning about regional/institutional protocol differences&lt;/li&gt;
            &lt;li&gt;Shows specific examples of what NOT to use this tool for&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using CrCl Trainer, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20CrCl%20Trainer%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20CrCl%20Trainer%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get CrCl Trainer Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start practicing renal calculations offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk7Z4rD31ggKsqTE6ivo?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8643018291547616132'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8643018291547616132'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/07/crcl-trainer-cockcroft-gault-calculator.html' title='CrCl Trainer: Cockcroft-Gault Creatinine Clearance Calculator'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-2450934410828176222</id><published>2026-07-28T17:31:37.104+00:00</published><updated>2026-07-28T17:31:37.105+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="BCPS"/><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="NAPLEX"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacists"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><category scheme="http://www.blogger.com/atom/ns#" term="PTCB"/><category scheme="http://www.blogger.com/atom/ns#" term="Study Tools"/><title type='text'>ExamFlow: Pharmacy Certification Study Calendar Tool (NAPLEX, BCPS, PTCB)</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;ExamFlow&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;A study-calendar tool for pharmacy certification exam candidates.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/nz01FpT3/examflow1.jpg&quot; alt=&quot;ExamFlow Study Calendar Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            ExamFlow organizes exam-blueprint study topics into a personal calendar for candidates preparing for NAPLEX, BCPS, or PTCB certification. It is a scheduling and tracking tool — it does not teach content, test competency, or certify exam readiness.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            After choosing an exam and a target date, the user builds a study calendar either by manually dragging individual topics onto specific days or by using the auto-generate function (choosing which days of the week to study and how many topics per day ). Each day can be opened to review its assigned topics and mark them complete. Topic lists are drawn from each exam&#39;s published blueprint (NABP for NAPLEX, BPS for BCPS, PTCB for PTCB), with source citations shown inside the tool.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Three certification tracks to choose from — NAPLEX, BCPS, and PTCB — each with its own topic/domain blueprint&lt;/li&gt;
                    &lt;li&gt;Live countdown showing days remaining until the selected exam date&lt;/li&gt;
                    &lt;li&gt;Auto-generate function that distributes topics across chosen study days and a set number of topics per day&lt;/li&gt;
                    &lt;li&gt;Manual drag-and-drop placement of individual topics onto any calendar day&lt;/li&gt;
                    &lt;li&gt;Day view for reviewing a single day&#39;s assigned topics&lt;/li&gt;
                    &lt;li&gt;Per-topic completion tracking (mark individual topics done / not done)&lt;/li&gt;
                    &lt;li&gt;Progress panel showing overall and per-domain completion&lt;/li&gt;
                    &lt;li&gt;Reference panel listing the source blueprint and guideline citations for each exam&lt;/li&gt;
                    &lt;li&gt;Print/export function for the study calendar&lt;/li&gt;
                    &lt;li&gt;Progress saves automatically in the browser and stays in sync across browser tabs open to the tool&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/YCHt7HP5/examflow2.jpg&quot; alt=&quot;ExamFlow Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;On the setup screen, choose your certification exam (NAPLEX, BCPS, or PTCB ) and enter your target exam date&lt;/li&gt;
            &lt;li&gt;The calendar view opens, showing a live countdown to your exam date&lt;/li&gt;
            &lt;li&gt;Either drag topics from the reference panel onto calendar days yourself, or click &quot;Auto-Generate&quot; to distribute them automatically across chosen study days&lt;/li&gt;
            &lt;li&gt;Click any day to view its assigned topics and mark individual ones complete&lt;/li&gt;
            &lt;li&gt;Track your overall and per-domain progress in the progress panel&lt;/li&gt;
            &lt;li&gt;Print or export your calendar at any time&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~98 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Chrome, Firefox, Safari, Edge (modern versions)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.3&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;April 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmacy students and candidates preparing for NAPLEX, BCPS, or PTCB certification&lt;/li&gt;
                    &lt;li&gt;Self-directed candidates organizing study time against official exam-blueprint topics&lt;/li&gt;
                    &lt;li&gt;Personal study planning and progress tracking&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams&lt;/li&gt;
                    &lt;li&gt;Production use without expert validation&lt;/li&gt;
                    &lt;li&gt;Teaching or explaining topic content — it schedules topics, it does not present or test the material itself&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 13 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection required&lt;/li&gt;
            &lt;li&gt;No data collection — all progress is stored locally in your browser only&lt;/li&gt;
            &lt;li&gt;Zero external script or style dependencies&lt;/li&gt;
            &lt;li&gt;Detects and warns on accidental entry of sensitive information (email addresses, Social Security numbers, phone numbers) in the notes field&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works on modern browsers — Chrome, Firefox, Safari, Edge&lt;/li&gt;
            &lt;li&gt;Lightweight file (~98 KB) — opens instantly&lt;/li&gt;
            &lt;li&gt;Input validation with clear error messages (e.g., rejects invalid or past exam dates)&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Version number and last-updated date shown in the tool&lt;/li&gt;
            &lt;li&gt;Source citations included and linked in-app (NABP, BPS, PTCB, ACC/AHA, USP, Surviving Sepsis Campaign)&lt;/li&gt;
            &lt;li&gt;States its own assumptions and scope limitations directly in the tool&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States which exams and geographic region the content is scoped to, with a regional-variation warning&lt;/li&gt;
            &lt;li&gt;Lists specific examples of what not to use the tool for&lt;/li&gt;
            &lt;li&gt;Notes that content is fixed as of a stated date, with no automatic updates&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using ExamFlow, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20ExamFlow%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20ExamFlow%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get ExamFlow Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start organizing your study schedule offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk7XQSMooK1dEqS8codc?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/2450934410828176222'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/2450934410828176222'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/07/examflow-pharmacy-certification-study-calendar.html' title='ExamFlow: Pharmacy Certification Study Calendar Tool (NAPLEX, BCPS, PTCB)'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-5057856311390185933</id><published>2026-07-28T15:54:28.473+00:00</published><updated>2026-07-28T15:56:40.260+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Simulators"/><category scheme="http://www.blogger.com/atom/ns#" term="Patient Counseling"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacists"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>ShowDontTell: Pharmacy SIG Code to Patient Instruction Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;ShowDontTell — Patient Instruction Cards&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;A searchable reference tool that converts prescription SIG codes into plain-language, patient-ready instruction cards.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/ZYND4SZn/showdonttell.jpg&quot; alt=&quot;ShowDontTell Patient Instruction Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            This tool helps pharmacy professionals and pharmacy students turn prescription shorthand (SIG codes like &quot;bid,&quot; &quot;qhs,&quot; &quot;prn&quot; ) into simplified, plain-language instructions that can be shown or printed directly for a patient. It covers 34 common medication instructions across six categories: Timing, With/Without Food, Special Instructions, Route, Storage, and Safety. It is designed as a patient-counseling communication aid, not a source of clinical decision-making.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The user types a SIG code, an abbreviation, or a plain-language phrase into a search field (or taps one of ten quick-pick shortcuts). The tool matches the input against the SIG code list, the instruction title, and the instruction description at once, and displays the matching instruction card(s) for the user to select. The selected card can then be shown to the patient in a dedicated full-screen &quot;Present Mode,&quot; or printed directly.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Search matches on more than one field at once — the SIG abbreviation, the instruction title, and the instruction description, in the language currently selected.&lt;/li&gt;
                    &lt;li&gt;Ten one-tap quick-pick shortcuts for the most common instructions (bid, tid, qid, qhs, prn, with food, do not crush, stay upright, avoid alcohol, refrigerate).&lt;/li&gt;
                    &lt;li&gt;34 pre-written instruction cards across 6 categories (Timing, With/Without Food, Special Instructions, Route, Storage, Safety).&lt;/li&gt;
                    &lt;li&gt;Save any instruction card to a personal favorites list, stored locally for quick access next time.&lt;/li&gt;
                    &lt;li&gt;Full-screen &quot;Show Patient&quot; presentation mode, designed to be shown directly to a patient at the point of care.&lt;/li&gt;
                    &lt;li&gt;Within Present Mode, step through multiple matching cards in sequence without leaving full-screen view.&lt;/li&gt;
                    &lt;li&gt;Adjustable on-screen text size in the browse view — the selected size carries over automatically into Present Mode.&lt;/li&gt;
                    &lt;li&gt;Full interface available in four languages (English, Spanish, Arabic, Chinese), including right-to-left layout for Arabic.&lt;/li&gt;
                    &lt;li&gt;One-tap printing of the currently selected instruction card.&lt;/li&gt;
                    &lt;li&gt;On-screen warning when a typed abbreviation has more than one recognized clinical meaning (e.g., &quot;OD&quot; can mean &quot;once daily&quot; or &quot;right eye&quot;).&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/8kfxcvdC/showdonttell1.jpg&quot; alt=&quot;ShowDontTell Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Type a SIG code or plain-language phrase into the search box, or tap a quick-pick shortcut.&lt;/li&gt;
            &lt;li&gt;Select the matching instruction card from the results list on the left.&lt;/li&gt;
            &lt;li&gt;Review the patient-ready card shown on the right.&lt;/li&gt;
            &lt;li&gt;Tap &quot;Show Patient&quot; to display it full-screen for the patient, or &quot;Print&quot; to print it.&lt;/li&gt;
            &lt;li&gt;Optionally tap the star icon to save the card to your favorites list.&lt;/li&gt;
            &lt;li&gt;Switch the interface language or adjust text size at any time from the header controls.&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~102 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Chrome, Firefox, Safari, Edge (current versions — not tested against specific version numbers )&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English, Spanish, Arabic, Chinese (interface)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.0.0&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;April 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmacy professionals and pharmacy staff preparing patient-ready medication instructions&lt;/li&gt;
                    &lt;li&gt;Pharmacy and health-profession students learning patient counseling language&lt;/li&gt;
                    &lt;li&gt;Reference during patient counseling or for printed take-home instructions&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams&lt;/li&gt;
                    &lt;li&gt;Production use without expert validation&lt;/li&gt;
                    &lt;li&gt;Pregnant or lactating patients (not validated for this population)&lt;/li&gt;
                    &lt;li&gt;Pediatric use, unless a specific step explicitly says so&lt;/li&gt;
                    &lt;li&gt;Acute illness or critical-care settings&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 14 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works entirely offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No external servers or third-party connections — nothing is transmitted anywhere&lt;/li&gt;
            &lt;li&gt;On-screen reminder not to enter patient names into the search field&lt;/li&gt;
            &lt;li&gt;Saved favorites are stored only in your browser and never leave your device&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works in current versions of Chrome, Firefox, Safari, and Edge&lt;/li&gt;
            &lt;li&gt;Lightweight file (~102 KB) — opens instantly, nothing to install&lt;/li&gt;
            &lt;li&gt;Keyboard-accessible interface with screen-reader labels on every interactive element&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Version number and last-updated date shown directly in the tool&lt;/li&gt;
            &lt;li&gt;Clinical sources cited in the tool (USP &amp;lt;17&amp;gt;, ISMP 2024, AHRQ 3rd Ed.)&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States which patient populations this tool does not cover (pregnant/lactating, pediatric unless noted, acute illness/critical care)&lt;/li&gt;
            &lt;li&gt;Includes a note on regional/local pharmacy standard variation&lt;/li&gt;
            &lt;li&gt;Shows specific examples of what not to use the tool for&lt;/li&gt;
            &lt;li&gt;Includes a fixed-content notice — this tool does not update automatically&lt;/li&gt;
            &lt;li&gt;Flags on-screen when a searched abbreviation has more than one recognized clinical meaning&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using ShowDontTell, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20ShowDontTell%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20ShowDontTell%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get ShowDontTell Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start converting SIG codes offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk7VW2m5n9SKlvvGV5NO?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5057856311390185933'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5057856311390185933'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2026/07/showdonttell-pharmacy-sig-code-patient-instructions.html' title='ShowDontTell: Pharmacy SIG Code to Patient Instruction Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-1777887451042696648</id><published>2025-10-01T15:19:00.005+00:00</published><updated>2026-07-28T15:29:04.753+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Simulators"/><category scheme="http://www.blogger.com/atom/ns#" term="Nursing Students"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacology"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>StemMaster: Pharmacology Drug-Name Stems Flashcard Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;StemMaster&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;A flashcard, quiz, and reference tool for learning drug-name stem conventions used in pharmacology.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/jd6BTbKx/stemmaster.jpg&quot; alt=&quot;StemMaster Pharmacology Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            StemMaster is an offline HTML tool for learning drug-name stem conventions — the suffixes and prefixes (such as -pril, -mab, -vastatin ) that indicate a drug&#39;s class or mechanism in pharmacology naming. It is designed for pharmacy, nursing, medical, and other health-science students studying drug nomenclature. It addresses the recurring study task of memorizing and recognizing stem-to-class relationships across a broad range of drug categories, rather than looking each one up individually.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The tool contains 109 drug-name stem entries organized into 9 categories (Cardiovascular, Infectious, Oncology, Neuro/Psych, Endocrine, GI, Respiratory, Immunology, and Misc/Other). Each entry lists the stem itself, its drug class, its mechanism, and example drug names. Users move between four modes — Flashcards, Quiz, Reference, and Progress — depending on whether they want to study, test themselves, look something up, or check how they&#39;re doing.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Flashcard mode with a four-option self-rating system (Again / Hard / Good / Easy) after flipping each card&lt;/li&gt;
                    &lt;li&gt;Cards you rate lower reappear more often on later passes; cards you rate highest are shown less often but still occasionally resurface for review&lt;/li&gt;
                    &lt;li&gt;A streak counter tracks consecutive correct ratings/answers, with a separate best-streak record&lt;/li&gt;
                    &lt;li&gt;Multiple-choice quiz mode with a running correct/wrong score&lt;/li&gt;
                    &lt;li&gt;Search box matches on more than one field at once — you can type either a stem (e.g. &quot;-pril&quot;) or an actual drug name (e.g. &quot;lisinopril&quot;) and get the same result&lt;/li&gt;
                    &lt;li&gt;Category filter chips let you narrow flashcards, quiz, or the reference table to one of the 9 categories, each showing a live count of entries&lt;/li&gt;
                    &lt;li&gt;Reference mode: a full searchable table of all 109 entries, sortable by browsing category, with a print function for a paper copy&lt;/li&gt;
                    &lt;li&gt;Progress mode: a per-category breakdown showing how many stems are reviewed, mastered, still need work, or not yet seen, with a mastery percentage bar for each category&lt;/li&gt;
                    &lt;li&gt;Overall header stats: total stem count, current streak, and total mastered count, visible at all times&lt;/li&gt;
                    &lt;li&gt;Keyboard shortcuts: Space or Enter to flip a flashcard, number keys 1–4 to rate it, arrow key to advance&lt;/li&gt;
                    &lt;li&gt;Progress, ratings, and quiz scores are saved automatically between sessions on the same device&lt;/li&gt;
                    &lt;li&gt;Flashcards and mode-switch buttons are keyboard-navigable and labeled for screen readers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/pT4MmY1H/stemmaster1.jpg&quot; alt=&quot;StemMaster Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Open the HTML file in any browser — no installation or internet connection needed&lt;/li&gt;
            &lt;li&gt;On first open, read the disclaimer screen and click &quot;I Understand&quot; to continue&lt;/li&gt;
            &lt;li&gt;Start in Flashcards mode: read the stem side, click the card (or press Space/Enter ) to flip it, then rate yourself with Again / Hard / Good / Easy&lt;/li&gt;
            &lt;li&gt;Optionally narrow the deck first using the category chips at the top, or type a stem or drug name into the search box&lt;/li&gt;
            &lt;li&gt;Switch to Quiz mode to answer multiple-choice questions and track your correct/wrong score&lt;/li&gt;
            &lt;li&gt;Switch to Reference mode to search or browse the full table of entries, or click Print for a paper copy&lt;/li&gt;
            &lt;li&gt;Switch to Progress mode at any time to see your mastery breakdown by category&lt;/li&gt;
            &lt;li&gt;Progress is saved automatically — closing and reopening the file keeps your ratings, scores, and streak&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~116 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Modern browsers (Chrome, Firefox, Safari, Edge) — built with standard web features; not version-tested individually&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.0&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;2026-07-15&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmacy, nursing, medical, and other health-science students studying drug-name nomenclature&lt;/li&gt;
                    &lt;li&gt;Self-study and exam-practice supplementing (not replacing) coursework&lt;/li&gt;
                    &lt;li&gt;Quick reference while reviewing drug classes&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams as sole preparation&lt;/li&gt;
                    &lt;li&gt;Production use without expert validation&lt;/li&gt;
                    &lt;li&gt;Dosing, interaction-checking, or any calculation-based task — the tool contains no calculators&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 12 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all progress stays on your device (browser local storage)&lt;/li&gt;
            &lt;li&gt;Zero external dependencies — no fonts, scripts, or content loaded from the internet&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Lightweight file (~116 KB) — opens instantly, no installation needed&lt;/li&gt;
            &lt;li&gt;Error handling for storage issues, with a clear on-screen message if progress can&#39;t be saved&lt;/li&gt;
            &lt;li&gt;Keyboard-accessible flashcards and labeled controls for screen readers&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Version number and last-updated date shown in the tool&lt;/li&gt;
            &lt;li&gt;General data-source basis stated, with U.S.-specific regulatory notes flagged where they appear&lt;/li&gt;
            &lt;li&gt;States clearly that content is static and may not reflect the newest approvals or safety updates&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States who the tool is designed for and what it does not cover&lt;/li&gt;
            &lt;li&gt;Flags that some regulatory notes are U.S.-specific and may not apply elsewhere&lt;/li&gt;
            &lt;li&gt;Includes specific examples of what NOT to use the tool for&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using StemMaster, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20StemMaster%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20StemMaster%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get StemMaster Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start mastering drug nomenclature offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk6HmxJNPhVTCLSbYFE2?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/1777887451042696648'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/1777887451042696648'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/10/stemmaster-pharmacology-drug-stems-flashcards.html' title='StemMaster: Pharmacology Drug-Name Stems Flashcard Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-2279871171682292500</id><published>2025-10-01T14:46:00.004+00:00</published><updated>2026-07-28T15:08:40.309+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Reference"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Writers"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>AbbrVault: Medical Writing &amp; Clinical Abbreviation Reference Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    /* إصلاح مشكلة الحرف الأول في عنوان بلوجر */
    .post-title::first-letter,
    .entry-title::first-letter,
    .post-title h1::first-letter,
    .post-title h2::first-letter,
    .post-title h3::first-letter,
    h1.post-title::first-letter,
    h2.post-title::first-letter,
    h3.post-title::first-letter,
    .post-outer .post-title::first-letter, 
    .post-body::first-letter {
        font-size: inherit !important;
        float: none !important;
        margin: 0 !important;
        padding: 0 !important;
        color: inherit !important;
        background: transparent !important;
        line-height: inherit !important;
        display: inline !important;
        font-weight: inherit !important;
    }

    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;AbbrVault — Medical Writing Reference&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;An offline reference tool for pharmaceutical and medical abbreviations, with an automatic flag for terms ISMP designates as error-prone.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/RVpyh0kJ/abbrvault.jpg&quot; alt=&quot;AbbrVault Medical Writing Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            AbbrVault is a searchable reference library of pharmaceutical and medical abbreviations, built for people who need to look up or standardize terminology while drafting clinical, regulatory, or academic documents. It addresses the problem of inconsistent, ambiguous, or unsafe abbreviation use by combining a searchable library with an automatic flag for abbreviations that ISMP designates as error-prone or &quot;Do Not Use.&quot;
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The library contains 725 entries across 15 subject categories — including routes of administration, dosing frequency, dosage forms, statistics, regulatory/ICH terminology, adverse events, laboratory values, and pharmacokinetics — compiled from terminology used by ICH, FDA, EMA, ISMP (both the U.S. and Canada lists ), MedDRA, and CDISC. The user searches or browses the library, adds relevant entries to a personal document list (which can include their own custom entries), and exports the finished list as plain text, Markdown, an HTML table, or a Word-pasteable format.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Searchable library of 725 pharmaceutical/medical abbreviation entries&lt;/li&gt;
                    &lt;li&gt;Search matches against both the abbreviation itself and its full expansion/definition in the same search box&lt;/li&gt;
                    &lt;li&gt;15 subject-matter categories to filter by (Routes of Administration, Dosing Frequency, Dosage Forms, Study Design, Statistics, Regulatory/ICH, Adverse Events, Laboratory, Pharmacokinetics, Vital Signs &amp; Physical, Time &amp; Duration, Organizations, Document Types, Clinical Terms, Miscellaneous), plus an &quot;All Abbreviations&quot; view&lt;/li&gt;
                    &lt;li&gt;Automatic visual flag (badge and colored border) on any entry ISMP designates as &quot;Do Not Use&quot; or error-prone&lt;/li&gt;
                    &lt;li&gt;Build a personal, ordered document list by adding entries from the library&lt;/li&gt;
                    &lt;li&gt;Add custom abbreviation entries of your own alongside the built-in library&lt;/li&gt;
                    &lt;li&gt;Custom entries are automatically screened for common sensitive-data patterns before being added&lt;/li&gt;
                    &lt;li&gt;Sort your document list three ways: order added, alphabetically, or grouped by category&lt;/li&gt;
                    &lt;li&gt;Reorder your document list by dragging entries (available in &quot;order added&quot; mode)&lt;/li&gt;
                    &lt;li&gt;Remove individual entries from your document list, or clear all custom entries at once&lt;/li&gt;
                    &lt;li&gt;Export your document list in four formats: plain text, Markdown, an HTML table, or tab-separated (Word-pasteable)&lt;/li&gt;
                    &lt;li&gt;Copy the export directly to your clipboard, with an automatic fallback method if the browser blocks the standard copy action&lt;/li&gt;
                    &lt;li&gt;Download the export as a file&lt;/li&gt;
                    &lt;li&gt;Print your document list directly from the browser&lt;/li&gt;
                    &lt;li&gt;Your document list and custom entries are saved automatically in your browser and persist between sessions on the same device&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/3x6sSw9R/abbrvault2.jpg&quot; alt=&quot;AbbrVault Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Type a term into the search box, or browse by selecting a category from the sidebar&lt;/li&gt;
            &lt;li&gt;Review the results — entries ISMP flags as &quot;Do Not Use&quot; or error-prone are marked with a warning badge&lt;/li&gt;
            &lt;li&gt;Click the &quot;+&quot; button on any entry to add it to your document list&lt;/li&gt;
            &lt;li&gt;Optionally, add your own terms using the &quot;Add Custom Entry&quot; form&lt;/li&gt;
            &lt;li&gt;Sort your document list by order added, alphabetically, or by category, and drag to reorder when needed&lt;/li&gt;
            &lt;li&gt;Open the export panel and choose a format: plain text, Markdown, HTML table, or Word-tabbed&lt;/li&gt;
            &lt;li&gt;Copy, download, or print the finished list&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~115 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Tested on a current version of Chrome. Expected to work on recent versions of Firefox, Safari, and Edge based on standard web features used (not separately tested )&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.1&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;July 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Medical writers and regulatory affairs professionals drafting clinical or regulatory documents&lt;/li&gt;
                    &lt;li&gt;Pharmacy, nursing, and medical students learning standard pharmaceutical/medical abbreviations&lt;/li&gt;
                    &lt;li&gt;Clinical research coordinators compiling a document-specific abbreviation list&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams&lt;/li&gt;
                    &lt;li&gt;Production use in real patient records, prescriptions, or medication orders without expert validation&lt;/li&gt;
                    &lt;li&gt;Use as your institution&#39;s official, exhaustive abbreviation policy — the tool itself states it is not a comprehensive list&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 11 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all data stays in your browser&#39;s local storage on your device&lt;/li&gt;
            &lt;li&gt;Blocks accidental entry of sensitive information (SSNs, phone numbers, credit card numbers, email addresses, medical record/patient ID numbers, long numeric IDs) when adding custom entries&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Tested on a current version of Chrome; expected to work on recent Firefox, Safari, and Edge versions (not separately tested)&lt;/li&gt;
            &lt;li&gt;Single file, ~115 KB — opens instantly, no installation&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Version number and last-updated date shown in the tool itself&lt;/li&gt;
            &lt;li&gt;Sources cited within the tool (ICH, FDA, EMA, ISMP — both the U.S. and Canada lists — MedDRA, CDISC)&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States specific exclusions for what this tool should not be used for (e.g., an active patient&#39;s medical record, prescription, or medication order)&lt;/li&gt;
            &lt;li&gt;Includes a warning that ISMP designations and terminology vary by country and institution&lt;/li&gt;
            &lt;li&gt;Shows specific examples of what not to use this tool for&lt;/li&gt;
            &lt;li&gt;States that the reference content is static and when it was last reviewed&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using AbbrVault, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20AbbrVault%20Reference%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20AbbrVault%20Reference%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get AbbrVault Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start building your reference lists offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk6Fy6AHj9Fs6NkZZ1pY?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/2279871171682292500'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/2279871171682292500'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/10/abbrvault-medical-writing-abbreviation-reference.html' title='AbbrVault: Medical Writing &amp; Clinical Abbreviation Reference Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-3177423917133766965</id><published>2025-10-01T12:31:00.005+00:00</published><updated>2026-07-28T14:37:11.020+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Calculators"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Simulators"/><category scheme="http://www.blogger.com/atom/ns#" term="Nursing Students"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>CaCorrect: Albumin-Adjusted Calcium Calculator &amp; Quiz Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    /* إصلاح مشكلة الحرف الأول في عنوان بلوجر */
    .post-title::first-letter,
    .entry-title::first-letter,
    .post-title h1::first-letter,
    .post-title h2::first-letter,
    .post-title h3::first-letter,
    h1.post-title::first-letter,
    h2.post-title::first-letter,
    h3.post-title::first-letter,
    .post-outer .post-title::first-letter, 
    .post-body::first-letter {
        font-size: inherit !important;
        float: none !important;
        margin: 0 !important;
        padding: 0 !important;
        color: inherit !important;
        background: transparent !important;
        line-height: inherit !important;
        display: inline !important;
        font-weight: inherit !important;
    }

    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;CaCorrect&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;A single-file HTML tool for calculating and practicing albumin-adjusted (corrected) serum calcium using the Payne 1973 formula.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/Hkv9gc7B/cacorrect.jpg&quot; alt=&quot;CaCorrect Tool on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            CaCorrect is an offline educational tool for calculating and practicing corrected calcium interpretation using the Payne 1973 albumin-adjustment formula. It is intended for healthcare students and professionals learning to interpret total calcium results in the context of abnormal serum albumin, and covers the calculation itself, its result categories, and practice against a set of scenarios.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The tool provides three modes: a calculator, a set of practice cases, and a quiz mode. In the calculator, the user enters a measured total calcium value and a serum albumin value; the tool applies the Payne 1973 formula (Corrected Ca = Measured Ca + 0.8 × [4.0 − Albumin] ) and returns the corrected value along with a classification (Hypocalcemia, Normal, or Hypercalcemia) based on an 8.5–10.5 mg/dL reference range. The Practice Cases and Quiz Mode present 25 fictional scenarios covering a range of conditions (e.g., malnutrition, chronic kidney disease, malignancy, pregnancy) for the user to work through using the same formula.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Corrected calcium calculator using the Payne 1973 albumin-adjustment formula&lt;/li&gt;
                    &lt;li&gt;Automatic classification of the corrected result as Hypocalcemia, Normal, or Hypercalcemia&lt;/li&gt;
                    &lt;li&gt;Calculation assumptions displayed alongside every result&lt;/li&gt;
                    &lt;li&gt;Unit-conversion note for calcium (mg/dL vs. mmol/L)&lt;/li&gt;
                    &lt;li&gt;&quot;Copy Result&quot; button that copies the corrected value, inputs, and formula reference as text&lt;/li&gt;
                    &lt;li&gt;25 fictional practice case scenarios spanning a range of conditions and calcium/albumin combinations&lt;/li&gt;
                    &lt;li&gt;&quot;Random Case&quot; button that loads one practice case at a time&lt;/li&gt;
                    &lt;li&gt;&quot;Show All Cases&quot; button that loads all 25 practice cases at once&lt;/li&gt;
                    &lt;li&gt;Quiz Mode that presents a case and asks the user to calculate the corrected value and select its category&lt;/li&gt;
                    &lt;li&gt;Quiz progress tracking: rolling percentage correct (last 10 answers), a running &quot;X of Y correct&quot; count, and a streak counter&lt;/li&gt;
                    &lt;li&gt;Detection and blocking of apparent real patient identifiers entered into the calculator (e.g., SSN-like numbers, email addresses, credit-card-like numbers, medical record numbers)&lt;/li&gt;
                    &lt;li&gt;Range checks that reject calcium or albumin entries outside realistic physiological limits, with an explanatory message&lt;/li&gt;
                    &lt;li&gt;Keyboard navigation between the three modes (arrow keys)&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/SR9vXLCH/cacorrect2.jpg&quot; alt=&quot;CaCorrect Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Open the file in a web browser — no installation or internet connection required.&lt;/li&gt;
            &lt;li&gt;Read and acknowledge the introductory notice to access the tool.&lt;/li&gt;
            &lt;li&gt;On the Calculator tab, enter a measured calcium value and an albumin value, then select &quot;Calculate&quot; to see the corrected value, its category, and the assumptions used.&lt;/li&gt;
            &lt;li&gt;Optionally select &quot;Copy Result&quot; to copy the result as text, or &quot;Reset&quot; to clear the fields.&lt;/li&gt;
            &lt;li&gt;On the Practice Cases tab, select &quot;Random Case&quot; to work through one scenario at a time, or &quot;Show All Cases&quot; to view all 25 at once.&lt;/li&gt;
            &lt;li&gt;On the Quiz Mode tab, review the case shown, enter your calculated value and select a category, then select &quot;Submit Answer&quot; to see feedback and updated progress.&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~72 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Expected to work on current versions of Chrome, Firefox, Safari, and Edge&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline )&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.1&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;July 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Healthcare students learning to interpret calcium results in the context of abnormal albumin&lt;/li&gt;
                    &lt;li&gt;Nursing, pharmacy, and allied health professionals reviewing or practicing corrected calcium calculations&lt;/li&gt;
                    &lt;li&gt;Self-study or supplementary coursework practice&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams&lt;/li&gt;
                    &lt;li&gt;Production use without expert validation&lt;/li&gt;
                    &lt;li&gt;Patients with CKD Stage 4–5/ESRD/dialysis, critical illness with acid-base disturbances, paraproteinemia (e.g., multiple myeloma), pregnancy, or pediatric patients — the formula is particularly unreliable in these populations&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 14 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — nothing is sent over the network or stored outside your current browser session&lt;/li&gt;
            &lt;li&gt;Blocks apparent real patient identifiers from being entered (e.g., SSN-like numbers, emails, credit-card-like numbers, medical record numbers)&lt;/li&gt;
            &lt;li&gt;Validates that entered calcium and albumin values are within realistic physiological ranges&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Expected to work on current versions of Chrome, Firefox, Safari, and Edge&lt;/li&gt;
            &lt;li&gt;Lightweight file (~72 KB) — opens instantly&lt;/li&gt;
            &lt;li&gt;Error messages shown directly next to the relevant input field&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Based on the Payne 1973 albumin-adjusted calcium formula (version and year stated in the tool)&lt;/li&gt;
            &lt;li&gt;Formula and reference-range sources cited within the tool, including a &quot;Current Evidence&quot; note on more recent research questioning the formula&#39;s reliability&lt;/li&gt;
            &lt;li&gt;Assumptions used in each calculation displayed alongside the result&lt;/li&gt;
            &lt;li&gt;Clear unit labels throughout (mg/dL, g/dL), with a conversion note for mmol/L&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States the population this tool is traditionally applied to, and the populations it is particularly unreliable for&lt;/li&gt;
            &lt;li&gt;Includes a warning that reference ranges are US-based and may vary by country/laboratory&lt;/li&gt;
            &lt;li&gt;Shows specific examples of what NOT to use this tool for&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using CaCorrect, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20CaCorrect%20Tool&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20CaCorrect%20Tool%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get CaCorrect Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start practicing offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk6DZk5WmS97it93GewW?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3177423917133766965'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3177423917133766965'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/10/cacorrect-albumin-adjusted-calcium-calculator.html' title='CaCorrect: Albumin-Adjusted Calcium Calculator &amp; Quiz Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-436709151682825478</id><published>2025-10-01T12:21:00.004+00:00</published><updated>2026-07-28T14:18:28.910+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Abbreviations"/><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Simulators"/><category scheme="http://www.blogger.com/atom/ns#" term="Nursing Students"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>RxDecoder QuizMaster: Pharmacy Abbreviations Flashcard Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    /* إصلاح مشكلة الحرف الأول في عنوان بلوجر */
    .post-title::first-letter,
    .entry-title::first-letter,
    .post-title h1::first-letter,
    .post-title h2::first-letter,
    .post-title h3::first-letter,
    h1.post-title::first-letter,
    h2.post-title::first-letter,
    h3.post-title::first-letter,
    .post-outer .post-title::first-letter, 
    .post-body::first-letter {
        font-size: inherit !important;
        float: none !important;
        margin: 0 !important;
        padding: 0 !important;
        color: inherit !important;
        background: transparent !important;
        line-height: inherit !important;
        display: inline !important;
        font-weight: inherit !important;
    }

    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;RxDecoder QuizMaster&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;A pharmacy abbreviation reference and self-testing tool covering 210 clinical abbreviations.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/mDGCSQH0/Rx-Decoder.jpg&quot; alt=&quot;RxDecoder QuizMaster on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            RxDecoder QuizMaster is a study tool for recognizing and understanding pharmacy and clinical abbreviations. It is built for pharmacy, nursing, and allied-health students, and for practicing professionals who want to review or refresh their knowledge of prescription shorthand. It addresses a specific, well-documented patient-safety problem: many common clinical abbreviations are ambiguous or easily misread, and error-prone abbreviations are a recognized contributor to medication errors.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The tool presents one abbreviation at a time as a flashcard; the user reveals its meaning, then self-rates their recall. Content covers frequency/dosing shorthand (e.g., qd, bid, tid ), routes of administration, timing and meal-related instructions, Latin prescription terms, measurement units, dispensing terms, and general clinical abbreviations. Abbreviations are drawn primarily from US clinical standards (ASHP, ISMP, Ansel&#39;s) and Joint Commission guidance, cross-checked against the ISMP 2024 List of Error-Prone Abbreviations, with high-alert entries visibly flagged.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Flashcard quiz covering 210 pharmacy/clinical abbreviations, presented one at a time&lt;/li&gt;
                    &lt;li&gt;Weighted review ordering — previously missed cards are about 4x more likely to come up early in a session, and &quot;almost&quot; cards about 2x, so weaker terms resurface sooner (each session is still randomized, not a fixed order)&lt;/li&gt;
                    &lt;li&gt;Three-way self-rating per card (Missed / Almost / Got It) that feeds the weighting above&lt;/li&gt;
                    &lt;li&gt;Live session stats bar tracking streak, known, unsure, and missed counts&lt;/li&gt;
                    &lt;li&gt;Category filtering across 7 groups: Frequency, Route, Timing, Latin, Measures, Dispense, Misc&lt;/li&gt;
                    &lt;li&gt;Dedicated Search mode that matches a query against the abbreviation itself, its short meaning, and its full explanation text in a single search&lt;/li&gt;
                    &lt;li&gt;Weak Spots mode — automatically builds a review list of every card previously missed or marked unsure, ranked by how often each was missed&lt;/li&gt;
                    &lt;li&gt;One-click &quot;Practice&quot; button to drill a single card directly from the Weak Spots list&lt;/li&gt;
                    &lt;li&gt;ISMP warning badges (⚠) shown on abbreviations flagged as error-prone, visible on both the flashcard and in search results&lt;/li&gt;
                    &lt;li&gt;Status dot shown next to each result in Search mode, color-coded to whether you&#39;ve previously marked that card known, unsure, or missed&lt;/li&gt;
                    &lt;li&gt;Printable summary sheet via a dedicated Print Sheet button, with output that reflects your current category filter&lt;/li&gt;
                    &lt;li&gt;Session progress (streak, known/unsure/missed counts, per-card history) is saved automatically in your browser and restored the next time you open the tool&lt;/li&gt;
                    &lt;li&gt;One-click &quot;Reset Session&quot; to clear saved progress and start over&lt;/li&gt;
                    &lt;li&gt;Keyboard shortcuts — Space to flip the active card, 1/2/3 to rate it Missed/Almost/Got It&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/xdN35fFn/rxdecoder.jpg&quot; alt=&quot;RxDecoder QuizMaster Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Open the HTML file in a web browser — no installation needed&lt;/li&gt;
            &lt;li&gt;Read the introductory disclaimer screen, shown on first use&lt;/li&gt;
            &lt;li&gt;Choose a mode: Quiz Me, Search, or Weak Spots&lt;/li&gt;
            &lt;li&gt;In Quiz Me, optionally filter by category, then click the card or press Space to reveal its meaning&lt;/li&gt;
            &lt;li&gt;Rate the card Missed, Almost, or Got It — your rating adjusts how soon that card reappears&lt;/li&gt;
            &lt;li&gt;Switch to Search at any time to look up a specific abbreviation directly&lt;/li&gt;
            &lt;li&gt;Visit Weak Spots to review only the cards you&#39;ve previously missed or marked unsure, ranked by difficulty, or tap Practice on any single card&lt;/li&gt;
            &lt;li&gt;Use Print Sheet to generate a printable version of the current filtered list&lt;/li&gt;
            &lt;li&gt;Progress saves automatically as you go; use Reset Session at any time to start fresh&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~100 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Current versions of Chrome, Firefox, Safari, and Edge (specific minimum versions not independently tested )&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;3.6&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;June 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmacy, nursing, and allied-health students learning to recognize clinical abbreviations&lt;/li&gt;
                    &lt;li&gt;Practicing healthcare professionals reviewing or refreshing abbreviation knowledge&lt;/li&gt;
                    &lt;li&gt;Self-directed study and repeated quiz-style review&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exam preparation (supplementary use only, not a substitute for accredited training)&lt;/li&gt;
                    &lt;li&gt;Production or institutional use without expert validation&lt;/li&gt;
                    &lt;li&gt;Serving as an official institutional reference or a record of any specific facility&#39;s approved abbreviation policy&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 12 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all progress stays on your device (browser local storage only)&lt;/li&gt;
            &lt;li&gt;Zero external dependencies — no fonts or scripts loaded from the internet&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works in current versions of Chrome, Firefox, Safari, and Edge&lt;/li&gt;
            &lt;li&gt;Lightweight file (~100 KB) — opens instantly&lt;/li&gt;
            &lt;li&gt;Handles storage errors gracefully — a failed save won&#39;t crash the tool&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Version and last-updated date shown in the tool (Version 3.6, June 2026)&lt;/li&gt;
            &lt;li&gt;Sources cited: ASHP, ISMP, Ansel&#39;s, and Joint Commission guidance, cross-checked against the ISMP 2024 List of Error-Prone Abbreviations&lt;/li&gt;
            &lt;li&gt;States that abbreviation standards and prohibited-abbreviation lists vary by country and institution&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States who the tool is built for and what it doesn&#39;t replace&lt;/li&gt;
            &lt;li&gt;Lists specific examples of what not to use this tool for&lt;/li&gt;
            &lt;li&gt;Static-content notice — content is fixed as of the listed date, with no automatic updates&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through AI based iterative check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using RxDecoder QuizMaster, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20RxDecoder%20QuizMaster&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20RxDecoder%20QuizMaster%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get RxDecoder QuizMaster Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start practicing offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk69UVjb6rHqZQwthMWI?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/436709151682825478'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/436709151682825478'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/10/rxdecoder-quizmaster-pharmacy-abbreviations.html' title='RxDecoder QuizMaster: Pharmacy Abbreviations Flashcard Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-3705690458424693505</id><published>2025-09-27T23:39:00.012+00:00</published><updated>2026-07-28T13:54:01.293+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Inventory Training"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Simulators"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacists"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacy Students"/><title type='text'>StorageSmart: Pharmacy Inventory &amp; Storage Trainer Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch;
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem;
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;StorageSmart — Pharmacy Inventory Trainer&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;An interactive quiz, searchable reference table, and progress tracker for pharmacy storage and handling classification of 188 real branded medications.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/sx27GTp3/Storage-Smart.jpg&quot; alt=&quot;StorageSmart Pharmacy Trainer on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            StorageSmart is an educational tool for practicing correct storage and handling classification of real branded medications across 8 categories: Refrigerated, Frozen, Controlled Substance, Hazardous Drug, Flammable, Light-Sensitive, Protect from Moisture, and Room Temperature. It is designed for pharmacy students, technicians, and pharmacists who want to build or test their recall of storage requirements — including DEA controlled-substance scheduling and USP &amp;lt;800&amp;gt; hazardous-drug handling — for real, named products rather than generic categories.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            The tool has three modes. In Quiz mode, a drug card is shown and the user selects its correct storage category from four options; the tool gives immediate feedback plus the specific handling rule for that drug. In Reference mode, the same 188-drug database can be searched (matching brand name, generic name, drug class, or the handling-rule text itself ) or filtered by storage category, and viewed as a table. In Progress mode, mastery is tracked per storage category based on quiz performance, stored locally in the browser.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Interactive quiz covering 188 real branded medications across 8 storage/handling categories&lt;/li&gt;
                    &lt;li&gt;Immediate answer feedback showing the correct category and the drug&#39;s specific handling rule&lt;/li&gt;
                    &lt;li&gt;Category filter — quiz and reference view can both be restricted to a single storage category (e.g., practice only Controlled Substances)&lt;/li&gt;
                    &lt;li&gt;Reference table search that matches four fields at once: brand name, generic name, drug class, and the handling-rule text — not just the drug name&lt;/li&gt;
                    &lt;li&gt;Searchable, filterable reference table showing all matching drugs with their storage category, generic name/class, and handling rule&lt;/li&gt;
                    &lt;li&gt;Printable &quot;Cheat Sheet&quot; — exports the full reference table to a print-formatted view&lt;/li&gt;
                    &lt;li&gt;Per-category progress tracking (mastery by storage category), stored locally in your browser&lt;/li&gt;
                    &lt;li&gt;Running session stats: correct answers, incorrect answers, and current streak&lt;/li&gt;
                    &lt;li&gt;One-click progress reset (with confirmation prompt) to start tracking over&lt;/li&gt;
                    &lt;li&gt;Storage categories cross-reference DEA controlled-substance scheduling (Schedule II–V) and USP &amp;lt;800&amp;gt; hazardous-drug handling classifications, stated explicitly per drug where applicable&lt;/li&gt;
                    &lt;li&gt;Keyboard shortcuts in Quiz mode — number keys (1-4) to answer, Space/Enter to continue to the next drug&lt;/li&gt;
                    &lt;li&gt;Works entirely offline — no internet connection required after the file is opened&lt;/li&gt;
                    &lt;li&gt;No data leaves your device — all progress/stats stay in local browser storage only&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/nr4HGxpY/storage-smart.jpg&quot; alt=&quot;StorageSmart Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Open the HTML file in any modern browser — no installation needed&lt;/li&gt;
            &lt;li&gt;Read and acknowledge the initial disclaimer screen (shown once per version )&lt;/li&gt;
            &lt;li&gt;Choose a mode from the top bar: Quiz, Reference, or Progress&lt;/li&gt;
            &lt;li&gt;In Quiz mode: read the drug shown, select its correct storage category from the four options, review the feedback and handling rule, then continue to the next drug&lt;/li&gt;
            &lt;li&gt;Optional: use the category filter to focus the quiz on one storage category at a time&lt;/li&gt;
            &lt;li&gt;In Reference mode: type in the search box (matches brand, generic, class, or rule text) and/or use the category filter to narrow the table&lt;/li&gt;
            &lt;li&gt;In Reference mode: select &quot;Cheat Sheet&quot; to open a print-formatted version of the current table&lt;/li&gt;
            &lt;li&gt;In Progress mode: review mastery by category, or select &quot;Reset Progress&quot; to clear all tracked stats&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~221 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Chrome 90+, Firefox 88+, Safari 14+, Edge 90+&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.0&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;2026-07-22&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmacy students building recall of storage/handling classification&lt;/li&gt;
                    &lt;li&gt;Pharmacy technicians and pharmacists using it as a self-study or refresher reference&lt;/li&gt;
                    &lt;li&gt;Personal practice, review, or continuing-education support&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exam preparation as a sole resource&lt;/li&gt;
                    &lt;li&gt;Production use (e.g., as an actual pharmacy SOP or inventory reference) without expert validation&lt;/li&gt;
                    &lt;li&gt;Practice settings outside the United States (content is based on US frameworks — DEA scheduling, USP &amp;lt;800&amp;gt;)&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool includes 11 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all progress and stats stay on your device&lt;/li&gt;
            &lt;li&gt;Zero external dependencies — no CDN or third-party resources loaded&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Uses standard, long-supported web technology — no specialized browser or plugin required&lt;/li&gt;
            &lt;li&gt;Lightweight file (~221 KB)&lt;/li&gt;
            &lt;li&gt;Keyboard shortcuts available for answering quiz questions&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Sources cited for storage/handling classifications (DEA scheduling, USP &amp;lt;800&amp;gt;)&lt;/li&gt;
            &lt;li&gt;Version and last-updated date stated in the tool&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States which audience the tool is designed for and what it is not designed for&lt;/li&gt;
            &lt;li&gt;Includes a warning about regional (US-specific) standard differences&lt;/li&gt;
            &lt;li&gt;Shows specific examples of what NOT to use this tool for&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using StorageSmart, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- PRE-FILLED MESSAGE LINK --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20StorageSmart%20Trainer&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20StorageSmart%20Trainer%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get StorageSmart Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start practicing offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk64YYPUFH54UyY7RW7f?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3705690458424693505'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3705690458424693505'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/09/storagesmart-pharmacy-inventory-trainer.html' title='StorageSmart: Pharmacy Inventory &amp; Storage Trainer Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-8833925641110182705</id><published>2025-09-26T19:11:00.011+00:00</published><updated>2026-07-28T13:59:04.304+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Digital Products"/><category scheme="http://www.blogger.com/atom/ns#" term="HTML Tools"/><category scheme="http://www.blogger.com/atom/ns#" term="Medical Sales"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharma Reps"/><category scheme="http://www.blogger.com/atom/ns#" term="Sales Training"/><category scheme="http://www.blogger.com/atom/ns#" term="Simulators"/><title type='text'>RolePlay Pro: Pharma Sales Objection Simulator Tool</title><content type='html'>&lt;!-- ### START: LANDING PAGE STYLES (Comprehensive &amp; Elegant Edition) ### --&gt;
&lt;style&gt;
    .lp-container {
        font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, Helvetica, Arial, sans-serif;
        line-height: 1.6;
        color: #333;
        background-color: #fff;
        padding: 1rem;
    }
    .lp-header {
        text-align: center;
        padding: 3rem 1rem;
        background-color: #f8f9fa;
        border-radius: 12px;
    }
    .lp-title {
        font-size: 2.8rem;
        font-weight: 800;
        color: #1a2b48;
        margin: 0 0 1rem 0;
    }
    .lp-subtitle {
        font-size: 1.3rem;
        color: #555;
        max-width: 700px;
        margin: 0 auto;
    }
    .lp-main-image {
        width: 100%;
        max-width: 700px;
        margin: 2rem auto;
        display: block;
        border-radius: 8px;
        box-shadow: 0 10px 25px rgba(0,0,0,0.1);
    }
    .lp-section {
        max-width: 900px;
        margin: 4rem auto;
    }
    .lp-section-title {
        font-size: 2.2rem;
        font-weight: 700;
        color: #1a2b48;
        text-align: center;
        margin-bottom: 2.5rem;
    }
    .lp-section-subtitle {
        font-size: 1.5rem;
        font-weight: 700;
        color: #1a2b48;
        margin-top: 2rem;
        margin-bottom: 1rem;
        border-bottom: 2px solid #f0f0f0;
        padding-bottom: 0.5rem;
    }
    .lp-text-block {
        font-size: 1.1rem;
        color: #444;
        margin-bottom: 1.5rem;
        line-height: 1.8;
    }
    
    /* Standard Grid */
    .lp-grid-two-col {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
        align-items: start;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col {
            grid-template-columns: 1fr 1fr;
        }
    }

    /* NEW: Sticky Grid for long lists next to an image */
    .lp-grid-two-col-sticky {
        display: grid;
        grid-template-columns: 1fr;
        gap: 2rem;
    }
    @media (min-width: 768px) {
        .lp-grid-two-col-sticky {
            grid-template-columns: 1fr 1fr;
            align-items: stretch; /* Allows the right column to be as tall as the left */
        }
    }
    .lp-sticky-wrapper {
        position: -webkit-sticky;
        position: sticky;
        top: 2rem; /* Image sticks 2rem from the top of the screen while scrolling */
    }

    .lp-grid-image {
        width: 100%;
        border-radius: 8px;
        box-shadow: 0 8px 20px rgba(0,0,0,0.08);
        margin-top: 1rem;
    }
    
    /* 1. Elegant Positive List (Blue border, Green Check) */
    .lp-list {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #007bff;
    }
    .lp-list li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%2328a745&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cpolyline points=&#39;20 6 9 17 4 12&#39;%3E%3C/polyline%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 2. Elegant Negative List (Red border, Red Cross) */
    .lp-list-negative {
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-negative li {
        padding: 0.75rem 0.75rem 0.75rem 2.5rem;
        position: relative;
        font-size: 1.05rem;
        background-color: #fff5f5;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #dc3545;
    }
    .lp-list-negative li::before {
        content: &#39;&#39;;
        position: absolute;
        left: 0.8rem;
        top: 1rem;
        width: 16px;
        height: 16px;
        background-image: url(&quot;data:image/svg+xml,%3Csvg xmlns=&#39;http://www.w3.org/2000/svg&#39; viewBox=&#39;0 0 24 24&#39; fill=&#39;none&#39; stroke=&#39;%23dc3545&#39; stroke-width=&#39;3&#39; stroke-linecap=&#39;round&#39; stroke-linejoin=&#39;round&#39;%3E%3Cline x1=&#39;18&#39; y1=&#39;6&#39; x2=&#39;6&#39; y2=&#39;18&#39;%3E%3C/line%3E%3Cline x1=&#39;6&#39; y1=&#39;6&#39; x2=&#39;18&#39; y2=&#39;18&#39;%3E%3C/line%3E%3C/svg%3E&quot; );
        background-size: contain;
        background-repeat: no-repeat;
    }

    /* 3. Elegant Numbered List (Dark border, Number Circles) */
    .lp-list-step {
        counter-reset: lp-counter;
        list-style-type: none;
        padding-left: 0;
    }
    .lp-list-step li {
        position: relative;
        padding: 0.75rem 0.75rem 0.75rem 3rem;
        font-size: 1.05rem;
        background-color: #f8f9fa;
        margin-bottom: 0.5rem;
        border-radius: 5px;
        border-left: 4px solid #1a2b48;
    }
    .lp-list-step li::before {
        counter-increment: lp-counter;
        content: counter(lp-counter);
        position: absolute;
        left: 0.8rem;
        top: 0.75rem;
        width: 22px;
        height: 22px;
        background-color: #1a2b48;
        color: white;
        border-radius: 50%;
        display: flex;
        align-items: center;
        justify-content: center;
        font-size: 0.85rem;
        font-weight: bold;
    }

    .lp-table {
        width: 100%;
        border-collapse: collapse;
        margin-top: 1rem;
        background-color: #fff;
        box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        border-radius: 8px;
        overflow: hidden;
    }
    .lp-table th, .lp-table td {
        padding: 14px 16px;
        border-bottom: 1px solid #e0e0e0;
        text-align: left;
        font-size: 1rem;
    }
    .lp-table th {
        background-color: #f8f9fa;
        font-weight: 700;
        color: #1a2b48;
        width: 35%;
    }
    .lp-table tr:last-child th, .lp-table tr:last-child td {
        border-bottom: none;
    }
    .lp-warning-box {
        background-color: #fff3cd;
        border-left: 4px solid #ffc107;
        padding: 1rem 1.5rem;
        margin: 2rem auto;
        max-width: 900px;
        border-radius: 4px;
        color: #856404;
        font-size: 1.05rem;
    }
    .lp-philosophy-section, .lp-feedback-section {
        background-color: #f8f9fa;
        border: 1px solid #e0e0e0;
        padding: 2rem;
        border-radius: 12px;
        text-align: center;
    }
    .lp-philosophy-section p, .lp-feedback-section p {
        font-size: 1.1rem;
        max-width: 650px;
        margin: 0 auto 1rem auto;
    }
    .lp-feedback-section a {
        color: #007bff;
        font-weight: bold;
        text-decoration: none;
    }
    .lp-feedback-section a:hover {
        text-decoration: underline;
    }
    .lp-cta-section {
        background-color: #1a2b48;
        color: #fff;
        text-align: center;
        padding: 3rem 1.5rem;
        border-radius: 12px;
        margin-top: 4rem;
    }
    .lp-cta-title {
        font-size: 1.8rem;
        font-weight: 700;
        margin: 0 0 1rem 0;
    }
    .lp-cta-price {
        font-size: 3rem;
        font-weight: 800;
        margin-bottom: 0.5rem;
    }
    .lp-cta-price-note {
        font-size: 1rem;
        margin-bottom: 1.5rem;
        color: #ccc;
    }
    .checkout-button {
        display: inline-block !important;
        background-color: #007bff !important;
        color: white !important;
        padding: 1rem 2.5rem !important;
        border-radius: 8px !important;
        text-decoration: none !important;
        font-size: 1.2rem !important;
        font-weight: 700 !important;
        border: none !important;
        cursor: pointer !important;
        transition: transform 0.2s ease, box-shadow 0.2s ease !important;
        box-shadow: 0 4px 15px rgba(0, 123, 255, 0.2);
    }
    .checkout-button:hover {
        transform: translateY(-3px);
        box-shadow: 0 8px 20px rgba(0, 123, 255, 0.3);
        background-color: #0056b3 !important;
    }
&lt;/style&gt;
&lt;!-- ### END: LANDING PAGE STYLES ### --&gt;

&lt;!-- ### START: LANDING PAGE CONTENT ### --&gt;
&lt;div class=&quot;lp-container&quot;&gt;

    &lt;!-- Header Section --&gt;
    &lt;header class=&quot;lp-header&quot;&gt;
        &lt;h1 class=&quot;lp-title&quot;&gt;RolePlay Pro — Pharma Objection Simulator&lt;/h1&gt;
        &lt;p class=&quot;lp-subtitle&quot;&gt;A single-file HTML tool for practicing pharmaceutical sales objection-handling through roleplay scenarios.&lt;/p&gt;
    &lt;/header&gt;

    &lt;!-- Main Product Image (Hero) --&gt;
    &lt;img src=&quot;https://i.postimg.cc/nVs8Py6b/roleplay-pro.jpg&quot; alt=&quot;RolePlay Pro Simulator on a laptop&quot; class=&quot;lp-main-image&quot;&gt;

    &lt;!-- Warning Box --&gt;
    &lt;div class=&quot;lp-warning-box&quot;&gt;
        &lt;strong&gt;⚠️ AI-built tool — human expert review required before real-world use.&lt;/strong&gt;
    &lt;/div&gt;

    &lt;!-- What This Tool Does Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;What This Tool Does&lt;/h2&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            RolePlay Pro presents pharmaceutical sales representatives with simulated physician objections drawn from 23 scenarios across 10 therapeutic areas (Cardiovascular, Oncology, Diabetes &amp; Metabolic, CNS/Neurology, Respiratory, Immunology/Rheumatology, Infectious Disease, Gastroenterology, Pain Management, Dermatology ), each tagged Easy, Medium, or Hard. Each scenario presents a fictional HCP profile and a specific objection for the user to practice responding to.
        &lt;/p&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;
            After the user formulates their own response, the tool reveals a model response broken into an Acknowledge / Bridge / Resolve structure, referencing named clinical trials, published guidelines, and drug mechanisms relevant to the objection. The user self-rates their own response as &quot;Strong&quot; or &quot;Needs Work,&quot; and can add free-text coaching notes to each session-log entry. Users can also filter scenarios by therapeutic area or difficulty, create their own custom objection-and-response pairs, and print a scenario/response sheet for offline reference.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Features &amp; Functions Section (UPDATED WITH STICKY IMAGE) --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Features &amp; Functions&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col-sticky&quot;&gt;
            &lt;div&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;23 pre-built objection-handling scenarios across 10 therapeutic areas&lt;/li&gt;
                    &lt;li&gt;Three difficulty levels (Easy, Medium, Hard) plus an &quot;All&quot; view&lt;/li&gt;
                    &lt;li&gt;Filter scenarios by therapeutic area, by difficulty, or both combined&lt;/li&gt;
                    &lt;li&gt;Model responses structured as Acknowledge / Bridge / Resolve&lt;/li&gt;
                    &lt;li&gt;Self-rating on each completed scenario (&quot;Strong Response&quot; / &quot;Needs Work&quot;)&lt;/li&gt;
                    &lt;li&gt;Free-text coaching notes field attached to each session-log entry&lt;/li&gt;
                    &lt;li&gt;Running session tally of total scenarios, &quot;Strong,&quot; and &quot;Needs Work&quot; counts, saved between visits&lt;/li&gt;
                    &lt;li&gt;Create custom objection-and-response scenarios with your own therapeutic area and HCP name&lt;/li&gt;
                    &lt;li&gt;Quick-add option to log a real objection you heard, tagged to a therapeutic area, without writing a full model response&lt;/li&gt;
                    &lt;li&gt;Separate reset controls for the session log and for custom scenarios&lt;/li&gt;
                    &lt;li&gt;Print function that formats the current scenario and its response for a printed page&lt;/li&gt;
                    &lt;li&gt;Keyboard shortcuts: Space to reveal a response or advance, Right Arrow to advance, R to reveal, Escape to close an open dialog&lt;/li&gt;
                    &lt;li&gt;Blocks saving a custom scenario whose text appears to contain an email address, phone number, credit card number, Social Security Number, or medical record number, with a warning before it&#39;s stored&lt;/li&gt;
                    &lt;li&gt;Repeat-avoidance so recently shown scenarios are less likely to repeat immediately in a row&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;!-- Sticky Image Container --&gt;
                &lt;div class=&quot;lp-sticky-wrapper&quot;&gt;
                    &lt;img src=&quot;https://i.postimg.cc/7YCRKSJH/roleplay1.png&quot; alt=&quot;RolePlay Pro Interface Screenshot&quot; class=&quot;lp-grid-image&quot; style=&quot;margin-top: 0;&quot;&gt;
                &lt;/div&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- How to Use This Tool Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;How to Use This Tool&lt;/h2&gt;
        &lt;ul class=&quot;lp-list-step&quot;&gt;
            &lt;li&gt;Open the file in a browser — no installation needed&lt;/li&gt;
            &lt;li&gt;Select a therapeutic area from the left panel, or leave it on &quot;All&quot;&lt;/li&gt;
            &lt;li&gt;Choose a difficulty level (Easy, Medium, Hard, or All ) from the top bar&lt;/li&gt;
            &lt;li&gt;Click &quot;New Scenario&quot; to display an objection from a simulated HCP&lt;/li&gt;
            &lt;li&gt;Formulate your own response, then reveal the model response to compare&lt;/li&gt;
            &lt;li&gt;Rate your own response as &quot;Strong Response&quot; or &quot;Needs Work&quot;&lt;/li&gt;
            &lt;li&gt;Optionally add a coaching note in the session log for that entry&lt;/li&gt;
            &lt;li&gt;Click &quot;Skip&quot; to move to a new scenario without rating the current one&lt;/li&gt;
            &lt;li&gt;Use &quot;+ Custom&quot; to add your own objection and response, or &quot;Quick Add&quot; in the log panel for a fast entry&lt;/li&gt;
            &lt;li&gt;Use &quot;🖨 Print&quot; to print the current scenario and response&lt;/li&gt;
            &lt;li&gt;Use &quot;↺ Reset Log&quot; or &quot;↺ Reset Custom&quot; to clear session history or custom scenarios separately&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/section&gt;

    &lt;!-- Technical Specifications Table --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Technical Specifications&lt;/h2&gt;
        &lt;table class=&quot;lp-table&quot;&gt;
            &lt;tbody&gt;
                &lt;tr&gt;
                    &lt;th&gt;Format&lt;/th&gt;
                    &lt;td&gt;Single HTML file&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;File Size&lt;/th&gt;
                    &lt;td&gt;~114 KB&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Compatibility&lt;/th&gt;
                    &lt;td&gt;Tested in Chrome/Edge 90+; expected to work in Firefox 88+ and Safari 14+, not separately verified&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Internet Required&lt;/th&gt;
                    &lt;td&gt;No (works 100% offline)&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Installation&lt;/th&gt;
                    &lt;td&gt;None — open file in any browser&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Language&lt;/th&gt;
                    &lt;td&gt;English&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Version&lt;/th&gt;
                    &lt;td&gt;1.3&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Last Updated&lt;/th&gt;
                    &lt;td&gt;July 2026&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Validation&lt;/th&gt;
                    &lt;td&gt;AI based Check-and-fix cycles — expert review required&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                    &lt;th&gt;Status&lt;/th&gt;
                    &lt;td&gt;AI-generated educational prototype&lt;/td&gt;
                &lt;/tr&gt;
            &lt;/tbody&gt;
        &lt;/table&gt;
    &lt;/section&gt;

    &lt;!-- Who Should Use This Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Who Should Use This&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Designed For:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Pharmaceutical sales representatives practicing objection-handling dialogue&lt;/li&gt;
                    &lt;li&gt;Sales training or L&amp;D use for onboarding or ongoing practice&lt;/li&gt;
                    &lt;li&gt;Self-paced rehearsal of physician conversations before a real call&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;NOT Designed For:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Clinical decision-making or patient care&lt;/li&gt;
                    &lt;li&gt;Professional certification or licensing exams&lt;/li&gt;
                    &lt;li&gt;Production or promotional use without expert validation&lt;/li&gt;
                    &lt;li&gt;Real, identifiable physician or patient information — the tool&#39;s own scenario fields are meant for fictional names and generic situations only&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
    &lt;/section&gt;

    &lt;!-- Quality &amp; Compliance Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;Quality &amp; Compliance&lt;/h2&gt;
        &lt;p class=&quot;lp-text
-block&quot;&gt;This tool includes 12 verified features:&lt;/p&gt;
        
        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Your Data &amp; Privacy:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Works 100% offline — no internet connection needed&lt;/li&gt;
            &lt;li&gt;No data collection — all data stays on your device&lt;/li&gt;
            &lt;li&gt;Blocks accidental entry of sensitive information (email addresses, phone numbers, credit card numbers, Social Security Numbers, medical record numbers) in custom scenario fields, with a warning before saving&lt;/li&gt;
            &lt;li&gt;Zero external dependencies — no CDN or third-party script calls&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Reliability &amp; Compatibility:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Directly tested in Chrome and Edge 90+; expected (not separately verified) to work in Firefox 88+ and Safari 14+&lt;/li&gt;
            &lt;li&gt;Lightweight file (~114 KB) — opens instantly&lt;/li&gt;
            &lt;li&gt;Keyboard-operable scenario navigation (Space, Right Arrow, R, Escape)&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Sources &amp; Transparency:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;Scenario dialogue references named clinical trials and published society guidelines&lt;/li&gt;
            &lt;li&gt;Version and last-updated date displayed in the tool&lt;/li&gt;
            &lt;li&gt;Full disclaimer text available on demand from within the tool&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Scope &amp; Limitations:&lt;/h3&gt;
        &lt;ul class=&quot;lp-list&quot;&gt;
            &lt;li&gt;States what the tool does not do (medical advice, diagnosis, treatment recommendations, dosing, patient-specific guidance)&lt;/li&gt;
            &lt;li&gt;Includes examples of what not to use the tool for&lt;/li&gt;
            &lt;li&gt;States that content is fixed with no automatic updates, and that currency should be independently verified&lt;/li&gt;
        &lt;/ul&gt;

        &lt;h3 class=&quot;lp-section-subtitle&quot;&gt;Validation Process:&lt;/h3&gt;
        &lt;p class=&quot;lp-text-block&quot;&gt;This tool was refined through iterative AI based check-and-fix cycles covering: Logic and functionality, Scientific content accuracy, Compliance and safety.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- License Terms Section --&gt;
    &lt;section class=&quot;lp-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot;&gt;License Terms&lt;/h2&gt;
        &lt;div class=&quot;lp-grid-two-col&quot;&gt;
             &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #28a745; border-bottom-color: #28a745;&quot;&gt;Allowed:&lt;/h3&gt;
                &lt;ul class=&quot;lp-list&quot;&gt;
                    &lt;li&gt;Personal educational use&lt;/li&gt;
                    &lt;li&gt;Internal training within your organization&lt;/li&gt;
                    &lt;li&gt;Academic coursework and self-study&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
            &lt;div&gt;
                &lt;h3 class=&quot;lp-section-subtitle&quot; style=&quot;color: #dc3545; border-bottom-color: #dc3545;&quot;&gt;Not Allowed:&lt;/h3&gt;
                 &lt;ul class=&quot;lp-list-negative&quot;&gt;
                    &lt;li&gt;Production or operational use without expert validation&lt;/li&gt;
                    &lt;li&gt;Redistribution or resale (unless Commercial Resale License purchased)&lt;/li&gt;
                    &lt;li&gt;Clinical decision-making for patient care&lt;/li&gt;
                    &lt;li&gt;Removing or modifying disclaimers&lt;/li&gt;
                &lt;/ul&gt;
            &lt;/div&gt;
        &lt;/div&gt;
        &lt;p class=&quot;lp-text-block&quot; style=&quot;margin-top: 1.5rem; font-style: italic; color: #666;&quot;&gt;
            Provided &quot;as-is&quot; for educational purposes only. All outputs must be independently verified by qualified professionals before any real-world application. This tool reflects a completed development stage and may see further refinement in future updates.
        &lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Fair Price Philosophy Section --&gt;
    &lt;section class=&quot;lp-section lp-philosophy-section&quot; style=&quot;background-color: #e9f5ff; border-color: #bde0ff;&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1.5rem;&quot;&gt;Our Fair Price Philosophy&lt;/h2&gt;
        &lt;p style=&quot;color: #034078;&quot;&gt;We&#39;ve enabled the &#39;Pay What You Want&#39; option so you can download and evaluate the tool for free. If you find it valuable and useful to your practice, we encourage you to return and contribute a price that feels right to you and fairly reflects the value this interactive resource brings to your practice.&lt;/p&gt;
    &lt;/section&gt;

    &lt;!-- Feedback Section --&gt;
     &lt;section class=&quot;lp-section lp-feedback-section&quot;&gt;
        &lt;h2 class=&quot;lp-section-title&quot; style=&quot;margin-bottom: 1rem;&quot;&gt;Your Feedback Matters&lt;/h2&gt;
        &lt;p&gt;We are constantly working to improve our tools. After using RolePlay Pro, we would be grateful if you could share your thoughts on its functionality and usefulness.&lt;/p&gt;
        
        &lt;!-- UPDATED CONTACT LINK WITH SIMPLIFIED PRE-FILLED MESSAGE --&gt;
        &lt;a href=&quot;mailto:drugpamphletstore@gmail.com?subject=Product%20Feedback%3A%20RolePlay%20Pro%20Simulator&amp;body=Hello%20Drug%20Pamphlet%20Store%20Team%2C%0D%0A%0D%0AI%20recently%20used%20the%20RolePlay%20Pro%20Simulator%20and%20wanted%20to%20share%20my%20thoughts%20with%20you%3A%0D%0A%0D%0A%5BType%20your%20feedback%20here...%5D%0D%0A%0D%0AThank%20you%2C%0D%0A%5BYour%20Name%5D&quot; style=&quot;display: inline-block; margin-top: 10px; color: #007bff; font-weight: bold; text-decoration: none; border: 1px solid #007bff; padding: 8px 20px; border-radius: 6px; transition: all 0.2s ease;&quot;&gt;✉️ Send Us Your Feedback&lt;/a&gt;
    &lt;/section&gt;

    &lt;!-- Final Call to Action (CTA) Section --&gt;
    &lt;section class=&quot;lp-cta-section&quot;&gt;
        &lt;h3 class=&quot;lp-cta-title&quot;&gt;Get RolePlay Pro Today&lt;/h3&gt;
        &lt;div class=&quot;lp-cta-price&quot;&gt;$7+&lt;/div&gt;
        &lt;p class=&quot;lp-cta-price-note&quot;&gt;(Suggested Price: $7 - $13 | Pay What&#39;s Fair)&lt;/p&gt;
        &lt;p&gt;Download the single HTML file instantly and start practicing offline.&lt;/p&gt;
        
        &lt;!-- DODO PAYMENTS BUY NOW BUTTON --&gt;
        &lt;a href=&quot;https://checkout.dodopayments.com/buy/pdt_0Nk5qTpagnP2lW5IRnnbT?quantity=1&quot; class=&quot;checkout-button&quot;&gt;Download The Tool&lt;/a&gt;
    &lt;/section&gt;

&lt;/div&gt;
&lt;!-- ### END: LANDING PAGE CONTENT ### --&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8833925641110182705'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8833925641110182705'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/09/roleplay-pro-pharma-objection-simulator.html' title='RolePlay Pro: Pharma Sales Objection Simulator Tool'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-6731084012895295891</id><published>2025-08-29T23:12:00.003+00:00</published><updated>2025-08-29T23:12:59.518+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="acne vulgaris"/><category scheme="http://www.blogger.com/atom/ns#" term="ACNESCAVE"/><category scheme="http://www.blogger.com/atom/ns#" term="adapalene"/><category scheme="http://www.blogger.com/atom/ns#" term="BIOPHARM"/><category scheme="http://www.blogger.com/atom/ns#" term="Comedonal Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Egypt"/><category scheme="http://www.blogger.com/atom/ns#" term="SAJA PHARMA"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Retinoid"/><title type='text'>ACNESCAVE (Adapalene) Gel: A User&#39;s Guide for Acne Treatment</title><content type='html'>&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;Disclaimer:&lt;/strong&gt; This article is for educational and informational purposes only. It does not substitute official prescribing information or professional medical advice. Patients should consult a dermatologist or pharmacist before starting treatment with adapalene.&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;ACNESCAVE® (Adapalene 0.1%): A Topical Retinoid Guide&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;ACNESCAVE® is a topical gel containing Adapalene, a third-generation retinoid designed for the treatment of mild to moderate acne vulgaris. It works by normalizing skin cell turnover to prevent clogged pores and exhibits anti-inflammatory properties. Unlike older retinoids, adapalene offers a favorable tolerability profile, with minimal systemic absorption. It is effective as a standalone therapy or in combination with other acne treatments, with visible results typically appearing after 8-12 weeks of consistent use.&lt;/p&gt;

&lt;!-- Manufacturer &amp; Marketer --&gt;
&lt;h3&gt;Manufacturer &amp; Marketer&lt;/h3&gt;
&lt;p&gt;Manufactured by &lt;strong&gt;BIOPHARM&lt;/strong&gt; and marketed by &lt;strong&gt;SAJA PHARMA&lt;/strong&gt;. This reflects a common business model in the region where local manufacturing is combined with regional marketing expertise.&lt;/p&gt;

&lt;!-- Category &amp; Active Ingredient --&gt;
&lt;h3&gt;Category &amp; Active Ingredient&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Category:&lt;/strong&gt; Topical Retinoid (Third-generation), Anti-Acne Agent.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Active Ingredient:&lt;/strong&gt; Adapalene.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Available Forms &amp; Strengths in Egypt --&gt;
&lt;h3&gt;Available Forms &amp; Strengths in Egypt&lt;/h3&gt;
&lt;p&gt;ACNESCAVE is available as:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Topical Gel:&lt;/strong&gt; 0.1% strength in a 30 g tube.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Properties and Mechanism of Action --&gt;
&lt;h3&gt;Properties and Mechanism of Action&lt;/h3&gt;
&lt;p&gt;Adapalene is a chemically stable, retinoid-like compound. Its mechanism of action involves:&lt;/p&gt;
&lt;ol&gt;
    &lt;li&gt;&lt;strong&gt;Normalization of Keratinization:&lt;/strong&gt; It binds to specific retinoic acid nuclear receptors (RARs), modulating cellular differentiation and keratinization. This prevents the formation of microcomedones, the initial lesions of acne.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Anti-inflammatory Effects:&lt;/strong&gt; It inhibits the inflammatory response by modulating the chemotactic and chemokinetic responses of polymorphonuclear leukocytes and by inhibiting the metabolism of arachidonic acid to inflammatory mediators.&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- Pharmacokinetics --&gt;
&lt;h3&gt;Pharmacokinetics&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Absorption:&lt;/strong&gt; Systemic absorption from topical application is very low and often undetectable. This minimal absorption contributes to its favorable safety profile compared to oral retinoids.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Metabolism &amp; Excretion:&lt;/strong&gt; Any small amount absorbed is thought to be rapidly metabolized and excreted primarily via the biliary route.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications&lt;/h3&gt;
&lt;p&gt;ACNESCAVE is indicated for the topical treatment of acne vulgaris, including:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;Comedonal acne (blackheads and whiteheads).&lt;/li&gt;
    &lt;li&gt;Papular and pustular acne (inflammatory lesions).&lt;/li&gt;
    &lt;li&gt;It can be used as monotherapy for mild acne or as part of a combination regimen for moderate acne (e.g., with benzoyl peroxide or topical/oral antibiotics).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Dosage and Administration --&gt;
&lt;h3&gt;Dosage and Administration&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Apply a thin layer of the gel to the clean, dry, affected areas of the skin.&lt;/li&gt;
    &lt;li&gt;Application should be done once daily, preferably in the evening before bedtime.&lt;/li&gt;
    &lt;li&gt;A pea-sized amount is usually sufficient to cover the entire face.&lt;/li&gt;
    &lt;li&gt;Avoid contact with the eyes, lips, and mucous membranes.&lt;/li&gt;
    &lt;li&gt;Consistent daily use is necessary for optimal results.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Contraindications --&gt;
&lt;h3&gt;Contraindications&lt;/h3&gt;
&lt;p&gt;Do not use ACNESCAVE if you have:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;A known hypersensitivity or allergy to adapalene or any of the gel&#39;s components.&lt;/li&gt;
    &lt;li&gt;The gel should not be applied to areas with cuts, abrasions, eczema, or sunburn.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Warnings &amp; Precautions --&gt;
&lt;h3&gt;Warnings &amp; Precautions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Initial Flare-up:&lt;/strong&gt; A temporary worsening of acne may occur during the first few weeks of treatment. This is normal and should subside with continued use.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Sun Sensitivity:&lt;/strong&gt; Adapalene can increase your skin&#39;s sensitivity to sunlight. Minimize sun exposure and use a broad-spectrum sunscreen (SPF 30 or higher) and protective clothing.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Skin Irritation:&lt;/strong&gt; If excessive irritation (redness, peeling, dryness) occurs, reduce the frequency of application or temporarily discontinue use.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Avoid Abrasives:&lt;/strong&gt; Use of harsh soaps, abrasive cleansers, or products with high concentrations of alcohol or astringents may increase skin irritation.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Drug Interactions --&gt;
&lt;h3&gt;Drug Interactions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Other Topical Irritants:&lt;/strong&gt; Caution is advised when using other potentially irritating topical products (e.g., medicated cleansers, products containing sulfur, resorcinol, or salicylic acid) concurrently.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Combination Therapy:&lt;/strong&gt; Adapalene can be safely and effectively used in combination with other anti-acne agents like benzoyl peroxide and clindamycin. It is often recommended to apply them at different times of the day (e.g., one in the morning, one in the evening).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Use in Specific Populations --&gt;
&lt;h3&gt;Use in Specific Populations&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Pregnancy:&lt;/strong&gt; Although systemic absorption is minimal, the use of topical retinoids during pregnancy is generally not recommended as a precaution. Consult a physician before use.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Lactation:&lt;/strong&gt; It is not known if adapalene is excreted in human milk. Caution should be exercised, and application to the chest area should be avoided.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Pediatrics:&lt;/strong&gt; Safety and effectiveness have been established in patients 12 years of age and older.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects --&gt;
&lt;h3&gt;Side Effects&lt;/h3&gt;
&lt;p&gt;Most side effects are localized to the application site and are typically mild to moderate in severity, often decreasing after the first month of use.&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Very Common:&lt;/strong&gt; Dryness, scaling, peeling, redness (erythema), and a burning or stinging sensation.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Common:&lt;/strong&gt; Itching (pruritus) and sun sensitivity.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Uncommon/Rare:&lt;/strong&gt; Contact dermatitis, skin discomfort, eyelid irritation, or worsening of acne.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Storage --&gt;
&lt;h3&gt;Storage&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Store at a controlled room temperature, below 25°C.&lt;/li&gt;
    &lt;li&gt;Keep the tube tightly closed when not in use.&lt;/li&gt;
    &lt;li&gt;Protect from freezing and direct light. Keep out of reach of children.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Presentation / Package --&gt;
&lt;h3&gt;Presentation / Package&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;ACNESCAVE® 0.1% Gel:&lt;/strong&gt; Available in a 30 g tube.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- FAQ --&gt;
&lt;h3&gt;Frequently Asked Questions (FAQ)&lt;/h3&gt;
&lt;dl&gt;
    &lt;dt&gt;&lt;strong&gt;Q1: How is adapalene different from other retinoids like tretinoin?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Adapalene is a third-generation retinoid that is more chemically stable and more selective in its receptor binding, which generally results in better tolerability and less skin irritation compared to older retinoids like tretinoin.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q2: Can I use moisturizer with ACNESCAVE?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Yes, using a non-comedogenic moisturizer is highly recommended to help manage the dryness and irritation that can occur with adapalene use. Apply the moisturizer as needed.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q3: What happens if I apply more gel than recommended?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Applying more than a thin layer will not produce faster or better results and will likely increase the risk of skin irritation, redness, and peeling.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q4: Can ACNESCAVE be used for anti-aging or wrinkles?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: While other retinoids are used for anti-aging, adapalene is specifically studied and approved for the treatment of acne. Its effects on wrinkles are not as well-established as other retinoids like tretinoin.&lt;/dd&gt;
&lt;/dl&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;Zaenglein, A. L., et al. (2016). &quot;Guidelines of care for the management of acne vulgaris.&quot; &lt;em&gt;Journal of the American Academy of Dermatology&lt;/em&gt;.&lt;/li&gt;
    &lt;li&gt;Thielitz, A., &amp; Gollnick, H. (2008). &quot;Topical retinoids in acne vulgaris: update on efficacy and safety.&quot; &lt;em&gt;American Journal of Clinical Dermatology&lt;/em&gt;.&lt;/li&gt;
    &lt;li&gt;European Medicines Agency (EMA). &quot;Adapalene - Product Information&quot;.&lt;/li&gt;
    &lt;li&gt;Medscape Reference. &quot;Adapalene Monograph&quot;.&lt;/li&gt;
&lt;/ol&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/6731084012895295891'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/6731084012895295891'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acnescave-adapalene-gel-users-guide-for.html' title='ACNESCAVE (Adapalene) Gel: A User&#39;s Guide for Acne Treatment'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-6300379442453680827</id><published>2025-08-29T22:46:00.003+00:00</published><updated>2025-08-29T22:46:45.433+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ACNELOFIX"/><category scheme="http://www.blogger.com/atom/ns#" term="Egypt"/><category scheme="http://www.blogger.com/atom/ns#" term="Isotretinoin"/><category scheme="http://www.blogger.com/atom/ns#" term="Melano Pharma"/><category scheme="http://www.blogger.com/atom/ns#" term="Nodulocystic Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Retinoid"/><category scheme="http://www.blogger.com/atom/ns#" term="Severe Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Teratogen"/><title type='text'>ACNELOFIX (Isotretinoin): The Ultimate Guide to Uses and Critical Warnings</title><content type='html'>&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;Disclaimer:&lt;/strong&gt; This document is for educational purposes only and does not replace the advice of a qualified healthcare professional. Isotretinoin is a potent medication with significant risks and must only be used under the supervision of a dermatologist.&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;ACNELOFIX® (Isotretinoin): The Complete Guide&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;ACNELOFIX®, containing the active ingredient Isotretinoin, is a powerful oral retinoid medication used to treat severe, resistant, or scarring acne. It works by dramatically reducing sebum production, shrinking sebaceous glands, and normalizing skin cell turnover. Due to its high risk of severe birth defects and other significant side effects, its use is strictly controlled and requires close medical supervision, including regular monitoring and a mandatory pregnancy prevention program for female patients.&lt;/p&gt;

&lt;!-- Manufacturer --&gt;
&lt;h3&gt;Manufacturer&lt;/h3&gt;
&lt;p&gt;MELANO PHARMA, Egypt.&lt;/p&gt;

&lt;!-- Category &amp; Active Ingredient --&gt;
&lt;h3&gt;Category &amp; Active Ingredient&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Category:&lt;/strong&gt; Oral Retinoid, Anti-Acne Agent (Vitamin A derivative).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Active Ingredient:&lt;/strong&gt; Isotretinoin.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Available Forms &amp; Strengths in Egypt --&gt;
&lt;h3&gt;Available Forms &amp; Strengths in Egypt&lt;/h3&gt;
&lt;p&gt;ACNELOFIX is available as:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Capsules:&lt;/strong&gt; 20 mg.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Properties and Mechanism of Action --&gt;
&lt;h3&gt;Properties and Mechanism of Action&lt;/h3&gt;
&lt;p&gt;Isotretinoin addresses all four major pathogenic factors in acne development:&lt;/p&gt;
&lt;ol&gt;
    &lt;li&gt;&lt;strong&gt;Sebum Production:&lt;/strong&gt; It significantly reduces the size of sebaceous glands and decreases sebum production by up to 80%.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Comedogenesis:&lt;/strong&gt; It normalizes follicular keratinization, preventing the formation of microcomedones (the precursor to all acne lesions).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Bacterial Colonization:&lt;/strong&gt; By reducing sebum (the food source for bacteria), it indirectly inhibits the growth of &lt;em&gt;Cutibacterium acnes&lt;/em&gt;.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Inflammation:&lt;/strong&gt; It exhibits direct anti-inflammatory properties.&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- Pharmacokinetics --&gt;
&lt;h3&gt;Pharmacokinetics&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Absorption:&lt;/strong&gt; Highly lipophilic; absorption is significantly increased (approximately doubled) when taken with a high-fat meal.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Distribution:&lt;/strong&gt; Binds extensively to plasma proteins (&gt;99%), primarily albumin.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Metabolism:&lt;/strong&gt; Metabolized in the liver into several active metabolites.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Elimination Half-life:&lt;/strong&gt; Approximately 10-20 hours.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Excretion:&lt;/strong&gt; Eliminated in both urine and feces in roughly equal amounts.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications&lt;/h3&gt;
&lt;p&gt;Isotretinoin is reserved for the treatment of:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;Severe nodular or conglobate acne.&lt;/li&gt;
    &lt;li&gt;Acne that is resistant to adequate courses of standard therapy with systemic antibiotics and topical treatments.&lt;/li&gt;
    &lt;li&gt;Acne associated with significant physical scarring or psychosocial distress.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Dosage and Administration --&gt;
&lt;h3&gt;Dosage and Administration&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Dosing:&lt;/strong&gt; The therapeutic dose typically ranges from 0.5 to 1 mg/kg/day, usually given in two divided doses.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Cumulative Dose:&lt;/strong&gt; The goal is to reach a total cumulative dose of 120-150 mg/kg over the entire treatment course to minimize the risk of relapse.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Duration:&lt;/strong&gt; A typical course of treatment lasts 15-20 weeks.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Administration:&lt;/strong&gt; Capsules must be taken with food (preferably a fatty meal) to ensure adequate absorption. Do not crush or chew the capsules.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Contraindications --&gt;
&lt;h3&gt;Contraindications&lt;/h3&gt;
&lt;p&gt;Isotretinoin is absolutely contraindicated in patients with:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Pregnancy:&lt;/strong&gt; It is a potent human teratogen.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Lactation (Breastfeeding).&lt;/strong&gt;&lt;/li&gt;
    &lt;li&gt;Known hypersensitivity to isotretinoin or any of its excipients.&lt;/li&gt;
    &lt;li&gt;Severe liver impairment.&lt;/li&gt;
    &lt;li&gt;Uncontrolled hyperlipidemia (excessively high blood fats).&lt;/li&gt;
    &lt;li&gt;Concomitant use with tetracycline antibiotics.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Warnings &amp; Precautions --&gt;
&lt;h3&gt;Warnings &amp; Precautions&lt;/h3&gt;
&lt;div style=&quot;border:2px solid red; padding:10px; margin:10px 0;&quot;&gt;
    &lt;h4 style=&quot;color:red; margin-top:0;&quot;&gt;BLACK BOX WARNING: PREGNANCY&lt;/h4&gt;
    &lt;p&gt;&lt;strong&gt;Isotretinoin must not be used by female patients who are or may become pregnant.&lt;/strong&gt; There is an extremely high risk of severe, life-threatening birth defects if pregnancy occurs while taking isotretinoin in any amount, even for a short period. A mandatory pregnancy prevention program is required for all female patients of childbearing potential.&lt;/p&gt;
&lt;/div&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Psychiatric Effects:&lt;/strong&gt; Monitor for depression, mood disturbances, psychosis, and suicidal ideation. Patients should report any such symptoms immediately.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Monitoring:&lt;/strong&gt; Regular blood tests are required to monitor liver function (LFTs) and fasting lipid levels (cholesterol, triglycerides) before and during therapy.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Pseudotumor Cerebri:&lt;/strong&gt; (Benign Intracranial Hypertension) - Risk is increased with concomitant tetracycline use. Monitor for headache, nausea, vomiting, and visual disturbances.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Skin and Eyes:&lt;/strong&gt; Causes dryness of skin, lips, and eyes. Use moisturizers and artificial tears. May decrease night vision.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Initial Flare-up:&lt;/strong&gt; An initial worsening of acne may occur in the first few weeks of treatment.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Blood Donation:&lt;/strong&gt; Do not donate blood during therapy and for at least one month after the last dose to prevent a pregnant patient from receiving your blood.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Drug Interactions --&gt;
&lt;h3&gt;Drug Interactions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Tetracyclines (e.g., Doxycycline, Minocycline):&lt;/strong&gt; Contraindicated. Increases the risk of pseudotumor cerebri.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Vitamin A Supplements:&lt;/strong&gt; Avoid completely, as they can lead to additive toxic effects (hypervitaminosis A).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Progestin-only &quot;mini-pills&quot;:&lt;/strong&gt; May be an inadequate method of contraception during therapy.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Alcohol:&lt;/strong&gt; May increase the risk of developing high triglyceride levels.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Use in Specific Populations --&gt;
&lt;h3&gt;Use in Specific Populations&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Pregnancy:&lt;/strong&gt; Category X. Absolutely contraindicated.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Lactation:&lt;/strong&gt; Contraindicated.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Pediatrics:&lt;/strong&gt; Not recommended for children under 12 years. Used for severe acne in adolescents after puberty.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects --&gt;
&lt;h3&gt;Side Effects&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Very Common (Mucocutaneous):&lt;/strong&gt; Dry lips (cheilitis), dry skin, dry eyes, dry nose leading to nosebleeds (epistaxis).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Common (Musculoskeletal &amp; Skin):&lt;/strong&gt; Muscle pain (myalgia), joint pain (arthralgia), back pain, rash, photosensitivity.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Metabolic:&lt;/strong&gt; Elevated triglycerides, elevated cholesterol, elevated liver enzymes.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Psychiatric:&lt;/strong&gt; Depression, mood changes (see Warnings).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Serious/Rare:&lt;/strong&gt; Pancreatitis, pseudotumor cerebri, inflammatory bowel disease (IBD), severe allergic reactions, persistent decreased night vision.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Storage --&gt;
&lt;h3&gt;Storage&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Store at a controlled room temperature below 25°C.&lt;/li&gt;
    &lt;li&gt;Protect from light and moisture.&lt;/li&gt;
    &lt;li&gt;Keep out of reach of children.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Presentation / Package --&gt;
&lt;h3&gt;Presentation / Package&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;ACNELOFIX® 20 mg:&lt;/strong&gt; Box containing 20 capsules.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- FAQ --&gt;
&lt;h3&gt;Frequently Asked Questions (FAQ)&lt;/h3&gt;
&lt;dl&gt;
    &lt;dt&gt;&lt;strong&gt;Q1: Why is isotretinoin considered a last-resort treatment?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Due to its potential for severe side effects, especially the high risk of birth defects, it is reserved for severe, scarring, or treatment-resistant acne where the benefits outweigh the significant risks.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q2: Will my acne get worse before it gets better?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Yes, an initial flare-up of acne is common during the first month of treatment. This is usually temporary and a sign that the medication is working.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q3: Can I undergo cosmetic procedures like waxing or laser while on isotretinoin?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: No. Your skin will be very fragile. It is recommended to avoid waxing, dermabrasion, or laser skin treatments during therapy and for at least 6 months after stopping to prevent scarring.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q4: Is it true that acne can come back after treatment?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: While isotretinoin offers a high rate of long-term remission, relapse can occur. The risk is lower if the full cumulative dose (120-150 mg/kg) is completed. A second course may be necessary in some cases.&lt;/dd&gt;
&lt;/dl&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;Zaenglein, A. L., et al. (2016). &quot;Guidelines of care for the management of acne vulgaris.&quot; &lt;em&gt;Journal of the American Academy of Dermatology&lt;/em&gt;.&lt;/li&gt;
    &lt;li&gt;Layton, A. M. (2009). &quot;The use of isotretinoin in acne.&quot; &lt;em&gt;Dermato-endocrinology&lt;/em&gt;.&lt;/li&gt;
    &lt;li&gt;European Medicines Agency (EMA). &quot;Isotretinoin - Product Information&quot;.&lt;/li&gt;
    &lt;li&gt;U.S. Food and Drug Administration (FDA). &quot;iPLEDGE REMS Program&quot;.&lt;/li&gt;
&lt;/ol&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/6300379442453680827'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/6300379442453680827'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acnelofix-isotretinoin-ultimate-guide.html' title='ACNELOFIX (Isotretinoin): The Ultimate Guide to Uses and Critical Warnings'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-6025055898028433653</id><published>2025-08-29T12:01:00.000+00:00</published><updated>2025-08-29T12:01:36.894+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Antibiotic"/><category scheme="http://www.blogger.com/atom/ns#" term="Bacterial Infections"/><category scheme="http://www.blogger.com/atom/ns#" term="Black Box Warning"/><category scheme="http://www.blogger.com/atom/ns#" term="Ciprofloxacin"/><category scheme="http://www.blogger.com/atom/ns#" term="Egypt"/><category scheme="http://www.blogger.com/atom/ns#" term="Fluoroquinolone"/><category scheme="http://www.blogger.com/atom/ns#" term="Mifoxin"/><category scheme="http://www.blogger.com/atom/ns#" term="MISR Pharma"/><category scheme="http://www.blogger.com/atom/ns#" term="Tendon Rupture"/><title type='text'>Mifoxin (Ciprofloxacin): A Guide to Uses, Dosage, and Serious Safety Warnings </title><content type='html'>&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;Disclaimer:&lt;/strong&gt; This information is for educational purposes only and is not a substitute for professional medical advice. Do not self-medicate or stop prescribed treatment without consulting your physician or pharmacist.&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;Mifoxin® (Ciprofloxacin)&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;Mifoxin®, with the active ingredient Ciprofloxacin, is a potent fluoroquinolone antibiotic used to treat a wide range of serious bacterial infections. Due to significant safety concerns, including the risk of disabling and potentially permanent side effects involving tendons, muscles, joints, nerves, and the central nervous system, its use is generally reserved for infections where other antibiotic options are not suitable. It works by inhibiting essential bacterial enzymes, leading to cell death.&lt;/p&gt;

&lt;!-- Manufacturer --&gt;
&lt;h3&gt;Manufacturer&lt;/h3&gt;
&lt;p&gt;MISR Company for Pharmaceutical Industries (MISR PHARM IND S.A.E.), Egypt.&lt;/p&gt;

&lt;!-- Category &amp; Active Ingredient --&gt;
&lt;h3&gt;Category &amp; Active Ingredient&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Category:&lt;/strong&gt; Antibiotic (Fluoroquinolone).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Active Ingredient:&lt;/strong&gt; Ciprofloxacin (as Hydrochloride Monohydrate).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Available Forms &amp; Strengths in Egypt --&gt;
&lt;h3&gt;Available Forms &amp; Strengths in Egypt&lt;/h3&gt;
&lt;p&gt;Mifoxin is available in the following forms:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Film-coated tablets:&lt;/strong&gt; 250 mg.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Film-coated tablets:&lt;/strong&gt; 500 mg.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Properties and Mechanism of Action --&gt;
&lt;h3&gt;Properties and Mechanism of Action&lt;/h3&gt;
&lt;p&gt;Ciprofloxacin is a bactericidal antibiotic belonging to the fluoroquinolone class. It functions by inhibiting two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are crucial for bacterial DNA replication, transcription, repair, and recombination. By blocking these processes, ciprofloxacin prevents bacterial cell division and ultimately causes cell death.&lt;/p&gt;

&lt;!-- Pharmacokinetics --&gt;
&lt;h3&gt;Pharmacokinetics&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Absorption:&lt;/strong&gt; Oral bioavailability is approximately 70%. Peak serum concentrations are reached within 1-2 hours.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Distribution:&lt;/strong&gt; Widely distributed throughout the body, penetrating well into tissues and fluids.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Metabolism:&lt;/strong&gt; Partially metabolized in the liver (around 15% of the dose).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Excretion:&lt;/strong&gt; Primarily excreted unchanged in the urine. The elimination half-life is about 4 hours in individuals with normal renal function.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications&lt;/h3&gt;
&lt;p&gt;Ciprofloxacin is indicated for the treatment of various bacterial infections. &lt;strong&gt;Important:&lt;/strong&gt; Due to safety risks, it should be reserved for use in patients who have no alternative treatment options for the following conditions: Acute Bacterial Sinusitis, Acute Bacterial Exacerbation of Chronic Bronchitis, and Uncomplicated Urinary Tract Infections.&lt;/p&gt;
&lt;p&gt;It is also used for more serious infections, including:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;Lower respiratory tract infections (e.g., pneumonia).&lt;/li&gt;
    &lt;li&gt;Complicated urinary tract infections and pyelonephritis.&lt;/li&gt;
    &lt;li&gt;Infectious diarrhea and typhoid fever.&lt;/li&gt;
    &lt;li&gt;Bone and joint infections.&lt;/li&gt;
    &lt;li&gt;Complicated intra-abdominal infections.&lt;/li&gt;
    &lt;li&gt;Skin and soft tissue infections.&lt;/li&gt;
    &lt;li&gt;Prostatitis and certain genital infections like gonorrhea.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Dosage and Administration --&gt;
&lt;h3&gt;Dosage and Administration&lt;/h3&gt;
&lt;p&gt;Dosage and duration vary depending on the type and severity of the infection. Always follow the physician&#39;s prescription.&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Adults (Oral):&lt;/strong&gt; Doses typically range from 250 mg to 750 mg twice daily.
        &lt;ul&gt;
            &lt;li&gt;&lt;strong&gt;UTIs:&lt;/strong&gt; 250-500 mg twice daily.&lt;/li&gt;
            &lt;li&gt;&lt;strong&gt;Respiratory/Bone/Skin infections:&lt;/strong&gt; 500-750 mg twice daily.&lt;/li&gt;
            &lt;li&gt;&lt;strong&gt;Infectious Diarrhea:&lt;/strong&gt; 500 mg twice daily for 5-7 days.&lt;/li&gt;
            &lt;li&gt;&lt;strong&gt;Uncomplicated Gonorrhea:&lt;/strong&gt; A single dose of 250-500 mg.&lt;/li&gt;
        &lt;/ul&gt;
    &lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Renal Impairment:&lt;/strong&gt; Dose adjustment is necessary for patients with impaired kidney function. The dose and/or frequency will be reduced based on creatinine clearance.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Contraindications --&gt;
&lt;h3&gt;Contraindications&lt;/h3&gt;
&lt;p&gt;Ciprofloxacin should not be used in:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;Patients with a history of hypersensitivity to ciprofloxacin or any other quinolone antibiotic.&lt;/li&gt;
    &lt;li&gt;Patients with a history of tendon disorders related to fluoroquinolone use.&lt;/li&gt;
    &lt;li&gt;Concomitant administration with tizanidine.&lt;/li&gt;
    &lt;li&gt;It is generally contraindicated in children and adolescents (under 18 years), during pregnancy, and while breastfeeding due to the risk of cartilage damage.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Warnings &amp; Precautions --&gt;
&lt;h3&gt;Warnings &amp; Precautions&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;BLACK BOX WARNING: Fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions. Discontinue immediately and avoid use in patients with these reactions.&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Tendinitis and Tendon Rupture:&lt;/strong&gt; Increased risk, especially in the elderly, patients taking corticosteroids, and in transplant recipients. Can occur within hours or days of starting or even months after completion.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Peripheral Neuropathy:&lt;/strong&gt; Risk of sensory or sensorimotor axonal polyneuropathy. Symptoms can occur soon after initiation and may be permanent.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Central Nervous System Effects:&lt;/strong&gt; Increased risk of seizures, increased intracranial pressure, dizziness, confusion, tremors, hallucinations, and suicidal thoughts or acts.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Aortic Aneurysm and Dissection:&lt;/strong&gt; Increased risk. Avoid use in patients with a known history or risk factors for aortic aneurysm.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Photosensitivity/Phototoxicity:&lt;/strong&gt; Moderate to severe reactions can occur. Avoid excessive exposure to sunlight or UV light.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Crystalluria:&lt;/strong&gt; Ensure adequate hydration to prevent the formation of highly concentrated urine.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Drug Interactions --&gt;
&lt;h3&gt;Drug Interactions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Absorption Interactions:&lt;/strong&gt; Antacids, sucralfate, or products containing magnesium, aluminum, iron, or calcium can significantly reduce the absorption of ciprofloxacin. Administer ciprofloxacin at least 2 hours before or 6 hours after these products.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Theophylline &amp; Caffeine:&lt;/strong&gt; Ciprofloxacin can increase the levels of these drugs, leading to toxicity.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Warfarin:&lt;/strong&gt; May enhance the anticoagulant effect. INR should be monitored closely.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;NSAIDs:&lt;/strong&gt; Concomitant use may increase the risk of CNS stimulation and seizures.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Diabetes Medications:&lt;/strong&gt; May cause significant disturbances in blood glucose (hypoglycemia or hyperglycemia).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects --&gt;
&lt;h3&gt;Side Effects&lt;/h3&gt;
&lt;p&gt;Common side effects include nausea, diarrhea, and vomiting. Other significant side effects are listed under &quot;Warnings &amp; Precautions.&quot;&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Gastrointestinal:&lt;/strong&gt; Nausea, vomiting, diarrhea, abdominal pain.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Central Nervous System:&lt;/strong&gt; Dizziness, headache, restlessness.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Skin:&lt;/strong&gt; Rash, pruritus, photosensitivity.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Musculoskeletal:&lt;/strong&gt; Tendinitis, tendon rupture, arthralgia (joint pain).&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Hypersensitivity:&lt;/strong&gt; Allergic reactions, including anaphylaxis.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Use in Pregnancy &amp; Lactation --&gt;
&lt;h3&gt;Use in Pregnancy &amp; Lactation&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Pregnancy:&lt;/strong&gt; Contraindicated. Based on animal studies, fluoroquinolones may cause damage to cartilage in the developing fetus.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Lactation:&lt;/strong&gt; Ciprofloxacin is excreted in breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Overdose --&gt;
&lt;h3&gt;Overdose&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Symptoms:&lt;/strong&gt; May include GI distress, CNS effects, and acute renal impairment.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Management:&lt;/strong&gt; Symptomatic and supportive. Gastric emptying via lavage may be performed. Maintain adequate hydration. Hemodialysis or peritoneal dialysis removes only a small amount of the drug.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Storage --&gt;
&lt;h3&gt;Storage&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Store below 30°C in a dry place, protected from direct sunlight.&lt;/li&gt;
    &lt;li&gt;Keep out of reach of children.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Presentation / Package --&gt;
&lt;h3&gt;Presentation / Package&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Box containing 10 film-coated tablets (250 mg or 500 mg).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- FAQ --&gt;
&lt;h3&gt;Frequently Asked Questions (FAQ)&lt;/h3&gt;
&lt;dl&gt;
    &lt;dt&gt;&lt;strong&gt;Q1: Can Mifoxin be used for a cold or the flu?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: No. Ciprofloxacin is an antibiotic and is completely ineffective against viral infections like the common cold or influenza.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q2: Why is Mifoxin not recommended for children?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Studies have shown that fluoroquinolones can cause damage to weight-bearing joints and cartilage in developing animals, so it is generally avoided in patients under 18.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q3: Should I avoid any foods while taking Mifoxin?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Yes. Avoid taking ciprofloxacin with dairy products (like milk, yogurt) or calcium-fortified juices alone, as they can decrease its absorption. However, you may take it with a meal that contains these products.&lt;/dd&gt;
    &lt;dt&gt;&lt;strong&gt;Q4: What should I do if I feel pain in my heel or shoulder while taking Mifoxin?&lt;/strong&gt;&lt;/dt&gt;
    &lt;dd&gt;A: Stop taking the medication immediately, avoid exercise, and contact your doctor. This could be a sign of tendinitis or tendon rupture, a serious side effect.&lt;/dd&gt;
&lt;/dl&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;U.S. Food and Drug Administration (FDA). Ciprofloxacin Prescribing Information (including Black Box Warning).&lt;/li&gt;
    &lt;li&gt;British National Formulary (BNF), &quot;Ciprofloxacin&quot;.&lt;/li&gt;
    &lt;li&gt;Martindale: The Complete Drug Reference.&lt;/li&gt;
    &lt;li&gt;MISR Company for Pharmaceutical Industries, Product Leaflet.&lt;/li&gt;
&lt;/ol&gt;
</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/6025055898028433653'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/6025055898028433653'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2013/09/mifoxin.html' title='Mifoxin (Ciprofloxacin): A Guide to Uses, Dosage, and Serious Safety Warnings '/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-290222786223929441</id><published>2025-08-22T13:11:00.000+00:00</published><updated>2025-08-22T13:11:02.305+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="ACNEFENCE"/><category scheme="http://www.blogger.com/atom/ns#" term="Acnefence Gel"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Capital Pharma"/><category scheme="http://www.blogger.com/atom/ns#" term="Chamomile"/><category scheme="http://www.blogger.com/atom/ns#" term="Glycolic Acid"/><category scheme="http://www.blogger.com/atom/ns#" term="Green Tea Extract"/><category scheme="http://www.blogger.com/atom/ns#" term="Retinyl Palmitate"/><category scheme="http://www.blogger.com/atom/ns#" term="Salicylic Acid"/><category scheme="http://www.blogger.com/atom/ns#" term="Vitamin C"/><category scheme="http://www.blogger.com/atom/ns#" term="Vitamin E"/><title type='text'>ACNEFENCE Topical Gel 50 gm | Anti-Acne Treatment with Glycolic &amp; Salicylic Acid</title><content type='html'>&lt;!DOCTYPE html&gt;
&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
  &lt;meta charset=&quot;UTF-8&quot;&gt;
  &lt;meta name=&quot;viewport&quot; content=&quot;width=device-width, initial-scale=1.0&quot;&gt;
  &lt;title&gt;ACNEFENCE Topical Gel 50 gm | Anti-Acne Treatment&lt;/title&gt;
  &lt;meta name=&quot;description&quot; content=&quot;ACNEFENCE Gel with Glycolic acid, Salicylic acid, Retinyl Palmitate, and antioxidants for acne-prone skin. Full monograph, uses, FAQ.&quot;&gt;
  &lt;meta name=&quot;keywords&quot; content=&quot;ACNEFENCE, Acnefence Gel, Anti-acne, Glycolic Acid, Salicylic Acid, Retinyl Palmitate, Vitamin E, Vitamin C, Capital Pharma&quot;&gt;
&lt;/head&gt;
&lt;body&gt;
  &lt;article&gt;
    &lt;h1&gt;ACNEFENCE TOPICAL GEL 50 GM – Full Monograph&lt;/h1&gt;

    &lt;h2&gt;1. Brand Name&lt;/h2&gt;
    &lt;p&gt;ACNEFENCE Topical Gel 50 gm&lt;/p&gt;

    &lt;h2&gt;2. Generic/Active Ingredients&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Glycolic Acid&lt;/li&gt;
      &lt;li&gt;Salicylic Acid&lt;/li&gt;
      &lt;li&gt;Green Tea Extract&lt;/li&gt;
      &lt;li&gt;Chamomile&lt;/li&gt;
      &lt;li&gt;Retinyl Palmitate (Vitamin A derivative)&lt;/li&gt;
      &lt;li&gt;Vitamin E (Tocopherol)&lt;/li&gt;
      &lt;li&gt;Ascorbic Acid (Vitamin C)&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;3. Dosage Form &amp; Strength&lt;/h2&gt;
    &lt;p&gt;Topical Gel – 50 gm tube&lt;/p&gt;

    &lt;h2&gt;4. Pharmacological Class&lt;/h2&gt;
    &lt;p&gt;Anti-acne, keratolytic, antioxidant, skin care&lt;/p&gt;

    &lt;h2&gt;5. Manufacturer / Distributor&lt;/h2&gt;
    &lt;p&gt;&lt;strong&gt;El-Helou Perfumes &amp; Cosmetics&lt;/strong&gt;, marketed by &lt;strong&gt;Capital Pharma&lt;/strong&gt; (Egypt)&lt;/p&gt;

    &lt;h2&gt;6. Mechanism of Action&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;&lt;strong&gt;Glycolic Acid&lt;/strong&gt;: Exfoliates dead skin, improves texture, unclogs pores.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Salicylic Acid&lt;/strong&gt;: Penetrates pores, dissolves sebum/debris, reduces comedones.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Green Tea Extract&lt;/strong&gt;: Antioxidant, reduces sebum, anti-inflammatory.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Chamomile&lt;/strong&gt;: Soothes skin, reduces redness and irritation.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Retinyl Palmitate&lt;/strong&gt;: Increases cell turnover, reduces acne formation.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Vitamin E &amp; C&lt;/strong&gt;: Antioxidants, improve healing, reduce oxidative stress and pigmentation.&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;7. Indications (Uses)&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Treatment of mild to moderate acne&lt;/li&gt;
      &lt;li&gt;Oily and acne-prone skin care&lt;/li&gt;
      &lt;li&gt;Adjunct therapy for post-acne marks&lt;/li&gt;
      &lt;li&gt;Skin rejuvenation &amp; texture improvement&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;8. Contraindications&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Hypersensitivity to any ingredient&lt;/li&gt;
      &lt;li&gt;Severe irritation or eczema on application area&lt;/li&gt;
      &lt;li&gt;Not suitable for rosacea or very sensitive skin&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;9. Warnings &amp; Precautions&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;For external use only&lt;/li&gt;
      &lt;li&gt;Avoid contact with eyes, mouth, mucous membranes&lt;/li&gt;
      &lt;li&gt;May increase photosensitivity → use sunscreen&lt;/li&gt;
      &lt;li&gt;Use with caution in pregnancy (Retinyl Palmitate)&lt;/li&gt;
      &lt;li&gt;Discontinue if severe irritation or allergy develops&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;10. Drug Interactions&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Avoid with strong exfoliants (benzoyl peroxide, retinoids, peeling agents)&lt;/li&gt;
      &lt;li&gt;Caution with topical corticosteroids or alcohol-based products&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;11. Side Effects&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;&lt;strong&gt;Common&lt;/strong&gt;: Mild redness, dryness, peeling, tingling&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Less common&lt;/strong&gt;: Stinging, irritation, photosensitivity&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;Rare&lt;/strong&gt;: Allergic contact dermatitis&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;12. Overdose / Toxicity&lt;/h2&gt;
    &lt;p&gt;Topical overdose unlikely. Excessive use may cause severe irritation and peeling. If ingested, seek medical attention.&lt;/p&gt;

    &lt;h2&gt;13. Dosage &amp; Administration&lt;/h2&gt;
    &lt;p&gt;Apply a thin layer on cleansed, dry skin once daily (preferably at night). May increase to twice daily if tolerated. Use sunscreen during the day.&lt;/p&gt;

    &lt;h2&gt;14. Storage&lt;/h2&gt;
    &lt;p&gt;Store below 25°C. Protect from sunlight. Keep out of reach of children.&lt;/p&gt;

    &lt;h2&gt;15. Available Forms / Packaging&lt;/h2&gt;
    &lt;p&gt;ACNEFENCE Gel – 50 gm tube&lt;/p&gt;

    &lt;h2&gt;16. Price&lt;/h2&gt;
    &lt;p&gt;Varies by region. Check with local pharmacies.&lt;/p&gt;

    &lt;h2&gt;17. Alternatives&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Adapalene gel&lt;/li&gt;
      &lt;li&gt;Benzoyl peroxide gel&lt;/li&gt;
      &lt;li&gt;Salicylic acid cleansers&lt;/li&gt;
      &lt;li&gt;Niacinamide anti-acne creams&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;18. Similar Products&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Acne-Stop Gel (Mash Premiere)&lt;/li&gt;
      &lt;li&gt;Acne-Jed Gel (JEDCO)&lt;/li&gt;
      &lt;li&gt;Erythromycin + Zinc solutions&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;19. Frequently Asked Questions (FAQ)&lt;/h2&gt;
    &lt;p&gt;&lt;strong&gt;Q1:&lt;/strong&gt; Can I use ACNEFENCE with benzoyl peroxide?&lt;br&gt;
    &lt;em&gt;A:&lt;/em&gt; Not recommended at the same time. Alternate days may be possible with doctor guidance.&lt;/p&gt;

    &lt;p&gt;&lt;strong&gt;Q2:&lt;/strong&gt; Is it safe during pregnancy?&lt;br&gt;
    &lt;em&gt;A:&lt;/em&gt; Contains Retinyl Palmitate. Avoid unless prescribed.&lt;/p&gt;

    &lt;p&gt;&lt;strong&gt;Q3:&lt;/strong&gt; When will I see results?&lt;br&gt;
    &lt;em&gt;A:&lt;/em&gt; Usually 4–8 weeks of consistent use.&lt;/p&gt;

    &lt;p&gt;&lt;strong&gt;Q4:&lt;/strong&gt; Does it help acne scars?&lt;br&gt;
    &lt;em&gt;A:&lt;/em&gt; Helps with pigmentation, but not deep scars.&lt;/p&gt;

    &lt;p&gt;&lt;strong&gt;Q5:&lt;/strong&gt; Should I use sunscreen?&lt;br&gt;
    &lt;em&gt;A:&lt;/em&gt; Yes, sunscreen is essential during treatment.&lt;/p&gt;

    &lt;h2&gt;References&lt;/h2&gt;
    &lt;ol&gt;
      &lt;li&gt;Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016.&lt;/li&gt;
      &lt;li&gt;Bowe WP, Logan AC. Clinical implications of diet in acne. Dermatoendocrinol. 2011.&lt;/li&gt;
      &lt;li&gt;Green Tea Extract in Dermatology: Clin Dermatol. 2009.&lt;/li&gt;
      &lt;li&gt;CIR Safety assessments for glycolic acid, salicylic acid, and retinyl palmitate.&lt;/li&gt;
    &lt;/ol&gt;

    &lt;h2&gt;Disclaimer&lt;/h2&gt;
    &lt;p&gt;This content is for educational purposes only and does not replace professional medical advice. Consult a dermatologist before using ACNEFENCE Gel or starting any acne treatment.&lt;/p&gt;

    &lt;hr&gt;
    &lt;p&gt;&lt;strong&gt;Labels:&lt;/strong&gt; ACNEFENCE, Acnefence Gel, Anti-acne, Glycolic Acid, Salicylic Acid, Retinyl Palmitate, Vitamin E, Vitamin C, Capital Pharma&lt;/p&gt;
  &lt;/article&gt;
&lt;/body&gt;
&lt;/html&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/290222786223929441'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/290222786223929441'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acnefence-topical-gel-50-gm-anti-acne.html' title='ACNEFENCE Topical Gel 50 gm | Anti-Acne Treatment with Glycolic &amp; Salicylic Acid'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-3923070536645205621</id><published>2025-08-22T12:31:00.004+00:00</published><updated>2025-08-22T12:31:49.743+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="acne facial gel"/><category scheme="http://www.blogger.com/atom/ns#" term="acne foaming cleanser"/><category scheme="http://www.blogger.com/atom/ns#" term="acne skincare"/><category scheme="http://www.blogger.com/atom/ns#" term="Acne Treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="ACNEBLESS"/><category scheme="http://www.blogger.com/atom/ns#" term="anti-acne cream"/><category scheme="http://www.blogger.com/atom/ns#" term="dermatology"/><category scheme="http://www.blogger.com/atom/ns#" term="Kempetro"/><category scheme="http://www.blogger.com/atom/ns#" term="Novell Pharma"/><category scheme="http://www.blogger.com/atom/ns#" term="skin care routine"/><title type='text'>ACNEBLESS | Complete Anti-Acne Skincare System (Cream, Gel &amp; Foaming Cleanser) – Novell Pharma</title><content type='html'>&lt;!DOCTYPE html&gt;
&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
  &lt;meta charset=&quot;UTF-8&quot;&gt;
  &lt;title&gt;ACNEBLESS | Complete Anti-Acne Skincare Range&lt;/title&gt;
  &lt;meta name=&quot;description&quot; content=&quot;ACNEBLESS cream, cleansing foaming gel, and facial gel for acne care, developed by Novell Pharma. Safe daily skincare routine.&quot;&gt;
  &lt;meta name=&quot;keywords&quot; content=&quot;ACNEBLESS, acne cream, acne gel, acne foaming cleanser, Novell Pharma, acne treatment, skin care, anti-acne&quot;&gt;
&lt;/head&gt;
&lt;body&gt;
  &lt;article&gt;
    &lt;h1&gt;ACNEBLESS | Complete Anti-Acne Skincare Range&lt;/h1&gt;

    &lt;h2&gt;1. Brand Name&lt;/h2&gt;
    &lt;p&gt;ACNEBLESS®&lt;/p&gt;

    &lt;h2&gt;2. Manufacturer&lt;/h2&gt;
    &lt;p&gt;Kempetro for Chemical Industries → Novell Pharma&lt;/p&gt;

    &lt;h2&gt;3. Category&lt;/h2&gt;
    &lt;p&gt;Dermatological | Anti-acne skincare&lt;/p&gt;

    &lt;h2&gt;4. Active Ingredients&lt;/h2&gt;
    &lt;p&gt;Exact active constituents are not fully disclosed by the manufacturer. The formulation is specifically designed for acne-prone skin and marketed as part of Novell Pharma’s dermatology line.&lt;/p&gt;

    &lt;h2&gt;5. Available Forms&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;ACNEBLESS Cream 50 g&lt;/li&gt;
      &lt;li&gt;ACNEBLESS Facial Cleansing Foaming Gel 200 ml&lt;/li&gt;
      &lt;li&gt;ACNEBLESS Facial Gel 50 ml&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;6. Mechanism of Action&lt;/h2&gt;
    &lt;p&gt;ACNEBLESS products work through a multi-targeted skincare approach:
      &lt;ul&gt;
        &lt;li&gt;Regulating excess sebum production&lt;/li&gt;
        &lt;li&gt;Reducing bacterial colonization on skin&lt;/li&gt;
        &lt;li&gt;Improving keratinocyte turnover and preventing clogged pores&lt;/li&gt;
        &lt;li&gt;Maintaining skin hydration and barrier protection&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/p&gt;

    &lt;h2&gt;7. Indications&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Mild to moderate acne (comedonal and inflammatory)&lt;/li&gt;
      &lt;li&gt;Excess oily skin and enlarged pores&lt;/li&gt;
      &lt;li&gt;Daily supportive care in acne-prone skin&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;8. Contraindications&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Known hypersensitivity to any component of the formulation&lt;/li&gt;
      &lt;li&gt;Not recommended for use on broken or eczematous skin&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;9. Precautions&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Avoid direct eye contact.&lt;/li&gt;
      &lt;li&gt;If excessive irritation occurs, discontinue use.&lt;/li&gt;
      &lt;li&gt;For external use only.&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;10. Side Effects&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Mild skin dryness or peeling&lt;/li&gt;
      &lt;li&gt;Temporary stinging or burning sensation&lt;/li&gt;
      &lt;li&gt;Redness in sensitive individuals&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;11. Drug Interactions&lt;/h2&gt;
    &lt;p&gt;No systemic interactions expected as this is a topical cosmetic-dermatological line. However, concurrent use with strong prescription acne medications (e.g., isotretinoin, benzoyl peroxide, retinoids) may increase irritation.&lt;/p&gt;

    &lt;h2&gt;12. Dosage &amp; Administration&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;&lt;strong&gt;ACNEBLESS Cream:&lt;/strong&gt; Apply thin layer to affected areas once or twice daily.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;ACNEBLESS Facial Gel:&lt;/strong&gt; Use daily on acne-prone facial zones.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;ACNEBLESS Cleansing Foaming Gel:&lt;/strong&gt; Apply to wet skin twice daily, massage gently, then rinse.&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;13. Overdose&lt;/h2&gt;
    &lt;p&gt;Not applicable to topical use. Excessive application may cause local irritation.&lt;/p&gt;

    &lt;h2&gt;14. Use in Pregnancy &amp; Lactation&lt;/h2&gt;
    &lt;p&gt;Topical cosmetic-dermatological products are generally considered safe. However, safety has not been fully established in pregnancy and breastfeeding. Consult a physician before use.&lt;/p&gt;

    &lt;h2&gt;15. Storage&lt;/h2&gt;
    &lt;p&gt;Store at room temperature (below 25°C). Keep out of reach of children.&lt;/p&gt;

    &lt;h2&gt;16. Price in Egypt&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;ACNEBLESS Cream 50 g — Price not listed&lt;/li&gt;
      &lt;li&gt;ACNEBLESS Foaming Gel 200 ml — Price not listed&lt;/li&gt;
      &lt;li&gt;ACNEBLESS Facial Gel 50 ml — Price not listed&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;17. Alternatives&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;ACNE-STOP System (Mash Premiere)&lt;/li&gt;
      &lt;li&gt;ACNE-JED Gel (Adapalene)&lt;/li&gt;
      &lt;li&gt;Other topical anti-acne formulations containing salicylic acid or retinoids&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;18. References&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Novell Pharma official product catalogue&lt;/li&gt;
      &lt;li&gt;General dermatology practice guidelines for acne management&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Frequently Asked Questions (FAQ)&lt;/h2&gt;
    &lt;p&gt;&lt;strong&gt;Q1: Can ACNEBLESS be used with prescription acne medications?&lt;/strong&gt;&lt;br&gt;
    A: Yes, but avoid combining with strong topical retinoids or benzoyl peroxide unless directed by a dermatologist.&lt;/p&gt;

    &lt;p&gt;&lt;strong&gt;Q2: How soon does ACNEBLESS show results?&lt;/strong&gt;&lt;br&gt;
    A: Visible improvements may be seen within 2–4 weeks of consistent use.&lt;/p&gt;

    &lt;p&gt;&lt;strong&gt;Q3: Is ACNEBLESS suitable for sensitive skin?&lt;/strong&gt;&lt;br&gt;
    A: It is generally well tolerated, but a patch test is recommended before full application.&lt;/p&gt;

    &lt;h2&gt;Disclaimer&lt;/h2&gt;
    &lt;p&gt;This article is for educational purposes only and not a substitute for medical advice. Always consult your dermatologist or healthcare provider before starting any acne treatment.&lt;/p&gt;
  &lt;/article&gt;
&lt;/body&gt;
&lt;/html&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3923070536645205621'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3923070536645205621'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acnebless-complete-anti-acne-skincare.html' title='ACNEBLESS | Complete Anti-Acne Skincare System (Cream, Gel &amp; Foaming Cleanser) – Novell Pharma'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-5314543478242484164</id><published>2025-08-22T12:18:00.003+00:00</published><updated>2025-08-22T12:18:35.968+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Acne Cream"/><category scheme="http://www.blogger.com/atom/ns#" term="Acne Treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="ACNE-STOP"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="comedolytic"/><category scheme="http://www.blogger.com/atom/ns#" term="facial wash"/><category scheme="http://www.blogger.com/atom/ns#" term="Mash Premiere"/><category scheme="http://www.blogger.com/atom/ns#" term="NDGA"/><category scheme="http://www.blogger.com/atom/ns#" term="oleanolic acid"/><category scheme="http://www.blogger.com/atom/ns#" term="osmotic gel"/><category scheme="http://www.blogger.com/atom/ns#" term="Propolis"/><category scheme="http://www.blogger.com/atom/ns#" term="sebum control"/><category scheme="http://www.blogger.com/atom/ns#" term="skin care"/><title type='text'>ACNE-STOP System | Anti-Acne Cream &amp; Facial Wash with Oleanolic Acid, NDGA &amp; Propolis</title><content type='html'>&lt;!DOCTYPE html&gt;
&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
  &lt;meta charset=&quot;UTF-8&quot;&gt;
  &lt;title&gt;ACNE-STOP System | Cream &amp; Facial Wash for Acne Treatment&lt;/title&gt;
  &lt;meta name=&quot;description&quot; content=&quot;ACNE-STOP cream and wash with oleanolic acid, NDGA, propolis, and osmotic gel for acne care and skin health.&quot;&gt;
  &lt;meta name=&quot;keywords&quot; content=&quot;ACNE-STOP, acne treatment, oleanolic acid, NDGA, propolis, osmotic gel, Mash Premiere, anti-acne, skin care, cream, wash&quot;&gt;
&lt;/head&gt;
&lt;body&gt;
  &lt;article&gt;
    &lt;h1&gt;ACNE-STOP System (Cream + Facial Wash)&lt;/h1&gt;
    &lt;h2&gt;Category&lt;/h2&gt;
    &lt;p&gt;Skin care – Anti-acne product&lt;/p&gt;

    &lt;h2&gt;Active Ingredients&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Oleanolic Acid&lt;/li&gt;
      &lt;li&gt;NDGA (Nordihydroguaiaretic Acid)&lt;/li&gt;
      &lt;li&gt;Propolis&lt;/li&gt;
      &lt;li&gt;Osmotic Gel&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Mechanism of Action&lt;/h2&gt;
    &lt;p&gt;
      Oleanolic acid reduces sebum production and has anti-inflammatory activity.  
      NDGA inhibits 5-lipoxygenase, reducing comedogenesis and acne inflammation.  
      Propolis provides antibacterial and healing effects.  
      Osmotic gel enhances delivery and helps unclog pores.
    &lt;/p&gt;

    &lt;h2&gt;Therapeutic Indications&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Treatment of mild to moderate acne vulgaris&lt;/li&gt;
      &lt;li&gt;Reduction of excess sebum and oily skin&lt;/li&gt;
      &lt;li&gt;Improvement of skin texture and prevention of comedones&lt;/li&gt;
      &lt;li&gt;Adjunct therapy with systemic or topical anti-acne agents&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Pharmacokinetics&lt;/h2&gt;
    &lt;p&gt;
      Topically applied; minimal systemic absorption.  
      Local action on sebaceous glands and pilosebaceous units.  
      Safe for repeated use due to low systemic bioavailability.
    &lt;/p&gt;

    &lt;h2&gt;Dosage &amp; Administration&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;&lt;strong&gt;ACNE-STOP Cream:&lt;/strong&gt; Apply thinly to affected areas twice daily.&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;ACNE-STOP Facial Wash:&lt;/strong&gt; Use to cleanse face once or twice daily before applying cream.&lt;/li&gt;
      &lt;li&gt;Recommended duration: at least 8 weeks for best results.&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Available Forms&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;ACNE-STOP Cream 30 g&lt;/li&gt;
      &lt;li&gt;ACNE-STOP Facial Wash 250 ml&lt;/li&gt;
      &lt;li&gt;ACNE-STOP System (Cream + Wash)&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Side Effects&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Mild skin irritation&lt;/li&gt;
      &lt;li&gt;Redness or dryness, especially at start of therapy&lt;/li&gt;
      &lt;li&gt;Rare: allergic reaction to propolis&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Contraindications&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Known hypersensitivity to any component (oleanolic acid, NDGA, propolis, osmotic gel)&lt;/li&gt;
      &lt;li&gt;Severe eczema or damaged skin areas&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Precautions &amp; Warnings&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Avoid contact with eyes and mucous membranes.&lt;/li&gt;
      &lt;li&gt;Discontinue use if severe irritation occurs.&lt;/li&gt;
      &lt;li&gt;Not recommended for children under 12 years without medical advice.&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Drug Interactions&lt;/h2&gt;
    &lt;p&gt;
      No major drug interactions reported.  
      Can be used with systemic acne medications (e.g., antibiotics, isotretinoin) under supervision.  
      Avoid simultaneous use with strong peeling agents to minimize irritation.
    &lt;/p&gt;

    &lt;h2&gt;Use in Pregnancy &amp; Lactation&lt;/h2&gt;
    &lt;p&gt;
      Safety not fully established.  
      Use with caution during pregnancy and breastfeeding; consult a physician before use.
    &lt;/p&gt;

    &lt;h2&gt;Use in Pediatrics &amp; Geriatrics&lt;/h2&gt;
    &lt;p&gt;
      Pediatric: Limited safety data below 12 years of age.  
      Geriatric: Safe with normal topical use.
    &lt;/p&gt;

    &lt;h2&gt;Overdose&lt;/h2&gt;
    &lt;p&gt;
      Topical overdose unlikely; may cause increased irritation or dermatitis.  
      Ingestion requires symptomatic treatment and medical attention.
    &lt;/p&gt;

    &lt;h2&gt;Storage&lt;/h2&gt;
    &lt;p&gt;
      Store at room temperature below 25°C.  
      Keep out of reach of children.
    &lt;/p&gt;

    &lt;h2&gt;Price &amp; Manufacturer&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;&lt;strong&gt;ACNE-STOP Cream 30 g:&lt;/strong&gt; Mash Premiere&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;ACNE-STOP Facial Wash 250 ml:&lt;/strong&gt; Mash Premiere&lt;/li&gt;
      &lt;li&gt;&lt;strong&gt;ACNE-STOP System:&lt;/strong&gt; Mash Premiere&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Summary&lt;/h2&gt;
    &lt;p&gt;
      ACNE-STOP is a dermatological system combining cream and facial wash with natural actives (oleanolic acid, NDGA, propolis) in an osmotic gel base.  
      It helps reduce acne lesions, sebum production, and skin inflammation, making it a safe and effective option for acne management.
    &lt;/p&gt;

    &lt;h2&gt;Frequently Asked Questions (FAQ)&lt;/h2&gt;
    &lt;h3&gt;How long does ACNE-STOP take to show results?&lt;/h3&gt;
    &lt;p&gt;Visible improvement may appear within 4 weeks; optimal results after 8-12 weeks.&lt;/p&gt;

    &lt;h3&gt;Can ACNE-STOP be combined with other acne treatments?&lt;/h3&gt;
    &lt;p&gt;Yes, it may be combined with oral or topical treatments, but consult a dermatologist first.&lt;/p&gt;

    &lt;h3&gt;Is ACNE-STOP safe for sensitive skin?&lt;/h3&gt;
    &lt;p&gt;It may cause mild irritation initially. Start with once-daily use if sensitive.&lt;/p&gt;

    &lt;h3&gt;Can I use makeup with ACNE-STOP?&lt;/h3&gt;
    &lt;p&gt;Yes, but apply cream first, allow absorption, then use non-comedogenic makeup.&lt;/p&gt;

    &lt;h2&gt;References&lt;/h2&gt;
    &lt;ul&gt;
      &lt;li&gt;Thiboutot D, et al. &quot;Acne Pathogenesis and Treatment.&quot; J Am Acad Dermatol. 2009.&lt;/li&gt;
      &lt;li&gt;Premiere Pharma Product Information Leaflet: ACNE-STOP System.&lt;/li&gt;
      &lt;li&gt;PubChem Database: Oleanolic Acid, NDGA, Propolis properties.&lt;/li&gt;
    &lt;/ul&gt;

    &lt;h2&gt;Disclaimer&lt;/h2&gt;
    &lt;p&gt;
      This information is provided for educational purposes only and does not replace medical advice.  
      Consult a qualified healthcare provider before starting or changing any treatment.
    &lt;/p&gt;
  &lt;/article&gt;
&lt;/body&gt;
&lt;/html&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5314543478242484164'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5314543478242484164'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acne-stop-system-anti-acne-cream-facial.html' title='ACNE-STOP System | Anti-Acne Cream &amp; Facial Wash with Oleanolic Acid, NDGA &amp; Propolis'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-3193293477269743441</id><published>2025-08-22T12:09:00.003+00:00</published><updated>2025-08-22T12:09:59.316+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Acne Treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="acne vulgaris"/><category scheme="http://www.blogger.com/atom/ns#" term="ACNE-JED"/><category scheme="http://www.blogger.com/atom/ns#" term="adapalene"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="comedones"/><category scheme="http://www.blogger.com/atom/ns#" term="Jedco"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharco"/><category scheme="http://www.blogger.com/atom/ns#" term="Retinoid"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Gel"/><title type='text'>ACNE-JED 0.1% Gel | Adapalene Topical Retinoid for Acne Treatment</title><content type='html'>&lt;!DOCTYPE html&gt;
&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
  &lt;meta charset=&quot;UTF-8&quot;&gt;
  &lt;meta name=&quot;viewport&quot; content=&quot;width=device-width, initial-scale=1.0&quot;&gt;
  &lt;title&gt;ACNE-JED 0.1% Gel | Adapalene Topical Anti-Acne Treatment&lt;/title&gt;
  &lt;meta name=&quot;description&quot; content=&quot;ACNE-JED 0.1% gel (adapalene). Topical retinoid for acne vulgaris. Uses, dosage, side effects, interactions, and safety guide.&quot;&gt;
  &lt;meta name=&quot;keywords&quot; content=&quot;ACNE-JED, adapalene, anti-acne, topical gel, acne vulgaris, PHARCO, JEDCO, acne treatment, retinoid&quot;&gt;
&lt;/head&gt;
&lt;body&gt;
  &lt;article&gt;
    &lt;h1&gt;ACNE-JED 0.1% Topical Gel (Adapalene)&lt;/h1&gt;
    
    &lt;section&gt;
      &lt;h2&gt;1. Category and Active Ingredient&lt;/h2&gt;
      &lt;p&gt;&lt;strong&gt;Category:&lt;/strong&gt; Anti-acne topical retinoid&lt;br&gt;
      &lt;strong&gt;Active Ingredient:&lt;/strong&gt; Adapalene 0.1%&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;2. Manufacturer&lt;/h2&gt;
      &lt;p&gt;JEDCO International Co. for Pharmaceuticals, Egypt.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;3. Summary&lt;/h2&gt;
      &lt;p&gt;ACNE-JED 0.1% topical gel contains adapalene, a third-generation synthetic retinoid used in the treatment of acne vulgaris. It works by modulating cellular differentiation and keratinization, preventing the formation of new acne lesions, and reducing inflammation.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;4. Available Forms&lt;/h2&gt;
      &lt;p&gt;Topical gel, 15 g tube (0.1% adapalene).&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;5. Mechanism of Action&lt;/h2&gt;
      &lt;p&gt;Adapalene binds to retinoic acid nuclear receptors, normalizing the differentiation of follicular epithelial cells, reducing microcomedone formation, and exhibiting anti-inflammatory effects.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;6. Indications&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Treatment of mild to moderate acne vulgaris (comedonal, papular, pustular).&lt;/li&gt;
        &lt;li&gt;Reduction of acne-related inflammation and lesions.&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;7. Contraindications&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Hypersensitivity to adapalene or any component of the gel.&lt;/li&gt;
        &lt;li&gt;Not recommended during pregnancy (Category C).&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;8. Dosage and Administration&lt;/h2&gt;
      &lt;p&gt;Apply a thin film of ACNE-JED gel once daily in the evening to affected areas after gently cleansing and drying the skin. Avoid eyes, lips, and mucous membranes. Clinical improvement usually appears after 8–12 weeks of consistent use.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;9. Pharmacokinetics&lt;/h2&gt;
      &lt;p&gt;Adapalene is minimally absorbed through the skin (&lt;0.01% systemic absorption). It is metabolized hepatically and eliminated primarily via bile.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;10. Side Effects&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Common: Skin irritation, erythema, dryness, peeling, burning sensation.&lt;/li&gt;
        &lt;li&gt;Less common: Photosensitivity reactions.&lt;/li&gt;
        &lt;li&gt;Rare: Severe local hypersensitivity.&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;11. Drug Interactions&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Avoid concurrent use with other strong topical acne agents (benzoyl peroxide, salicylic acid, alpha-hydroxy acids) unless directed by a physician due to additive irritation.&lt;/li&gt;
        &lt;li&gt;Use caution with concomitant topical drying products (astringents, medicated soaps).&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;12. Warnings and Precautions&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Avoid sun exposure and use sunscreen as adapalene increases photosensitivity.&lt;/li&gt;
        &lt;li&gt;Do not apply to broken, eczematous, or sunburned skin.&lt;/li&gt;
        &lt;li&gt;Safety during pregnancy not established; use only if potential benefit outweighs risk.&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;13. Use in Pregnancy and Lactation&lt;/h2&gt;
      &lt;p&gt;&lt;strong&gt;Pregnancy:&lt;/strong&gt; Category C; not recommended unless prescribed by a physician.&lt;br&gt;
      &lt;strong&gt;Lactation:&lt;/strong&gt; Excretion in human milk not established; avoid application on chest area during breastfeeding.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;14. Overdose&lt;/h2&gt;
      &lt;p&gt;Topical overdose may cause severe skin irritation and erythema. In case of accidental ingestion, seek medical attention immediately.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;15. Storage&lt;/h2&gt;
      &lt;p&gt;Store below 25°C, away from direct light and heat. Keep out of reach of children.&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;16. Price&lt;/h2&gt;
      &lt;p&gt;Price may vary by pharmacy and region. (Check local Egyptian market listing).&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;17. Similar Products&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Adapalene 0.1% gel (generic versions)&lt;/li&gt;
        &lt;li&gt;Differin gel 0.1% (Adapalene)&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;18. Alternatives&lt;/h2&gt;
      &lt;ul&gt;
        &lt;li&gt;Benzoyl peroxide topical preparations&lt;/li&gt;
        &lt;li&gt;Topical clindamycin&lt;/li&gt;
        &lt;li&gt;Topical azelaic acid&lt;/li&gt;
        &lt;li&gt;Oral antibiotics (in moderate-severe acne)&lt;/li&gt;
      &lt;/ul&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;19. Frequently Asked Questions (FAQ)&lt;/h2&gt;
      &lt;h3&gt;Q1: How long does ACNE-JED take to work?&lt;/h3&gt;
      &lt;p&gt;Noticeable improvement typically occurs after 8–12 weeks of consistent nightly use.&lt;/p&gt;
      &lt;h3&gt;Q2: Can I use ACNE-JED with benzoyl peroxide?&lt;/h3&gt;
      &lt;p&gt;It may be combined under medical supervision, often applied at different times of the day to reduce irritation.&lt;/p&gt;
      &lt;h3&gt;Q3: Is ACNE-JED safe for sensitive skin?&lt;/h3&gt;
      &lt;p&gt;Adapalene can cause initial irritation. Start with limited frequency (every other day) if skin is sensitive.&lt;/p&gt;
      &lt;h3&gt;Q4: Can pregnant women use ACNE-JED?&lt;/h3&gt;
      &lt;p&gt;No, adapalene is not recommended during pregnancy (Category C).&lt;/p&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;References&lt;/h2&gt;
      &lt;ol&gt;
        &lt;li&gt;European Medicines Agency (EMA) – Adapalene Gel: Summary of Product Characteristics.&lt;/li&gt;
        &lt;li&gt;American Academy of Dermatology. Acne Treatment Guidelines (2021).&lt;/li&gt;
        &lt;li&gt;DailyMed – Adapalene Topical Gel, USP 0.1% labeling information.&lt;/li&gt;
      &lt;/ol&gt;
    &lt;/section&gt;

    &lt;section&gt;
      &lt;h2&gt;Disclaimer&lt;/h2&gt;
      &lt;p&gt;This information is provided for educational purposes only and does not replace professional medical advice. Always consult a licensed healthcare provider before starting or changing any medication.&lt;/p&gt;
    &lt;/section&gt;
  &lt;/article&gt;
&lt;/body&gt;
&lt;/html&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3193293477269743441'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3193293477269743441'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acne-jed-01-gel-adapalene-topical.html' title='ACNE-JED 0.1% Gel | Adapalene Topical Retinoid for Acne Treatment'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-7880043963330870855</id><published>2025-08-22T12:01:00.002+00:00</published><updated>2025-08-22T12:01:36.355+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="acne care"/><category scheme="http://www.blogger.com/atom/ns#" term="acne vulgaris"/><category scheme="http://www.blogger.com/atom/ns#" term="ACNE ZINC"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Erythromycin"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharco"/><category scheme="http://www.blogger.com/atom/ns#" term="pimples solution"/><category scheme="http://www.blogger.com/atom/ns#" term="skin treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Solution"/><category scheme="http://www.blogger.com/atom/ns#" term="Zinc Acetate"/><title type='text'>ACNE ZINC Solution 20ml | Erythromycin + Zinc for Acne Treatment</title><content type='html'>&lt;!DOCTYPE html&gt;
&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
  &lt;meta charset=&quot;UTF-8&quot;&gt;
  &lt;title&gt;ACNE ZINC Topical Solution 20 ml – Erythromycin + Zinc Acetate&lt;/title&gt;
  &lt;meta name=&quot;description&quot; content=&quot;ACNE ZINC topical solution 20 ml with erythromycin + zinc acetate for acne treatment. Reduces inflammation &amp; controls bacterial growth.&quot;&gt;
  &lt;meta name=&quot;keywords&quot; content=&quot;ACNE ZINC, erythromycin, zinc acetate, topical solution, acne treatment, PHARCO, anti-acne, skin care, pimples, topical antibiotic&quot;&gt;
&lt;/head&gt;
&lt;body&gt;
  &lt;h1&gt;ACNE ZINC Topical Solution 20 ml&lt;/h1&gt;
  &lt;h2&gt;Generic Name:&lt;/h2&gt;
  &lt;p&gt;Erythromycin + Zinc Acetate&lt;/p&gt;

  &lt;h2&gt;Brand Name:&lt;/h2&gt;
  &lt;p&gt;ACNE ZINC&lt;/p&gt;

  &lt;h2&gt;Drug Class:&lt;/h2&gt;
  &lt;p&gt;Topical antibiotic and anti-acne preparation&lt;/p&gt;

  &lt;h2&gt;Manufacturer:&lt;/h2&gt;
  &lt;p&gt;PHARCO Pharmaceuticals&lt;/p&gt;

  &lt;h2&gt;Composition:&lt;/h2&gt;
  &lt;p&gt;Each 1 ml of solution contains:
    &lt;ul&gt;
      &lt;li&gt;Erythromycin 40 mg&lt;/li&gt;
      &lt;li&gt;Zinc acetate 12 mg&lt;/li&gt;
    &lt;/ul&gt;
    Vehicle: alcohol-based topical solution.
  &lt;/p&gt;

  &lt;h2&gt;Mechanism of Action:&lt;/h2&gt;
  &lt;p&gt;
    Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby suppressing Propionibacterium acnes growth.  
    Zinc acetate has anti-inflammatory properties and enhances the penetration and stability of erythromycin. The combination reduces bacterial colonization, inflammation, and sebum activity, leading to acne improvement.
  &lt;/p&gt;

  &lt;h2&gt;Indications:&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;Treatment of mild to moderate acne vulgaris.&lt;/li&gt;
    &lt;li&gt;Reduction of inflammatory papules and pustules.&lt;/li&gt;
    &lt;li&gt;Adjunct therapy with systemic acne treatments.&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;Dosage &amp; Administration:&lt;/h2&gt;
  &lt;p&gt;
    &lt;strong&gt;Adults &amp; Adolescents (≥12 years):&lt;/strong&gt; Apply a thin film to the affected areas of the skin twice daily (morning and evening) after cleansing and drying the skin.  
    &lt;br&gt;Duration: Typically 6–12 weeks, depending on clinical response.
  &lt;/p&gt;

  &lt;h2&gt;Dosage Form &amp; Strength:&lt;/h2&gt;
  &lt;p&gt;Topical solution, 20 ml bottle (Erythromycin 4% + Zinc acetate 1.2%).&lt;/p&gt;

  &lt;h2&gt;Contraindications:&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;Hypersensitivity to erythromycin, zinc, or any component of the formulation.&lt;/li&gt;
    &lt;li&gt;History of hypersensitivity to other macrolide antibiotics.&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;Warnings &amp; Precautions:&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;For external use only – avoid contact with eyes, mouth, or mucous membranes.&lt;/li&gt;
    &lt;li&gt;Discontinue use if severe irritation, erythema, or allergic reaction occurs.&lt;/li&gt;
    &lt;li&gt;Prolonged use may lead to bacterial resistance.&lt;/li&gt;
    &lt;li&gt;Use with caution in patients with very sensitive or dry skin.&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;Side Effects:&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;Local irritation: dryness, redness, peeling, burning or stinging sensation.&lt;/li&gt;
    &lt;li&gt;Allergic contact dermatitis (rare).&lt;/li&gt;
    &lt;li&gt;Possible development of antibiotic resistance with long-term use.&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;Drug Interactions:&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;Avoid concomitant use with other topical acne therapies (benzoyl peroxide, tretinoin) at the same time of application to reduce irritation.&lt;/li&gt;
    &lt;li&gt;May interact with systemic erythromycin (risk of bacterial resistance).&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;Use in Pregnancy &amp; Lactation:&lt;/h2&gt;
  &lt;p&gt;
    &lt;strong&gt;Pregnancy:&lt;/strong&gt; Topical erythromycin is considered low-risk as systemic absorption is minimal. Use only if clearly needed.  
    &lt;br&gt;&lt;strong&gt;Lactation:&lt;/strong&gt; Unknown if excreted in breast milk after topical use; avoid application to breast area during breastfeeding.
  &lt;/p&gt;

  &lt;h2&gt;Pediatric Use:&lt;/h2&gt;
  &lt;p&gt;Safe and effective use has been established in children ≥12 years. Safety in younger children has not been established.&lt;/p&gt;

  &lt;h2&gt;Overdose:&lt;/h2&gt;
  &lt;p&gt;Topical overdose is unlikely. Accidental oral ingestion may cause gastrointestinal upset and requires symptomatic treatment.&lt;/p&gt;

  &lt;h2&gt;Storage:&lt;/h2&gt;
  &lt;p&gt;Store below 25°C. Keep bottle tightly closed. Keep out of reach of children. Flammable – keep away from open flame.&lt;/p&gt;

  &lt;h2&gt;Packaging:&lt;/h2&gt;
  &lt;p&gt;20 ml glass or plastic bottle with applicator.&lt;/p&gt;

  &lt;h2&gt;Available Forms:&lt;/h2&gt;
  &lt;p&gt;Topical solution 20 ml.&lt;/p&gt;

  &lt;h2&gt;Frequently Asked Questions (FAQ):&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Q: How long does it take for ACNE ZINC to show results?&lt;/strong&gt;&lt;br&gt;A: Improvement is usually seen after 4–6 weeks of consistent use.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Q: Can I use ACNE ZINC with benzoyl peroxide?&lt;/strong&gt;&lt;br&gt;A: They can be used in combination, but not at the same time of day. Apply one in the morning and the other at night to reduce irritation.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Q: Is ACNE ZINC effective against severe cystic acne?&lt;/strong&gt;&lt;br&gt;A: It is mainly for mild to moderate acne. Severe acne may require systemic therapy under medical supervision.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Q: Can I apply makeup over ACNE ZINC?&lt;/strong&gt;&lt;br&gt;A: Yes, but allow the solution to dry completely before applying cosmetics.&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;References:&lt;/h2&gt;
  &lt;ul&gt;
    &lt;li&gt;Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. &lt;em&gt;J Am Acad Dermatol.&lt;/em&gt; 2016;74(5):945–973.&lt;/li&gt;
    &lt;li&gt;British National Formulary (BNF) – Erythromycin with zinc acetate, topical.&lt;/li&gt;
    &lt;li&gt;PHARCO Pharmaceuticals official prescribing information.&lt;/li&gt;
  &lt;/ul&gt;

  &lt;h2&gt;Disclaimer:&lt;/h2&gt;
  &lt;p&gt;
    This information is provided for educational purposes only and does not substitute professional medical advice. Always consult your physician or pharmacist before starting or stopping any medication.
  &lt;/p&gt;
&lt;/body&gt;
&lt;/html&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/7880043963330870855'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/7880043963330870855'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acne-zinc-solution-20ml-erythromycin.html' title='ACNE ZINC Solution 20ml | Erythromycin + Zinc for Acne Treatment'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-3070117659051485092</id><published>2025-08-12T22:24:00.000+00:00</published><updated>2025-08-12T22:24:01.542+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Acne Treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="Acne-Free"/><category scheme="http://www.blogger.com/atom/ns#" term="Amoun"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Retinoid"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Cream"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Gel"/><category scheme="http://www.blogger.com/atom/ns#" term="Tretinoin"/><title type='text'>ACNE-FREE (Tretinoin): A Complete Guide to Using This Retinoid</title><content type='html'>&lt;!-- Brand Post: ACNE-FREE (Tretinoin) --&gt;

&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;color: red;&quot;&gt;MEDICAL INFORMATION:&lt;/span&gt; This is a prescription medication. This information is for educational purposes only and is not a substitute for professional medical advice from a dermatologist. Do not use this product without a doctor&#39;s prescription and supervision.&lt;/strong&gt;&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;ACNE-FREE® (Tretinoin): A Guide to the Retinoid Acne Treatment&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;ACNE-FREE® is a brand of topical Tretinoin, a powerful and widely-used retinoid for the treatment of acne vulgaris. Manufactured by Amoun Pharmaceutical Co., it works by accelerating skin cell turnover, which helps to unclog pores and prevent new acne lesions from forming. It is effective for treating comedonal acne (blackheads and whiteheads) as well as inflammatory acne. Tretinoin is also known for its anti-aging benefits, such as improving skin texture and reducing fine lines (off-label use).&lt;/p&gt;

&lt;!-- Manufacturer --&gt;
&lt;h3&gt;Manufacturer&lt;/h3&gt;
&lt;p&gt;Amoun Pharmaceutical Company S.A.E., Egypt.&lt;/p&gt;

&lt;!-- Category &amp; Active Ingredient --&gt;
&lt;h3&gt;Category &amp; Active Ingredient&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Category:&lt;/strong&gt; Topical Retinoid; Anti-Acne.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Active Ingredient:&lt;/strong&gt; Tretinoin.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Available Forms &amp; Strengths --&gt;
&lt;h3&gt;Available Forms &amp; Strengths&lt;/h3&gt;
&lt;p&gt;ACNE-FREE is available in two different formulations and strengths to suit different skin types and severities of acne:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;ACNE-FREE 0.025% Gel (30 gm):&lt;/strong&gt; The gel base is lighter, less greasy, and is typically better suited for individuals with oily or combination skin. &lt;em&gt;(Note: May not be available in all pharmacies — check local stock).&lt;/em&gt;&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;ACNE-FREE 0.05% Cream (30 gm):&lt;/strong&gt; The cream base is generally more moisturizing and is often preferred for individuals with normal to dry or sensitive skin.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Mechanism of Action --&gt;
&lt;h3&gt;Mechanism of Action&lt;/h3&gt;
&lt;p&gt;Tretinoin, a derivative of Vitamin A, works by binding to specific retinoic acid receptors in the skin cells. This interaction modifies gene expression, leading to several key effects:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Increased Cell Turnover:&lt;/strong&gt; It speeds up the life cycle of skin cells, causing them to divide and die more rapidly, so new, healthier cells can take their place.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Unclogging Pores:&lt;/strong&gt; By promoting the shedding of dead skin cells, it prevents them from clogging pores, which is the primary cause of blackheads and whiteheads.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Anti-inflammatory Properties:&lt;/strong&gt; It helps to reduce the inflammation associated with acne.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications for ACNE-FREE®&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Treatment of acne vulgaris (both comedonal and inflammatory acne).&lt;/li&gt;
    &lt;li&gt;Off-label: improving signs of photoaging (sun damage), such as fine wrinkles, skin roughness, and hyperpigmentation.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- How to Use --&gt;
&lt;h3&gt;How to Use ACNE-FREE® (Tretinoin)&lt;/h3&gt;
&lt;div style=&quot;border: 2px solid #c0392b; padding: 15px; margin: 20px 0; background-color: #f9ebea;&quot;&gt;
    &lt;h3 style=&quot;color: #922b21;&quot;&gt;Strict Application Protocol is Crucial&lt;/h3&gt;
    &lt;ol&gt;
        &lt;li&gt;Use only &lt;strong&gt;at night&lt;/strong&gt;, as Tretinoin is degraded by sunlight.&lt;/li&gt;
        &lt;li&gt;Wash your face with a gentle, non-medicated cleanser and pat dry. Wait 20-30 minutes to ensure your skin is completely dry, as applying to damp skin can increase irritation.&lt;/li&gt;
        &lt;li&gt;Squeeze a &lt;strong&gt;pea-sized amount&lt;/strong&gt; onto your fingertip. This is enough for the entire face.&lt;/li&gt;
        &lt;li&gt;Gently dot the product on your forehead, cheeks, nose, and chin, then spread it evenly in a thin layer.&lt;/li&gt;
        &lt;li&gt;Avoid the sensitive areas around the eyes, corners of the nose, and mouth.&lt;/li&gt;
    &lt;/ol&gt;
&lt;/div&gt;

&lt;!-- Important Usage Tips: The &quot;Tretinoin Rules&quot; --&gt;
&lt;h3&gt;Important Usage Tips: The &quot;Tretinoin Rules&quot;&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Start Low and Go Slow:&lt;/strong&gt; Begin by applying it every third night for a couple of weeks, then every other night, before attempting nightly use as your skin adapts.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;The &quot;Purge&quot;:&lt;/strong&gt; It&#39;s common for acne to appear worse during the first 2-6 weeks of use. This is called the &quot;purging&quot; phase, where the tretinoin is bringing underlying clogs to the surface. Do not stop treatment.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Moisturize, Moisturize, Moisturize:&lt;/strong&gt; Use a good, non-comedogenic moisturizer to combat the dryness and irritation. You can even &quot;buffer&quot; by applying moisturizer before and/or after the tretinoin.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Sunscreen is Non-Negotiable:&lt;/strong&gt; Tretinoin makes your skin highly sensitive to the sun. You MUST use a broad-spectrum sunscreen with SPF 30 or higher every single day, even on cloudy days.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Avoid mixing with Benzoyl Peroxide at the same time:&lt;/strong&gt; If both are prescribed, use Benzoyl Peroxide in the morning and Tretinoin at night to prevent reduced effectiveness.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects &amp; Precautions --&gt;
&lt;h3&gt;Side Effects &amp; Precautions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Common side effects, especially during the initial adjustment period (retinization), include: dryness, peeling, redness, and a feeling of warmth or stinging.&lt;/li&gt;
    &lt;li&gt;Do not use if you are pregnant, planning to become pregnant, or breastfeeding.&lt;/li&gt;
    &lt;li&gt;Avoid using other potentially irritating products at the same time (e.g., other exfoliants like salicylic acid or glycolic acid, harsh scrubs, or alcohol-based toners) unless advised by your doctor.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Frequently Asked Questions (FAQ) --&gt;
&lt;h3&gt;Frequently Asked Questions (FAQ)&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;What&#39;s the difference between the 0.025% and 0.05% strengths?&lt;/strong&gt;&lt;br&gt;
The 0.025% is a lower strength, often used for beginners or those with sensitive skin to allow the skin to acclimate. The 0.05% is a standard, higher strength that is more potent but may also cause more initial irritation. Your doctor will determine the right strength for you.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Cream or Gel: Which one is for me?&lt;/strong&gt;&lt;br&gt;
Generally, the cream is better for dry or normal skin due to its more emollient base, while the gel is preferred for oily skin as it&#39;s lighter and absorbs quickly. However, the choice depends on your skin&#39;s specific needs and tolerance.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;How long until I see results?&lt;/strong&gt;&lt;br&gt;
Visible improvement in acne can take 8-12 weeks of consistent use. Improvements in skin texture and fine lines can take 6 months or longer. Patience is key.&lt;/p&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;
        &lt;strong&gt;American Academy of Dermatology (AAD):&lt;/strong&gt; For professional guidelines on retinoid use.
        &lt;a href=&quot;https://www.aad.org/public/diseases/acne/derm-treat/retinoid-retinol&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;AAD - Retinoid vs. Retinol&lt;/a&gt;
    &lt;/li&gt;
    &lt;li&gt;
        &lt;strong&gt;U.S. National Library of Medicine (MedlinePlus):&lt;/strong&gt; For detailed patient information on Tretinoin.
        &lt;a href=&quot;https://medlineplus.gov/druginfo/meds/a682437.html&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;Tretinoin Topical - MedlinePlus&lt;/a&gt;
    &lt;/li&gt;
    &lt;li&gt;
        &lt;strong&gt;Product Information:&lt;/strong&gt; Sourced from Amoun Pharmaceutical Company S.A.E. marketing materials and product packaging.
    &lt;/li&gt;
&lt;/ol&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3070117659051485092'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/3070117659051485092'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acne-free-tretinoin-cream-gel-egypt.html' title='ACNE-FREE (Tretinoin): A Complete Guide to Using This Retinoid'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-8770743089294461949</id><published>2025-08-12T22:15:00.002+00:00</published><updated>2025-08-12T22:15:34.820+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Acne Biotic"/><category scheme="http://www.blogger.com/atom/ns#" term="Acne Treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="APC"/><category scheme="http://www.blogger.com/atom/ns#" term="Arab Drug Company"/><category scheme="http://www.blogger.com/atom/ns#" term="Erythromycin"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Solution"/><category scheme="http://www.blogger.com/atom/ns#" term="Zinc Acetate"/><title type='text'>ACNE BIOTIC Paint: A Guide to the Erythromycin-Zinc Acne Solution</title><content type='html'>&lt;!-- Brand Post: ACNE BIOTIC Paint --&gt;

&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;color: red;&quot;&gt;MEDICAL INFORMATION:&lt;/span&gt; This is a prescription medication. This information is for educational purposes only and is not a substitute for professional medical advice from a dermatologist. Do not use this product without a doctor&#39;s prescription and supervision.&lt;/strong&gt;&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;ACNE BIOTIC® Paint: A Guide to the Topical Acne Solution&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;ACNE BIOTIC® Paint is a topical solution used for the treatment of acne vulgaris. It combines two active ingredients: &lt;strong&gt;Erythromycin&lt;/strong&gt;, an antibiotic that fights acne-causing bacteria, and &lt;strong&gt;Zinc Acetate&lt;/strong&gt;, which enhances the antibiotic&#39;s effectiveness and provides anti-inflammatory benefits. This combination makes it particularly effective for treating inflammatory acne (red, swollen pimples).&lt;/p&gt;

&lt;!-- Manufacturer &amp; Marketer --&gt;
&lt;h3&gt;Manufacturer &amp; Marketer&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Marketed by:&lt;/strong&gt; Arab Drug Company.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Manufactured by:&lt;/strong&gt; APC (Arab Perfumes, Chemicals and Pharmaceuticals Co.).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Category &amp; Active Ingredients --&gt;
&lt;h3&gt;Category &amp; Active Ingredients&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Category:&lt;/strong&gt; Topical Anti-Acne; Antibiotic with Anti-inflammatory Agent.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Active Ingredients:&lt;/strong&gt; Erythromycin + Zinc Acetate.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Available Forms --&gt;
&lt;h3&gt;Available Forms&lt;/h3&gt;
&lt;p&gt;ACNE BIOTIC is available as a 15 ml topical solution (&quot;Paint&quot;).&lt;/p&gt;

&lt;!-- Mechanism of Action --&gt;
&lt;h3&gt;Mechanism of Action&lt;/h3&gt;
&lt;p&gt;The effectiveness of ACNE BIOTIC comes from the synergistic action of its two components:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Erythromycin:&lt;/strong&gt; A macrolide antibiotic that works by inhibiting the growth of &lt;em&gt;Propionibacterium acnes&lt;/em&gt;, the primary bacteria involved in acne. By reducing bacterial numbers, it also helps to decrease the inflammation they cause.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Zinc Acetate:&lt;/strong&gt; Zinc has natural anti-inflammatory properties, helping to calm redness and irritation. More importantly, it forms a complex with erythromycin, which is thought to improve the penetration of the antibiotic into the skin and enhance its local effectiveness. Zinc also helps to regulate sebum (oil) production.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications for ACNE BIOTIC®&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;For the topical treatment of mild to moderate inflammatory acne vulgaris.&lt;/li&gt;
    &lt;li&gt;Effective for reducing the number of papules and pustules (inflammatory pimples).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- How to Use --&gt;
&lt;h3&gt;How to Use ACNE BIOTIC® Paint&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;Wash the affected area with a gentle cleanser and pat the skin completely dry.&lt;/li&gt;
    &lt;li&gt;Using the applicator provided, apply a thin layer of the solution directly to the affected areas of the skin.&lt;/li&gt;
    &lt;li&gt;Allow the solution to dry.&lt;/li&gt;
    &lt;li&gt;This is typically done &lt;strong&gt;twice daily&lt;/strong&gt; (morning and evening), or as directed by your doctor.&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- Important Usage Tips --&gt;
&lt;h3&gt;Important Usage Tips&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Apply to Dry Skin:&lt;/strong&gt; Ensure your skin is fully dry before application to maximize effectiveness.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Consistency is Crucial:&lt;/strong&gt; Use the medication regularly as prescribed for several weeks to see the best results.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Moisturize:&lt;/strong&gt; While generally less drying than products with benzoyl peroxide, it&#39;s still a good practice to use a light, non-comedogenic moisturizer to maintain skin health.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Sun Protection:&lt;/strong&gt; While not as sensitizing as other acne treatments, daily sunscreen use is always recommended for acne-prone skin to prevent post-inflammatory hyperpigmentation (dark spots).&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects &amp; Precautions --&gt;
&lt;h3&gt;Side Effects &amp; Precautions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;The most common side effects are mild and localized, such as a temporary stinging or burning sensation upon application, and potential skin dryness or redness.&lt;/li&gt;
    &lt;li&gt;Discontinue use and consult your doctor if you experience severe irritation or an allergic reaction.&lt;/li&gt;
    &lt;li&gt;For external use only. Avoid contact with eyes, mouth, and other mucous membranes.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Frequently Asked Questions (FAQ) --&gt;
&lt;h3&gt;Frequently Asked Questions (FAQ)&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;How is ACNE BIOTIC different from other acne treatments?&lt;/strong&gt;&lt;br&gt;
Its main feature is the combination of an antibiotic (Erythromycin) with Zinc. The zinc is believed to boost the antibiotic&#39;s performance and provide its own anti-inflammatory benefits, making it a unique approach compared to single-ingredient products.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;How long does it take to see results?&lt;/strong&gt;&lt;br&gt;
Like most topical acne treatments, it can take anywhere from 4 to 12 weeks of consistent use to see a significant improvement in your skin. Patience and regular application are key.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Do I need a prescription for ACNE BIOTIC?&lt;/strong&gt;&lt;br&gt;
Yes. Because it contains an antibiotic (Erythromycin), this product requires a doctor&#39;s prescription to ensure it is appropriate for your condition and to help prevent the global issue of antibiotic resistance.&lt;/p&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;
        &lt;strong&gt;U.S. National Library of Medicine (PubMed):&lt;/strong&gt; For clinical studies on the efficacy of Erythromycin-Zinc combinations.
        &lt;a href=&quot;https://pubmed.ncbi.nlm.nih.gov/?term=erythromycin+zinc+acne&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;PubMed - Erythromycin Zinc Acne Studies&lt;/a&gt;
    &lt;/li&gt;
    &lt;li&gt;
        &lt;strong&gt;British National Formulary (BNF):&lt;/strong&gt; For professional information on topical acne preparations.
        &lt;a href=&quot;https://bnf.nice.org.uk/treatment-summaries/acne-vulgaris/&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;NICE BNF - Acne Vulgaris&lt;/a&gt;
    &lt;/li&gt;
    &lt;li&gt;
        &lt;strong&gt;Product Information:&lt;/strong&gt; Sourced from The Arab Drug Company marketing materials and product packaging.
    &lt;/li&gt;
&lt;/ol&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8770743089294461949'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/8770743089294461949'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acne-biotic-paint-erythromycin-zinc-egypt.html' title='ACNE BIOTIC Paint: A Guide to the Erythromycin-Zinc Acne Solution'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-5828824618065255653</id><published>2025-08-12T21:50:00.003+00:00</published><updated>2025-08-12T21:50:35.113+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Acne Benz"/><category scheme="http://www.blogger.com/atom/ns#" term="Acne Treatment"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Benzoyl Peroxide"/><category scheme="http://www.blogger.com/atom/ns#" term="Erythromycin"/><category scheme="http://www.blogger.com/atom/ns#" term="Global Napi"/><category scheme="http://www.blogger.com/atom/ns#" term="GNP"/><category scheme="http://www.blogger.com/atom/ns#" term="Topical Gel"/><title type='text'>ACNE BENZ Gel: A Guide to This Combination Acne Treatment</title><content type='html'>&lt;!-- Brand Post: ACNE BENZ Topical Gel - Final Optimized Version --&gt;

&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;color: red;&quot;&gt;MEDICAL INFORMATION:&lt;/span&gt; This is a prescription medication. The following information is for educational purposes only and is not a substitute for professional medical advice from a dermatologist. Use only under medical supervision.&lt;/strong&gt;&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;ACNE BENZ® Topical Gel: Combination Acne Treatment&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;ACNE BENZ® is a combination topical gel used for the treatment of acne vulgaris. Manufactured by Global Napi Pharmaceuticals Co., Egypt, it contains two active ingredients: &lt;strong&gt;Benzoyl Peroxide&lt;/strong&gt;, which kills acne-causing bacteria and helps unclog pores, and &lt;strong&gt;Erythromycin&lt;/strong&gt;, an antibiotic that reduces inflammation and controls bacterial growth. This dual-action formula is particularly effective for treating inflammatory acne (papules and pustules).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Note:&lt;/strong&gt; Some local drug databases list this product as (N/A - Not Available), which may indicate temporary unavailability or discontinuation. Always confirm with a pharmacy for current supply status.&lt;/p&gt;

&lt;!-- Manufacturer --&gt;
&lt;h3&gt;Manufacturer&lt;/h3&gt;
&lt;p&gt;Global Napi Pharmaceuticals Co., Egypt.&lt;/p&gt;

&lt;!-- Category &amp; Active Ingredients --&gt;
&lt;h3&gt;Category &amp; Active Ingredients&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Category:&lt;/strong&gt; Topical Anti-Acne; Antibiotic with Keratolytic Agent.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Active Ingredients:&lt;/strong&gt; Benzoyl Peroxide + Erythromycin.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Available Forms --&gt;
&lt;h3&gt;Available Forms&lt;/h3&gt;
&lt;p&gt;Available as a 30 g topical gel.&lt;/p&gt;

&lt;!-- Mechanism of Action --&gt;
&lt;h3&gt;Mechanism of Action&lt;/h3&gt;
&lt;p&gt;The effectiveness of ACNE BENZ® comes from its two active components working synergistically:&lt;/p&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Benzoyl Peroxide:&lt;/strong&gt; A potent antimicrobial agent that releases oxygen to kill &lt;em&gt;Cutibacterium acnes&lt;/em&gt; (formerly &lt;em&gt;Propionibacterium acnes&lt;/em&gt;), the primary bacteria involved in acne. It also acts as a keratolytic, helping exfoliate the outer skin layer and unclog pores.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Erythromycin:&lt;/strong&gt; A macrolide antibiotic that inhibits bacterial protein synthesis, preventing bacterial growth and reducing inflammation, which helps minimize redness and swelling.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Topical treatment of mild to moderate inflammatory acne vulgaris.&lt;/li&gt;
    &lt;li&gt;Effective for papules, pustules, and inflamed acne lesions.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- How to Use --&gt;
&lt;h3&gt;How to Use ACNE BENZ® Gel&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;Cleanse the affected area with a mild, non-irritating cleanser and pat dry.&lt;/li&gt;
    &lt;li&gt;Apply a thin layer over the entire acne-affected area once or twice daily, as directed by a doctor.&lt;/li&gt;
    &lt;li&gt;Wash hands after application.&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- Important Usage Tips --&gt;
&lt;h3&gt;Important Usage Tips&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Patch Test:&lt;/strong&gt; Apply to a small skin area before first use to check for excessive irritation.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Moisturize:&lt;/strong&gt; Use a non-comedogenic moisturizer to help manage dryness and irritation.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Sun Exposure:&lt;/strong&gt; Benzoyl Peroxide can increase skin irritation from UV exposure. Use broad-spectrum sunscreen during the day.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Bleaching Effect:&lt;/strong&gt; May bleach hair and colored fabrics. Let gel dry completely before contact.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Avoid Harsh Products:&lt;/strong&gt; Avoid other strong exfoliants or irritating products unless recommended by a doctor.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects &amp; Precautions --&gt;
&lt;h3&gt;Side Effects &amp; Precautions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;Common: Dryness, peeling, redness, mild burning or stinging at the start of therapy.&lt;/li&gt;
    &lt;li&gt;Stop use and seek medical advice if severe irritation, swelling, or allergic reaction occurs.&lt;/li&gt;
    &lt;li&gt;For external use only; avoid contact with eyes, lips, mouth, and broken skin.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- FAQ --&gt;
&lt;h3&gt;Frequently Asked Questions (FAQ)&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Can I apply ACNE BENZ® only to spots?&lt;/strong&gt;&lt;br&gt;
It is usually recommended to apply to the entire affected area, not just individual pimples, to prevent new lesions from forming.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Why does it bleach fabrics?&lt;/strong&gt;&lt;br&gt;
Benzoyl Peroxide is an oxidizing agent that can remove color from fabrics. Ensure the gel dries fully before skin touches clothes, towels, or bedding.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Do I need a prescription?&lt;/strong&gt;&lt;br&gt;
Yes. Containing an antibiotic, ACNE BENZ® should be prescribed by a healthcare professional to avoid misuse and bacterial resistance.&lt;/p&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;&lt;strong&gt;American Academy of Dermatology (AAD):&lt;/strong&gt; &lt;a href=&quot;https://www.aad.org/member/clinical-quality/guidelines/acne&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;AAD Acne Guidelines&lt;/a&gt;&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;MedlinePlus:&lt;/strong&gt; &lt;a href=&quot;https://medlineplus.gov/druginfo/meds/a603001.html&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;Erythromycin and Benzoyl Peroxide Topical&lt;/a&gt;&lt;/li&gt;
    &lt;li&gt;Global Napi Pharmaceuticals product literature and common formulation data.&lt;/li&gt;
&lt;/ol&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5828824618065255653'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5828824618065255653'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acne-benz-gel-benzoyl-peroxide-erythromycin-egypt.html' title='ACNE BENZ Gel: A Guide to This Combination Acne Treatment'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-5840400061415282598.post-5155296761473554588</id><published>2025-08-12T20:36:00.002+00:00</published><updated>2025-08-12T20:36:18.328+00:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Acless Soap"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-Acne"/><category scheme="http://www.blogger.com/atom/ns#" term="Cetrimide"/><category scheme="http://www.blogger.com/atom/ns#" term="Hi-Care"/><category scheme="http://www.blogger.com/atom/ns#" term="Medicated Soap"/><category scheme="http://www.blogger.com/atom/ns#" term="Oily Skin"/><category scheme="http://www.blogger.com/atom/ns#" term="Salicylic Acid"/><category scheme="http://www.blogger.com/atom/ns#" term="Skincare"/><category scheme="http://www.blogger.com/atom/ns#" term="Tea Tree Oil"/><title type='text'>Acless Soap: A Guide to This Medicated Anti-Acne Cleanser</title><content type='html'>&lt;!-- Brand Post: Acless Soap - Final Accurate Version --&gt;

&lt;!-- Disclaimer --&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;color: red;&quot;&gt;MEDICAL INFORMATION:&lt;/span&gt; This information is for educational purposes only and is not a substitute for professional medical advice from a dermatologist. Always perform a patch test before using a new skincare product. Discontinue use if significant irritation occurs.&lt;/strong&gt;&lt;/p&gt;

&lt;!-- Drug Name --&gt;
&lt;h2&gt;Acless® Soap: A Medicated Cleanser for Oily &amp; Acne-Prone Skin&lt;/h2&gt;

&lt;!-- Summary --&gt;
&lt;h3&gt;Summary&lt;/h3&gt;
&lt;p&gt;Acless® Soap is a medicated cleansing bar designed specifically for oily and acne-prone skin. Owned and marketed by NP Pharmaceutical and manufactured by Hi-Care, it combines a powerful blend of antiseptic, exfoliating, and soothing ingredients. The soap works by deeply cleansing pores, removing excess oils (sebum), fighting acne-causing bacteria, and promoting a clearer, healthier-looking complexion.&lt;/p&gt;

&lt;!-- Manufacturer &amp; Marketer --&gt;
&lt;h3&gt;Manufacturer &amp; Marketer&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Manufactured by:&lt;/strong&gt; Hi-Care.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Marketed by:&lt;/strong&gt; NP Pharmaceutical.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Category --&gt;
&lt;h3&gt;Category&lt;/h3&gt;
&lt;p&gt;Medicated Skincare; Anti-Acne Cleanser.&lt;/p&gt;

&lt;!-- Available Forms --&gt;
&lt;h3&gt;Available Forms&lt;/h3&gt;
&lt;p&gt;Acless is available as a 100 gm cleansing bar.&lt;/p&gt;

&lt;!-- Key Ingredients and Their Roles --&gt;
&lt;h3&gt;Key Ingredients and Their Roles&lt;/h3&gt;
&lt;p&gt;Acless Soap features a multi-action formula to target acne from different angles:&lt;/p&gt;
&lt;table style=&quot;width:100%; border-collapse: collapse;&quot;&gt;
    &lt;thead&gt;
        &lt;tr style=&quot;background-color:#f2f2f2;&quot;&gt;
            &lt;th style=&quot;border: 1px solid #ddd; padding: 8px; text-align: left;&quot;&gt;Ingredient&lt;/th&gt;
            &lt;th style=&quot;border: 1px solid #ddd; padding: 8px; text-align: left;&quot;&gt;Primary Role&lt;/th&gt;
        &lt;/tr&gt;
    &lt;/thead&gt;
    &lt;tbody&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Salicylic Acid&lt;/strong&gt;&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Exfoliant (Keratolytic):&lt;/strong&gt; Penetrates deep into pores to dissolve oil and dead skin cells, preventing clogs.&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Cetrimide&lt;/strong&gt;&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Powerful Antiseptic:&lt;/strong&gt; Effectively kills a broad spectrum of bacteria and other microorganisms on the skin&#39;s surface.&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Tea Tree Oil&lt;/strong&gt;&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Natural Antiseptic &amp; Anti-inflammatory:&lt;/strong&gt; Fights acne-causing bacteria and helps to reduce redness and swelling.&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Zinc Oxide&lt;/strong&gt;&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Soothing &amp; Astringent:&lt;/strong&gt; Helps to calm irritated skin, reduce inflammation, and absorb excess oil.&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Panthenol&lt;/strong&gt; (Pro-vitamin B5)&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Moisturizer &amp; Healer:&lt;/strong&gt; Hydrates the skin and supports the skin barrier, helping to counteract potential dryness.&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Allantoin&lt;/strong&gt;&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Soothing &amp; Keratolytic:&lt;/strong&gt; Calms irritation, promotes healing, and helps to soften the skin and shed dead cells.&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;Titanium Dioxide&lt;/strong&gt;&lt;/td&gt;
            &lt;td style=&quot;border: 1px solid #ddd; padding: 8px;&quot;&gt;&lt;strong&gt;UV Filter &amp; Opacifier:&lt;/strong&gt; Provides mild physical protection against the sun and gives the soap its opaque color.&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/tbody&gt;
&lt;/table&gt;

&lt;!-- Indications --&gt;
&lt;h3&gt;Indications for Acless® Soap&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;As a daily cleanser for oily and acne-prone skin.&lt;/li&gt;
    &lt;li&gt;To help manage and prevent mild to moderate acne (blackheads, whiteheads, and pimples).&lt;/li&gt;
    &lt;li&gt;To reduce excess skin oiliness and shine.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- How to Use --&gt;
&lt;h3&gt;How to Use Acless® Soap&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;Wet your face and hands with lukewarm water.&lt;/li&gt;
    &lt;li&gt;Work the soap into a rich lather in your hands.&lt;/li&gt;
    &lt;li&gt;Gently massage the lather onto your face and other affected areas, avoiding the eye area.&lt;/li&gt;
    &lt;li&gt;Leave the lather on the skin for 30-60 seconds.&lt;/li&gt;
    &lt;li&gt;Rinse thoroughly with lukewarm water and pat the skin dry with a clean towel.&lt;/li&gt;
    &lt;li&gt;Use &lt;strong&gt;once or twice daily&lt;/strong&gt;, or as directed by your dermatologist.&lt;/li&gt;
&lt;/ol&gt;

&lt;!-- Important Usage Tips --&gt;
&lt;h3&gt;Important Usage Tips&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;&lt;strong&gt;Start Slowly:&lt;/strong&gt; If you are new to medicated cleansers, start by using the soap once a day to see how your skin reacts.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Moisturize:&lt;/strong&gt; It is crucial to follow up with a suitable, non-comedogenic (non-pore-clogging) moisturizer to prevent dryness.&lt;/li&gt;
    &lt;li&gt;&lt;strong&gt;Sun Protection:&lt;/strong&gt; Ingredients like Salicylic Acid can make your skin more sensitive to the sun. Always use a broad-spectrum sunscreen during the day.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- Side Effects &amp; Precautions --&gt;
&lt;h3&gt;Side Effects &amp; Precautions&lt;/h3&gt;
&lt;ul&gt;
    &lt;li&gt;The most common side effect is &lt;strong&gt;dryness, peeling, or mild irritation&lt;/strong&gt;. This can usually be managed by using the soap less frequently and applying a good moisturizer.&lt;/li&gt;
    &lt;li&gt;Discontinue use if you experience severe redness, burning, or an allergic reaction.&lt;/li&gt;
    &lt;li&gt;For external use only. Avoid contact with eyes, lips, and mouth.&lt;/li&gt;
&lt;/ul&gt;

&lt;!-- References --&gt;
&lt;h3&gt;References&lt;/h3&gt;
&lt;ol&gt;
    &lt;li&gt;
        &lt;strong&gt;American Academy of Dermatology (AAD):&lt;/strong&gt; For general information on treating acne.
        &lt;a href=&quot;https://www.aad.org/public/diseases/acne/skin-care/tips&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;AAD - Acne Treatment Tips&lt;/a&gt;
    &lt;/li&gt;
    &lt;li&gt;
        &lt;strong&gt;U.S. National Library of Medicine (PubChem):&lt;/strong&gt; For information on key ingredients like Cetrimide and Salicylic Acid.
        &lt;a href=&quot;https://pubchem.ncbi.nlm.nih.gov/&quot; target=&quot;_blank&quot; rel=&quot;noopener nofollow&quot;&gt;PubChem Database&lt;/a&gt;
    &lt;/li&gt;
    &lt;li&gt;
        &lt;strong&gt;Product Information:&lt;/strong&gt; Sourced from NP Pharmaceutical marketing materials and Hi-Care manufacturing details.
    &lt;/li&gt;
&lt;/ol&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5155296761473554588'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5840400061415282598/posts/default/5155296761473554588'/><link rel='alternate' type='text/html' href='http://drugpamphlet.blogspot.com/2025/08/acless-soap-anti-acne-egypt.html' title='Acless Soap: A Guide to This Medicated Anti-Acne Cleanser'/><author><name>Dermatologist</name><uri>http://www.blogger.com/profile/14062486310683791948</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author></entry></feed>